1
1 of 2
- Smilow Cancer Hospital at Greenwich77 Lafayette PlaceGreenwich, CT 06830
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
William K. Oh, MD
Genitourinary Oncology
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Biography
William K. Oh, MD, is a genitourinary oncologist with decades of experience specializing in prostate cancer. He integrates molecular and genetic testing into routine cancer care, ensuring that patients receive the most personalized treatment plans possible. Throughout his career he has focused on decreasing barriers to the delivery of care for prostate cancer nationally.
Dr. Oh is the director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital, where he leads efforts to develop cohesive programs that combine basic and translational science with clinical trials. He also oversees the Precision Medicine Tumor Board, which is pivotal in guiding treatment decisions based on genetic and molecular data. Additionally, he serves as the service line medical director of Smilow Cancer Hospital at Greenwich Hospital, where he continues to develop integrated oncology care teams and expand the impact of multidisciplinary cancer care for patients in the region.
Dr. Oh completed his undergraduate degree at Yale University, received his medical degree from New York University School of Medicine, and did his internship and residency at Brigham and Women’s Hospital before his clinical fellowship in medical oncology at Dana-Farber Cancer Institute.
Dr. Oh currently serves as chair of the American Cancer Society's National Prostate Cancer Roundtable, whose mission is to improve prostate cancer outcomes and survivorship through increasing awareness and equitable access to prevention, screening, and treatment. Also, he is the chair of the Medical Advisory Council for the Chemotherapy Foundation, which is committed to discovering novel therapies for cancer.
“I love taking care of patients because it brings me tremendous personal satisfaction to both help them and learn from them,” Dr. Oh says. “I also love the precision medicine part of my job, but in the end, my patient care responsibilities always bring me back to what it’s all about and why we’re all here and I enjoy getting to know my patients and their generosity of spirit and courage. I take a lot of lessons from that.”
Titles
- Director, Precision Medicine, Yale Cancer Center and Smilow Cancer Hospital
- Service Line Medical Director, Smilow Cancer Hospital at Greenwich Hospital
Education & Training
- MDNew York University School of Medicine
- BSYale University, Molecular Biophysics and Biochemistry
Additional Information
Publications
- Carlsson S, Oh W. How Can Guidelines Give Clearer Guidance on Prostate Cancer Screening? JAMA Oncology 2024, 10: 1497-1498. PMID: 39325462, DOI: 10.1001/jamaoncol.2024.3909.
- Oh W, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson S, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci L, Omlin A, Palapattu G, Riaz I, Ryan C, Schoen M, Washington S, Gillessen S. What’s in a Name? Why Words Matter in Advanced Prostate Cancer. European Urology 2024, 87: 101-103. PMID: 39472202, DOI: 10.1016/j.eururo.2024.10.017.
- Lee K, Mai Y, Liu Z, Raja K, Jun T, Ma M, Wang T, Ai L, Calay E, Oh W, Schadt E, Wang X. CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics. Scientific Reports 2024, 14: 25387. PMID: 39455879, PMCID: PMC11511882, DOI: 10.1038/s41598-024-77447-x.
- Gillessen S, Turco F, Davis I, Efstathiou J, Fizazi K, James N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Zilli T, Agarwal N, Antonarakis E, Aparicio A, Armstrong A, Bastos D, Attard G, Axcrona K, Ayadi M, Beltran H, Bjartell A, Blanchard P, Bourlon M, Briganti A, Bulbul M, Buttigliero C, Caffo O, Castellano D, Castro E, Cheng H, Chi K, Clarke C, Clarke N, de Bono J, De Santis M, Duran I, Efstathiou E, Ekeke O, El Nahas T, Emmett L, Fanti S, Fatiregun O, Feng F, Fong P, Fonteyne V, Fossati N, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Hofman M, Hope T, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Joshua A, Kanesvaran R, Keizman D, Khauli R, Kramer G, Loeb S, Mahal B, Maluf F, Mateo J, Matheson D, Matikainen M, McDermott R, McKay R, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Mutambirwa S, Nguyen P, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Renard-Penna R, Ryan C, Saad F, Sade J, Sandhu S, Sartor O, Schaeffer E, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Suzuki H, Taplin M, Thellenberg-Karlsson C, Tilki D, Türkeri L, Uemura H, Ürün Y, Vale C, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). European Urology 2024, 87: 157-216. PMID: 39394013, DOI: 10.1016/j.eururo.2024.09.017.
- Chakrani Z, Patel M, Mellgard G, McCroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao C, Ganta T, Patel V. The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Clinical Genitourinary Cancer 2024, 22: 102227. PMID: 39437664, DOI: 10.1016/j.clgc.2024.102227.
- Mellgard G, Saffran N, Chakrani Z, McCroskery S, Taylor N, Patel M, Liaw B, Galsky M, Oh W, Tsao C, Patel V. Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy. American Journal Of Clinical Oncology 2024, 47: 459-464. PMID: 39087466, DOI: 10.1097/coc.0000000000001115.
- Lee K, Liu Z, Mai Y, Jun T, Ma M, Wang T, Ai L, Calay E, Oh W, Stolovitzky G, Schadt E, Wang X. Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 2024, 3: e50800. PMID: 39073872, PMCID: PMC11319878, DOI: 10.2196/50800.
- Wang L, Izadmehr S, Sfakianos J, Tran M, Beaumont K, Brody R, Cordon-Cardo C, Horowitz A, Sebra R, Oh W, Bhardwaj N, Galsky M, Zhu J. Single-cell transcriptomic-informed deconvolution of bulk data identifies immune checkpoint blockade resistance in urothelial cancer. IScience 2024, 27: 109928. PMID: 38812546, PMCID: PMC11133924, DOI: 10.1016/j.isci.2024.109928.
- Garraway I, Carlsson S, Nyame Y, Vassy J, Chilov M, Fleming M, Frencher S, George D, Kibel A, King S, Kittles R, Mahal B, Pettaway C, Rebbeck T, Rose B, Vince R, Winn R, Yamoah K, Oh W. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evidence 2024, 3: evidoa2300289. PMID: 38815168, DOI: 10.1056/evidoa2300289.
- Chakrani Z, Mellgard G, Saffran N, McCroskery S, Taylor N, Patel M, Liaw B, Galsky M, Oh W, Tsao C, Patel V. Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy. American Journal Of Clinical Oncology 2024, 47: 271-278. PMID: 38344754, DOI: 10.1097/coc.0000000000001087.
- Garraway I, Carlsson S, Nyame Y, Vassey J, Chilov M, Fleming M, Frencher S, George D, Kibel A, King S, Kittles R, Mahal B, Pettaway C, Rebbeck T, Rose B, Vince R, Winn R, Yamoah K, Oh W. Prostate Cancer Foundation (PCF) screening guidelines for prostate cancer in Black men in the United States. Journal Of Clinical Oncology 2024, 42: 264-264. DOI: 10.1200/jco.2024.42.4_suppl.264.
- Liaw B, Joshi H, Sheng T, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC. Journal Of Clinical Oncology 2024, 42: 147-147. DOI: 10.1200/jco.2024.42.4_suppl.147.
- Williams C, Starks D, Rojas-Espaillat L, Meissner T, Elsey R, Jun T, Solomon B, Feng S, Koenen M, van Oosbree A, Clem A, Lee J, Oh W. Comprehensive molecular profiling and deep clinical annotation of electronic health records in patients with cancer: Implementation of the Avera/Sema4 oncology and analytics protocol (ASAP) in gynecologic oncology (1255). Gynecologic Oncology 2023, 176: s161-s162. DOI: 10.1016/j.ygyno.2023.06.164.
- Lee K, Liu Z, Chandran U, Kalsekar I, Laxmanan B, Higashi M, Jun T, Ma M, Li M, Mai Y, Gilman C, Wang T, Ai L, Aggarwal P, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X. Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing. JMIR AI 2023, 2: e44537. PMID: 38875565, PMCID: PMC11041451, DOI: 10.2196/44537.
- Ganta T, Anker J, Miller E, Tsao K, Oh W. Real world utilization and outcomes of immunotherapy regimens in metastatic castration resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2023, 41: e17038-e17038. DOI: 10.1200/jco.2023.41.16_suppl.e17038.
- Liu Z, Lee K, Cohn D, Zhang M, Ai L, Li M, Zhang X, Jun T, Higashi M, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X, Li S. Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival. Journal Of Thoracic Disease 2023, 0: 0-0. PMID: 37324065, PMCID: PMC10267939, DOI: 10.21037/jtd-22-1481.
- Gillessen S, Bossi A, Davis I, de Bono J, Fizazi K, James N, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis E, Aparicio A, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow R, Bulbul M, Caffo O, Castellano D, Castro E, Cheng H, Chi K, Chowdhury S, Clarke C, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman M, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Kanesvaran R, Kellokumpu-Lehtinen P, Khauli R, Klotz L, Kramer G, Leibowitz R, Logothetis C, Mahal B, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Nguyen P, Oh W, Ost P, O'Sullivan J, Padhani A, Pezaro C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Steuber T, Suzuki H, Sydes M, Taplin M, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H, Ürün Y, Vale C, van Oort I, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Zilli T, Omlin A. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. European Journal Of Cancer 2023, 185: 178-215. PMID: 37003085, DOI: 10.1016/j.ejca.2023.02.018.
- Ganta T, Anker J, Miller E, Kannry J, Bhardwaj A, Tsao K, Oh W. Oncologist-driven development of an electronic health record (EHR) clinical data visualization tool for prostate cancer. Journal Of Clinical Oncology 2023, 41: 267-267. DOI: 10.1200/jco.2023.41.6_suppl.267.
- Chakrani Z, Mellgard G, Mccroskery S, Saffran N, Taylor N, Liaw B, Oh W, Tsao K, Patel V. Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART). Journal Of Clinical Oncology 2023, 41: 135-135. DOI: 10.1200/jco.2023.41.6_suppl.135.
- Mellgard G, Mccroskery S, Chakrani Z, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao K, Patel V. Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy. Journal Of Clinical Oncology 2023, 41: 118-118. DOI: 10.1200/jco.2023.41.6_suppl.118.
- Mellgard G, Chakrani Z, Mccroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao K, Patel V. Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies. Journal Of Clinical Oncology 2023, 41: 117-117. DOI: 10.1200/jco.2023.41.6_suppl.117.
- Liaw B, Tsao C, Seng S, Jun T, Gong Y, Galsky M, Oh W. Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer. The Oncologist 2022, 28: 366-e224. PMID: 36519763, PMCID: PMC10078918, DOI: 10.1093/oncolo/oyac224.
- Gillessen S, Bossi A, Davis I, de Bono J, Fizazi K, James N, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis E, Aparicio A, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow R, Bulbul M, Caffo O, Castellano D, Castro E, Cheng H, N. K, Chowdhury S, Clarke C, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman M, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Kanesvaran R, Kellokumpu-Lehtinen P, Khauli R, Klotz L, Kramer G, Leibowitz R, Logothetis C, Mahal B, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Nguyen P, Oh W, Ost P, O’Sullivan J, Padhani A, Pezaro C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Steuber T, Suzuki H, Sydes M, Taplin M, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H, Ürün Y, Vale C, van Oort I, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Zilli T, Omlin A. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. European Urology 2022, 83: 267-293. PMID: 36494221, PMCID: PMC7614721, DOI: 10.1016/j.eururo.2022.11.002.
- Higashi M, Kruszka P, Francis M, Parsons K, Oh W, Onel K. Pediatric Age at Hematopoietic Stem Cell Transplant: Associations with Non-Malignant Genetic Disease and Race. Blood 2022, 140: 7973-7974. DOI: 10.1182/blood-2022-170315.
- Lee K, Paek H, Ai L, Liu Z, Jin L, Li M, Jun T, Higashi M, Onel K, Oh W, Pan Q, Stolovitzky G, Schadt E, Wang X. Treatment Profile of CAR-T Cell Therapy Induced Cytokine Release Syndrome and Neurotoxicity: Insights from Real-World Evidence. Blood 2022, 140: 12750-12752. DOI: 10.1182/blood-2022-166716.
- Al-Kateb H, Jun T, Hayes J, Rossi M, Hantash F, Oh W, Onel K. Prevalence of Pathogenic Germline Mutations in Solid Tumor Predisposition Genes Detected By Tumor-Normal Whole Exome Sequencing Analysis Among Adults with Hematologic Malignancies. Blood 2022, 140: 7852-7853. DOI: 10.1182/blood-2022-159618.
- Calvo M, Caruthers S, Tripodi J, Houldsworth J, Fink M, Newman S, Chen R, Zhang W, Liu L, Shi Y, Jun T, Onel K, Oh W, Edelmann L, Schadt E, Rossi M, Hantash F, Al-Kateb H. 61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma. Cancer Genetics 2022, 268: 20. DOI: 10.1016/j.cancergen.2022.10.064.
- Griffin J, Tsao C, Patel V, Liaw B, Guin S, Joshi H, Rossi M, Hantash F, Zhou X, Tewari A, Galsky M, Oh W, Chen R, Jun T. Clinical actionability and utilization of next-generation sequencing for prostate cancer in a changing treatment landscape. Frontiers In Urology 2022, 2: 997396. DOI: 10.3389/fruro.2022.997396.
- Sasenick J, Kleinfeld A, Huber A, Oh W, Hegyi T, Weinberger B. Effects of lipid emulsions on unbound bilirubin and response to phototherapy in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2022, 35: 10395-10400. PMID: 36176060, PMCID: PMC9852034, DOI: 10.1080/14767058.2022.2128656.
- Jin L, Govindaraj S, Liu Z, Ai L, Higashi M, Jun T, Lee K, Raja K, Zhang X, Li M, Calay E, Savic R, Ghosh K, Kasarskis A, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X. Seasonal variations of hospitalizations for chronic rhinosinusitis by different endotypes. ISEE Conference Abstracts 2022, 2022 DOI: 10.1289/isee.2022.p-1062.
- Mellgard G, Chakrani Z, McCroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao C, Patel V. 1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy. Annals Of Oncology 2022, 33: s1129. DOI: 10.1016/j.annonc.2022.07.1407.
- Guin S, Liaw B, Jun T, Ayers K, Patel B, O’Connell T, Deitz M, Klein M, Mullaney T, Prentice T, Newman S, Fink M, Zhou X, Schadt E, Chen R, Oh W. Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience. PLOS ONE 2022, 17: e0264800. PMID: 35984843, PMCID: PMC9390935, DOI: 10.1371/journal.pone.0264800.
- Qin Q, Jun T, Wang B, Patel V, Mellgard G, Zhong X, Gogerly-Moragoda M, Parikh A, Leiter A, Gallagher E, Alerasool P, Garcia P, Joshi H, MBBS, Galsky M, Oh W, Tsao C. Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discover Oncology 2022, 13: 73. PMID: 35960456, PMCID: PMC9374856, DOI: 10.1007/s12672-022-00538-6.
- Mellgard G, Patel V, Zhong X, Joshi H, Qin Q, Wang B, Parikh A, Jun T, Alerasool P, Garcia P, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. Journal Of Cancer Research And Clinical Oncology 2022, 149: 2833-2841. PMID: 35788726, PMCID: PMC10739778, DOI: 10.1007/s00432-022-04159-y.
- Jin L, Ai L, Lee K, Liu Z, Raja K, Cohn D, Zhang X, Higashi M, Jun T, Oh W, Calay E, Savic R, Ghosh K, Kasarskis A, Pan Q, Stolovitzky G, Govindaraj S, Schadt E, Wang X. HSD34 Treatment Patterns and Healthcare-Resource Utilization Among Chronic Rhinosinusitis with Nasal Polyps Patients: In the New Era of Biologics. Value In Health 2022, 25: s486. DOI: 10.1016/j.jval.2022.04.1035.
- Jun T, Oh W. Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen? JAMA Oncology 2022, 8: 972-974. PMID: 35551363, DOI: 10.1001/jamaoncol.2022.0511.
- Guin S, Jun T, Patel V, Ayers K, Deitz M, Cai Y, Zhou X, Tsao C, Oh W, Chen R, Liaw B. Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer. JCO Clinical Cancer Informatics 2022, 6: e2200010. PMID: 35696627, PMCID: PMC9225507, DOI: 10.1200/cci.22.00010.
- Ai L, Higashi M, Lee K, Liu Z, Jin L, Raja K, Mai Y, Jun T, Oh W, Beckmann A, Schadt E, Schadt Z, Wallsten R, Calay E, Kasarskis A, Pan Q, Schadt E, Wang X. AB0227 TREATMENT SEQUENCING PATTERNS AND COMPARATIVE EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM A REAL-WORLD SETTING. Annals Of The Rheumatic Diseases 2022, 81: 1241. DOI: 10.1136/annrheumdis-2022-eular.4655.
- Williams C, Starks D, Elsey R, Meissner T, Solomon B, Albano M, Hantash F, Schadt E, Rojas-Espaillat L, Lee J, Oh W. Implementation of the Avera/Sema4 oncology and analytics protocol (ASAP). Journal Of Clinical Oncology 2022, 40: tps6605-tps6605. DOI: 10.1200/jco.2022.40.16_suppl.tps6605.
- Jun T, Oh W, Schadt E, Higashi M. Health outcomes modelling of RNA-based versus DNA-based detection of driver gene rearrangements in non-small cell lung cancer. Journal Of Clinical Oncology 2022, 40: e18837-e18837. DOI: 10.1200/jco.2022.40.16_suppl.e18837.
- Patel K, Jun T, Chhadwa S, Zabala V, Gill S, Branchcomb R, Naidu S, Nathwani N, Hansen G, Hubbert A, Mukhi H, Mehta D, Nixon S, Kodali A, Zimmerman M, Hantash F, Oh W. Social determinants of health in a prospective study of whole-exome sequencing in advanced cancer patients from underserved communities. Journal Of Clinical Oncology 2022, 40: e18539-e18539. DOI: 10.1200/jco.2022.40.16_suppl.e18539.
- Patel K, Oh W, Jun T, Naidu S, Nathwani N, Hansen G, Hubert A, Mukhi H, Chhadwa S, Zabala V, Gill S, Branchcomb R, Mehta D, Nixon S, Kodali A, Zimmerman M. Clinical utility of widespread germline testing of cancer patients in a diverse community cancer clinic. Journal Of Clinical Oncology 2022, 40: e18537-e18537. DOI: 10.1200/jco.2022.40.16_suppl.e18537.
- Williams C, Guin S, Elsey R, Meißner T, Xu B, Sun Y, Amallraja A, Jun T, Schadt E, Chen R, Zhou X, Higashi M, Lee J, Oh W. Landscape of tumor genetic testing and targeted therapies over an eight-year span in a rural population. Journal Of Clinical Oncology 2022, 40: e15036-e15036. DOI: 10.1200/jco.2022.40.16_suppl.e15036.
- Lee K, Cohn D, Liu Z, Ai L, Paek H, Jin L, Raja K, Li M, Zhang X, Jun T, Higashi M, Oh W, Calay E, Savic R, Ghosh K, Kasarskis A, Mullaney T, Pan Q, Schadt E, Wang X. Phenotypic and endotypic features of COPD associated with lung cancer development. Journal Of Clinical Oncology 2022, 40: e13563-e13563. DOI: 10.1200/jco.2022.40.16_suppl.e13563.
- Williams C, Karagoz K, Elsey R, Meißner T, Higashi M, Schadt E, Jun T, Wang X, Chen R, Zhou X, Guin S, Lee J, Oh W. QOPI Clinical Informatics: A digital platform to enable real-time quality reporting, clinical decision support, and rapid learning. Journal Of Clinical Oncology 2022, 40: e13545-e13545. DOI: 10.1200/jco.2022.40.16_suppl.e13545.
- Karagoz K, Ayers K, Patel B, Wells J, Newman S, Oh W, Zhou X, Chen R, Guin S. Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology. Journal Of Clinical Oncology 2022, 40: 6584-6584. DOI: 10.1200/jco.2022.40.16_suppl.6584.
- Kier M, Li Z, Casasanta N, Patel R, Agarwal P, Zimmerman B, Yang Y, Fink M, Zhou X, Newman S, Chen R, Schadt E, Oh W, Tiersten A. Socioeconomic disparities in supportive therapy use and tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer. Journal Of Clinical Oncology 2022, 40: 523-523. DOI: 10.1200/jco.2022.40.16_suppl.523.
- Laptook A, Chalak L, Pappas A, Davis A, Sanchez P, Van Meurs K, Oh W, Sommers R, Shankaran S, Hensman A, Rouse D, McDonald S, Das A, Goldberg R, Ambalavanan N, Gyamfi-Bannerman C, Thom E, Higgins R. The effects of betamethasone on the amplitude integrated EEG of infants born at 34- or 35-weeks gestation. Journal Of Perinatology 2022, 42: 1615-1621. PMID: 35618748, PMCID: PMC9699898, DOI: 10.1038/s41372-022-01415-4.
- Shah N, Patel V, Zhong X, Pina L, Hawley J, Lin E, Gartrell B, Febles V, Wise D, Qin Q, Mellgard G, Joshi H, Nauseef J, Green D, Vlachostergios P, Kwon D, Huang F, Liaw B, Tagawa S, Kantoff P, Morris M, Oh W. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI Cancer Spectrum 2022, 6: pkac035. PMID: 35657341, PMCID: PMC9165550, DOI: 10.1093/jncics/pkac035.
- Lee K, Liu Z, Ma M, Chandran U, Kalsekar I, Laxmanan B, Li M, Mai Y, Gilman C, Wang T, Zhang M, Ai L, Aggarwal P, Pan Q, Oh W, Schadt E, Wang X. Automated Extraction and Longitudinal Analysis of Ground Glass OpacityFeatures in Lung Cancer Patients Powered by Natural Language Processing. 2022, a5077-a5077. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5077.
- Oh W, Rettig M. Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 16-17. PMID: 35579581.
- Oh W. Clinical observations regarding the use of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 13-16. PMID: 35579580.
- Rettig M, Beltran H, Oh W. Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 1-20. PMID: 35579577.
- Griffin J, Jun T, Guin S, Liaw B, Patel V, Tsao C, Rossi M, Chen R, Zhou X, Hantash F, Oh W. MP27-10 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR PROSTATE CANCER IN THE CONTEXT OF A CHANGING TREATMENT LANDSCAPE. Journal Of Urology 2022, 207: e453. DOI: 10.1097/ju.0000000000002570.10.
- Jun T, Hahn N, Sonpavde G, Albany C, MacVicar G, Hauke R, Fleming M, Gourdin T, Jana B, Oh W, Taik P, Wang H, Varadarajan A, Uzilov A, Galsky M. Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma. The Oncologist 2022, 27: 432-e452. PMID: 35438782, PMCID: PMC9177111, DOI: 10.1093/oncolo/oyab075.
- Gillessen S, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology 2022, 82: 115-141. PMID: 35450732, DOI: 10.1016/j.eururo.2022.04.002.
- Turco F, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ekeke O, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Gillessen S, Omlin A. Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]. European Urology 2022, 82: e18-e19. PMID: 35440417, PMCID: PMC9012951, DOI: 10.1016/j.eururo.2022.04.004.
- Mack P, Klein M, Ayers K, Zhou X, Guin S, Fink M, Rossi M, AI-Kateb H, O’Connell T, Hantash F, Oh W, Newman S, Schadt E, Chen R, Hirsch F. Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma. The Oncologist 2022, 27: 476-486. PMID: 35298662, PMCID: PMC9177106, DOI: 10.1093/oncolo/oyac035.
- Yu H, Tuminello S, Alpert N, van Gerwen M, Yoo S, Mulholland D, Aaronson S, Donovan M, Oh W, Gong Y, Wang L, Zhu J, Taioli E. Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases. Carcinogenesis 2022, 43: 528-537. PMID: 35239955, PMCID: PMC9234756, DOI: 10.1093/carcin/bgac025.
- Li S, Jun T, Tyler J, Schadt E, Kao Y, Wang Z, Konig M, Bettegowda C, Vogelstein J, Papadopoulos N, Parsons R, Chen R, Schadt E, Li L, Oh W. Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients. Frontiers In Medicine 2022, 9: 849222. PMID: 35295598, PMCID: PMC8919772, DOI: 10.3389/fmed.2022.849222.
- Welén K, Rosendal E, Freyhult E, Oh W, Gisslén M, Ahlm C, Connolly A, Överby A, Josefsson A. Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients. European Urology 2022, 81: e143-e144. PMID: 35248411, PMCID: PMC8864103, DOI: 10.1016/j.eururo.2022.02.016.
- Griffin J, Jun T, Liaw B, Guin S, Tsao C, Patel V, Rossi M, Zhou X, Hantash F, Chen R, Oh W. Clinical utility of next-generation sequencing for prostate cancer in the context of a changing treatment landscape. Journal Of Clinical Oncology 2022, 40: 112-112. DOI: 10.1200/jco.2022.40.6_suppl.112.
- Turco F, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ekeke Onyeanunam N, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Pablo Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Gillessen S, Omlin A. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology 2022, 82: 6-11. PMID: 35393158, PMCID: PMC8849852, DOI: 10.1016/j.eururo.2022.02.010.
- Patel R, Li Z, Zimmerman B, Fink M, Wells J, Zhou X, Ayers K, Redfern A, Newman S, Schadt E, Oh W, Chen R, Tiersten A. Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer. Breast Cancer Research And Treatment 2022, 192: 313-319. PMID: 35006484, DOI: 10.1007/s10549-021-06504-0.
- Mirza H, Garcia J, Bell C, Jones K, Flynn V, Pepe J, Oh W. Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants. American Journal Of Perinatology 2021, 40: 1345-1350. PMID: 34384119, DOI: 10.1055/a-1585-6093.
- Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?Lin J, Zhang Y, Hou W, Qin Q, Galsky M, Oh W, Tsao C. Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging? Journal Of Kidney Cancer And VHL 2021, 8: 13-19. PMID: 34722126, PMCID: PMC8523177, DOI: 10.15586/jkcvhl.v8i4.202.
- Cirulli G, Martini A, Gandaglia G, Fossati N, Necchi A, Raggi D, Stabile A, Cucchiara V, Leni R, Robesti D, Pellegrino F, Nocera L, Scuderi S, Karakiewicz P, Galsky M, Oh W, Sfakianos J, Parikh A, Tsao C, Montorsi F, Briganti A. SC206 The obesity paradox in metastatic castration resistant prostate cancer. European Urology Open Science 2021, 32: s101. DOI: 10.1016/s2666-1683(21)00897-1.
- Izadmehr S, Lundon D, Mohamed N, Katims A, Patel V, Eilender B, Mehrazin R, Badani K, Sfakianos J, Tsao C, Wiklund P, Oh W, Cordon-Cardo C, Tewari A, Galsky M, Kyprianou N. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic. Frontiers In Oncology 2021, 11: 734963. PMID: 34646777, PMCID: PMC8504458, DOI: 10.3389/fonc.2021.734963.
- Mirza H, Garcia J, Bell C, Jones K, Flynn V, Pepe J, Oh W. Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants. American Journal Of Perinatology 2021 DOI: 10.1055/s-0041-1735623.
- Mack P, Klein M, Ayers K, Uzilov A, Zhou X, Corrigan D, Dietz M, Fink M, Guin S, Kip N, Rossi M, Oh W, Hantash F, Newman S, Schadt E, Chen R, Hirsch F. 1271P Molecular driver mutations in never-smokers with lung adenocarcinoma. Annals Of Oncology 2021, 32: s993. DOI: 10.1016/j.annonc.2021.08.1873.
- Martini A, Cirulli G, Parikh A, Sfakianos J, Galsky M, Oh W, Tsao C, Gandaglia G, Fossati N, Stabile A, Necchi A, Cucchiara V, Pellegrino F, Scuderi S, Karakiewicz P, Montorsi F, Briganti A. MP24-09 BALANCING EFFICACY AND TOXICITY OF DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. RESULTS FROM A POOLED ANALYSIS OF THREE PROSPECTIVE RANDOMIZED TRIALS. Journal Of Urology 2021, 206: e415-e415. DOI: 10.1097/ju.0000000000002015.09.
- Martini A, Cirulli G, Gandaglia G, Fossati N, Necchi A, Stabile A, Cucchiara V, Mazzone E, Karakiewicz P, Sfakianos J, Galsky M, Oh W, Gallagher E, Montorsi F, Briganti A. PD05-01 THE OBESITY PARADOX IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER. Journal Of Urology 2021, 206: e55-e55. DOI: 10.1097/ju.0000000000001969.01.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care 2021, 44: 2438-2444. PMID: 34462270, PMCID: PMC8929179, DOI: 10.2337/dci21-0034.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. The Journal Of Clinical Endocrinology & Metabolism 2021, 107: 1-9. PMID: 34459898, PMCID: PMC8825709, DOI: 10.1210/clinem/dgab585.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: Definition and interpretation of remission in type 2 diabetes. Diabetic Medicine 2021, 39: e14669. PMID: 34460965, DOI: 10.1111/dme.14669.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 2021, 64: 2359-2366. PMID: 34458934, DOI: 10.1007/s00125-021-05542-z.
- Koshkin V, Patel V, Ali A, Bilen M, Ravindranathan D, Park J, Kellezi O, Cieslik M, Shaya J, Cabal A, Brown L, Labriola M, Graham L, Pritchard C, Tripathi A, Nusrat S, Barata P, Jang A, Chen S, Garje R, Acharya L, Hwang C, Pilling A, Oh W, Jun T, Natesan D, Nguyen C, Kilari D, Pierro M, Thapa B, Cackowski F, Mack A, Heath E, Marshall C, Tagawa S, Halabi S, Schweizer M, Armstrong A, Dorff T, Alva A, McKay R. PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. Prostate Cancer And Prostatic Diseases 2021, 25: 388-396. PMID: 34363009, PMCID: PMC9385488, DOI: 10.1038/s41391-021-00433-1.
- Singh D, Patel V, Oh W, Aguirre-Ghiso J. Prostate Cancer Dormancy and Reactivation in Bone Marrow. Journal Of Clinical Medicine 2021, 10: 2648. PMID: 34208521, PMCID: PMC8234151, DOI: 10.3390/jcm10122648.
- Cirulli G, Martini A, Pellegrino F, Scuderi S, Parikh A, Oh W, Sfakianos J, Karakiewicz P, Galsky M, Tsao C, Cucchiara V, Stabile A, Gandaglia G, Fossati N, Necchi A, Montorsi F, Briganti A. P0860 Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials. European Urology 2021, 79: s1203-s1204. DOI: 10.1016/s0302-2838(21)01234-3.
- Cirulli G, Martini A, Sfakianos J, Gandaglia G, Fossati N, Stabile A, Cucchiara V, Mazzone E, Necchi A, Karakiewicz P, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. P0855 The obesity paradox in metastatic castration resistant prostate cancer. European Urology 2021, 79: s1195-s1196. DOI: 10.1016/s0302-2838(21)01229-x.
- A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 PandemicTremblay D, Dunn A, Oh W. A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic. Quality Management In Health Care 2021, 30: 276-279. PMID: 34048378, PMCID: PMC8462300, DOI: 10.1097/qmh.0000000000000324.
- Liaw B, Guin S, Jun T, Ayers K, Patel B, O'Connell T, Dietz M, Klein M, Prentice T, Newman S, Fink M, Zhou X, Schadt E, Chen R, Oh W. Comparative efficacy of docetaxel versus novel hormonal agent in de novo metastatic hormone-sensitive prostate cancer: Real-world data curated by deidentified chart abstraction. Journal Of Clinical Oncology 2021, 39: e17047-e17047. DOI: 10.1200/jco.2021.39.15_suppl.e17047.
- Liaw B, Zhong X, Tsao C, Bakst R, Stewart R, Stock R, Galsky M, Oh W. Prostate cancer intensive, non-cross reactive therapy (PRINT) for CRPC: Interim analysis of efficacy endpoints. Journal Of Clinical Oncology 2021, 39: e17027-e17027. DOI: 10.1200/jco.2021.39.15_suppl.e17027.
- Ayers K, Mullaney T, Zhou X, Liu J, Lee K, Ma M, Jones S, Li L, Redfern A, Jappe W, Liu Z, Goldsweig H, Yadav K, Hahner N, Dietz M, Zimmerman M, Prentice T, Newman S, Veluswamy R, Wisnivesky J, Hirsch F, Oh W, Li S, Schadt E, Chen R. Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers. The Oncologist 2021, 26: e1226-e1239. PMID: 33829580, PMCID: PMC8265370, DOI: 10.1002/onco.13780.
- Bikkasani K, Qin Q, Zhong X, Lin J, Galsky M, Oh W, Tsao C. Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? Clinical Genitourinary Cancer 2021, 19: e346-e351. PMID: 34011488, DOI: 10.1016/j.clgc.2021.04.003.
- Wang L, Sfakianos J, Beaumont K, Akturk G, Horowitz A, Sebra R, Farkas A, Gnjatic S, Hake A, Izadmehr S, Wiklund P, Oh W, Szabo P, Wind-Rotolo M, Unsal-Kacmaz K, Yao X, Schadt E, Sharma P, Bhardwaj N, Zhu J, Galsky M. Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing. Clinical Cancer Research 2021, 27: 4287-4300. PMID: 33837006, PMCID: PMC8338756, DOI: 10.1158/1078-0432.ccr-20-4574.
- Adams-Chapman I, Watterberg K, Nolen T, Hirsch S, Cole C, Cotten C, Oh W, Poindexter B, Zaterka-Baxter K, Das A, Lacy C, Scorsone A, Duncan A, DeMauro S, Goldstein R, Colaizy T, Wilson-Costello D, Purdy I, Hintz S, Heyne R, Myers G, Fuller J, Merhar S, Harmon H, Peralta-Carcelen M, Kilbride H, Maitre N, Vohr B, Natarajan G, Mintz-Hittner H, Quinn G, Wallace D, Olson R, Orge F, Tsui I, Gaynon M, Hutchinson A, He Y, Winter T, Yang M, Haider K, Cogen M, Hug D, Bremer D, Donahue J, Lucas W, Phelps D, Higgins R. Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. Journal Of Perinatology 2021, 41: 2072-2087. PMID: 33758387, PMCID: PMC8349854, DOI: 10.1038/s41372-021-01018-5.
- Patel V, Zhong X, Shah N, Pina Martina L, Hawley J, Lin E, Gartrell B, Adorno Febles V, Wise D, Qin Q, Mellgard G, Nauseef J, Green D, Vlachostergios P, Kwon D, Huang F, Liaw B, Tagawa S, Morris M, Oh W. The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. Journal Of Clinical Oncology 2021, 39: 41-41. DOI: 10.1200/jco.2021.39.6_suppl.41.
- Martini A, Parikh A, Sfakianos J, Montorsi F, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data. Prostate Cancer And Prostatic Diseases 2021, 24: 743-749. PMID: 33531652, DOI: 10.1038/s41391-021-00326-3.
- Rosenkrantz T, Oh W. Polycythemia and Hyperviscosity in the Newborn. 2021, 185-200. DOI: 10.1017/9781108773584.013.
- Parikh A, Zhong X, Mellgard G, Qin Q, Patel V, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher E, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh W, Tsao C. Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy. American Journal Of Clinical Oncology 2021, 44: 114-120. PMID: 33417323, PMCID: PMC7902456, DOI: 10.1097/coc.0000000000000793.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Carayannopoulos M, Oh W. Unbound bilirubin levels in phototherapy‐treated preterm infants receiving soy‐based lipid emulsion. Pediatrics International 2020, 62: 1357-1363. PMID: 32535983, DOI: 10.1111/ped.14346.
- Mateo J, McKay R, Abida W, Aggarwal R, Alumkal J, Alva A, Feng F, Gao X, Graff J, Hussain M, Karzai F, Montgomery B, Oh W, Patel V, Rathkopf D, Rettig M, Schultz N, Smith M, Solit D, Sternberg C, Van Allen E, VanderWeele D, Vinson J, Soule H, Chinnaiyan A, Small E, Simons J, Dahut W, Miyahira A, Beltran H. Accelerating precision medicine in metastatic prostate cancer. Nature Cancer 2020, 1: 1041-1053. PMID: 34258585, PMCID: PMC8274325, DOI: 10.1038/s43018-020-00141-0.
- Wang Z, Zheutlin A, Kao Y, Ayers K, Gross S, Kovatch P, Nirenberg S, Charney A, Nadkarni G, De Freitas J, O’Reilly P, Just A, Horowitz C, Martin G, Branch A, Glicksberg B, Charney D, Reich D, Oh W, Schadt E, Chen R, Li L. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records. BMJ Open 2020, 10: e040441. PMID: 33109676, PMCID: PMC7592304, DOI: 10.1136/bmjopen-2020-040441.
- Schmid S, Omlin A, Higano C, Sweeney C, Chanza N, Mehra N, Kuppen M, Beltran H, Condeduca V, de Almeida D, Maluf F, Oh W, Tsao C, Sartor O, Ledet E, Di Lorenzo G, Yip S, N. K, Bianchini D, De Giorgi U, Hansen A, Beer T, Pernelle L, Morales-Barrera R, Tucci M, Castro E, Karalis K, Bergman A, Le M, Zürrer-Härdi U, Pezaro C, Suzuki H, Zivi A, Klingbiel D, Schär S, Gillessen S. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. JAMA Network Open 2020, 3: e2021692. PMID: 33112397, PMCID: PMC7593810, DOI: 10.1001/jamanetworkopen.2020.21692.
- Marco B, Martini A, Pfail J, Gandaglia G, Fossati N, Scuderi S, Fallara G, Barletta F, Robesti D, Rizzo A, Basile G, Bravi C, Rosiello G, Nocera L, Stabile A, Gallina A, Salonia A, Montorsi F, Briganti A, Galsky M, Oh W. SC242 Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial. European Urology Open Science 2020, 20: s142. DOI: 10.1016/s2666-1683(20)35564-6.
- Cignoli D, Martini A, Sfakianos J, Gandaglia G, Fossati N, Salonia A, Barletta F, Scuderi S, Robesti D, Bravi C, Mazzone E, Rosiello G, Fallara G, Nocera L, Cirulli G, Stabile A, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. SC56 The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials. European Urology Open Science 2020, 20: s55-s56. DOI: 10.1016/s2666-1683(20)35378-7.
- Martini A, Parikh A, Gandaglia G, Fossati N, Fallara G, Barletta F, Scuderi S, Robesti D, Cannoletta D, Leni R, Cucchiara V, Bravi C, Mazzone E, Rosiello G, Basile G, Nocera L, Necchi A, Moschini M, Sfakianos J, Galsky M, Oh W, Tsao C, Montorsi F, Briganti A. SC241 Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data. European Urology Open Science 2020, 20: s141-s142. DOI: 10.1016/s2666-1683(20)35563-4.
- Lowrance W, Breau R, Chou R, Chapin B, Crispino T, Dreicer R, Jarrard D, Kibel A, Morgan T, Morgans A, Oh W, Resnick M, Zietman A, Cookson M. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. Journal Of Urology 2020, 205: 14-21. PMID: 32960679, DOI: 10.1097/ju.0000000000001375.
- Lowrance W, Breau R, Chou R, Chapin B, Crispino T, Dreicer R, Jarrard D, Kibel A, Morgan T, Morgans A, Oh W, Resnick M, Zietman A, Cookson M. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. Journal Of Urology 2020, 205: 22-29. PMID: 32960678, DOI: 10.1097/ju.0000000000001376.
- Brion L, Phelps D, Ward R, Nolen T, Hallman N, Das A, Zaccaro D, Ball M, Watterberg K, Frantz I, Cotten C, Poindexter B, Oh W, Lugo R, Van Meurs K, O’Shea T, Zaterka-Baxter K, Higgins R. Blood myo-inositol concentrations in preterm and term infants. Journal Of Perinatology 2020, 41: 247-254. PMID: 32934363, PMCID: PMC7889639, DOI: 10.1038/s41372-020-00799-5.
- Patel V, Oh W, Galsky M. Treatment of muscle‐invasive and advanced bladder cancer in 2020. CA A Cancer Journal For Clinicians 2020, 70: 404-423. PMID: 32767764, DOI: 10.3322/caac.21631.
- Abramson D, Fallon J, Biran N, Francis J, Jaben K, Oh W. Lacrimal sac adenocarcinoma managed with androgen deprivation. American Journal Of Ophthalmology Case Reports 2020, 19: 100607. PMID: 32760849, PMCID: PMC7393461, DOI: 10.1016/j.ajoc.2020.100607.
- Patel V, Zhong X, Liaw B, Tremblay D, Tsao C, Galsky M, Oh W. Does androgen deprivation therapy protect against severe complications from COVID-19? Annals Of Oncology 2020, 31: 1419-1420. PMID: 32653425, PMCID: PMC7347319, DOI: 10.1016/j.annonc.2020.06.023.
- Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh W, Naymagon L. Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study. Blood 2020, 136: 144-147. PMID: 32462179, PMCID: PMC7332896, DOI: 10.1182/blood.2020006941.
- Ayers K, Liu Z, Ma M, Lee K, Newman S, Li L, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Oh W, Schadt E, Li D, Chen R. Using real-world data to investigate time-dependent blood count response to PD-1 and PD-L1 inhibitors and its impact on survival in advanced non-small cell lung cancers. Journal Of Clinical Oncology 2020, 38: e21514-e21514. DOI: 10.1200/jco.2020.38.15_suppl.e21514.
- Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRPC—Early observations of efficacy. Journal Of Clinical Oncology 2020, 38: e17575-e17575. DOI: 10.1200/jco.2020.38.15_suppl.e17575.
- Lin J, Zhong X, Galsky M, Oh W, Tsao C. Predictors of successful randomized phase III studies in the treatment metastatic renal cell carcinoma: A meta-analysis. Journal Of Clinical Oncology 2020, 38: e17105-e17105. DOI: 10.1200/jco.2020.38.15_suppl.e17105.
- Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Zhong X, Parikh A, Leiter A, Gallagher E, Galsky M, Oh W, Tsao C. Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors. Journal Of Clinical Oncology 2020, 38: e15160-e15160. DOI: 10.1200/jco.2020.38.15_suppl.e15160.
- Lin J, Patel V, Qin Q, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Zhong X, Oh W, Galsky M, Tsao C. What happens at radiographic disease progression in patients with metastatic cancer receiving immune checkpoint inhibitors? A single institution analysis. Journal Of Clinical Oncology 2020, 38: e15157-e15157. DOI: 10.1200/jco.2020.38.15_suppl.e15157.
- Parikh A, Mellgard G, Qin Q, Patel V, Wang B, Zhong X, Leiter A, Gallagher E, Galsky M, Oh W, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Tsao C. Risk factors for emergency room and hospital care for patients with advanced solid tumors on immune checkpoint inhibitor therapy. Journal Of Clinical Oncology 2020, 38: e15142-e15142. DOI: 10.1200/jco.2020.38.15_suppl.e15142.
- Ganta T, Jun T, Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Clinical efficacy of immunotherapy for the treatment of solid tumors in patients with chronic kidney disease. Journal Of Clinical Oncology 2020, 38: e15109-e15109. DOI: 10.1200/jco.2020.38.15_suppl.e15109.
- Jun T, Ganta T, Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Smoking status and immunotherapy outcomes in smoking-associated cancers. Journal Of Clinical Oncology 2020, 38: e15097-e15097. DOI: 10.1200/jco.2020.38.15_suppl.e15097.
- Patel V, Qin Q, Wang B, Gogerly-Moragoda M, Mellgard G, Zhong X, Parikh A, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. Journal Of Clinical Oncology 2020, 38: e15068-e15068. DOI: 10.1200/jco.2020.38.15_suppl.e15068.
- Schweizer M, Ha G, Gulati R, Brown L, McKay R, Dorff T, Hoge A, Reichel J, Vats P, Kilari D, Patel V, Oh W, Chinnaiyan A, Pritchard C, Armstrong A, Montgomery R, Alva A. CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade. JCO Precision Oncology 2020, 4: 382-392. PMID: 32671317, PMCID: PMC7363399, DOI: 10.1200/po.19.00383.
- Martini A, Pfail J, Montorsi F, Galsky M, Oh W. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial. Prostate Cancer And Prostatic Diseases 2020, 23: 638-645. PMID: 32313142, DOI: 10.1038/s41391-020-0231-5.
- Martini* A, Parikh A, Sfakianos J, Fossati N, Gandaglia G, Scuderi S, Cannoletta D, Fallara G, Mazzone E, Stabile A, Barletta F, Robesti D, Bravi C, Briganti A, Montorsi F, Oh W, Galsky M, Tsao C. PD16-07 PREDICTING TOXICITY-RELATED DOCETAXEL DISCONTINUATION AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER USING OPEN PHASE 3 TRIAL DATA. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.07.
- Martini A, Pfail* J, Fossati N, Gandaglia G, Fallara G, Barletta F, Scuderi S, Robesti D, Salonia A, Briganti A, Montorsi F, Galsky M, Oh W. PD16-06 SURROGATE ENDPOINTS FOR OVERALL SURVIVAL FOR PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER IN THE CHAARTED TRIAL. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.06.
- Martini* A, Sfakianos J, Gandaglia G, Fossati N, Barletta F, Scuderi S, Robesti D, Fallara G, Salonia A, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. PD16-05 THE INVERSE CORRELATION BETWEEN OBESITY AND MORTALITY IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: RESULTS FROM THE CONTROL ARMS OF ASCENT2, MAINSAL AND VENICE TRIALS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.05.
- Oh W. COVID-19 infection in cancer patients: early observations and unanswered questions. Annals Of Oncology 2020, 31: 838-839. PMID: 32243894, PMCID: PMC7270512, DOI: 10.1016/j.annonc.2020.03.297.
- Liu M, Oxnard G, Klein E, Swanton C, Seiden M, Consortium C, investigators C, Liu M, Oxnard G, Klein E, Smith D, Richards D, Yeatman T, Cohn A, Lapham R, Clement J, Parker A, Tummala M, McIntyre K, Sekeres M, Bryce A, Siegel R, Wang X, Cosgrove D, Abu-Rustum N, Trent J, Thiel D, Becerra C, Agrawal M, Garbo L, Giguere J, Michels R, Harris R, Richey S, McCarthy T, Waterhouse D, Couch F, Wilks S, Krie A, Balaraman R, Restrepo A, Meshad M, Rieger-Christ K, Sullivan T, Lee C, Greenwald D, Oh W, Tsao C, Fleshner N, Kennecke H, Khalil M, Spigel D, Manhas A, Ulrich B, Kovoor P, Stokoe C, Courtright J, Yimer H, Larson T, Swanton C, Seiden M, investigators S, Cummings S, GRAIL I, Absalan F, Alexander G, Allen B, Amini H, Aravanis A, Bagaria S, Bazargan L, Beausang J, Berman J, Betts C, Blocker A, Bredno J, Calef R, Cann G, Carter J, Chang C, Chawla H, Chen X, Chien T, Civello D, Davydov K, Demas V, Desai M, Dong Z, Fayzullina S, Fields A, Filippova D, Freese P, Fung E, Gnerre S, Gross S, Halks-Miller M, Hall M, Hartman A, Hou C, Hubbell E, Hunkapiller N, Jagadeesh K, Jamshidi A, Jiang R, Jung B, Kim T, Klausner R, Kurtzman K, Lee M, Lin W, Lipson J, Liu H, Liu Q, Lopatin M, Maddala T, Maher M, Melton C, Mich A, Nautiyal S, Newman J, Newman J, Nicula V, Nicolaou C, Nikolic O, Pan W, Patel S, Prins S, Rava R, Ronaghi N, Sakarya O, Satya R, Schellenberger J, Scott E, Sehnert A, Shaknovich R, Shanmugam A, Shashidhar K, Shen L, Shenoy A, Shojaee S, Singh P, Steffen K, Tang S, Toung J, Valouev A, Venn O, Williams R, Wu T, Xu H, Yakym C, Yang X, Yecies J, Yip A, Youngren J, Yue J, Zhang J, Zhang L, Zhang L, Zhang N, Advisors, Curtis C, Berry D. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Annals Of Oncology 2020, 31: 745-759. PMID: 33506766, PMCID: PMC8274402, DOI: 10.1016/j.annonc.2020.02.011.
- Qin Q, Patel V, Mellgard G, Parikh A, Wang B, Alerasool P, Garcia P, Jaladanki S, Leiter A, Carroll E, Brooks D, Shimol J, Eisenberg E, Gallagher E, Galsky M, Oh W, Tsao C. Type, timing, and risk factors associated with immune-related adverse event development in patients with advanced genitourinary cancers treated with immune checkpoint inhibitor. Journal Of Clinical Oncology 2020, 38: 480-480. DOI: 10.1200/jco.2020.38.6_suppl.480.
- Patel V, Qin Q, Mellgard G, Parikh A, Wang B, Alerasool P, Garcia P, Jaladanki S, Leiter A, Carroll E, Brooks D, Shimol J, Eisenberg E, Gallagher E, Galsky M, Oh W, Tsao C. Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors. Journal Of Clinical Oncology 2020, 38: 482-482. DOI: 10.1200/jco.2020.38.6_suppl.482.
- Parikh A, Martini A, Sfakianos J, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data. Journal Of Clinical Oncology 2020, 38: 75-75. DOI: 10.1200/jco.2020.38.6_suppl.75.
- PRINT: Prostate cancer intensive, non-cross reactive therapy for CRP—Early observations of efficacy.Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRP—Early observations of efficacy. Journal Of Clinical Oncology 2020, 38: 89-89. DOI: 10.1200/jco.2020.38.6_suppl.89.
- Lin J, Caress A, Ahmed F, Taylor N, Gong Y, Oh W. Elevated circulating CCL2 in prostate cancer patients. Journal Of Clinical Oncology 2020, 38: 201-201. DOI: 10.1200/jco.2020.38.6_suppl.201.
- Schweizer M, Gulati R, Brown L, McKay R, Dorff T, Kilari D, Vats P, Patel V, Oh W, Armstrong A, Montgomery R, Alva A. CDK12 -mutated prostate cancer (PC): Clinical outcomes to standard therapies and immune checkpoint blockade. Journal Of Clinical Oncology 2020, 38: 191-191. DOI: 10.1200/jco.2020.38.6_suppl.191.
- Gillessen S, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Chi K, Clarke N, Davis I, de Bono J, Drake C, Duran I, Eeles R, Efstathiou E, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano C, Hofman M, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli R, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Reiter R, Roach M, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Small E, Smith M, Soule H, Sternberg C, Steuber T, Suzuki H, Sweeney C, Sydes M, Taplin M, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology 2020, 77: 508-547. PMID: 32001144, DOI: 10.1016/j.eururo.2020.01.012.
- Mirza H, Varich L, Sensakovic W, Guruvadoo K, Royall I, Britt C, Vicenti R, Oh W. Tracheomegaly among Extremely Preterm Infants on Prolonged Mechanical Ventilation. The Journal Of Pediatrics 2019, 218: 231-233.e1. PMID: 31711760, DOI: 10.1016/j.jpeds.2019.10.024.
- Fei K, Lin J, Supoyo S, Franco R, Abramson S, Hoke G, Oh W, Stock R, Bickell N. Impact of Age and Life-expectancy on Treatment Receipt in High-risk Prostate Cancer. Journal Of Advances In Medicine And Medical Research 2019, 1-9. DOI: 10.9734/jammr/2019/v30i1130248.
- Mirza H, Garcia J, McKinley G, Hubbard L, Sensing W, Schneider J, Oh W, Wadhawan R. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. Journal Of Perinatology 2019, 39: 1648-1655. PMID: 31554913, DOI: 10.1038/s41372-019-0496-5.
- Mehrazin R, Oh W. Prostate Cancer. 2019, 23-31. DOI: 10.1002/9781119189596.ch2.
- Gong Y, Wang L, Yu H, Alpert N, Cohen M, Prophete C, Horton L, Sisco M, Park S, Lee H, Zelikoff J, Chen L, Hashim D, Suarez-Farinas M, Donovan M, Aaronson S, Galsky M, Zhu J, Taioli E, Oh W. Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade. Molecular Cancer Research 2019, 17: 1605-1612. PMID: 31221798, PMCID: PMC6684261, DOI: 10.1158/1541-7786.mcr-19-0115.
- Wang L, Gong Y, Saci A, Szabo P, Martini A, Necchi A, Siefker-Radtke A, Pal S, Plimack E, Sfakianos J, Bhardwaj N, Horowitz A, Farkas A, Mulholland D, Fischer B, Oh W, Sharma P, Zhu J, Galsky M. Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. European Urology 2019, 76: 599-603. PMID: 31272788, PMCID: PMC6801024, DOI: 10.1016/j.eururo.2019.06.025.
- Niglio S, Jia R, Ji J, Ruder S, Patel V, Martini A, Sfakianos J, Marqueen K, Waingankar N, Mehrazin R, Wiklund P, Oh W, Mazumdar M, Ferket B, Galsky M. Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis. European Urology 2019, 76: 782-789. PMID: 31200951, DOI: 10.1016/j.eururo.2019.05.037.
- Patel V, Oh W. The evolving landscape of immunotherapy in advanced prostate cancer. Immunotherapy 2019, 11: 903-912. PMID: 31161846, DOI: 10.2217/imt-2019-0019.
- Ma M, Zhou X, Goldsweig H, Hahner N, Han D, Dietz M, Jones S, Mullaney T, Redfern A, Jappe W, Liu Z, Yadav K, Zimmerman M, Prentice T, Pan Q, Hirsch F, Oh W, Schadt E, Li D, Chen R. Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC). Journal Of Clinical Oncology 2019, 37: e20642-e20642. DOI: 10.1200/jco.2019.37.15_suppl.e20642.
- Liu Z, Ma M, Grover K, Li L, Goldsweig H, Yadav K, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Pan Q, Oh W, Schadt E, Li D, Chen R. Investigating racial differences in treatment responses through analysis of real-world data (RWD). Journal Of Clinical Oncology 2019, 37: e18141-e18141. DOI: 10.1200/jco.2019.37.15_suppl.e18141.
- McCafferty J, Grover K, Li L, Li Z, Fink M, Goldsweig H, Ma M, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Pan Q, Oh W, Schadt E, Li D, Chen R. A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients. Journal Of Clinical Oncology 2019, 37: e18031-e18031. DOI: 10.1200/jco.2019.37.15_suppl.e18031.
- Chong* J, Muhleman M, Say R, Kostakoglu L, Ahmed J, Tewari A, Stock R, Oh W. MP13-01 PET/CT WITH 18 F-FLUCICLOVINE TO PREDICT RECURRENCE IN POST-TREATMENT PROSTATE CANCER AND ITS ROLE IN ALTERING TREATMENT PLANS. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555214.12968.a4.
- Bikkasani K, Qin Q, Lin J, Galsky M, Liaw B, Oh W, Tsao C. Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer. Journal Of Clinical Oncology 2019, 37: 184-184. DOI: 10.1200/jco.2019.37.7_suppl.184.
- Taplin M, Hussain A, Shah S, Shore N, Agrawal M, Clark W, Edenfield W, Nordquist L, Sartor O, Butrynski J, Chatta G, Fleming M, Oh W, Bradley B, Piel J, Nash D, Colak G, Li J, Lebedinsky C, Antonarakis E. ProSTAR: A phase Ib/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2019, 37: tps335-tps335. DOI: 10.1200/jco.2019.37.7_suppl.tps335.
- Lin J, Oh W, Liaw B, Galsky M, Tsao C. Evolving patterns of metastatic renal cell carcinoma: A meta-analysis. Journal Of Clinical Oncology 2019, 37: 563-563. DOI: 10.1200/jco.2019.37.7_suppl.563.
- Patel V, Oh W, Galsky M, Liaw B, Tsao C. Effect of concurrent beta-blocker (BB) use in patients receiving immune checkpoint inhibitors for metastatic urothelial (mUC) and renal cell carcinomas (mRCC). Journal Of Clinical Oncology 2019, 37: 467-467. DOI: 10.1200/jco.2019.37.7_suppl.467.
- Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRPC—Early observations of feasibility and efficacy. Journal Of Clinical Oncology 2019, 37: 310-310. DOI: 10.1200/jco.2019.37.7_suppl.310.
- Qin Q, Bikkasani K, Oh W, Liaw B, Galsky M, Tsao C. Patients with an extremely high prostate-specific antigen at prostate cancer diagnosis: A single institution analysis. Journal Of Clinical Oncology 2019, 37: 309-309. DOI: 10.1200/jco.2019.37.7_suppl.309.
- Chong J, Muhleman M, Say R, Kostakoglu L, Ahmed J, Tewari A, Stock R, Oh W. Positron emission tomography with 18F-fluciclovine to predict recurrence in post-treatment recurrent prostate cancer and its role in altering treatment plans. Journal Of Clinical Oncology 2019, 37: 214-214. DOI: 10.1200/jco.2019.37.7_suppl.214.
- Ahmed J, Muhleman M, Chong J, Tewari A, Oh W, Kostakoglu L, Stock R. Application of 18-F Fluciclovine PET/CT in Guiding Salvage Radiation Therapy for Recurrent Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e95-e96. DOI: 10.1016/j.ijrobp.2018.07.371.
- Phelps D, Watterberg K, Nolen T, Cole C, Cotten C, Oh W, Poindexter B, Zaterka-Baxter K, Das A, Lacy C, Scorsone A, Walsh M, Bell E, Kennedy K, Schibler K, Sokol G, Laughon M, Lakshminrusimha S, Truog W, Garg M, Carlo W, Laptook A, Van Meurs K, Carlton D, Graf A, DeMauro S, Brion L, Shankaran S, Orge F, Olson R, Mintz-Hittner H, Yang M, Haider K, Wallace D, Chung M, Hug D, Tsui I, Cogen M, Donahue J, Gaynon M, Hutchinson A, Bremer D, Quinn G, He Y, Lucas W, Winter T, Kicklighter S, Kumar K, Chess P, Colaizy T, Hibbs A, Ambalavanan N, Harmon H, McGowan E, Higgins R. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. JAMA 2018, 320: 1649-1658. PMID: 30357297, DOI: 10.1001/jama.2018.14996.
- Omidele O, Schiff H, Oh W, Tewari A. Multimodal therapy in the treatment of metastatic prostate cancer: A case report. Urology Case Reports 2018, 21: 92-94. PMID: 30258788, PMCID: PMC6154777, DOI: 10.1016/j.eucr.2018.09.010.
- Friedlander P, Wood K, Wassmann K, Christenfeld A, Bhardwaj N, Oh W. A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. Journal For ImmunoTherapy Of Cancer 2018, 6: 90. PMID: 30227886, PMCID: PMC6145108, DOI: 10.1186/s40425-018-0408-9.
- Oh W, Cheng W, Miao R, Vekeman F, Gauthier-Loiselle M, Duh M, Drea E, Szatrowski T. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting. Urologic Oncology Seminars And Original Investigations 2018, 36: 500.e1-500.e9. PMID: 30201382, DOI: 10.1016/j.urolonc.2018.08.002.
- Wang L, Saci A, Szabo P, Chasalow S, Castillo-Martin M, Domingo-Domenech J, Siefker-Radtke A, Sharma P, Sfakianos J, Gong Y, Dominguez-Andres A, Oh W, Mulholland D, Azrilevich A, Hu L, Cordon-Cardo C, Salmon H, Bhardwaj N, Zhu J, Galsky M. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications 2018, 9: 3503. PMID: 30158554, PMCID: PMC6115401, DOI: 10.1038/s41467-018-05992-x.
- Patel V, Liaw B, Oh W. The role of ketoconazole in current prostate cancer care. Nature Reviews Urology 2018, 15: 643-651. PMID: 30154429, DOI: 10.1038/s41585-018-0077-y.
- Lowrance W, Murad M, Oh W, Jarrard D, Resnick M, Cookson M. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018. Journal Of Urology 2018, 200: 1264-1272. PMID: 30086276, DOI: 10.1016/j.juro.2018.07.090.
- Resende Salgado L, Rhome R, Oh W, Stone N, Stock R. Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy. Brachytherapy 2018, 17: 874-881. PMID: 30061057, DOI: 10.1016/j.brachy.2018.07.008.
- Lee E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, Wang L, Oh W, Galsky M, Cordon-Cardo C, Zhu J. Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR. Oncogene 2018, 37: 5858-5872. PMID: 29970902, PMCID: PMC6212417, DOI: 10.1038/s41388-018-0367-0.
- Hashim D, Boffetta P, Galsky M, Oh W, Lucchini R, Crane M, Luft B, Moline J, Udasin I, Harrison D, Taioli E. Prostate cancer characteristics in the World Trade Center cohort, 2002–2013. European Journal Of Cancer Prevention 2018, 27: 347-354. PMID: 27898584, PMCID: PMC5443704, DOI: 10.1097/cej.0000000000000315.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Effects of soybean lipid infusion on triglyceride and unbound free fatty acid levels in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2018, 32: 3226-3231. PMID: 29618229, PMCID: PMC6551293, DOI: 10.1080/14767058.2018.1461827.
- Chong J, Oh W, Liaw B. Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date. OncoTargets And Therapy 2018, 11: 2141-2147. PMID: 29695920, PMCID: PMC5905496, DOI: 10.2147/ott.s147168.
- McClinch K, Avelar R, Callejas D, Izadmehr S, Wiredja D, Perl A, Sangodkar J, Kastrinsky D, Schlatzer D, Cooper M, Kiselar J, Stachnik A, Yao S, Hoon D, McQuaid D, Zaware N, Gong Y, Brautigan D, Plymate S, Sprenger C, Oh W, Levine A, Kirschenbaum A, Sfakianos J, Sears R, DiFeo A, Ioannou Y, Ohlmeyer M, Narla G, Galsky M. Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer. Cancer Research 2018, 78: canres.0123.2017. PMID: 29358171, PMCID: PMC5899650, DOI: 10.1158/0008-5472.can-17-0123.
- Mirza H, Garcia J, Crawford E, Pepe J, Zussman M, Wadhawan R, Oh W. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia. The Journal Of Pediatrics 2018, 198: 187-193.e1. PMID: 29625730, DOI: 10.1016/j.jpeds.2018.02.034.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Unbound bilirubin measurements by a novel probe in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2018, 32: 2721-2726. PMID: 29504491, PMCID: PMC6135709, DOI: 10.1080/14767058.2018.1448380.
- Levin R, Given R, Nemeth P, Bosch B, Chapas-Reed J, Oh W. Multicenter extension and switch study evaluating the safety of long-term treatment with abiraterone acetate fine particle formulation (AAFP) in patients with metastatic castration-resistant prostate cancer (mCRPC): The STAAR-E study. Journal Of Clinical Oncology 2018, 36: 181-181. DOI: 10.1200/jco.2018.36.6_suppl.181.
- Liaw B, Oh W. Prostate Cancer. 2018, 344-362. DOI: 10.1002/9781118592168.ch26.
- Tsao C, Oh W. First-Line Treatment of Hormone-Sensitive Metastatic Prostate Cancer: Is There a Single Standard of Care? Journal Of Clinical Oncology 2018, 36: jco.2017.77.431. PMID: 29432079, DOI: 10.1200/jco.2017.77.4315.
- Oh W, Przystac L, McKinley L, Tucker R, McGowan E, Vohr B. Association of intralipid intake in extremely low birthweight infants with neurodevelopmental outcomes. Acta Paediatrica 2018, 107: 600-604. PMID: 29274180, DOI: 10.1111/apa.14201.
- Azad A, Chang P, Devuni D, Bichoupan K, Kesar V, Branch A, Oh W, Galsky M, Ahmad J, Odin J. Real World Experience of Drug Induced Liver Injury in Patients Undergoing Chemotherapy. Journal Of Clinical Gastroenterology And Hepatology 2018, 2 PMID: 30637414, PMCID: PMC6327955, DOI: 10.21767/2575-7733.1000047.
- Rosenkrantz T, Sarkar S, Oh W. Polycythemia and Fetal-Maternal Bleeding. 2017, 431-442. DOI: 10.1017/9781316275498.029.
- Galsky M, Wang H, Hahn N, Twardowski P, Pal S, Albany C, Fleming M, Starodub A, Hauke R, Yu M, Zhao Q, Sonpavde G, Donovan M, Patel V, Sfakianos J, Domingo-Domenech J, Oh W, Akers N, Losic B, Gnjatic S, Schadt E, Chen R, Kim-Schulze S, Bhardwaj N, Uzilov A. Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. European Urology 2017, 73: 751-759. PMID: 29248319, DOI: 10.1016/j.eururo.2017.12.001.
- Bickell N, Lin J, Abramson S, Hoke G, Oh W, Hall S, Stock R, Fei K, McAlearney A. Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers. JCO Oncology Practice 2017, 14: jop.2017.025957. PMID: 29194001, PMCID: PMC5765902, DOI: 10.1200/jop.2017.025957.
- Lieberman-Cribbin W, Galsky M, Casey M, Liu B, Oh W, Flores R, Taioli E. Hospital Centralization Impacts High-Risk Lung and Bladder Cancer Surgical Patients. Cancer Investigation 2017, 35: 652-661. PMID: 29243986, DOI: 10.1080/07357907.2017.1406495.
- Galsky M, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Hu L, Tsao C, Sfakianos J, Mehrazin R, Waingankar N, Oh W, Mazumdar M, Ferket B. Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer. JCO Clinical Cancer Informatics 2017, 1: 1-12. PMID: 30657403, PMCID: PMC6874030, DOI: 10.1200/cci.17.00116.
- Galsky M, Shahin M, Jia R, Shaffer D, Gimpel-Tetra K, Tsao C, Baker C, Leiter A, Holland J, Sablinski T, Mehrazin R, Sfakianos J, Acon P, Oh W. Telemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate Cancer. JCO Clinical Cancer Informatics 2017, 1: 1-10. PMID: 30657386, DOI: 10.1200/cci.17.00044.
- Drudge-Coates L, Oh W, Tombal B, Delacruz A, Tomlinson B, Ripley A, Mastris K, O'Sullivan J, Shore N. Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey. Clinical Genitourinary Cancer 2017, 16: e411-e419. PMID: 29111175, DOI: 10.1016/j.clgc.2017.09.015.
- Galsky M, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Ramireddy K, Hu L, Tsao C, Sfakianos J, Mehrazin R, Hassanzadeh N, Waingankar N, Oh W, Kohli A, Otobo E, Mazumdar M, Ferket B. A Web-Based Tool to Facilitate Shared Decision-Making Regarding Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer. Iproceedings 2017, 3: e43. DOI: 10.2196/iproc.8456.
- Friedlander P, Wassmann K, Christenfeld A, Fisher D, Kyi C, Kirkwood J, Bhardwaj N, Oh W. Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab. Journal For ImmunoTherapy Of Cancer 2017, 5: 67. PMID: 28807052, PMCID: PMC5557000, DOI: 10.1186/s40425-017-0272-z.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Dhawan R, Duh M. Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting. Medical Oncology 2017, 34: 160. PMID: 28795333, PMCID: PMC5550521, DOI: 10.1007/s12032-017-1014-2.
- Gillessen S, Attard G, Beer T, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung B, Clarke N, Daugaard G, Davis I, de Bono J, dos Reis R, Drake C, Eeles R, Efstathiou E, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano C, James N, Kantoff P, Kellokumpu-Lehtinen P, Khauli R, Kramer G, Logothetis C, Maluf F, Morgans A, Morris M, Mottet N, Murthy V, Oh W, Ost P, Padhani A, Parker C, Pritchard C, Roach M, Rubin M, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg C, Suzuki H, Sweeney C, Sydes M, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European Urology 2017, 73: 178-211. PMID: 28655541, DOI: 10.1016/j.eururo.2017.06.002.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Dhawan R, Duh M. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting. Clinical Genitourinary Cancer 2017, 16: 50-57. PMID: 28729067, DOI: 10.1016/j.clgc.2017.06.004.
- Pomerantz M, Spisák S, Jia L, Cronin A, Csabai I, Ledet E, Sartor A, Rainville I, O'Connor E, Herbert Z, Szállási Z, Oh W, Kantoff P, Garber J, Schrag D, Kibel A, Freedman M. The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer. Cancer 2017, 123: 3532-3539. PMID: 28608931, PMCID: PMC5802871, DOI: 10.1002/cncr.30808.
- Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed ExtubationChawla S, Natarajan G, Shankaran S, Carper B, Brion L, Keszler M, Carlo W, Ambalavanan N, Gantz M, Das A, Finer N, Goldberg R, Cotten C, Higgins R, Network E, Jobe A, Caplan M, Polin R, Laptook R, Oh W, Hensman A, Gingras D, Barnett S, Lillie S, Francis K, Andrews D, Angela K, Walsh M, Fanaroff A, Newman N, Siner B, Schibler K, Donovan E, Narendran V, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Goldberg R, Auten K, Fisher K, Foy K, Siaw G, Stoll B, Buchter S, Piazza A, Carlton D, Hale E, Archer S, Poindexter B, Lemons J, Hamer F, Herron D, Miller L, Wilson L, Berberich M, Blaisdell C, Gail D, Kiley J, Poole W, Cunningham M, Hastings B, Irene A, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Ball M, Proud M, Frantz I, Fiascone J, Furey A, MacKinnon B, Nylen E, Collins M, Cosby S, Phillips V, Rasmussen M, Wozniak P, Rich W, Arnell K, Bridge R, Demetrio C, Bell E, Widness J, Klein J, Johnson K, Duara S, Everett-Thomas R, Watterberg K, Ohls R, Rohr J, Lacy C, Phelps D, Laroia N, Reubens L, Burnell E, Sánchez P, Rosenfeld C, Salhab W, Allen J, Guzman A, Hensley G, Lepps M, Martin M, Miller N, Solis A, Vasil D, Wilder K, Kennedy K, Tyson J, Morris B, Harris B, Lis A, Martin S, McDavid G, Tate P, Wright S, Yoder B, Faix R, Burnett J, Jensen J, Osborne K, Spencer C, Weaver-Lewis K, O'Shea T, Peters N, Sood B, Bara R, Billian E, Johnson M, Ehrenkranz R, Jacobs H, Bhandari V, Cervone P, Gettner P, Konstantino M, Poulsen J, Taft J. Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation. The Journal Of Pediatrics 2017, 189: 113-119.e2. PMID: 28600154, PMCID: PMC5657557, DOI: 10.1016/j.jpeds.2017.04.050.
- Kyi C, Sabado R, Blazquez A, Posner M, Genden E, Miles B, Khorasani H, Dottino P, Irie H, Port E, Wolf A, Cho H, Parekh S, Mandeli J, Galsky M, Oh W, Gnjatic S, Schadt E, Friedlander P, Bhardwaj N. A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers. Journal Of Clinical Oncology 2017, 35: tps3114-tps3114. DOI: 10.1200/jco.2017.35.15_suppl.tps3114.
- Di Fiore J, Martin R, Li H, Morris N, Carlo W, Finer N, Walsh M, Health A, Jobe A, Caplan M, Polin R, Laptook R, Oh W, Hensman A, Gingras D, Barnett S, Lillie S, Francis K, Andrews D, Angela K, Fanaroff A, Newman N, Siner B, Zadell A, Schibler K, Donovan E, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Goldberg R, Cotten C, Wallace D, Freedman S, Auten K, Fisher K, Foy K, Stoll B, Piazza A, Buchter S, Carlton D, Hutchinson A, Hale E, Higgins R, Archer S, Poindexter B, Lemons J, Hamer F, Herron D, Miller L, Wilson L, Berberich M, Blaisdell C, Gail D, Kiley J, Gantz M, Das A, Crawford M, Hastings B, Irene A, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Ball M, Proud M, Frantz I, Fiascone J, Furey A, MacKinnon B, Nylen E, Ambalavanan N, Collins M, Cosby S, Phillips V, Rasmussen M, Wozniak P, Rich W, Arnell K, Bridge R, Demetrio C, Bell E, Widness J, Klein J, Johnson K, Duara S, Everett-Thomas R, Watterberg K, Ohls R, Rohr J, Lacy C, Phelps D, Laroia N, Markowitz G, Reubens L, Burnell E, Sánchez P, Rosenfeld C, Salhab W, Allen J, Grau L, Guzman A, Hensley G, Lepps M, Martin M, Miller N, Solis A, Vasil D, Wilder K, Kennedy K, Tyson J, Morris B, Harris B, Lis A, Martin S, McDavid G, Tate P, Wright S, Yoder B, Faix R, Burnett J, Jensen J, Osborne K, Spencer C, Weaver-Lewis K, O'Shea T, Peters N, Shankaran S, Sood B, Bara R, Billian E, Johnson M, Ehrenkranz R, Narendran V, Bhandari V, Jacobs H, Cervone P, Gettner P, Konstantino M, Poulsen J, Taft J. Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. The Journal Of Pediatrics 2017, 186: 49-56.e1. PMID: 28279433, PMCID: PMC5484739, DOI: 10.1016/j.jpeds.2017.01.057.
- Friedlander P, Wassman K, Kyi C, Oh W, Bhardwaj N. Correlation of consistent blood-based gene expression with change in CTLA4 in two large independent clinical studies of patients with advanced melanoma treated with tremelimumab. Journal Of Clinical Oncology 2017, 35: 6-6. DOI: 10.1200/jco.2017.35.7_suppl.6.
- Oh W, Kandadi H, Sheikh N, Galsky M. Blood-based predictive biomarkers for overall survival (OS) in patients (pts) receiving the immunotherapy sipuleucel-T (sip-T). Journal Of Clinical Oncology 2017, 35: 36-36. DOI: 10.1200/jco.2017.35.7_suppl.36.
- Galsky M, Shahin M, Olson A, Shaffer D, Gimpel-Tetra K, Tsao C, Baker C, Leiter A, Holland J, Sablinski T, Mehrazin R, Sfakianos J, Acon P, Oh W. Telemedicine-enabled clinical trial of metformin in patients (pts) with biochemically-recurrent prostate cancer (PCa). Journal Of Clinical Oncology 2017, 35: 243-243. DOI: 10.1200/jco.2017.35.6_suppl.243.
- Oh W, Cheng W, Miao R, Vekeman F, Gauthier-Loiselle M, Duh M, Drea E, Szatrowski T. Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices. Journal Of Clinical Oncology 2017, 35: 214-214. DOI: 10.1200/jco.2017.35.6_suppl.214.
- Tsao C, Liaw B, He C, Galsky M, Sfakianos J, Oh W. Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications. Therapeutic Advances In Medical Oncology 2017, 9: 287-298. PMID: 28491148, PMCID: PMC5405995, DOI: 10.1177/1758834016687261.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Effects of Soybean Lipid Infusion on Unbound Free Fatty Acids and Unbound Bilirubin in Preterm Infants. The Journal Of Pediatrics 2017, 184: 45-50.e1. PMID: 28108102, PMCID: PMC5403563, DOI: 10.1016/j.jpeds.2016.12.026.
- McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. Journal For ImmunoTherapy Of Cancer 2016, 4: 92. PMID: 28031820, PMCID: PMC5170901, DOI: 10.1186/s40425-016-0198-x.
- Roubaud G, Liaw B, Oh W, Mulholland D. Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer. Nature Reviews Clinical Oncology 2016, 14: 269-283. PMID: 27874061, PMCID: PMC5567685, DOI: 10.1038/nrclinonc.2016.181.
- Tsao C, Sfakianos J, Liaw B, Gimpel‐Tetra K, Kemeny M, Bulone L, Shahin M, Oh W, Galsky M. Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer. The Oncologist 2016, 21: 1414-e9. PMID: 27742908, PMCID: PMC5153336, DOI: 10.1634/theoncologist.2016-0026.
- Stock R, Sfakianos J, Oh W, Stone N. Prostate-Specific Antigen Doubling Time Posttreatment Is the Most Significant Predictor of Survival Following the Brachytherapy Management of Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e236. DOI: 10.1016/j.ijrobp.2016.06.1216.
- Gong Y, Wang L, Chippada-Venkata U, Dai X, Oh W, Zhu J. Constructing bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression. Oncotarget 2016, 7: 68688-68707. PMID: 27626693, PMCID: PMC5356583, DOI: 10.18632/oncotarget.11925.
- Wang L, Oh W, Zhu J. Disease-specific classification using deconvoluted whole blood gene expression. Scientific Reports 2016, 6: 32976. PMID: 27596246, PMCID: PMC5011717, DOI: 10.1038/srep32976.
- Casey M, Wisnivesky J, Le V, Sarpel U, Stensland K, Oh W, Galsky M. The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer. Bladder Cancer 2016, 2: 319-327. PMID: 27500199, PMCID: PMC4969695, DOI: 10.3233/blc-160058.
- Tsao C, Galsky M, Oh W. Docetaxel for Metastatic Hormone-sensitive Prostate Cancer: Urgent Need to Minimize the Risk of Neutropenic Fever. European Urology 2016, 70: 707-708. PMID: 27417033, DOI: 10.1016/j.eururo.2016.06.041.
- Galsky M, Stensland K, Sfakianos J, Mehrazin R, Diefenbach M, Mohamed N, Tsao C, Boffetta P, Wiklund P, Oh W, Mazumdar M, Ferket B. Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement. Journal Of Clinical Oncology 2016, 34: 2627-2635. PMID: 27269939, PMCID: PMC5012691, DOI: 10.1200/jco.2016.67.5033.
- Patel V, McBride R, Lorduy A, Castillo-Martin M, Cha E, Berger M, Wang L, Oh W, Zhu J, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Prognostic significance of PIK3CA mutation in patients with muscle-invasive urothelial carcinoma (UC). Journal Of Clinical Oncology 2016, 34: e16002-e16002. DOI: 10.1200/jco.2016.34.15_suppl.e16002.
- Oh W, Kandadi H, Fan L, Sheikh N, Trager J, Galsky M. Blood-based predictive biomarkers for overall survival (OS) in patients (pts) receiving the immunotherapy sipuleucel-T (sip-T). Journal Of Clinical Oncology 2016, 34: 5026-5026. DOI: 10.1200/jco.2016.34.15_suppl.5026.
- McBride R, Patel V, Lorduy A, Castillo-Martin M, Cha E, Berger M, Wang L, Oh W, Zhu J, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Prognostic significance of DNA damage repair (DDR) mutations in patients with urothelial carcinoma (UC) and associations with tumor infiltrating lymphocytes (TILs). Journal Of Clinical Oncology 2016, 34: 4538-4538. DOI: 10.1200/jco.2016.34.15_suppl.4538.
- Galsky M, Stensland K, Sfakianos J, Mehrazin R, Diefenbach M, Tsao C, Boffetta P, Oh W, Mazumdar M, Ferket B. Comparative effectiveness of treatment strategies for urothelial cancer of the bladder (UCB) with clinical lymph node involvement (cN+). Journal Of Clinical Oncology 2016, 34: 4530-4530. DOI: 10.1200/jco.2016.34.15_suppl.4530.
- Oh W, Tombal B, Delacruz A, Tomlinson B, Vella Ripley A, Drudge-Coates L, Mastris K, O'Sullivan J, Shore N. Recognizing symptom burden in advanced prostate cancer: A global patient and caregiver survey. Journal Of Clinical Oncology 2016, 34: 10124-10124. DOI: 10.1200/jco.2016.34.15_suppl.10124.
- Heck M, Thalgott M, Schmid S, Oh W, Gong Y, Wang L, Zhu J, Seitz A, Porst D, Höppner M, Retz M, Gschwend J, Nawroth R. A 2‐Gene Panel Derived From Prostate Cancer‐Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration‐Resistant Prostate Cancer. The Prostate 2016, 76: 1160-1168. PMID: 27198487, DOI: 10.1002/pros.23202.
- Collazo-Lorduy A, Castillo-Martin M, Wang L, Patel V, Iyer G, Jordan E, Al-Ahmadie H, Leonard I, Oh W, Zhu J, McBride R, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition. European Urology 2016, 70: 771-775. PMID: 27178450, PMCID: PMC5489411, DOI: 10.1016/j.eururo.2016.04.037.
- Oh W, Miao R, Duh, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Fortier J, Dhawan R. PCN33 Treatment Sequences, Patient Characteristics, And Overall Survival Of Patients With Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer In The Community Setting. Value In Health 2016, 19: a139. DOI: 10.1016/j.jval.2016.03.1655.
- Colaizy T, Bartick M, Jegier B, Green B, Reinhold A, Schaefer A, Bogen D, Schwarz E, Stuebe A, Jobe A, Oh W, Vohr B, Walden R, Alksninis B, Hensman A, Leonard M, Noel L, Leach T, Watson V, Fanaroff A, Walsh M, Wilson-Costello D, Newman N, Siner B, Friedman H, Donovan E, Schibler K, Steichen J, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Gratton T, Stoll B, Adams-Chapman I, Hale E, LaRossa M, Carter S, Higgins R, Wright L, McClure E, Poindexter B, Lemons J, Dusick A, Kardatzke D, Lytle C, Appel D, Bohnke L, Eaken G, Herron D, Miller L, Richard L, Wilson L, Das A, Poole W, Wrage L, Hastings B, McClure E, Auman J, Taylor S, Stevenson D, Hintz S, Ball M, Kohn J, Baran J, Lee-Ancajas J, St. John N, Carlo W, Ambalavanan N, Nelson K, Peralta-Carcelen M, Bailey K, Biasini F, Chopko S, Collins M, Cosby S, Phillips V, Rector R, Finer N, Vaucher Y, Anderson J, Rasmussen M, Arnell K, Demetrio C, Fuller M, Henderson C, Posin D, Bell E, Colaizy T, Bauer C, Duara S, Worth A, Everett-Thomas R, Diaz A, Mathews E, Hamlin-Smith K, Jean-Gilles L, Calejo M, Frade S, Hiriart-Fajardo S, Gideon Y, Korones S, Bada H, Hudson T, Yolton K, Williams M, Laptook R, Salhab W, Broyles R, Madison S, Hickman J, Guzman A, Adams S, Madden L, Heyne E, Dooley C, Shankaran S, Delaney-Black V, Johnson Y, Bara R, Muran G, Kennedy D, Goldston L, Ehrenkranz R, Gettner P, Konstantino M, Romano E, Close N, Gilliam W, Poulsen J. Impact of Optimized Breastfeeding on the Costs of Necrotizing Enterocolitis in Extremely Low Birthweight Infants. The Journal Of Pediatrics 2016, 175: 100-105.e2. PMID: 27131403, PMCID: PMC5274635, DOI: 10.1016/j.jpeds.2016.03.040.
- Shevach J, Marcellino B, Oh W, Tsao C. Enzalutamide in Metastatic Castration Resistant Prostate Cancer. 2016, 157-169. DOI: 10.1007/978-3-319-31341-2_10.
- D'Angio CT, Ambalavanan N, Carlo WA, McDonald SA, Skogstrand K, Hougaard DM, Shankaran S, Goldberg RN, Ehrenkranz RA, Tyson JE, Stoll BJ, Das A, Higgins RD, Das A, McDonald S, Jobe A, Laptook R, Oh W, Rubin L, Hensman A, Fanaroff A, Walsh M, Newman N, Siner B, Donovan E, Narendran V, Alexander B, Grisby C, Hessling J, Mersmann M, Mincey H, Cotten C, Auten K, Hale E, Wright L, Yaffe S, McClure E, Poindexter B, Lemons J, Appel D, Herron D, Wilson L, Poole W, Hastings B, Zaterka-Baxter K, Auman J, Schaefer S, Stevenson D, Van Meurs K, Ball M, Skogstrand K, Hougaard D, Collins M, Cosby S, Finer N, Rasmussen M, Kaegi D, Arnell K, Demetrio C, Rich W, Bauer C, Duara S, Everett-Thomas R, Papile L, Lacy C, Korones S, Bada H, Hudson T, Laptook R, Salhab W, Madison S, Kennedy K, Morris B, Akpa E, Cluff P, Franco C, Lis A, McDavid G, Tate P, O'Shea T, Peters N, Konduri G, Bara R, Muran G, Gettner P, Konstantino M, Poulsen J. Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2016, 174: 45-51.e5. PMID: 27117196, PMCID: PMC4925295, DOI: 10.1016/j.jpeds.2016.03.058.
- Leiter A, Doucette J, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh W, Galsky M. Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma. Bladder Cancer 2016, 2: 341-349. PMID: 27500201, PMCID: PMC4969712, DOI: 10.3233/blc-160047.
- Phelps DL, Ward RM, Williams RL, Nolen TL, Watterberg KL, Oh W, Goedecke M, Ehrenkranz RA, Fennell T, Poindexter BB, Cotten CM, Hallman M, Frantz ID, Faix RG, Zaterka-Baxter KM, Das A, Ball MB, Lacy CB, Walsh MC, Carlo WA, Sánchez PJ, Bell EF, Shankaran S, Carlton DP, Chess PR, Higgins RD. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatric Research 2016, 80: 209-217. PMID: 27074126, PMCID: PMC5198845, DOI: 10.1038/pr.2016.97.
- Kesar V, Devuni D, Azad A, Bichoupan K, Branch A, Oh W, Galsky M, Ahmad J, Odin J. 357 The Clinical Spectrum of Liver Injury in Cancer Patients. Gastroenterology 2016, 150: s1029. DOI: 10.1016/s0016-5085(16)33482-5.
- Heck M, Thalgott M, Schmid S, Oh W, Gong Y, Wang L, Zhu J, Seitz A, Porst D, Höppner M, Retz M, Gschwend J, Nawroth R. 1072 A 2-gene panel derived from prostate cancer-enhanced transcripts in whole blood is prognostic for survival and predicts treatment benefit in metastatic castration-resistant prostate cancer. European Urology Open Science 2016, 15: e1072. DOI: 10.1016/s1569-9056(16)61073-4.
- Kim S, Isola L, Oh W. Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion. Anti-Cancer Drugs 2016, 27: 235-238. PMID: 26628483, DOI: 10.1097/cad.0000000000000321.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Boffetta P, Oh W, Mazumdar M, Wisnivesky J. Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer. Journal Of Clinical Oncology 2016, 34: 825-832. PMID: 26786930, DOI: 10.1200/jco.2015.64.1076.
- Galsky M, Stensland K, Sfakianos J, McBride R, Mehrazin R, Tsao C, Boffetta P, Oh W. Frequency and clinical implications of pathologic complete response (pCR) at cystectomy for muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy (NAC). Journal Of Clinical Oncology 2016, 34: 383-383. DOI: 10.1200/jco.2016.34.2_suppl.383.
- Galsky M, Hahn N, Albany C, Fleming M, Starodub A, Twardowski P, Pal S, Hauke R, Sonpavde G, Oh W, Bhardwaj N, Gnjatic S, Kim-Schulze S, Liu Z. Phase II trial of gemcitabine + cisplatin + ipilimumab in patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2016, 34: 357-357. DOI: 10.1200/jco.2016.34.2_suppl.357.
- Mirza H, Laptook R, Oh W, Vohr B, Stoll B, Kandefer S, Stonestreet B, Network A. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants. Archives Of Disease In Childhood Fetal & Neonatal 2016, 101: f418. PMID: 26733540, PMCID: PMC4935651, DOI: 10.1136/archdischild-2015-309112.
- Galsky M, Noah H, Starodub A, Hauke R, Twardowski P, Fleming M, Qi J, Sonpavde G, Patel M, Zhu J, Chippada-Venkata U, Albany C, Wang L, Merad M, Oh W, Bhardwaj N, Gnjatic S, Kim-Schulze S. Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer. Journal For ImmunoTherapy Of Cancer 2015, 3: p257. PMCID: PMC4649313, DOI: 10.1186/2051-1426-3-s2-p257.
- Mercer J, Erickson-Owens D, Vohr B, Tucker R, Parker A, Oh W, Padbury J. Effects of Placental Transfusion on Neonatal and 18 Month Outcomes in Preterm Infants: A Randomized Controlled Trial. The Journal Of Pediatrics 2015, 168: 50-55.e1. PMID: 26547399, PMCID: PMC4698069, DOI: 10.1016/j.jpeds.2015.09.068.
- Beer T, Vogelzang N, Bartůňková J, Miller K, Oh W, Oudard S, Pandha H, Sartor A, Špíšek R, Toole T, Borgstein N, Gerritsen W. Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer. Journal For ImmunoTherapy Of Cancer 2015, 3: p164. PMCID: PMC4646109, DOI: 10.1186/2051-1426-3-s2-p164.
- Williams E, Rodriguez-Bravo V, Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh W, Cordon-Cardo C, Domingo-Domenech J. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Journal Of Visualized Experiments 2015, 53182. PMID: 26555435, PMCID: PMC4692658, DOI: 10.3791/53182.
- Williams E, Rodriguez-Bravo V, Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh W, Cordon-Cardo C, Domingo-Domenech J. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Journal Of Visualized Experiments 2015 DOI: 10.3791/53182-v.
- Gartrell B, Small A, Oh W, Galsky M. Renal Cell Carcinoma and Targeted Therapy. 2015, 287-295. DOI: 10.1002/9781118468678.ch29.
- Galsky M, Hahn N, Wong B, Lee K, Argiriadi P, Albany C, Gimpel-Tetra K, Lowe N, Shahin M, Patel V, Tsao C, Oh W. Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma. Cancer Chemotherapy And Pharmacology 2015, 76: 1259-1265. PMID: 26464352, DOI: 10.1007/s00280-015-2884-7.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Fortier J, Dhawan R, Hennessy D, Duh M. 2512 Is there a difference in outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) who receive chemotherapy (CT) vs androgen receptor-targeted therapy (ART) after 1st-line ART in the community setting? European Journal Of Cancer 2015, 51: s478. DOI: 10.1016/s0959-8049(16)31332-6.
- Wang L, Gong Y, Chippada-Venkata U, Heck M, Retz M, Nawroth R, Galsky M, Tsao C, Schadt E, de Bono J, Olmos D, Zhu J, Oh W. A robust blood gene expression-based prognostic model for castration-resistant prostate cancer. BMC Medicine 2015, 13: 201. PMID: 26297150, PMCID: PMC4546313, DOI: 10.1186/s12916-015-0442-0.
- Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky M, Oh W. Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer. Frontiers In Oncology 2015, 5: 129. PMID: 26125012, PMCID: PMC4467174, DOI: 10.3389/fonc.2015.00129.
- Gillessen S, Omlin A, Attard G, de Bono J, Efstathiou E, Fizazi K, Halabi S, Nelson P, Sartor O, Smith M, Soule H, Akaza H, Beer T, Beltran H, Chinnaiyan A, Daugaard G, Davis I, De Santis M, Drake C, Eeles R, Fanti S, Gleave M, Heidenreich A, Hussain M, James N, Lecouvet F, Logothetis C, Mastris K, Nilsson S, Oh W, Olmos D, Padhani A, Parker C, Rubin M, Schalken J, Scher H, Sella A, Shore N, Small E, Sternberg C, Suzuki H, Sweeney C, Tannock I, Tombal B. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals Of Oncology 2015, 26: 1589-1604. PMID: 26041764, PMCID: PMC4511225, DOI: 10.1093/annonc/mdv257.
- Vogelzang N, Beer T, Bartunkova J, Kuklík R, Miller K, Oh W, Oudard S, Pandha H, Sartor A, Spisek R, Borgstein N, Gerritsen W. Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer. Journal Of Clinical Oncology 2015, 33: tps5070-tps5070. DOI: 10.1200/jco.2015.33.15_suppl.tps5070.
- Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky M, Oh W. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. Journal Of Clinical Oncology 2015, 33: e16036-e16036. DOI: 10.1200/jco.2015.33.15_suppl.e16036.
- Oh W, Miao R, Duh M, Vekeman F, Sung J, Cheng W, Hennessy D, Gauthier-Loiselle M, Fortier J, Dhawan R. Clinical features and overall survival (OS) in patients (pts) with post-docetaxel (DTX) metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) therapy in the community setting. Journal Of Clinical Oncology 2015, 33: e16029-e16029. DOI: 10.1200/jco.2015.33.15_suppl.e16029.
- Liaw B, Chippada-Venkata U, Gong Y, Wang L, Zhu J, Heck M, Tsao C, Galsky M, Oh W. Influence of prostate cancer disease state and therapeutic selection on peripheral whole-blood RNA signature. Journal Of Clinical Oncology 2015, 33: 5046-5046. DOI: 10.1200/jco.2015.33.15_suppl.5046.
- Galsky M, Hahn N, Albany C, Fleming M, Starodub A, Twardowski P, Hauke R, Sonpavde G, Merad M, Gnjatic S, Bhardwaj N, Chippada-Venkata U, Oh W, Kim-Schulze S. Impact of gemcitabine + cisplatin + ipilimumab on circulating immune cells in patients (pts) with metastatic urothelial cancer (mUC). Journal Of Clinical Oncology 2015, 33: 4586-4586. DOI: 10.1200/jco.2015.33.15_suppl.4586.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Hall S, Boffetta P, Oh W, Wisnivesky J. Effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa). Journal Of Clinical Oncology 2015, 33: 4517-4517. DOI: 10.1200/jco.2015.33.15_suppl.4517.
- Liaw B, Oh W. Is docetaxel the 'black widow' of mCRPC drugs? Nature Reviews Clinical Oncology 2015, 12: 316-318. PMID: 25917253, DOI: 10.1038/nrclinonc.2015.79.
- Leiter A, Doucette J, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh W, Galsky M. Impact of obesity in patients with metastatic urothelial carcinoma. Journal Of Clinical Oncology 2015, 33: 346-346. DOI: 10.1200/jco.2015.33.7_suppl.346.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Hall S, Boffetta P, Oh W, Wisnivesky J. Comparative effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa). Journal Of Clinical Oncology 2015, 33: 292-292. DOI: 10.1200/jco.2015.33.7_suppl.292.
- Liaw B, Chippada-Venkata U, Gong Y, Wang L, Zhu J, Heck M, Tsao C, Galsky M, Oh W. Influence of prostate cancer disease state and therapeutic selection on peripheral whole-blood RNA signature. Journal Of Clinical Oncology 2015, 33: 166-166. DOI: 10.1200/jco.2015.33.7_suppl.166.
- Liaw B, Shevach J, Oh W. Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy. Current Urology Reports 2015, 16: 13. PMID: 25677235, DOI: 10.1007/s11934-015-0486-x.
- Leiter A, Diefenbach M, Doucette J, Oh W, Galsky M. Clinical trial awareness: Changes over time and sociodemographic disparities. Clinical Trials 2015, 12: 215-223. PMID: 25673636, PMCID: PMC4667750, DOI: 10.1177/1740774515571917.
- Galsky M, Stensland K, McBride R, Latif A, Moshier E, Oh W, Wisnivesky J. Geographic Accessibility to Clinical Trials for Advanced Cancer in the United States. JAMA Internal Medicine 2015, 175: 293-295. PMID: 25437434, DOI: 10.1001/jamainternmed.2014.6300.
- Tsao C, Gray K, Nakabayashi M, Evan C, Kantoff P, Huang J, Galsky M, Pomerantz M, Oh W. Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease. Journal Of Urology 2015, 194: 91-97. PMID: 25623747, DOI: 10.1016/j.juro.2015.01.078.
- Casey M, Gross T, Wisnivesky J, Stensland K, Oh W, Galsky M. The Impact of Regionalization of Cystectomy on Racial Disparities in Bladder Cancer Care. Journal Of Urology 2015, 194: 36-41. PMID: 25623748, DOI: 10.1016/j.juro.2015.01.076.
- Gong Y, Chippada‐Venkata U, Galsky M, Huang J, Oh W. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer. The Prostate 2015, 75: 616-627. PMID: 25560638, DOI: 10.1002/pros.22945.
- Petrylak DP, Gandhi JG, Clark WR, Heath E, Lin J, Oh WK, Agus DB, Carthon B, Moran S, Kong N, Suri A, Bargfrede M, Liu G. Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel–prednisone in metastatic castration-resistant prostate cancer. Investigational New Drugs 2015, 33: 397-408. PMID: 25556680, PMCID: PMC4390470, DOI: 10.1007/s10637-014-0199-x.
- Tsao C, Liaw B, Oh W, Galsky M. Muscle invasive bladder cancer: closing the gap between practice and evidence. Minerva Urologica E Nefrologica 2014, 67: 65-73. PMID: 25424386.
- Ambalavanan N, Carlo W, Wrage L, Das A, Laughon M, Cotten C, Kennedy K, Laptook R, Shankaran S, Walsh M, Higgins R, Jobe A, Caplan M, Oh W, Vohr B, Hensman A, Stephens B, Alksninis B, Barnett S, Cashore W, Caskey M, Gargus R, Gingras D, Johnson K, Lainwala S, Leach T, Leonard M, Lillie S, Moore J, Noel L, Walden R, Watson V, Fanaroff A, Wilson-Costello D, Newman N, Siner B, Zadell A, Di Fiore J, Bhola M, Friedman H, Yalcinkaya G, Schibler K, Donovan E, Yolton K, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Gratton T, Goldberg R, Goldstein R, Ashley P, Auten K, Fisher K, Foy K, Freedman S, Gustafson K, Lohmeyer M, Malcolm W, Wallace D, Stoll B, Buchter S, Piazza A, Carlton D, Adams-Chapman I, Carter S, Hale E, Hutchinson A, LaRossa M, Archer S, Poindexter B, Dusick A, Lemons J, Wilson L, Hamer F, Cook A, Herron D, Lytle C, Minnich H, Poole W, Gantz M, Newman J, Hastings B, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Hintz S, Ball M, Bentley B, Bruno E, Davis A, DeAnda M, DeBattista A, Kohn J, Proud M, Pyle R, St John N, Weiss H, Frantz I, Fiascone J, McGowan E, Furey A, MacKinnon B, Nylen E, Brussa A, Sibley C, Peralta-Carcelen M, Collins M, Cosby S, Phillips V, Bailey K, Biasini F, Johnston K, Krzywanski S, Nelson K, Patterson C, Rector R, Rodrigues L, Soong A, Whitley S, Finer N, Rasmussen M, Wozniak P, Vaucher Y, Rich W, Arnell K, Bridge R, Demetrio C, Fuller M, Zlotnik P, Bell E, Widness J, Klein J, Acarregui M, Colaizy T, Johnson K, Eastman D, Duara S, Bauer C, Everett-Thomas R, Calejo M, Diaz A, Eguaras S, Garcia A, Hamlin-Smith K, Berkowits M, Fajardo-Hiriart S, Mathews E, Pierre H, Riguard A, Stroerger A, Watterberg K, Ohls R, Fuller J, Lacy C, Lowe J, Montman R, Phelps D, Myers G, Markowitz G, Reubens L, Hust D, Johnson J, Burnell E, Jensen R, Kushner E, Merzbach J, Yost K, Sánchez P, Rosenfeld C, Salhab W, Heyne R, Brion L, Adams S, Allen J, Grau L, Guzman A, Hensley G, Heyne E, Leps M, Madden L, Martin M, Miller N, Morgan J, Solis A, Torres L, Boatman C, Vasil D, Tyson J, Alaniz N, Evans P, Harris B, Green C, Jiminez M, Lis A, Martin S, McDavid G, Morris B, Poundstone M, Reddoch S, Siddiki S, Tate P, Whitely L, Wright S, Faix R, Yoder B, Baker S, Bird K, Burnett J, Osborne K, Spencer C, Steffen M, Weaver-Lewis K, O'Shea T, Dillard R, Washburn L, Peters N, Jackson B, Chiu K, Allred D, Goldstein D, Halfond R, Peterson C, Waldrep E, Welch C, Morris M, Hounshell G, Sood B, Pappas A, Bara R, Goldston L, Johnson M, Ehrenkranz R, Bhandari V, Williams J. PaCO2 in Surfactant, Positive Pressure, and Oxygenation Randomised Trial (SUPPORT). Archives Of Disease In Childhood Fetal & Neonatal 2014, 100: f145. PMID: 25425651, PMCID: PMC4336211, DOI: 10.1136/archdischild-2014-306802.
- Sonpavde G, Wang C, Galsky M, Oh W, Armstrong A. Cytotoxic chemotherapy in the contemporary management of metastatic castration‐resistant prostate cancer (mCRPC). BJU International 2014, 116: 17-29. PMID: 25046451, DOI: 10.1111/bju.12867.
- Courtney K, Manola J, Elfiky A, Ross R, Oh W, Yap J, Van den Abbeele A, Ryan C, Beer T, Loda M, Priolo C, Kantoff P, Taplin M. A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 2014, 13: 113-123. PMID: 25450031, PMCID: PMC4418946, DOI: 10.1016/j.clgc.2014.08.007.
- Leiter A, Sablinski T, Diefenbach M, Foster M, Greenberg A, Holland J, Oh W, Galsky M. Use of Crowdsourcing for Cancer Clinical Trial Development. Journal Of The National Cancer Institute 2014, 106: dju258. PMID: 25217580, DOI: 10.1093/jnci/dju258.
- Stensland K, McBride R, Latif A, Wisnivesky J, Hendricks R, Roper N, Boffetta P, Hall S, Oh W, Galsky M. Adult Cancer Clinical Trials That Fail to Complete: An Epidemic? Journal Of The National Cancer Institute 2014, 106: dju229. PMID: 25190726, DOI: 10.1093/jnci/dju229.
- Agarwal N, Apolo A, Tsao C, Lee K, Godbold J, Soto R, Poole A, Gimpel‐Tetra K, Lowe N, Oh W, Galsky M. Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First‐Line Therapy in Patients With Metastatic Urothelial Carcinoma. The Oncologist 2014, 19: 915-916. PMID: 25052451, PMCID: PMC4153455, DOI: 10.1634/theoncologist.2014-0153.
- Martin J, Oh W. Evidence-Based Therapeutic Approaches for mCRPC Patients: Rational Sequence of Standard Treatment Options and Design for Future Drug Development. Current Clinical Urology 2014, 321-327. DOI: 10.1007/978-1-4939-1176-9_23.
- Galsky M, Posner M, Holcombe R, Lee K, Misiukiewicz K, Tsao C, Godbold J, Soto R, Gimpel-Tetra K, Lowe N, Oh W. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer Chemotherapy And Pharmacology 2014, 74: 465-471. PMID: 25023489, PMCID: PMC4146643, DOI: 10.1007/s00280-014-2518-5.
- Elfiky A, Pomerantz M, Katz L, Oh W. Genitourinary Cancers. 2014, 118-129. DOI: 10.1093/med/9780199358274.003.0013.
- Gong Y, Chippada-Venkata U, Oh W. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression. Cancers 2014, 6: 1298-1327. PMID: 24978435, PMCID: PMC4190542, DOI: 10.3390/cancers6031298.
- Galsky M, Oh W. Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics. Cancer 2014, 120: 2944-2945. PMID: 24965362, DOI: 10.1002/cncr.28808.
- Saenger Y, Magidson J, Liaw B, de Moll E, Harcharik S, Fu Y, Wassmann K, Fisher D, Kirkwood J, Oh WK, Friedlander P. Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab. Clinical Cancer Research 2014, 20: 3310-3318. PMID: 24721645, DOI: 10.1158/1078-0432.ccr-13-2906.
- Bickell N, Hall S, Stock R, Fei K, Veluswamy R, Franco R, Oh W. Does race affect the quality of treatment for intermediate-risk and high-risk prostate cancer? Journal Of Clinical Oncology 2014, 32: e17678-e17678. DOI: 10.1200/jco.2014.32.15_suppl.e17678.
- Leiter A, Sablinski T, Diefenbach M, Foster M, Greenberg A, Holland J, Oh W, Galsky M. Use of crowdsourcing for cancer clinical trial development. Journal Of Clinical Oncology 2014, 32: e16019-e16019. DOI: 10.1200/jco.2014.32.15_suppl.e16019.
- The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questionsYu E, Oh W. The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions. Asian Journal Of Andrology 2014, 16: 331-333. PMID: 24759585, PMCID: PMC4023355, DOI: 10.4103/1008-682x.127813.
- Tsao C, Cutting E, Martin J, Oh W. The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer. Therapeutic Advances In Urology 2014, 6: 97-104. PMID: 24883107, PMCID: PMC4003844, DOI: 10.1177/1756287214528557.
- Tsao C, Small A, Hall S, Oh W, Galsky M, Buckstein M, Stock R, Ali G, Morris G. T2 Muscle-Invasive Bladder Cancer. Seminars In Oncology 2014, 41: e11-e18. PMID: 24787300, DOI: 10.1053/j.seminoncol.2014.03.005.
- Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM. Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease. Journal Of Investigative Dermatology 2014, 134: 2202-2211. PMID: 24522433, PMCID: PMC4291112, DOI: 10.1038/jid.2014.85.
- Morgan C, Oh W, Naik G, Galsky M, Sonpavde G. Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials. Critical Reviews In Oncology/Hematology 2014, 90: 253-261. PMID: 24500033, DOI: 10.1016/j.critrevonc.2013.12.001.
- Liaw B, Seng S, Galsky M, Tsao C, Febbo P, Oh W. Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer. Journal Of Clinical Oncology 2014, 32: 170-170. DOI: 10.1200/jco.2014.32.4_suppl.170.
- Galsky M, Latif A, Stensland K, Moshier E, McBride R, Hendricks R, Sonpavde G, Godbold J, Hall S, Oh W, Wisnivesky J. Distribution and geographic accessibility of prostate cancer clinical trials in the United States. Journal Of Clinical Oncology 2014, 32: 59-59. DOI: 10.1200/jco.2014.32.4_suppl.59.
- Oh W, Chippada Venkata U, Wang L, Reese E, Yee T, Kochukoshy T, Tsao C, Galsky M, Zhu J, Gong Y. Validation of a whole-blood RNA prognostic signature in metastatic castration-resistant prostate cancer (mCRPC) patients. Journal Of Clinical Oncology 2014, 32: 36-36. DOI: 10.1200/jco.2014.32.4_suppl.36.
- Tsao C, Agarwal N, Apolo A, Lee K, Godbold J, Oh W, Galsky M. Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma. Journal Of Clinical Oncology 2014, 32: 321-321. DOI: 10.1200/jco.2014.32.4_suppl.321.
- Casey M, Gross T, Stensland K, Oh W, Galsky M. Geographic and racial disparities in the utilization of low-volume cystectomy hospitals for bladder cancer. Journal Of Clinical Oncology 2014, 32: 302-302. DOI: 10.1200/jco.2014.32.4_suppl.302.
- Stensland K, McBride R, Wisnivesky J, Latif A, Hendricks R, Roper N, Boffetta P, Hall S, Oh W, Galsky M. Premature termination of genitourinary cancer clinical trials. Journal Of Clinical Oncology 2014, 32: 288-288. DOI: 10.1200/jco.2014.32.4_suppl.288.
- Naik G, Morgan C, Galsky M, Oh W, Sonpavde G. Meta-analysis of randomized trials to study the impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer. Journal Of Clinical Oncology 2014, 32: 28-28. DOI: 10.1200/jco.2014.32.4_suppl.28.
- Tsao C, Galsky M, Oh W. Is Metastatic Prostate Cancer Changing, and How Will We Know It? It's Time for Standard Nomenclature for Nonosseous Metastases in Clinical Trials of Patients with Metastatic Castration Resistant Prostate Cancer. European Urology 2014, 66: 184-185. PMID: 24433812, DOI: 10.1016/j.eururo.2013.12.061.
- Doctor S, Tsao C, Godbold J, Galsky M, Oh W. Is prostate cancer changing?: Evolving patterns of metastatic castration‐resistant prostate cancer. Cancer 2013, 120: 833-839. PMID: 25302607, DOI: 10.1002/cncr.28494.
- Sivendran S, Latif A, McBride R, Stensland K, Wisnivesky J, Haines L, Oh W, Galsky M. Adverse Event Reporting in Cancer Clinical Trial Publications. Journal Of Clinical Oncology 2013, 32: 83-89. PMID: 24323037, DOI: 10.1200/jco.2013.52.2219.
- OH W, McDERMOTT D, PORTA C, LEVY A, ELAIDI R, SCOTTE F, HAWKINS R, CASTELLANO D, BELLMUNT J, RHA S, SUN J, NATHAN P, FEINBERG B, SCOTT J, McDERMOTT R, AHN J, WAGSTAFF J, CHANG Y, OU Y, DONNELLAN P, HUANG C, McCAFFREY J, CHIANG P, CHUANG C, KORVES C, NEARY M, DIAZ J, MEHMUD F, DUH M. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review. International Journal Of Oncology 2013, 44: 5-16. PMID: 24247547, PMCID: PMC3867384, DOI: 10.3892/ijo.2013.2181.
- Ghavam S, Batra D, Mercer J, Kugelman A, Hosono S, Oh W, Rabe H, Kirpalani H. Effects of placental transfusion in extremely low birthweight infants: meta‐analysis of long‐ and short‐term outcomes. Transfusion 2013, 54: 1192-1198. PMID: 24843886, DOI: 10.1111/trf.12469.
- Oh W, Raju T. Not All “Term” Infants Are Created Equal. JAMA Pediatrics 2013, 167: 1001-1002. PMID: 24080941, DOI: 10.1001/jamapediatrics.2013.2593.
- Oh W, Venkata U, Wang L, Reese E, Yee T, Kochukoshy T, Tsao C, Galsky M, Zhu J, Gong Y. MC13-0070 Whole blood RNA signature as prognostic and predictive biomarker in genitourinary malignancies. European Journal Of Cancer 2013, 49: s32. DOI: 10.1016/s0959-8049(13)70178-3.
- Wadhawan R, Oh W, Hintz S, Blakely M, Das A, Bell E, Saha S, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. Journal Of Perinatology 2013, 34: 64-70. PMID: 24135709, PMCID: PMC3877158, DOI: 10.1038/jp.2013.128.
- Gong Y, Scott E, Lu R, Xu Y, Oh W, Yu Q. TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression. PLOS ONE 2013, 8: e77366. PMID: 24143225, PMCID: PMC3797040, DOI: 10.1371/journal.pone.0077366.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh W, Bamias A. Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy. Urologic Oncology Seminars And Original Investigations 2013, 32: 48.e1-48.e8. PMID: 24055428, DOI: 10.1016/j.urolonc.2013.07.001.
- Christensen R, Baer V, Gerday E, Sheffield M, Richards D, Shepherd J, Snow G, Bennett S, Frank E, Oh W. Whole-blood viscosity in the neonate: effects of gestational age, hematocrit, mean corpuscular volume and umbilical cord milking. Journal Of Perinatology 2013, 34: 16-21. PMID: 24030677, DOI: 10.1038/jp.2013.112.
- Stark AR, Carlo WA, Vohr BR, Papile LA, Saha S, Bauer CR, Oh W, Shankaran S, Tyson JE, Wright LL, Poole WK, Das A, Stoll BJ, Fanaroff AA, Korones SB, Ehrenkranz RA, Stevenson DK, Peralta-Carcelen M, Wilson-Costello DE, Bada HS, Heyne RJ, Johnson YR, Lee KG, Steichen JJ, Network E. Death or Neurodevelopmental Impairment at 18 to 22 Months Corrected Age in a Randomized Trial of Early Dexamethasone to Prevent Death or Chronic Lung Disease in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2013, 164: 34-39.e2. PMID: 23992673, PMCID: PMC4120744, DOI: 10.1016/j.jpeds.2013.07.027.
- Gartrell B, Ying J, Sivendran S, Boucher K, Choueiri T, Sonpavde G, Oh W, Agarwal N, Galsky M. Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. Targeted Oncology 2013, 9: 195-204. PMID: 23852656, PMCID: PMC4744485, DOI: 10.1007/s11523-013-0289-2.
- Galsky M, Oh W. Tumour angiogenesis: an elusive target in castration-resistant prostate cancer. The Lancet Oncology 2013, 14: 681-682. PMID: 23742876, DOI: 10.1016/s1470-2045(13)70239-0.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy. Cancer 2013, 119: 3020-3026. PMID: 23720197, DOI: 10.1002/cncr.28145.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Godbold J, Oh W, Bamias A. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy. Cancer 2013, 119: 3012-3019. PMID: 23720216, DOI: 10.1002/cncr.28146.
- Galsky M, Xie W, Nakabayashi M, Ross R, Fennessy F, Tempany C, Choueiri T, Khine K, Kantoff P, Taplin M, Oh W. Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer. Prostate Cancer And Prostatic Diseases 2013, 16: 266-270. PMID: 23712318, PMCID: PMC4026061, DOI: 10.1038/pcan.2013.15.
- Saenger Y, Magidson J, Liaw B, Wassmann K, Barker W, Harcharik S, Fisher D, Oh W, Friedlander P. Blood mRNA signature to predict survival in patients with metastatic melanoma treated with tremelimumab. Journal Of Clinical Oncology 2013, 31: 9080-9080. DOI: 10.1200/jco.2013.31.15_suppl.9080.
- Tsao C, Gray K, Nakabayashi M, Evan C, Galsky M, Kantoff P, Oh W, Pomerantz M. Association of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease. Journal Of Clinical Oncology 2013, 31: e16032-e16032. DOI: 10.1200/jco.2013.31.15_suppl.e16032.
- Stensland K, Latif A, Hendricks R, Roper N, McBride R, Hall S, Oh W, Galsky M. Prevalence and characteristics of prematurely terminated cancer clinical trials. Journal Of Clinical Oncology 2013, 31: 6613-6613. DOI: 10.1200/jco.2013.31.15_suppl.6613.
- Latif A, Stensland K, Hendricks R, Moshier E, Godbold J, Oh W, Galsky M. Cancer clinical trial accessibility in the United States: An analysis of travel distance. Journal Of Clinical Oncology 2013, 31: 6540-6540. DOI: 10.1200/jco.2013.31.15_suppl.6540.
- Doctor S, Tsao C, Godbold J, Galsky M, Oh W. Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011. Journal Of Clinical Oncology 2013, 31: 5015-5015. DOI: 10.1200/jco.2013.31.15_suppl.5015.
- Sivendran S, Chang R, Harcharik S, Hall L, Bernardo S, Moskalenko M, Phelps R, Sivendran M, Cohain A, DiFeo A, Parides M, Lebwohl M, Friedlander P, Banchereau J, Bhardwaj N, Oh W, Burakoff S, Palucka K, Merad M, Saenger Y. Immune gene expression in primary melanomas to predict lower risk of recurrence and death. Journal Of Clinical Oncology 2013, 31: 3014-3014. DOI: 10.1200/jco.2013.31.15_suppl.3014.
- Sivendran S, Agarwal N, Gartrell B, Ying J, Boucher K, Choueiri T, Sonpavde, Oh W, Galsky M. Metabolic complications with the use of mTOR inhibitors for cancer therapy. Cancer Treatment Reviews 2013, 40: 190-196. PMID: 23684373, PMCID: PMC4744486, DOI: 10.1016/j.ctrv.2013.04.005.
- Haines L, Bamias A, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde, Godbold J, Oh W, Galsky M. The Impact of Gender on Outcomes in Patients With Metastatic Urothelial Carcinoma. Clinical Genitourinary Cancer 2013, 11: 346-352. PMID: 23673281, DOI: 10.1016/j.clgc.2013.04.010.
- Cookson M, Roth B, Dahm P, Engstrom C, Freedland S, Hussain M, Lin D, Lowrance W, Murad M, Oh W, Penson D, Kibel A. Castration-Resistant Prostate Cancer: AUA Guideline. Journal Of Urology 2013, 190: 429-438. PMID: 23665272, DOI: 10.1016/j.juro.2013.05.005.
- Oh W. Cord milking at delivery improves the iron status of term infants at 6 weeks. BMJ Evidence-Based Medicine 2013, 18: e58. PMID: 23645906, DOI: 10.1136/eb-2013-101294.
- Mistry S, Oh W. New Paradigms in Microtubule-Mediated Endocrine Signaling in Prostate Cancer. Molecular Cancer Therapeutics 2013, 12: 555-566. PMID: 23635655, DOI: 10.1158/1535-7163.mct-12-0871.
- Tsao C, Liaw B, Yee T, Galsky M, Oh W. Metabolic and toxicological considerations of newly approved prostate cancer drugs. Expert Opinion On Drug Metabolism & Toxicology 2013, 9: 835-846. PMID: 23581700, DOI: 10.1517/17425255.2013.789019.
- Pollard M, Moskowitz A, Oh W, Galsky M, Hall S. 128 COST-EFFECTIVE ANALYSIS (CEA) OF THE CURRENT TREATMENT PARADIGM FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC). Journal Of Urology 2013, 189: e51-e52. DOI: 10.1016/j.juro.2013.02.1507.
- Mirza H, Oh W, Laptook, Vohr B, Tucker R, Stonestreet B. Indomethacin Prophylaxis to Prevent Intraventricular Hemorrhage: Association between Incidence and Timing of Drug Administration. The Journal Of Pediatrics 2013, 163: 706-710.e1. PMID: 23522865, PMCID: PMC3939677, DOI: 10.1016/j.jpeds.2013.02.030.
- Oh W, Doctor S, Godbold J, Galsky M, Tsao C. Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011. Journal Of Clinical Oncology 2013, 31: 195-195. DOI: 10.1200/jco.2013.31.6_suppl.195.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Kong N, Suri A, Bargfrede M, Liu G. A phase I/II study of safety and efficacy of orteronel (TAK-700), an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC): Updated phase II results. Journal Of Clinical Oncology 2013, 31: 59-59. DOI: 10.1200/jco.2013.31.6_suppl.59.
- Galsky M, Xie W, Nakabayashi M, Ross R, Fennessy F, Tempany C, Choueiri T, Khine K, Kantoff P, Taplin M, Oh W. Paradoxical significance of endorectal MRI (erMRI) response to neoadjuvant chemotherapy in patients with high-risk localized prostate cancer (HRLPC). Journal Of Clinical Oncology 2013, 31: 23-23. DOI: 10.1200/jco.2013.31.6_suppl.23.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Progression-free survival as an endpoint for clinical trials in first-line metastatic urothelial cancer. Journal Of Clinical Oncology 2013, 31: 251-251. DOI: 10.1200/jco.2013.31.6_suppl.251.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh W, Bamias A. Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy. Journal Of Clinical Oncology 2013, 31: 256-256. DOI: 10.1200/jco.2013.31.6_suppl.256.
- Bamias A, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Koutras A, Pu Y, Galsky M. Cisplatin-based combination chemotherapy in elderly patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2013, 31: 269-269. DOI: 10.1200/jco.2013.31.6_suppl.269.
- Gartrell B, Ying J, Sivendran S, Agarwal N, Boucher K, Choueiri T, Sonpavde G, Oh W, Galsky M. Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: A systematic review and meta-analysis. Journal Of Clinical Oncology 2013, 31: 362-362. DOI: 10.1200/jco.2013.31.6_suppl.362.
- Tsao C, Gray K, Nakabayashi M, Evan C, Galsky M, Kantoff P, Oh W, Pomerantz M. Association of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease. Journal Of Clinical Oncology 2013, 31: 157-157. DOI: 10.1200/jco.2013.31.6_suppl.157.
- Sivendran S, Ying J, Gartrell B, Agarwal N, Boucher K, Choueiri T, Sonpavde G, Oh W, Galsky M. Metabolic complications with the use of mTOR inhibitors for cancer therapy: A systematic review and meta-analysis. Journal Of Clinical Oncology 2013, 31: 398-398. DOI: 10.1200/jco.2013.31.6_suppl.398.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer. Urologic Oncology Seminars And Original Investigations 2013, 32: 30.e15-30.e21. PMID: 23428534, DOI: 10.1016/j.urolonc.2012.11.001.
- Nolen T, Das A, Higgins R, Tyson J, Oh W, Devaskar S, Londhe V. Vitamin A Supplementation in Extremely Low-Birth-Weight Infants: Subgroup Analysis in Small-for-Gestational-Age Infants. American Journal Of Perinatology 2013, 30: 771-780. PMID: 23329565, PMCID: PMC3923571, DOI: 10.1055/s-0032-1333410.
- Oh W. Early Onset Neonatal Group B Streptococcal Sepsis. American Journal Of Perinatology 2013, 30: 143-148. PMID: 23322392, DOI: 10.1055/s-0032-1332804.
- Rosenkrantz T, Oh W. Polycythemia and hyperviscosity in the newborn. 2013, 127-140. DOI: 10.1017/cbo9780511978135.011.
- Tsao C, Small A, Kates M, Moshier E, Wisnivesky J, Gartrell B, Sonpavde G, Godbold J, Palese M, Hall S, Oh W, Galsky M. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. World Journal Of Urology 2012, 31: 1535-1539. PMID: 23223962, PMCID: PMC4744480, DOI: 10.1007/s00345-012-1001-3.
- Tsao C, Gartrell B, Oh W, Galsky M. Emerging personalized approaches for the management of advanced urothelial carcinoma. Expert Review Of Anticancer Therapy 2012, 12: 1537-1543. PMID: 23253220, PMCID: PMC4744482, DOI: 10.1586/era.12.141.
- Seng S, Tsao C, Oh W. Chemotherapy and Associated Symptoms. 2012, 835-858. DOI: 10.1142/9789814354912_0071.
- Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis. Journal Of Clinical Oncology 2012, 30: 4416-4426. PMID: 23150697, DOI: 10.1200/jco.2012.42.4358.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Mortimer P, Liu G. P114 Safety and efficacy of orteronel (TAK-700), an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC): Phase 2 results from a phase 1/2 study. European Urology Open Science 2012, 11: 230. DOI: 10.1016/s1569-9056(13)60480-7.
- Proverbs-Singh T, Chiu S, Liu Z, Seng S, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2012, 104: 1837-1840. PMID: 23093559, DOI: 10.1093/jnci/djs435.
- Oh W. Fluid and Electrolyte Management of Very Low Birth Weight Infants. Pediatrics & Neonatology 2012, 53: 329-333. PMID: 23276435, DOI: 10.1016/j.pedneo.2012.08.010.
- Tsao C, Oh W. Enzalutamide in metastatic CRPC—old dog, new tricks. Nature Reviews Clinical Oncology 2012, 9: 613-614. PMID: 23044775, DOI: 10.1038/nrclinonc.2012.181.
- Ross R, Galsky M, Scher H, Magidson J, Wassmann K, Lee G, Katz L, Subudhi S, Anand A, Fleisher M, Kantoff P, Oh W. A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. The Lancet Oncology 2012, 13: 1105-1113. PMID: 23059047, DOI: 10.1016/s1470-2045(12)70263-2.
- Lin C, Galsky M, Krege S, Hahn N, Ecke T, Sonpavde G, Oh W, Bamias A. WS14-7 Efficacy of Cisplatin-Based Chemotherapy as First-Line Treatment in Asian Patients with Metastatic Urothelial Carcinoma Results of an Exploratory Subgroup Analysis of a Pool Analysis of Phase II/III Trials. Annals Of Oncology 2012, 23: xi96-xi97. DOI: 10.1016/s0923-7534(20)32244-4.
- Tsao C, Galsky M, Small A, Yee T, Oh W. Targeting the androgen receptor signalling axis in castration‐resistant prostate cancer (CRPC). BJU International 2012, 110: 1580-1588. PMID: 22985411, DOI: 10.1111/j.1464-410x.2012.11445.x.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Liu G. 918P Phase 2 Results from a Phase 1/2 Study of Tak-700 (ORTERONEL), An Oral, Investigational, Nonsteroidal 17,20-Lyase Inhibitor, with Docetaxel and Prednisone (DP) in Metastatic Castration-Resistant Prostate Cancer (MCRPC). Annals Of Oncology 2012, 23: ix302-ix303. DOI: 10.1016/s0923-7534(20)33476-1.
- Nakabayashi M, Werner L, Courtney K, Buckle G, Oh W, Bubley G, Hayes J, Weckstein D, Elfiky A, Sims D, Kantoff P, Taplin M. Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer. BJU International 2012, 110: 1729-1735. PMID: 22928480, DOI: 10.1111/j.1464-410x.2012.11456.x.
- Vinjamoori A, Jagannathan J, Shinagare A, Taplin M, Oh W, Van den Abbeele A, Ramaiya N. Atypical metastases from prostate cancer: 10-year experience at a single institution. American Journal Of Roentgenology 2012, 199: 367-72. PMID: 22826398, DOI: 10.2214/ajr.11.7533.
- Small A, Oh W. Bevacizumab treatment of prostate cancer. Expert Opinion On Biological Therapy 2012, 12: 1241-1249. PMID: 22775507, DOI: 10.1517/14712598.2012.704015.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde, Oh W, Galsky M. Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy. Cancer 2012, 118: 5947-5954. PMID: 22707387, DOI: 10.1002/cncr.27658.
- Wadhawan R, Oh W, Vohr B, Saha S, Das A, Bell E, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age. Archives Of Disease In Childhood Fetal & Neonatal 2012, 98: f127. PMID: 22684157, PMCID: PMC3753803, DOI: 10.1136/archdischild-2011-300659.
- Pomerantz M, Elfiky A, Katz L, Oh W. Genitourinary Cancers. 2012, 114-124. DOI: 10.1093/med/9780195366273.003.0013.
- Tyson J, Pedroza C, Langer J, Green C, Morris B, Stevenson D, Van Meurs K, Oh W, Phelps D, O'Shea M, McDavid G, Grisby C, Higgins R. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? Journal Of Perinatology 2012, 32: 677-684. PMID: 22652561, PMCID: PMC3558278, DOI: 10.1038/jp.2012.64.
- Tsao C, Small A, Moshier E, Gartrell B, Wisnivesky J, Sonpavde, Godbold J, Palese M, Hall S, Oh W, Galsky M. Trends in the Use of Cytoreductive Nephrectomy in the United States. Clinical Genitourinary Cancer 2012, 10: 159-163. PMID: 22651971, PMCID: PMC4744481, DOI: 10.1016/j.clgc.2012.03.008.
- Sivendran S, Liu Z, Portas L, Yu M, Hahn N, Sonpavde, Oh W, Galsky M. Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: A meta-analysis. Cancer Treatment Reviews 2012, 38: 919-925. PMID: 22651902, DOI: 10.1016/j.ctrv.2012.05.001.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Sonpavde G, Palese M, Hall S, Oh W, Galsky M. Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World Journal Of Urology 2012, 31: 1211-1217. PMID: 22622394, PMCID: PMC4744479, DOI: 10.1007/s00345-012-0873-6.
- Latif A, Small A, Moshier E, Adelson K, Raptis G, Godbold J, Oh W, Galsky M. Practice patterns in the use of adjuvant therapy for post-menopausal early-stage breast cancer in the pre- and post-Onco type DX era. Journal Of Clinical Oncology 2012, 30: e21032-e21032. DOI: 10.1200/jco.2012.30.15_suppl.e21032.
- Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis. Journal Of Clinical Oncology 2012, 30: e21016-e21016. DOI: 10.1200/jco.2012.30.15_suppl.e21016.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde G, Oh W, Galsky M. Prevalence and characteristics of patients with stage IV solid tumors who receive no anticancer therapy. Journal Of Clinical Oncology 2012, 30: 6065-6065. DOI: 10.1200/jco.2012.30.15_suppl.6065.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Kucuk O, Moran S, Wang J, Bargfrede M, Liu G. Phase I results from a phase I/II study of orteronel, an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2012, 30: 4656-4656. DOI: 10.1200/jco.2012.30.15_suppl.4656.
- Tsao C, Small A, Kates M, Gartrell B, Wisnivesky J, Sonpavde G, Palese M, Hall S, Oh W, Galsky M. Trends in the use of cytoreductive nephrectomy for metastatic renal cell carcinoma in the VEGFR tyrosine kinase inhibitor era. Journal Of Clinical Oncology 2012, 30: 4623-4623. DOI: 10.1200/jco.2012.30.15_suppl.4623.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. Journal Of Clinical Oncology 2012, 30: 4524-4524. DOI: 10.1200/jco.2012.30.15_suppl.4524.
- Oh W, Kantoff P, Scher H, Magidson J, Wassmann K, Lee G, Katz L, Subudhi S, Anand A, Fleisher M, Galsky M, Ross R. A validated whole-blood RNA transcript-based prognostic model that predicts survival in men with castration-resistant prostate cancer. Journal Of Clinical Oncology 2012, 30: 4516-4516. DOI: 10.1200/jco.2012.30.15_suppl.4516.
- Small A, Gong Y, Oh W, Hall S, van Rijn C, Galsky M. The Emerging Role of Circulating Tumor Cell Detection in Genitourinary Cancer. Journal Of Urology 2012, 188: 21-26. PMID: 22578722, DOI: 10.1016/j.juro.2012.02.2558.
- Tsao C, Small A, Galsky M, Oh W. Overcoming castration resistance in prostate cancer. Current Opinion In Urology 2012, 22: 167-174. PMID: 22472508, DOI: 10.1097/mou.0b013e3283523b8b.
- Galsky M, Small A, Tsao C, Oh W. Clinical development of novel therapeutics for castration‐resistant prostate cancer. CA A Cancer Journal For Clinicians 2012, 62: 299-308. PMID: 22535487, DOI: 10.3322/caac.21141.
- Morris B, Tyson J, Stevenson D, Oh W, Phelps D, O'Shea T, McDavid G, Van Meurs K, Vohr B, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins R. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. Journal Of Perinatology 2012, 33: 126-133. PMID: 22499082, PMCID: PMC3570170, DOI: 10.1038/jp.2012.39.
- Small A, Tsao C, Moshier E, Godbold J, Palese M, Hall S, Oh W, Galsky M. 659 RACIAL AND SOCIOECONOMIC DISPARITIES IN THE UTILIZATION OF NEPHRON-SPARING PROCEDURES FOR STAGE I KIDNEY CANCER IN THE UNITED STATES. Journal Of Urology 2012, 187: e269. DOI: 10.1016/j.juro.2012.02.739.
- Lee B, Garcia J, Dreicer R, Tendulkar R, Stephans K, Magi-Galluzzi C, Klein E, Oh W, Stephenson A. 336 ALL HIGH-GRADE PROSTATE CANCERS CREATED EQUALLY? AN ANALYSIS OF CLINICAL FEATURES AND SURVIVAL AMONG PATIENTS WITH BIOPSY GLEASON SCORE 8, 9, AND 10 DISEASE. Journal Of Urology 2012, 187: e137. DOI: 10.1016/j.juro.2012.02.397.
- Sommers R, Stonestreet B, Oh W, Laptook A, Yanowitz T, Raker C, Mercer J. Hemodynamic Effects of Delayed Cord Clamping in Premature Infants. Pediatrics 2012, 129: e667-e672. PMID: 22331336, PMCID: PMC3356138, DOI: 10.1542/peds.2011-2550.
- Tsao C, Moshier E, Small A, Sonpavde G, Godbold J, Oh W, Galsky M. Cytoreductive nephrectomy in the United States: Patterns of care and patient characteristics. Journal Of Clinical Oncology 2012, 30: 366-366. DOI: 10.1200/jco.2012.30.5_suppl.366.
- Small A, Tsao C, Moshier E, Godbold J, Sonpavde G, Oh W, Galsky M. Prevalence and characteristics of patients with metastatic prostate cancer who receive no anticancer therapy. Journal Of Clinical Oncology 2012, 30: 101-101. DOI: 10.1200/jco.2012.30.5_suppl.101.
- Ross R, Galsky M, Febbo P, Barry M, Richie J, Xie W, Fennessy F, Bhatt R, Hayes J, Choueiri T, Tempany C, Kantoff P, Taplin M, Oh W. Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer. Cancer 2012, 118: 4777-4784. PMID: 22282219, PMCID: PMC3791849, DOI: 10.1002/cncr.27416.
- Oh W. The Field of Neonatology. 2012, 85-90. DOI: 10.1007/978-3-642-02202-9_7.
- Oh W, Guignard J, Baumgart S. Preface. 2012, xi. DOI: 10.1016/b978-1-4377-2658-9.00022-4.
- Oh W. Infant of Diabetic Mother. 2012, 353-358. DOI: 10.1007/978-3-642-02202-9_30.
- Oh W. Disorders of Glucose Homeostasis in the Newborn. 2012, 347-351. DOI: 10.1007/978-3-642-02202-9_29.
- Oh W. Chapter 2 Body Water Changes in the Fetus and Newborn Normal Transition After Birth and the Effects of Intrauterine Growth Aberration*. 2012, 19-27. DOI: 10.1016/b978-1-4377-2658-9.00002-9.
- Lasky R, Church M, Orlando M, Morris B, Parikh N, Tyson J, McDavid G, Oh W, Stevenson D, Van Meurs K, Guillet R, Phelps D. The effects of aggressive vs. conservative phototherapy on the brainstem auditory evoked responses of extremely-low-birth-weight infants. Pediatric Research 2011, 71: 77-84. PMID: 22289854, PMCID: PMC3326602, DOI: 10.1038/pr.2011.17.
- Sun T, Oh W, Jacobus S, Regan M, Pomerantz M, Freedman M, Lee G, Kantoff P. The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness. Cancer Prevention Research 2011, 4: 2044-2050. PMID: 21900597, PMCID: PMC3773969, DOI: 10.1158/1940-6207.capr-11-0283.
- Tsao C, Moshier E, Seng S, Godbold J, Grossman S, Winston J, Oh W, Galsky M. Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer. Clinical Genitourinary Cancer 2011, 10: 15-20. PMID: 22130294, DOI: 10.1016/j.clgc.2011.10.004.
- Erickson-Owens D, Mercer J, Oh W. Umbilical cord milking in term infants delivered by cesarean section: a randomized controlled trial. Journal Of Perinatology 2011, 32: 580-584. PMID: 22094494, DOI: 10.1038/jp.2011.159.
- Nakabayashi M, Werner L, Oh W, Regan M, Kantoff P, Taplin M. Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 2011, 9: 95-103. PMID: 21958520, DOI: 10.1016/j.clgc.2011.06.006.
- Galsky M, Camacho L, Chiorean E, Mulkerin D, Hong D, Oh W, Bajorin D. Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors. Annals Of Oncology 2011, 23: 1037-1044. PMID: 21828377, DOI: 10.1093/annonc/mdr358.
- Carlo WA, McDonald SA, Tyson JE, Stoll BJ, Ehrenkranz RA, Shankaran S, Goldberg RN, Das A, Schendel D, Thorsen P, Skogstrand K, Hougaard DM, Oh W, Laptook R, Duara S, Fanaroff AA, Donovan EF, Korones SB, Stevenson DK, Papile LA, Finer NN, O’Shea T, Poindexter BB, Wright LL, Ambalavanan N, Higgins RD, Network E. Cytokines and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2011, 159: 919-925.e3. PMID: 21798559, PMCID: PMC3215787, DOI: 10.1016/j.jpeds.2011.05.042.
- Oh W, Galsky M, Stadler W, Srinivas S, Chu F, Bubley G, Goddard J, Dunbar J, Ross R. Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer. Urology 2011, 78: 626-630. PMID: 21762967, PMCID: PMC3166448, DOI: 10.1016/j.urology.2011.04.041.
- Galsky M, Seng S, Camacho L, Chiorean E, Mulkerin D, Hong D, Oh W, Bajorin D. Retrospective Analysis of Satraplatin in Patients with Metastatic Urothelial Cancer Refractory to Standard Platinum-Based Chemotherapy. Clinical Genitourinary Cancer 2011, 9: 27-30. PMID: 21700509, DOI: 10.1016/j.clgc.2011.05.003.
- Keating N, Landrum M, Lamont E, Bozeman S, Krasnow S, Shulman L, Brown J, Earle C, Oh W, Rabin M, McNeil B. Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Annals Of Internal Medicine 2011, 154: 727-36. PMID: 21646556, DOI: 10.7326/0003-4819-154-11-201106070-00004.
- Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, Oh W. Early Nutrition Mediates the Influence of Severity of Illness on Extremely LBW Infants. Pediatric Research 2011, 69: 522-529. PMID: 21378596, PMCID: PMC3090495, DOI: 10.1203/pdr.0b013e318217f4f1.
- Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg W, Balk S, Brown M, Taplin M, Oh W, Lee G, Kantoff P. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer. Journal Of Clinical Oncology 2011, 29: 2565-2573. PMID: 21606417, PMCID: PMC3138634, DOI: 10.1200/jco.2010.31.2405.
- Seng S, Galsky M, Tsao C, Li J, Febbo P, Oh W. Predicting response to platinum chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) using a genomic signature for “BRCAness”: A phase II clinical trial of satraplatin in men with mCRPC who have progressed on docetaxel. Journal Of Clinical Oncology 2011, 29: tps191-tps191. DOI: 10.1200/jco.2011.29.15_suppl.tps191.
- Tsao C, Seng S, Grossman S, Oh W, Galsky M. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with bladder cancer. Journal Of Clinical Oncology 2011, 29: e15139-e15139. DOI: 10.1200/jco.2011.29.15_suppl.e15139.
- Galsky M, Chen G, Oh W, Bellmunt J, Roth B, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Journal Of Clinical Oncology 2011, 29: e15027-e15027. DOI: 10.1200/jco.2011.29.15_suppl.e15027.
- Oh W, Galsky M, Barry M, Fennessey F, Richie J, Hayes J, Bhatt R, Taplin M, Febbo P, Ross R. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients (pts) with high-risk localized prostate cancer. Journal Of Clinical Oncology 2011, 29: 4642-4642. DOI: 10.1200/jco.2011.29.15_suppl.4642.
- Galsky M, Hahn N, Rosenberg J, Sonpavde G, Hutson T, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy. Journal Of Clinical Oncology 2011, 29: 2432-2438. PMID: 21555688, DOI: 10.1200/jco.2011.34.8433.
- Galsky M, Chen G, Oh W, Bellmunt J, Roth B, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Annals Of Oncology 2011, 23: 406-410. PMID: 21543626, DOI: 10.1093/annonc/mdr156.
- Pomerantz M, Werner L, Xie W, Regan M, Lee G, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh W, Kantoff P, Freedman M. Association of Prostate Cancer Risk Loci with Disease Aggressiveness and Prostate Cancer–Specific Mortality. Cancer Prevention Research 2011, 4: 719-728. PMID: 21367958, PMCID: PMC3811002, DOI: 10.1158/1940-6207.capr-10-0292.
- Tsao C, Seng S, Oh W, Galsky M. Endocrine therapy for prostate cancer: review of the latest clinical evidence. Clinical Investigation 2011, 1: 533-541. DOI: 10.4155/cli.11.28.
- Oh W, Fanaroff A, Carlo W, Donovan E, McDonald S, Poole W. Effects of delayed cord clamping in very-low-birth-weight infants. Journal Of Perinatology 2011, 31: s68-s71. PMID: 21448208, PMCID: PMC3327157, DOI: 10.1038/jp.2010.186.
- Tai S, Sun Y, Squires J, Zhang H, Oh W, Liang C, Huang J. PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate 2011, 71: 1668-1679. PMID: 21432867, PMCID: PMC3426349, DOI: 10.1002/pros.21383.
- Misra D, Xie W, Regan M, Ross R, Lee G, Germain D, Kantoff P, Oh W. Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy. BJU International 2011, 108: 1086-1091. PMID: 21410629, DOI: 10.1111/j.1464-410x.2010.10037.x.
- Sun T, Mary L, Oh W, Freedman M, Pomerantz M, Pienta K, Kantoff P. Inherited Variants in the Chemokine CCL2 Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort. Clinical Cancer Research 2011, 17: 1546-1552. PMID: 21135144, PMCID: PMC3060307, DOI: 10.1158/1078-0432.ccr-10-2015.
- Sonpavde G, Galsky M, Chen G, Bellmunt J, Roth B, Petrioli R, Hutson T, Dogliotti L, Dreicer R, Oh W. Meta-analysis of randomized trials comparing cisplatin versus carboplatin-based regimens for the first-line therapy of metastatic transitional cell carcinoma of the urothelium (TCCU). Journal Of Clinical Oncology 2011, 29: 247-247. DOI: 10.1200/jco.2011.29.7_suppl.247.
- Galsky M, Hahn N, Rosenberg J, Sonpavde G, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. Defining “cisplatin ineligible” patients with metastatic bladder cancer. Journal Of Clinical Oncology 2011, 29: 238-238. DOI: 10.1200/jco.2011.29.7_suppl.238.
- Galsky M, Hahn N, Rosenberg J, Sonpavde, Hutson T, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. The Lancet Oncology 2011, 12: 211-214. PMID: 21376284, DOI: 10.1016/s1470-2045(10)70275-8.
- Wadhawan R, Oh W, Vohr B, Wrage L, Das A, Bell E, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Neurodevelopmental Outcomes of Triplets or Higher-Order Extremely Low Birth Weight Infants. Pediatrics 2011, 127: e654-e660. PMID: 21357334, PMCID: PMC3304548, DOI: 10.1542/peds.2010-2646.
- Hintz S, Stevenson D, Yao Q, Wong R, Das A, Van Meurs K, Morris B, Tyson J, Oh W, Poole W, Phelps D, McDavid G, Grisby C, Higgins R, Information D. Is phototherapy exposure associated with better or worse outcomes in 501‐ to 1000‐g‐birth‐weight infants? Acta Paediatrica 2011, 100: 960-965. PMID: 21272067, PMCID: PMC3505994, DOI: 10.1111/j.1651-2227.2011.02175.x.
- Woo H, Lizarda A, Tucker R, Mitchell M, Vohr B, Oh W, Phornphutkul C. Congenital Hypothyroidism with a Delayed Thyroid-Stimulating Hormone Elevation in Very Premature Infants: Incidence and Growth and Developmental Outcomes. The Journal Of Pediatrics 2011, 158: 538-542. PMID: 21232766, DOI: 10.1016/j.jpeds.2010.10.018.
- Tsao C, Seng S, Oh W, Galsky M. Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer. Clinical Medicine Insights Oncology 2011, 5: cmo.s6566. PMID: 21695098, PMCID: PMC3117627, DOI: 10.4137/cmo.s6566.
- Abe M, Xie W, Regan M, King I, Stampfer M, Kantoff P, Oh W, Chan J. Single‐nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU International 2010, 107: 126-134. PMID: 20477822, PMCID: PMC3010266, DOI: 10.1111/j.1464-410x.2010.09344.x.
- Drzymalski D, Oh W, Werner L, Regan M, Kantoff P, Tuli S. Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article. Journal Of Neurosurgery Spine 2010, 13: 789-94. PMID: 21121759, DOI: 10.3171/2010.6.spine10167.
- Oh W, Burakoff S. Cancer Therapy from Bench to Bedside. Annals Of Global Health 2010, 77: 571-572. PMID: 21105120, DOI: 10.1002/msj.20221.
- Tsao C, Oh W. Selective cell death mediated by small conditional RNAs: a novel therapeutic approach to cancer therapy. Asian Journal Of Andrology 2010, 13: 181-2. PMID: 21076441, PMCID: PMC3739191, DOI: 10.1038/aja.2010.148.
- Pomerantz M, Shrestha Y, Flavin R, Regan M, Penney K, Mucci L, Stampfer M, Hunter D, Chanock S, Schafer E, Chan J, Tabernero J, Baselga J, Richardson A, Loda M, Oh W, Kantoff P, Hahn W, Freedman M. Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis. PLOS Genetics 2010, 6: e1001204. PMID: 21085629, PMCID: PMC2978684, DOI: 10.1371/journal.pgen.1001204.
- Anees M, Horak P, El‐Gazzar A, Susani M, Heinze G, Perco P, Loda M, Lis R, Krainer M, Oh W. Recurrence‐free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer 2010, 117: 1172-1182. PMID: 21381010, DOI: 10.1002/cncr.25504.
- Gansler T, Ganz P, Grant M, Greene F, Johnstone P, Mahoney M, Newman L, Oh W, Thomas C, Thun M, Vickers A, Wender R, Brawley O. Sixty Years of CA: A Cancer Journal for Clinicians. CA A Cancer Journal For Clinicians 2010, 60: 345-350. PMID: 21075954, DOI: 10.3322/caac.20088.
- Penney K, Pyne S, Schumacher F, Sinnott J, Mucci L, Kraft P, Ma J, Oh W, Kurth T, Kantoff P, Giovannucci E, Stampfer M, Hunter D, Freedman M. Genome-wide Association Study of Prostate Cancer Mortality. Cancer Epidemiology Biomarkers & Prevention 2010, 19: 2869-2876. PMID: 20978177, PMCID: PMC3197738, DOI: 10.1158/1055-9965.epi-10-0601.
- Sun T, Lee G, Oh W, Pomerantz M, Yang M, Xie W, Freedman M, Kantoff P. Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population. Clinical Cancer Research 2010, 16: 5244-5251. PMID: 20855462, PMCID: PMC2970725, DOI: 10.1158/1078-0432.ccr-10-1261.
- Choueiri T, McDermott D, Duh M, Sarda S, Neary M, Oh W. Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: Results from a medical chart review study. Urologic Oncology Seminars And Original Investigations 2010, 30: 848-855. PMID: 20926319, DOI: 10.1016/j.urolonc.2010.07.009.
- Oh W, Vargas R, Jacobus S, Leitzel K, Regan M, Hamer P, Pierce K, Brown‐Shimer S, Carney W, Ali S, Kantoff P, Lipton A. Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients. Cancer 2010, 117: 517-525. PMID: 20862742, DOI: 10.1002/cncr.25394.
- Galsky M, Dritselis A, Kirkpatrick P, Oh W. Cabazitaxel. Nature Reviews Drug Discovery 2010, 9: 677-678. PMID: 20811375, DOI: 10.1038/nrd3254.
- Choueiri T, Regan M, Rosenberg J, Oh W, Clement J, Amato A, McDermott D, Cho D, Atkins M, Signoretti S. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth factor‐targeted therapy. BJU International 2010, 106: 772-778. PMID: 20230385, DOI: 10.1111/j.1464-410x.2010.09218.x.
- Brick A, Niu J, Huang J, Oh W. Platinum Agents in Prostate Cancer. 2010, 153-161. DOI: 10.1007/978-1-60327-829-4_14.
- Sun T, Lee G, Werner L, Pomerantz M, Oh W, Kantoff P, Freedman M. Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy. Cancer Epidemiology Biomarkers & Prevention 2010, 19: 1871-1878. PMID: 20615892, PMCID: PMC3755451, DOI: 10.1158/1055-9965.epi-10-0216.
- Oh W, Vohr B. Introduction. Seminars In Perinatology 2010, 34: 181-182. PMID: 20494732, DOI: 10.1053/j.semperi.2010.02.001.
- Seng S, Tsao C, Galsky M, Oh W. Cytotoxic chemotherapy for castration resistant prostate cancer: 2010 and beyond. Drug Discovery Today Therapeutic Strategies 2010, 7: 17-22. DOI: 10.1016/j.ddstr.2011.02.001.
- Harrison M, Hahn N, Pili R, Oh W, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investigational New Drugs 2010, 29: 1465-1474. PMID: 20499131, PMCID: PMC3042040, DOI: 10.1007/s10637-010-9455-x.
- Buckle G, Werner L, Oh W, Bubley G, Hayes J, Weckstein D, Elfiky A, Sims D, Kantoff P, Taplin M. Phase II trial of RAD001 (R) and bicalutamide (B) for castration-resistant prostrate cancer (CPRC). Journal Of Clinical Oncology 2010, 28: 4660-4660. DOI: 10.1200/jco.2010.28.15_suppl.4660.
- Elfiky A, Cho D, McDermott D, Rosenberg J, Fortner B, Antràs L, Chen K, Duh M, Jayawant S, Oh W, Atkins M, Choueiri T. Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma. Urologic Oncology Seminars And Original Investigations 2010, 29: 756-763. PMID: 20451414, DOI: 10.1016/j.urolonc.2010.01.008.
- Oh W, McDermott D, Duh, Antràs L, Chen K, Sarda S, Luka A, Whittemore S, Ramamurthy P, Neary M, Choueiri T. PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY. Value In Health 2010, 13: a32. DOI: 10.1016/s1098-3015(10)72139-2.
- Dial E, Duh, Antras L, Rodermund D, Neary M, Choueiri T, Oh W. PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS). Value In Health 2010, 13: a76. DOI: 10.1016/s1098-3015(10)72356-1.
- Choueiri T, Duh M, Clement J, Brick A, Rogers M, Kwabi C, Shah K, Percy A, Antràs L, Jayawant S, Chen K, Wang S, Luka A, Neary M, McDermott D, Oh W. Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice‐based on medical chart review. BJU International 2010, 105: 1247-1254. PMID: 19863525, DOI: 10.1111/j.1464-410x.2009.08972.x.
- Weinberg A, Alemozaffar M, Soukup J, Kacker R, Choi W, Oh W, Hu J. 587 THE EFFECT OF NEO-ADJUVANT CHEMOTHERAPY ON RADICAL PROSTATECTOMY OUTCOMES IN INTERMEDIATE AND HIGH-RISK PROSTATE CANCER. Journal Of Urology 2010, 183: e230-e231. DOI: 10.1016/j.juro.2010.02.859.
- Oh W, Stevenson D, Tyson J, Morris B, Ahlfors C, Bender G, Wong R, Perritt R, Vohr B, Van Meurs K, Vreman H, Das A, Phelps D, O’Shea T, Higgins R, Bethesda O. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatrica 2010, 99: 673-678. PMID: 20105142, PMCID: PMC2875328, DOI: 10.1111/j.1651-2227.2010.01688.x.
- Bellmunt J, Oh W. Review: Castration-resistant prostate cancer: new science and therapeutic prospects. Therapeutic Advances In Medical Oncology 2010, 2: 189-207. PMID: 21789134, PMCID: PMC3126017, DOI: 10.1177/1758834009359769.
- Oh W, Hu J. Preface. Urologic Clinics Of North America 2010, 37: xiii. PMID: 20152513, DOI: 10.1016/j.ucl.2009.12.001.
- Schutz F, Oh W. Neoadjuvant and Adjuvant Therapies in Prostate Cancer. Urologic Clinics Of North America 2010, 37: 97-104. PMID: 20152523, DOI: 10.1016/j.ucl.2009.11.012.
- Oh W, Ross R, Choueiri T, Kantoff P, Corless C. 8 Cancer of the Genitourinary Tract. 2010, 233-277. DOI: 10.1016/b978-0-323-05905-3.00008-x.
- Oh W, Landrum M, Lamont E, McNeil B, Keating N. Does Oral Antiandrogen Use Before Leuteinizing Hormone-releasing Hormone Therapy in Patients With Metastatic Prostate Cancer Prevent Clinical Consequences of a Testosterone Flare? Urology 2009, 75: 642-647. PMID: 19962733, DOI: 10.1016/j.urology.2009.08.008.
- Taplin M, Regan M, Ko Y, Bubley G, Duggan S, Werner L, Beer T, Ryan C, Mathew P, Tu S, Denmeade S, Oh W, Sartor O, Mantzoros C, Rittmaster R, Kantoff P, Balk S. Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer. Clinical Cancer Research 2009, 15: 7099-7105. PMID: 19887483, PMCID: PMC3644858, DOI: 10.1158/1078-0432.ccr-09-1722.
- Nakabayashi M, Oh W, Jacobus S, Regan M, Taplin M, Kantoff P, Rosenberg J. Activity of ketoconazole after taxane‐based chemotherapy in castration‐resistant prostate cancer. BJU International 2009, 105: 1392-1396. PMID: 19863532, DOI: 10.1111/j.1464-410x.2009.08971.x.
- Mercer J, Vohr B, Erickson-Owens D, Padbury J, Oh W. Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping. Journal Of Perinatology 2009, 30: 11-16. PMID: 19847185, PMCID: PMC2799542, DOI: 10.1038/jp.2009.170.
- Heng D, Xie W, Regan M, Warren M, Golshayan A, Sahi C, Eigl B, Ruether J, Cheng T, North S, Venner P, Knox J, N. K, Kollmannsberger C, McDermott D, Oh W, Atkins M, Bukowski R, Rini B, Choueiri T. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study. Journal Of Clinical Oncology 2009, 27: 5794-5799. PMID: 19826129, DOI: 10.1200/jco.2008.21.4809.
- Sartor O, Nakabayashi M, Taplin M, Ross R, Kantoff P, Balk S, Oh W. Activity of Dutasteride Plus Ketoconazole in Castration-Refractory Prostate Cancer After Progression on Ketoconazole Alone. Clinical Genitourinary Cancer 2009, 7: e90-e92. PMID: 19815488, DOI: 10.3816/cgc.2009.n.030.
- Aggarwal R, Weinberg V, Small E, Oh W, Rushakoff R, Ryan C. The Mechanism of Action of Estrogen in Castration-Resistant Prostate Cancer: Clues From Hormone Levels. Clinical Genitourinary Cancer 2009, 7: e71-e76. PMID: 19815485, DOI: 10.3816/cgc.2009.n.027.
- Oh W, Magidson J, Bankaitis-Davis D, Siconolfi L, Schurko B, Cantu R, Braitsch S, Wassman K, Kantoff P, Ross R. PP138 A whole blood RNA transcript-based model to predict biopsy Gleason score in newly diagnosed prostate cancer patients. European Journal Of Cancer Supplements 2009, 7: 27. DOI: 10.1016/s1359-6349(09)72197-4.
- Jacobsen E, Chen J, Schurko B, Benson C, Oh W. Metastatic seminoma and grade 1 follicular lymphoma presenting concurrently in a supraclavicular lymph node: a case report. Cases Journal 2009, 2: 7273. PMID: 19918516, PMCID: PMC2769346, DOI: 10.4076/1757-1626-2-7273.
- Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak J, Berman B, Henderson B, Frenkel B, Haiman C, Freedman M, Tanay A, Coetzee G. Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus. PLOS Genetics 2009, 5: e1000597. PMID: 19680443, PMCID: PMC2717370, DOI: 10.1371/journal.pgen.1000597.
- Regan M, O'Donnell E, Kelly W, Halabi S, Berry W, Urakami S, Kikuno N, Oh W. Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials. Annals Of Oncology 2009, 21: 312-318. PMID: 19633053, PMCID: PMC2852201, DOI: 10.1093/annonc/mdp308.
- Duh M, Dial E, Choueiri T, Fournier A, Antras L, Rodermund D, Neary M, Oh W. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis*. Current Medical Research And Opinion 2009, 25: 2081-2090. PMID: 19586325, DOI: 10.1185/03007990903084800.
- Pomerantz M, Beckwith C, Regan M, Wyman S, Petrovics G, Chen Y, Hawksworth D, Schumacher F, Mucci L, Penney K, Stampfer M, Chan J, Ardlie K, Fritz B, Parkin R, Lin D, Dyke M, Herman P, Lee S, Oh W, Kantoff P, Tewari M, McLeod D, Srivastava S, Freedman M. Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression. Cancer Research 2009, 69: 5568-5574. PMID: 19549893, PMCID: PMC2884104, DOI: 10.1158/0008-5472.can-09-0387.
- Rosenkrantz T, Sarkar S, Oh W. Polycythemia and fetal–maternal bleeding. 2009, 317-324. DOI: 10.1017/cbo9780511581281.030.
- Chan J, Oh W, Xie W, Regan M, Stampfer M, King I, Abe M, Kantoff P. Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer. Journal Of Clinical Oncology 2009, 27: 3577-3583. PMID: 19528373, PMCID: PMC2720077, DOI: 10.1200/jco.2008.18.8938.
- Choueiri T, Regan M, Oh W, Clement J, Amato A, McDermott D, Cho D, Atkins M, Signoretti S. Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy. Journal Of Clinical Oncology 2009, 27: e16067-e16067. DOI: 10.1200/jco.2009.27.15_suppl.e16067.
- Vinson J, Mathew P, Beer T, Carducci M, Oh W, Small E, Wilding G, Higano C, Hussain M, Scher H. Prostate cancer clinical trials consortium: A multicenter mechanism for the rapid design, development, and implementation of early phase clinical trials. Journal Of Clinical Oncology 2009, 27: e16065-e16065. DOI: 10.1200/jco.2009.27.15_suppl.e16065.
- Dial E, Duh M, Fournier A, Antras L, Rodermund D, Neary M, Oh W. Cost implications of intravenous bevacizumab treatment in patients with renal cell carcinoma (RCC): A retrospective claims database analysis. Journal Of Clinical Oncology 2009, 27: 5112-5112. DOI: 10.1200/jco.2009.27.15_suppl.5112.
- Oh W, Febbo P, Richie J, Fennessy F, Scibelli G, Hayes J, Choueiri T, Tempany C, Taplin M, Ross R. A phase II study of neoadjuvant chemotherapy with docetaxel and bevacizumab in patients (pts) with high-risk localized prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. Journal Of Clinical Oncology 2009, 27: 5060-5060. DOI: 10.1200/jco.2009.27.15_suppl.5060.
- Ross R, Bankaitis-Davis D, Siconolfi L, Katz L, Storm K, Magidson J, Wassmann K, Oh W. Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone. Journal Of Clinical Oncology 2009, 27: 5052-5052. DOI: 10.1200/jco.2009.27.15_suppl.5052.
- Michaelson M, Regan M, Oh W, Kaufman D, Olivier K, Michaelson S, Spicer B, Gurski C, Kantoff P, Smith M. Phase II study of sunitinib in men with advanced prostate cancer. Annals Of Oncology 2009, 20: 913-920. PMID: 19403935, PMCID: PMC2674960, DOI: 10.1093/annonc/mdp111.
- Penney K, Salinas C, Pomerantz M, Schumacher F, Beckwith C, Lee G, Oh W, Sartor O, Ostrander E, Kurth T, Ma J, Mucci L, Stanford J, Kantoff P, Hunter D, Stampfer M, Freedman M. Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality. Clinical Cancer Research 2009, 15: 3223-3230. PMID: 19366828, PMCID: PMC2878092, DOI: 10.1158/1078-0432.ccr-08-2733.
- Ahlfors C, Vreman H, Wong R, Bender G, Oh W, Morris B, Stevenson D, Subcommittee T, Network O. Corrigendum to “Effects of sample dilution, peroxidise concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns” [Clinical Biochemistry 40 (2007) 261–267]. Clinical Biochemistry 2009, 42: 547. DOI: 10.1016/j.clinbiochem.2008.12.012.
- Priolo C, Oh W, Loda M. Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trials. IDrugs 2009, 12: 165-8. PMID: 19333896.
- Wadhawan R, Oh W, Perritt R, McDonald S, Das A, Poole W, Vohr B, Higgins R. Twin Gestation and Neurodevelopmental Outcome in Extremely Low Birth Weight Infants. Pediatrics 2009, 123: e220-e227. PMID: 19139085, PMCID: PMC2842087, DOI: 10.1542/peds.2008-1126.
- Sher D, Oh W. Reply. Urology 2009, 73: 362. DOI: 10.1016/j.urology.2008.09.016.
- Choueiri T, Xie W, D'Amico A, Ross R, Hu J, Pomerantz M, Regan M, Taplin M, Kantoff P, Sartor O, Oh W. Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy. Cancer 2009, 115: 981-987. PMID: 19152438, PMCID: PMC2931827, DOI: 10.1002/cncr.24064.
- Morris M, Basch E, Wilding G, Hussain M, Carducci M, Higano C, Kantoff P, Oh W, Small E, George D, Mathew P, Beer T, Slovin S, Ryan C, Logothetis C, Scher H. Department of Defense Prostate Cancer Clinical Trials Consortium: A New Instrument for Prostate Cancer Clinical Research. Clinical Genitourinary Cancer 2009, 7: 51-57. PMID: 19213669, PMCID: PMC3394090, DOI: 10.3816/cgc.2009.n.009.
- Sher D, Mantzoros C, Jacobus S, Regan M, Lee G, Oh W. Absence of Relationship Between Steroid Hormone Levels and Prostate Cancer Tumor Grade. Urology 2008, 73: 356-361. PMID: 19036418, DOI: 10.1016/j.urology.2008.07.068.
- Romanus D, Oh W, Cook F, Weeks J. PCN86 SYMPTOM PREVALENCE IN HORMONE REFRACTORY PROSTATE CANCER (HRPC). Value In Health 2008, 11: a487. DOI: 10.1016/s1098-3015(10)66623-5.
- Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O'Shea TM, McDavid GE, Perritt RL, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Pedroza C, Das A, Poole WK, Carlo WA, Duara S, Laptook AR, Salhab WA, Shankaran S, Poindexter BB, Fanaroff AA, Walsh MC, Rasmussen MR, Stoll BJ, Cotten CM, Donovan EF, Ehrenkranz RA, Guillet R, Higgins RD. Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight. New England Journal Of Medicine 2008, 359: 1885-1896. PMID: 18971491, PMCID: PMC2821221, DOI: 10.1056/nejmoa0803024.
- Rosenberg J, Oh W. What is the current status of second-line chemotherapy for castration-resistant prostate cancer? Nature Reviews Urology 2008, 5: 650-651. PMID: 18936787, DOI: 10.1038/ncpuro1232.
- Mathew P, Thall P, Wen S, Bucana C, Jones D, Horne E, Oh W, Morris M, Lee Y, Logothetis C, Lin S, Fidler I. Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer. British Journal Of Cancer 2008, 99: 1426-1432. PMID: 18841158, PMCID: PMC2579696, DOI: 10.1038/sj.bjc.6604706.
- Simon R, di Sant'Agnese P, Huang L, Xu H, Yao J, Yang Q, Liang S, Liu J, Yu R, Cheng L, Oh W, Palapattu G, Wei J, Huang J. CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. Human Pathology 2008, 40: 252-258. PMID: 18835619, DOI: 10.1016/j.humpath.2008.07.014.
- Oh W, Sedin G. Introduction. Seminars In Perinatology 2008, 32: 323-324. PMID: 18929154, DOI: 10.1053/j.semperi.2008.08.005.
- Schurko B, Oh W. Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer. Nature Reviews Clinical Oncology 2008, 5: 506-507. PMID: 18648352, DOI: 10.1038/ncponc1201.
- Sher D, Oh W, Jacobus S, Regan M, Lee G, Mantzoros C. Relationship between serum adiponectin and prostate cancer grade. The Prostate 2008, 68: 1592-1598. PMID: 18646046, DOI: 10.1002/pros.20823.
- Brick A, McDermott D, Clement J, Kwabi C, Shah K, Weiner J, Duh M, Neary M, Oh W, Choueiri T. Treatment discontinuations, dose reductions, and interruptions for angiogenesis inhibitor therapies in patients with metastatic renal cell carcinoma (mRCC). Journal Of Clinical Oncology 2008, 26: 14636-14636. DOI: 10.1200/jco.2008.26.15_suppl.14636.
- Dial E, Fournier A, Moyneur E, Neary M, Duh M, Oh W. Frequency and cost of adverse events in renal cell carcinoma (RCC) patients receiving angiogenesis inhibitor therapies. Journal Of Clinical Oncology 2008, 26: 14609-14609. DOI: 10.1200/jco.2008.26.15_suppl.14609.
- Pomerantz M, Beckwith C, Regan M, Xie W, Herman P, Chan J, Ardlie K, Oh W, Kantoff P, Freedman M. Quantitative gene expression at the 8q24 prostate cancer risk locus. Journal Of Clinical Oncology 2008, 26: 5055-5055. DOI: 10.1200/jco.2008.26.15_suppl.5055.
- Ross R, Manola J, Oh W, Ryan C, Kim J, Rastarhuyeva I, Yap J, Van Den Abbeele A, Kantoff P, Taplin M. Phase I trial of RAD001 (R) and docetaxel (D) in castration resistant prostate cancer (CRPC) with FDG-PET assessment of RAD001 activity. Journal Of Clinical Oncology 2008, 26: 5069-5069. DOI: 10.1200/jco.2008.26.15_suppl.5069.
- Taplin M, Ko Y, Regan M, Beer T, Carducci M, Mathew P, Bubley G, Oh W, Kantoff P, Balk S. Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC). Journal Of Clinical Oncology 2008, 26: 5068-5068. DOI: 10.1200/jco.2008.26.15_suppl.5068.
- Harrison M, Hahn N, Pili R, Oh W, Kim K, Wilding G, Sweeney C, Sidor C, Arnott J, Liu G. Phase II study of 2-methoxyestradiol (2ME2) NanoCrystal Dispersion (NCD) in patients with taxane-refractory, metastatic hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2008, 26: 5173-5173. DOI: 10.1200/jco.2008.26.15_suppl.5173.
- Jacobus S, Sher D, Regan M, Chamberland J, Oh W, Mantzoros C. Association between serum adiponectin and prostate cancer risk. Journal Of Clinical Oncology 2008, 26: 5147-5147. DOI: 10.1200/jco.2008.26.15_suppl.5147.
- Duh M, Fournier A, Moyneur E, Dial E, Neary M, Oh W. Dosing and switching patterns for renal cell carcinoma (RCC) patients receiving selected angiogenesis inhibitor therapies. Journal Of Clinical Oncology 2008, 26: 5111-5111. DOI: 10.1200/jco.2008.26.15_suppl.5111.
- Oh W, Leitzel K, Jacobus S, Vargas R, Regan M, Hamer P, Carney W, Ali S, Kantoff P, Lipton A. Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients. Journal Of Clinical Oncology 2008, 26: 11077-11077. DOI: 10.1200/jco.2008.26.15_suppl.11077.
- Clement J, McDermott D, Choueiri T, Brick A, Kwabi C, Shah K, Weiner J, Duh M, Neary M, Oh W. Patients with metastatic renal cell carcinoma (mRCC) receiving sunitinib in “real-world” clinical practice: Baseline characteristics and treatment efficacy. Journal Of Clinical Oncology 2008, 26: 16071-16071. DOI: 10.1200/jco.2008.26.15_suppl.16071.
- Oh W, Perritt R, Shankaran S, Merritts M, Donovan EF, Ehrenkranz RA, O'Shea TM, Tyson JE, Laptook R, Das A, Higgins RD. Association between Urinary Lactate to Creatinine Ratio and Neurodevelopmental Outcome in Term Infants with Hypoxic-Ischemic Encephalopathy. The Journal Of Pediatrics 2008, 153: 375-378.e2. PMID: 18534246, PMCID: PMC2953792, DOI: 10.1016/j.jpeds.2008.03.041.
- Fournier A, Duh, Moyneur É, Dial E, Neary M, Oh W. PUK15 COST IMPLICATIONS OF INTRAVENOUS (IV) BEVACIZUMAB TREATMENT IN PATIENTS WITH RENAL CELL CARCINOMA (RCC). Value In Health 2008, 11: a304-a305. DOI: 10.1016/s1098-3015(10)70960-8.
- Taplin M, Manola J, Oh W, Kantoff P, Bubley G, Smith M, Barb D, Mantzoros C, Gelmann E, Balk S. A phase II study of mifepristone (RU‐486) in castration‐resistant prostate cancer, with a correlative assessment of androgen‐related hormones. BJU International 2008, 101: 1084-1089. PMID: 18399827, DOI: 10.1111/j.1464-410x.2008.07509.x.
- Ross R, Oh W, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin M, Regan M, Kantoff P, Freedman M. Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer. Journal Of Clinical Oncology 2008, 26: 842-847. PMID: 18281655, DOI: 10.1200/jco.2007.13.6804.
- Ross R, Xie W, Regan M, Pomerantz M, Nakabayashi M, Daskivich T, Sartor O, Taplin M, Kantoff P, Oh W. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer. Cancer 2008, 112: 1247-1253. PMID: 18293426, DOI: 10.1002/cncr.23304.
- Keating N, O’Malley A, McNaughton‐Collins M, Oh W, Smith M. Use of androgen deprivation therapy for metastatic prostate cancer in older men. BJU International 2008, 101: 1077-1083. PMID: 18190632, PMCID: PMC2900629, DOI: 10.1111/j.1464-410x.2007.07405.x.
- Nakabayashi M, Sartor O, Jacobus S, Regan M, McKearn D, Ross R, Kantoff P, Taplin M, Oh W. Response to docetaxel/carboplatin‐based chemotherapy as first‐ and second‐line therapy in patients with metastatic hormone‐refractory prostate cancer. BJU International 2008, 101: 308-312. PMID: 18184327, DOI: 10.1111/j.1464-410x.2007.07331.x.
- Oh W, Guignard J, Baumgart S. Preface. 2008, xvii. DOI: 10.1016/b978-1-4160-3163-5.50006-3.
- Ross R, Beer T, Jacobus S, Bubley G, Taplin M, Ryan C, Huang J, Oh W. A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone‐refractory prostate cancer who are refractory to docetaxel. Cancer 2007, 112: 521-526. PMID: 18085595, DOI: 10.1002/cncr.23195.
- Bender G, Cashore W, Oh W. Ontogeny of Bilirubin-Binding Capacity and the Effect of Clinical Status in Premature Infants Born at Less Than 1300 Grams. Pediatrics 2007, 120: 1067-1073. PMID: 17974745, DOI: 10.1542/peds.2006-3024.
- Xie W, Nakabayashi M, Regan M, Oh W. Higher prostate‐specific antigen levels predict improved survival in patients with hormone‐refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Cancer 2007, 110: 2709-2715. PMID: 17960608, DOI: 10.1002/cncr.23111.
- Mathew P, Thall P, Bucana C, Oh W, Morris M, Jones D, Johnson M, Wen S, Pagliaro L, Tannir N, Tu S, Meluch A, Smith L, Cohen L, Kim S, Troncoso P, Fidler I, Logothetis C. Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases. Clinical Cancer Research 2007, 13: 5816-5824. PMID: 17908974, DOI: 10.1158/1078-0432.ccr-07-1269.
- Avigan D, Vasir B, George D, Oh W, Atkins M, McDermott D, Kantoff P, Figlin R, Vasconcelles M, Xu Y, Kufe D, Bukowski R. Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma. Journal Of Immunotherapy 2007, 30: 749-761. PMID: 17893567, DOI: 10.1097/cji.0b013e3180de4ce8.
- Daskivich T, Regan M, Oh W. Distinct Prognostic Role of Prostate-Specific Antigen Doubling Time and Velocity at Emergence of Androgen Independence in Patients Treated with Chemotherapy. Urology 2007, 70: 527-531. PMID: 17905110, DOI: 10.1016/j.urology.2007.04.035.
- Heller CD, O'Shea M, Yao Q, Langer J, Ehrenkranz RA, Phelps DL, Poole WK, Stoll B, Duara S, Oh W, Lemons J, Poindexter B. Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants. Pediatrics 2007, 120: 1-9. PMID: 17606555, DOI: 10.1542/peds.2006-1465.
- Nakabayashi M, Sartor O, Jacobus S, Regan M, McKearn D, Ross R, Kantoff P, Taplin M, Oh W. Response to docetaxel (D)/carboplatin (C)-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2007, 25: 5156-5156. DOI: 10.1200/jco.2007.25.18_suppl.5156.
- Oh W, Leitzel K, Kantoff P, Regan M, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali S, Lipton A. Elevated plasma TIMP-1 levels predict reduced survival in metastatic hormone-refractory prostate cancer patients. Journal Of Clinical Oncology 2007, 25: 5143-5143. DOI: 10.1200/jco.2007.25.18_suppl.5143.
- Samnotra V, Vassilopoulou-Sellin R, Fojo A, Oh W, LaRocca R, Ernstoff M, Memoli V, Cole B, Quinn D, Simmons P, Tretter C. A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC). Journal Of Clinical Oncology 2007, 25: 15527-15527. DOI: 10.1200/jco.2007.25.18_suppl.15527.
- Pomerantz M, Manola J, Taplin M, Bubley G, Inman M, Lowell J, Beard C, Kantoff P, Oh W. Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer. Journal Of Urology 2007, 177: 2146-2150. PMID: 17509304, DOI: 10.1016/j.juro.2007.01.119.
- Oh W. Editorial Comment. Journal Of Urology 2007, 177: 2145. DOI: 10.1016/j.juro.2007.01.265.
- Wadhawan R, Oh W, Perritt R, Laptook A, Poole K, Wright L, Fanaroff A, Duara S, Stoll B, Goldberg R. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. Journal Of Perinatology 2007, 27: 359-364. PMID: 17443198, DOI: 10.1038/sj.jp.7211751.
- Oh W. Timing of Umbilical Cord Clamping at Birth in Full-term Infants. JAMA 2007, 297: 1257-1258. PMID: 17374821, DOI: 10.1001/jama.297.11.1257.
- Nakabayashi M, Ling J, Xie W, Regan M, Oh W. Response to Vinorelbine With or Without Estramustine as Second-Line Chemotherapy in Patients with Hormone-Refractory Prostate Cancer. The Cancer Journal 2007, 13: 125-129. PMID: 17476141, DOI: 10.1097/ppo.0b013e3180465940.
- Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Daskivich T, Antràs L, Smith M, Neary M, Duh M. The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer 2007, 109: 1090-1096. PMID: 17311345, DOI: 10.1002/cncr.22504.
- Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook R, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK, Network N. Trends in neonatal morbidity and mortality for very low birthweight infants. American Journal Of Obstetrics And Gynecology 2007, 196: 147.e1-147.e8. PMID: 17306659, DOI: 10.1016/j.ajog.2006.09.014.
- Clyman R, Saha S, Jobe A, Oh W. Indomethacin Prophylaxis for Preterm Infants: The Impact of 2 Multicentered Randomized Controlled Trials on Clinical Practice. The Journal Of Pediatrics 2007, 150: 46-50.e2. PMID: 17188612, PMCID: PMC1849955, DOI: 10.1016/j.jpeds.2006.09.001.
- Oh W, Tay M, Huang J. Is there a role for platinum chemotherapy in the treatment of patients with hormone‐refractory prostate cancer? Cancer 2006, 109: 477-486. PMID: 17186531, DOI: 10.1002/cncr.22439.
- STERNBERG C, KRAINER M, OH W, BRACARDA S, BELLMUNT J, OZEN H, ZLOTTA A, BEER T, OUDARD S, RAUCHENWALD M, SKONECZNA I, BORNER M, FITZPATRICK J. The medical management of prostate cancer: a multidisciplinary team approach. BJU International 2006, 99: 22-27. PMID: 16956362, DOI: 10.1111/j.1464-410x.2006.06477.x.
- Daskivich T, Regan M, Oh W. Prostate Specific Antigen Doubling Time Calculation: Not as Easy as 1, 2, 4. Journal Of Urology 2006, 176: 1927-1937. PMID: 17070213, DOI: 10.1016/j.juro.2006.07.002.
- Mathew P, Thall P, Wen S, Horne E, Johnson M, Oh W, Morris M, Logothetis C, Fidler I, Bucana C. 79 POSTER Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebocontrolled trial of docetaxel +/− imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM). European Journal Of Cancer Supplements 2006, 4: 28. DOI: 10.1016/s1359-6349(06)70085-4.
- Nakabayashi M, Beard C, Kelly S, Carr-Locke D, Oh W. Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer. Urologic Oncology Seminars And Original Investigations 2006, 24: 503-508. PMID: 17138131, DOI: 10.1016/j.urolonc.2006.02.002.
- Oh W, Poindexter B, Perrit R, Lemons J, Bauer C, Ehrenkranz R, Stoll B, Poole K, Wright L. Reply. The Journal Of Pediatrics 2006, 149: 732. DOI: 10.1016/j.jpeds.2006.05.043.
- Ahlfors C, Vreman H, Wong R, Bender G, Oh W, Morris B, Stevenson D, Subcommittee T, Network O. Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns. Clinical Biochemistry 2006, 40: 261-267. PMID: 17069786, PMCID: PMC1945224, DOI: 10.1016/j.clinbiochem.2006.09.006.
- Oh W. Preface. Hematology/Oncology Clinics Of North America 2006, 20: xiii-xiv. DOI: 10.1016/j.hoc.2006.07.001.
- Nakabayashi M, Xie W, Regan M, Jackman D, Kantoff P, Oh W. Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer. Cancer 2006, 107: 975-981. PMID: 16862573, DOI: 10.1002/cncr.22085.
- Michaelson M, Kaufman D, Kantoff P, Oh W, Smith M. Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer 2006, 107: 530-535. PMID: 16804927, DOI: 10.1002/cncr.22043.
- Nakabayashi M, Xie W, Regan M, Jackman D, Kantoff P, Oh W. Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Journal Of Clinical Oncology 2006, 24: 4646-4646. DOI: 10.1200/jco.2006.24.18_suppl.4646.
- Regan M, Daskivich T, Kantoff P, Oh W. Utility of prostate specific antigen doubling time (PSA-DT) at the start of androgen independent prostate cancer (AIPC) and immediately before chemotherapy in predicting efficacy of taxane chemotherapy. Journal Of Clinical Oncology 2006, 24: 4640-4640. DOI: 10.1200/jco.2006.24.18_suppl.4640.
- Daskivich T, Regan M, Kantoff P, Oh W. Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy. Journal Of Clinical Oncology 2006, 24: 4616-4616. DOI: 10.1200/jco.2006.24.18_suppl.4616.
- Mathew P, Thall P, Johnson M, Oh W, Meluch A, Morris M, Troncoso P, Bucana C, Fidler I, Logothetis C. Preliminary results of a randomized placebo-controlled double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM). Journal Of Clinical Oncology 2006, 24: 4562-4562. DOI: 10.1200/jco.2006.24.18_suppl.4562.
- Pomerantz M, Manola J, Taplin M, Bubley G, Inman M, Lowell J, Kantoff P, Oh W. Phase II study of low dose (LD) and high dose (HD) premarin in androgen independent prostate cancer (AIPC). Journal Of Clinical Oncology 2006, 24: 4560-4560. DOI: 10.1200/jco.2006.24.18_suppl.4560.
- Oh W, Manola J, Ross R, Berkowitz A, Ryan C, Eilers K, Beer T. A phase II trial of docetaxel plus carboplatin in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel chemotherapy: Preliminary results. Journal Of Clinical Oncology 2006, 24: 14533-14533. DOI: 10.1200/jco.2006.24.18_suppl.14533.
- Hayes J, Oh W, Kantoff P, Manola J, Smith M, Gelmann E, Bubley G, Balk S, Taplin M. Mifepristone (RU-486) in androgen independent prostate cancer. Journal Of Clinical Oncology 2006, 24: 14508-14508. DOI: 10.1200/jco.2006.24.18_suppl.14508.
- Smith M, Manola J, Kaufman D, Oh W, Bubley G, Kantoff P. Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy. Journal Of Clinical Oncology 2006, 24: 2723-2728. PMID: 16782912, DOI: 10.1200/jco.2005.03.7804.
- Nakabayashi M, Bartlett R, Oh W. Treatment of Bicalutamide-Induced Gynecomastia With Breast-Reduction Surgery in Prostate Cancer. Journal Of Clinical Oncology 2006, 24: 2958-2959. PMID: 16782932, DOI: 10.1200/jco.2005.03.8505.
- Gilligan T, Oh W, Kantoff P. Carboplatin for Stage I Seminoma. Journal Of Clinical Oncology 2006, 24: 2971-2972. PMID: 16782940, DOI: 10.1200/jco.2005.05.3231.
- Oh W, Manola J, Babcic V, Harnam N, Kantoff P. Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes. Urology 2006, 67: 1235-1240. PMID: 16765185, DOI: 10.1016/j.urology.2006.01.006.
- Oh W, Hayes J, Evan C, Manola J, George D, Waldron H, Donovan M, Varner J, Orechia J, Katcher B, Lu D, Nevins A, Wright R, Tormey L, Talcott J, Rubin M, Loda M, Sellers W, Richie J, Kantoff P, Weeks J. Development of an Integrated Prostate Cancer Research Information System. Clinical Genitourinary Cancer 2006, 5: 61-66. PMID: 16859581, DOI: 10.3816/cgc.2006.n.019.
- Oh W, Bard H. Introduction. Seminars In Perinatology 2006, 30: 113. DOI: 10.1053/j.semperi.2006.04.002.
- Daskivich T, Oh W. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms? Urology 2006, 67: 1084.e15-1084.e17. PMID: 16698377, DOI: 10.1016/j.urology.2005.11.015.
- Daskivich T, Oh W. Recent progress in hormonal therapy for advanced prostate cancer. Current Opinion In Urology 2006, 16: 173-178. PMID: 16679855, DOI: 10.1097/01.mou.0000193392.77469.e2.
- Mercer J, Vohr B, McGrath M, Padbury J, Wallach M, Oh W. Delayed Cord Clamping in Very Preterm Infants Reduces the Incidence of Intraventricular Hemorrhage and Late-Onset Sepsis: A Randomized, Controlled Trial. Pediatrics 2006, 117: 1235-1242. PMID: 16585320, PMCID: PMC1564438, DOI: 10.1542/peds.2005-1706.
- Nakabayashi M, Oh W. Chemotherapy for high‐risk localized prostate cancer. BJU International 2006, 97: 679-683. PMID: 16536752, DOI: 10.1111/j.1464-410x.2006.06092.x.
- Shankaran S, Laptook R, Ehrenkranz R, Tyson J, McDonald S, Donovan E, Fanaroff A, Poole W, Wright L, Higgins R, Finer N, Carlo W, Duara S, Oh W, Cotton C, Stevenson D, Stoll B, Lemons J, Guillet R, Jobe A. Whole-Body Hypothermia for Neonates With Hypoxic–Ischemic Encephalopathy. Obstetrical & Gynecological Survey 2006, 61: 158-159. DOI: 10.1097/01.ogx.0000201910.42613.6c.
- Benjamin D, Stoll B, Fanaroff A, McDonald S, Oh W, Higgins R, Duara S, Poole K, Laptook A, Goldberg R. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months. Pediatrics 2006, 117: 84-92. PMID: 16396864, DOI: 10.1542/peds.2004-2292.
- Febbo P, Thorner A, Rubin M, Loda M, Kantoff P, Oh W, Golub T, George D. Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer. Clinical Cancer Research 2006, 12: 152-158. PMID: 16397037, DOI: 10.1158/1078-0432.ccr-05-1652.
- Rosenberg J, Galsky M, Rohs N, Weinberg V, Oh W, Kelly W, Small E. A retrospective evaluation of second‐line chemotherapy response in hormone‐refractory prostate carcinoma. Cancer 2005, 106: 58-62. PMID: 16329138, DOI: 10.1002/cncr.21559.
- Oh W, Poindexter B, Perritt R, Lemons J, Bauer C, Ehrenkranz R, Stoll B, Poole K, Wright L, Network F. Association between Fluid Intake and Weight Loss during the First Ten Days of Life and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2005, 147: 786-790. PMID: 16356432, DOI: 10.1016/j.jpeds.2005.06.039.
- Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Breierova L, Smith M, Neary M, Duh. CO4 A COMPARISON OF LOGISTIC REGRESSION AND COX PROPORTIONAL HAZARDS MODELS FOR IDENTIFICATION OF RISK FACTORS FOR RENAL IMPAIRMENT IN HORMONE REFRACTORY PROSTATE CANCER (HRPC) PATIENTS WITH BONE METASTASES (BM) TREATED WITH ZOLEDRONIC ACID (ZA). Value In Health 2005, 8: a16-a17. DOI: 10.1016/s1098-3015(10)67190-2.
- Oh W. Docetaxel in Hormone-Refractory Metastatic Prostate Cancer. Drugs 2005, 65: 2295-2297. DOI: 10.2165/00003495-200565160-00006.
- Shankaran S, Laptook R, Ehrenkranz R, Tyson J, McDonald S, Donovan E, Fanaroff A, Poole W, Wright L, Higgins R, Finer N, Carlo W, Duara S, Oh W, Cotten C, Stevenson D, Stoll B, Lemons J, Guillet R, Jobe A. Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy. New England Journal Of Medicine 2005, 353: 1574-1584. PMID: 16221780, DOI: 10.1056/nejmcps050929.
- Oh W. High-Risk Localized Prostate Cancer: Integrating Chemotherapy. The Oncologist 2005, 10: 18-22. PMID: 16272455, DOI: 10.1634/theoncologist.10-90002-18.
- Mercer J, Vohr B, Oh W. DELAYED CORD CLAMPING IN VERY PRETERM INFANTS REDUCES THE INCIDENCE OF INTRAVENTRICULAR HEMORRHAGE (IVH) AND LATE ONSET SEPSIS (LOS). Journal Of Midwifery & Women's Health 2005, 50: 439-439. DOI: 10.1016/j.jmwh.2005.04.012.
- Nakabayashi M, Regan M, Lifsey D, Kantoff P, Taplin M, Sartor O, Oh W. Efficacy of nilutamide as secondary hormonal therapy in androgen‐independent prostate cancer. BJU International 2005, 96: 783-786. PMID: 16153200, DOI: 10.1111/j.1464-410x.2005.05714.x.
- Naiman J, Rosenkrantz T, Oh W. Polycythemia and hyperviscosity in the newborn. 2005, 171-186. DOI: 10.1017/cbo9780511545306.011.
- Michael Cotten C, Oh W, McDonald S, Carlo W, Fanaroff A, Duara S, Stoll B, Laptook A, Poole K, Wright L, Goldberg R. Prolonged Hospital Stay for Extremely Premature Infants: Risk Factors, Center Differences, and the Impact of Mortality on Selecting a Best-Performing Center. Journal Of Perinatology 2005, 25: 650-655. PMID: 16079906, DOI: 10.1038/sj.jp.7211369.
- Mercer J, Vohr V, Oh W. 240 Delayed Cord Clamping in Very Low Birthweight Infants Reduces the Incidence of Intraventricular Hemorrhage and Late Onset Sepsis. Pediatric Research 2005, 58: 395-395. DOI: 10.1203/00006450-200508000-00269.
- Febbo P, Richie J, George D, Loda M, Manola J, Shankar S, Barnes A, Tempany C, Catalona W, Kantoff P, Oh W. Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer. Clinical Cancer Research 2005, 11: 5233-5240. PMID: 16033841, DOI: 10.1158/1078-0432.ccr-05-0299.
- Van Meurs K, Wright L, Ehrenkranz R, Lemons J, Ball M, Poole W, Perritt R, Higgins R, Oh W, Hudak M, Laptook R, Shankaran S, Finer N, Carlo W, Kennedy K, Fridriksson J, Steinhorn R, Sokol G, Konduri G, Aschner J, Stoll B, D'Angio C, Stevenson D. Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure. New England Journal Of Medicine 2005, 353: 13-22. PMID: 16000352, DOI: 10.1056/nejmoa043927.
- Stoll B, Hansen N, Higgins R, Fanaroff A, Duara S, Goldberg R, Laptook, Walsh M, Oh W, Hale E. Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis. The Pediatric Infectious Disease Journal 2005, 24: 635-639. PMID: 15999007, DOI: 10.1097/01.inf.0000168749.82105.64.
- Oh W, Manola J, Babcic V, Harnam N, Kantoff P. Response to second-line chemotherapy in patients with hormone refractory prostate cancer (HRPC) receiving two sequences of mitoxantrone (M) and taxanes (T). Journal Of Clinical Oncology 2005, 23: 4616-4616. DOI: 10.1200/jco.2005.23.16_suppl.4616.
- Nakabayashi M, Regan M, Lifsey D, Evan C, Kantoff P, Taplin M, Sartor O, Oh W. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer (AIPC). Journal Of Clinical Oncology 2005, 23: 4683-4683. DOI: 10.1200/jco.2005.23.16_suppl.4683.
- Michaelson M, Gilligan T, Oh W, Kantoff P, Taplin M, Izquierdo M, Flores L, Smith M. Phase II study of three hour, weekly infusion of trabectedin (ET-743) in men with metastatic, androgen-independent prostate carcinoma (AIPC). Journal Of Clinical Oncology 2005, 23: 4517-4517. DOI: 10.1200/jco.2005.23.16_suppl.4517.
- Oh W, George D, Tay M. Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy. Clinical Genitourinary Cancer 2005, 4: 61-64. PMID: 15992464, DOI: 10.3816/cgc.2005.n.014.
- Galsky M, Small E, Oh W, Chen I, Smith D, Colevas A, Martone L, Curley T, DeLaCruz A, Scher H, Kelly W. Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer. Journal Of Clinical Oncology 2005, 23: 1439-1446. PMID: 15735119, DOI: 10.1200/jco.2005.09.042.
- Hintz S, Poole W, Wright L, Fanaroff A, Kendrick D, Laptook A, Goldberg R, Duara S, Stoll B, Oh W. Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Archives Of Disease In Childhood Fetal & Neonatal 2005, 90: f128. PMID: 15724036, PMCID: PMC1721837, DOI: 10.1136/adc.2003.046268.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Jacobson J, Smith M, Kaufman D, Kantoff P. A Phase I Study of Estramustine, Weekly Docetaxel, and Carboplatin Chemotherapy in Patients with Hormone-Refractory Prostate Cancer. Clinical Cancer Research 2005, 11: 284-289. PMID: 15671557, DOI: 10.1158/1078-0432.284.11.1.
- Tay M, Oh W. Chapter 28 Metastatic Adenocarcinoma of the Prostate. 2005, 505-513. DOI: 10.1016/b978-0-7216-0003-1.50032-0.
- Ment LR, Vohr BR, Makuch RW, Westerveld M, Katz KH, Schneider KC, Duncan CC, Ehrenkranz R, Oh W, Philip AG, Scott DT, Allan WC. Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. The Journal Of Pediatrics 2004, 145: 832-834. PMID: 15580211, DOI: 10.1016/j.jpeds.2004.07.035.
- Oh W. AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER. Journal Of Urology 2004, 172: s34-s37. PMID: 15535440, DOI: 10.1097/01.ju.0000141674.92253.fe.
- CARROLL P, CHAN J, D’AMICO A, GELMANN E, IVERSEN P, KLOTZ L, NELSON J, NELSON P, NELSON W, OH W, ROSEN N, RUBIN M, SANDLER H, SELLERS W, SMITH M, XU J, McMANN M, KANTOFF P. FOURTH INTERNATIONAL CONFERENCE ON INNOVATIONS AND CHALLENGES IN PROSTATE CANCER. Journal Of Urology 2004, 172: s3-s5. PMID: 15535434, DOI: 10.1097/01.ju.0000142276.19511.ac.
- Nakabayashi M, Oh W. Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer. Current Treatment Options In Oncology 2004, 5: 349-355. PMID: 15341673, DOI: 10.1007/s11864-004-0025-3.
- Smith M, Manola J, Kaufman D, George D, Oh W, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff P. Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate‐specific antigen level after radical prostatectomy and/or radiation therapy. Cancer 2004, 101: 1569-1574. PMID: 15468186, DOI: 10.1002/cncr.20493.
- Kaufman D, Carducci M, Kuzel T, Todd M, Oh W, Smith M, Ye Z, Nicol S, Stadler W. A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. Urologic Oncology Seminars And Original Investigations 2004, 22: 393-397. PMID: 15464919, DOI: 10.1016/j.urolonc.2004.01.002.
- Oh W, Kantoff P, Weinberg V, Jones G, Rini B, Derynck M, Bok R, Smith M, Bubley G, Rosen R, DiPaola R, Small E. Prospective, Multicenter, Randomized Phase II Trial of the Herbal Supplement, PC-SPES, and Diethylstilbestrol in Patients With Androgen-Independent Prostate Cancer. Journal Of Clinical Oncology 2004, 22: 3705-3712. PMID: 15289492, DOI: 10.1200/jco.2004.10.195.
- George D, Oh W, Gilligan T, Masson E, Souppart C, Wang Y, Ho Y, Lebwohl D, Laurent D, Kantoff P. Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4689-4689. DOI: 10.1200/jco.2004.22.90140.4689.
- Tay M, George D, Gilligan T, Kelly S, Appleby L, Taplin M, Febbo P, Kantoff P, Oh W. Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy. Journal Of Clinical Oncology 2004, 22: 4679-4679. DOI: 10.1200/jco.2004.22.90140.4679.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Smith M, Kaufman D, Kantoff P. A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4656-4656. DOI: 10.1200/jco.2004.22.90140.4656.
- Kelly W, Galsky M, Small E, Oh W, Chen I, Smith D, Martone L, Curley T, Delacruz A, Scher H. Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castrate-metastatic prostate cancer (PCMPC): Updated results. Journal Of Clinical Oncology 2004, 22: 4509-4509. DOI: 10.1200/jco.2004.22.90140.4509.
- George D, Oh W, Gilligan T, Masson E, Souppart C, Wang Y, Ho Y, Lebwohl D, Laurent D, Kantoff P. Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4689-4689. DOI: 10.1200/jco.2004.22.14_suppl.4689.
- Tay M, George D, Gilligan T, Kelly S, Appleby L, Taplin M, Febbo P, Kantoff P, Oh W. Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy. Journal Of Clinical Oncology 2004, 22: 4679-4679. DOI: 10.1200/jco.2004.22.14_suppl.4679.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Smith M, Kaufman D, Kantoff P. A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4656-4656. DOI: 10.1200/jco.2004.22.14_suppl.4656.
- Kelly W, Galsky M, Small E, Oh W, Chen I, Smith D, Martone L, Curley T, Delacruz A, Scher H. Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castrate-metastatic prostate cancer (PCMPC): Updated results. Journal Of Clinical Oncology 2004, 22: 4509-4509. DOI: 10.1200/jco.2004.22.14_suppl.4509.
- Tay M, Kaufman D, Regan M, Leibowitz S, George D, Febbo P, Manola J, Smith M, Kaplan I, Kantoff P, Oh W. Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Annals Of Oncology 2004, 15: 974-978. PMID: 15151957, DOI: 10.1093/annonc/mdh221.
- Abe M, Manola J, Oh W, Parslow D, George D, Austin C, Kantoff P. Plasma Levels of Heat Shock Protein 70 in Patients with Prostate Cancer: A Potential Biomarker for Prostate Cancer. Clinical Genitourinary Cancer 2004, 3: 49-53. PMID: 15279691, DOI: 10.3816/cgc.2004.n.013.
- Poindexter B, Ehrenkranz R, Stoll B, Wright L, Poole W, Oh W, Bauer C, Papile L, Tyson J, Carlo W, Laptook A, Narendran V, Stevenson D, Fanaroff A, Korones S, Shankaran S, Finer N, Lemons J. Parenteral Glutamine Supplementation Does Not Reduce the Risk of Mortality or Late-Onset Sepsis in Extremely Low Birth Weight Infants. Pediatrics 2004, 113: 1209-1215. PMID: 15121931, DOI: 10.1542/peds.113.5.1209.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. To Tap or Not to Tap: High Likelihood of Meningitis Without Sepsis Among Very Low Birth Weight Infants. Pediatrics 2004, 113: 1181-1186. PMID: 15121927, DOI: 10.1542/peds.113.5.1181.
- Meadow W, Oh W, Vohr B, Tyson J, Fanaroff A, Stoll B, Ehrenkranz R, Carlo W, Shankaran S, Poole K, Perritt R, Wright L. Importance of Bilirubin Effect Questioned. Pediatrics 2004, 113: 627-628. PMID: 14993565, DOI: 10.1542/peds.113.3.627.
- Liu G, Gandara D, Lara P, Raghavan D, Doroshow J, Twardowski P, Kantoff P, Oh W, Kim K, Wilding G. A Phase II Trial of Flavopiridol (NSC #649890) in Patients with Previously Untreated Metastatic Androgen-Independent Prostate Cancer. Clinical Cancer Research 2004, 10: 924-928. PMID: 14871968, DOI: 10.1158/1078-0432.ccr-03-0050.
- George D, Regan M, Oh W, Tay M, Manola J, Decalo N, Duggan S, Dewolf W, Kantoff P, Bubley G. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology 2004, 63: 327-332. PMID: 14972483, DOI: 10.1016/j.urology.2003.09.059.
- Oh W, Halabi S, Kelly W, Werner C, Godley P, Vogelzang N, Small E, B F. A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma. Cancer 2003, 98: 2592-2598. PMID: 14669278, DOI: 10.1002/cncr.11829.
- Oh W. The Evolving Role of Chemotherapy and Other Systemic Therapies for Managing Localized Prostate Cancer. Journal Of Urology 2003, 170: s28-s34. PMID: 14610407, DOI: 10.1097/01.ju.0000095356.02647.64.
- CARROLL P, BENARON D, BLACKLEDGE G, COAKLEY F, D’AMICO A, HIGANO C, IVERSEN P, KATTAN M, NANUS D, NELSON J, OH W, ROACH M, SELLERS W, SMITH M, MCMANN M, KANTOFF P. Third International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. Journal Of Urology 2003, 170: s3-s5. PMID: 14610403, DOI: 10.1097/01.ju.0000095101.18470.a0.
- Oh W, Tyson J, Fanaroff A, Vohr B, Perritt R, Stoll B, Ehrenkranz R, Carlo W, Shankaran S, Poole K, Wright L. Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. Pediatrics 2003, 112: 773-779. PMID: 14523165, DOI: 10.1542/peds.112.4.773.
- LEIBOWITZ S, OH W. Overtreatment of a Patient With Presumed Recurrent Prostate Cancer Based on False-Positive Prostate Specific Antigen Results. Journal Of Urology 2003, 170: 1305. PMID: 14501750, DOI: 10.1097/01.ju.0000084670.47887.a5.
- Mercer J, McGrath M, Hensman A, Silver H, Oh W. Immediate and Delayed Cord Clamping in Infants Born Between 24 and 32 Weeks: A Pilot Randomized Controlled Trial. Journal Of Perinatology 2003, 23: 466-472. PMID: 13679933, DOI: 10.1038/sj.jp.7210970.
- Wadhawan R, Vohr B, Fanaroff A, Perritt R, Duara S, Stoll B, Goldberg R, Laptook, Poole K, Wright L, Oh W. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? American Journal Of Obstetrics And Gynecology 2003, 189: 501-506. PMID: 14520225, DOI: 10.1067/s0002-9378(03)00360-0.
- Bhayani S, Ong A, Oh W, Kantoff P, Kavoussi L. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology 2003, 62: 324-327. PMID: 12893344, DOI: 10.1016/s0090-4295(03)00324-8.
- Oh W, Manola J, Bittmann L, Brufsky A, Kaplan I, Smith M, Kaufman D, Kantoff P. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. Urology 2003, 62: 99-104. PMID: 12837431, DOI: 10.1016/s0090-4295(03)00145-6.
- Yu E, Oh W. Neoadjuvant therapy for high-risk localized prostate cancer. Current Oncology Reports 2003, 5: 250-257. PMID: 12667424, DOI: 10.1007/s11912-003-0118-3.
- Oh W, Kaplan I, Febbo P, Prisby J, Manola J, Kaufman D, Kantoff P. Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate Cancer: Feasibility and Toxicity. American Journal Of Clinical Oncology 2003, 26: 312. DOI: 10.1097/00000421-200306000-00021.
- Oh W, Kaplan I, Febbo P, Prisby J, Manola J, Kaufman D, Kantoff P. Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate Cancer. American Journal Of Clinical Oncology 2003, 26: 312-316. PMID: 12796607, DOI: 10.1097/01.coc.0000020921.08768.1f.
- Leibowitz S, Garber J, Fox E, Loda M, Kaufman D, Kantoff P, Oh W. Male Patients with Diagnoses of Both Breast Cancer and Prostate Cancer. The Breast Journal 2003, 9: 208-212. PMID: 12752629, DOI: 10.1046/j.1524-4741.2003.09312.x.
- Oh W. Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints. Urologic Oncology Seminars And Original Investigations 2003, 21: 229-234. PMID: 12810211, DOI: 10.1016/s1078-1439(03)00019-x.
- Oh W, Tully P, Kantoff P, Regan M. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma. Cancer 2003, 97: 2171-2179. PMID: 12712468, DOI: 10.1002/cncr.11344.
- Poindexter B, Ehrenkranz R, Stoll B, Koch M, Wright L, Oh W, Papile L, Bauer C, Carlo W, Donovan E, Fanaroff A, Korones S, Laptook R, Shankaran S, Stevenson D, Tyson J, Lemons J, Network I. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants 1 , 2 , 3. American Journal Of Clinical Nutrition 2003, 77: 737-743. PMID: 12600870, DOI: 10.1093/ajcn/77.3.737.
- Lee D, Sartor O, Kosty M, Oh W. Highlights from the Third Annual Meeting of the Society of Urologic Oncology; Bethesda, Maryland, December 13-14, 2002. Clinical Genitourinary Cancer 2003, 1: 203-206. PMID: 15040876, DOI: 10.1016/s1540-0352(11)70002-6.
- Rosenkrantz T, Oh W. Polycythemia. 2003, 578-585. DOI: 10.1017/cbo9780511544774.030.
- Michaelson M, Kaufman D, Oh W. Transitional cell carcinoma of the upper uroepithelial tract. Clinical Advances In Hematology And Oncology 2003, 1: 102-4; discussion 105. PMID: 16224387.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth- Weight Infants. Obstetrical & Gynecological Survey 2003, 58: 17-18. DOI: 10.1097/00006254-200301000-00010.
- Oh W. Predicting Outcome in Localized Prostate Cancer: How Far Have We Come? Cancer Investigation 2003, 21: 487-488. PMID: 12901296, DOI: 10.1081/cnv-120018656.
- Oh W, Small E. Complementary and alternative therapies in prostate cancer. Seminars In Oncology 2002, 29: 575-584. PMID: 12516040, DOI: 10.1053/sonc.2002.50007.
- Smith M, Kaufman D, George D, Oh W, Kazanis M, Manola J, Kantoff P. Selective aromatase inhibition for patients with androgen‐independent prostate carcinoma. Cancer 2002, 95: 1864-1868. PMID: 12404279, DOI: 10.1002/cncr.10844.
- Carlo W, Stark A, Wright L, Tyson J, Papile L, Shankaran S, Donovan E, Oh W, Bauer C, Saha S, Poole W, Stoll B, Network* F. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. The Journal Of Pediatrics 2002, 141: 370-375. PMID: 12219057, DOI: 10.1067/mpd.2002.127507.
- Oh W. The Evolving Role of Estrogen Therapy in Prostate Cancer. Clinical Genitourinary Cancer 2002, 1: 81-89. PMID: 15046698, DOI: 10.3816/cgc.2002.n.009.
- OH W. Secondary hormonal therapies in the treatment of prostate cancer. Urology 2002, 60: 87-92. PMID: 12231058, DOI: 10.1016/s0090-4295(02)01581-9.
- Carroll P, Kantoff P, Balk S, Brown M, D’amico A, George D, Grossfeld G, Johnson C, Kelly W, Klotz L, Lee W, Lubeck D, Mcleod D, Oh W, Pollack A, Sartor O, Smith M, Hart C. Overview consensus statement. Urology 2002, 60: 1-6. PMID: 12231036, DOI: 10.1016/s0090-4295(02)01559-5.
- Shankaran S, Laptook A, Wright L, Ehrenkranz R, Donovan E, Fanaroff A, Stark A, Tyson J, Poole K, Carlo W, Lemons J, Oh W, Stoll B, Papile L, Bauer C, Stevenson D, Korones S, McDonald S. Whole-Body Hypothermia for Neonatal Encephalopathy: Animal Observations as a Basis for a Randomized, Controlled Pilot Study in Term Infants. Pediatrics 2002, 110: 377-385. PMID: 12165594, DOI: 10.1542/peds.110.2.377.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh. W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110: 285-291. PMID: 12165580, DOI: 10.1542/peds.110.2.285.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook R, Stevenson D, Papile L, Poole W. Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants. New England Journal Of Medicine 2002, 347: 240-247. PMID: 12140299, DOI: 10.1056/nejmoa012657.
- D'Amico A, Saegaert T, Chen M, Renshaw A, George D, Oh W, Kantoff P. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high‐risk prostate cancer. Cancer 2002, 95: 275-280. PMID: 12124826, DOI: 10.1002/cncr.10673.
- Shankaran S, Papile L, Wright L, Ehrenkranz R, Mele L, Lemons J, Korones S, Stevenson D, Donovan E, Stoll B, Fanaroff A, Oh W, Verter J. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure. American Journal Of Obstetrics And Gynecology 2002, 187: 171-177. PMID: 12114906, DOI: 10.1067/mob.2002.122445.
- Coyle M, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. The Journal Of Pediatrics 2002, 140: 561-564. PMID: 12032522, DOI: 10.1067/mpd.2002.123099.
- Shankaran S, Fanaroff A, Wright L, Stevenson D, Donovan E, Ehrenkranz R, Langer J, Korones S, Stoll B, Tyson J, Bauer C, Lemons J, Oh W, Papile L. Risk factors for early death among extremely low-birth-weight infants. American Journal Of Obstetrics And Gynecology 2002, 186: 796-802. PMID: 11967510, DOI: 10.1067/mob.2002.121652.
- OH W, LODA M, KANTOFF P, JANICEK M. PROGRESSIVE SCLEROSIS OF ISOLATED FOOT METASTASIS OF PROSTATE CANCER. Journal Of Urology 2002, 167: 1392. DOI: 10.1097/00005392-200203000-00047.
- OH W, LODA M, KANTOFF P, JANICEK M. PROGRESSIVE SCLEROSIS OF ISOLATED FOOT METASTASIS OF PROSTATE CANCER. Journal Of Urology 2002, 167: 1392. PMID: 11832744, DOI: 10.1016/s0022-5347(05)65312-8.
- Oh W, Small E. PC-SPES and prostate cancer. Urologic Clinics Of North America 2002, 29: 59-66. PMID: 12109356, DOI: 10.1016/s0094-0143(02)00017-4.
- Oh W, George D, Kantoff P. Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC‐SPES in patients with advanced prostate carcinoma. Cancer 2002, 94: 686-689. PMID: 11857300, DOI: 10.1002/cncr.10269.
- Oh W, Manola J, George D, Fierman A, Fontaine-Rothe P, Morrissey S, Prisby J, Kaufman D, Shapiro C, Kantoff P, Smith M. A Phase II Trial of Interferon-Alpha and Toremifene in Advanced Renal Cell Cancer Patients. Cancer Investigation 2002, 20: 186-191. PMID: 11901538, DOI: 10.1081/cnv-120001145.
- Stevenson D, Fanaroff A, Maisels M, Young B, Wong R, Vreman H, MacMahon J, Yeung C, Seidman D, Gale R, Oh W, Bhutani V, Johnson L, Kaplan M, Hammerman C, Nakamura H. Prediction of Hyperbilirubinemia in Near-Term and Term Infants. Journal Of Perinatology 2001, 21: s63-s72. PMID: 11803421, DOI: 10.1038/sj.jp.7210638.
- DAmico A, Saegart T, Chen M, Renshaw A, George D, Oh W, Kantoff P. The impact of anemia on psa outcome following radiation and androgen suppression therapy in patients with high-risk prostate cancer. International Journal Of Radiation Oncology • Biology • Physics 2001, 51: 113. DOI: 10.1016/s0360-3016(01)02031-4.
- Oh W, George D, Kaufman D, Moss K, Smith M, Richie J, Kantoff P. Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report. Seminars In Oncology 2001, 28: 40-44. PMID: 11685727, DOI: 10.1016/s0093-7754(01)90153-8.
- Vohr B, Oh W, Stewart E, Bentkover J, Gabbard S, Lemons J, Papile L, Pye R. Comparison of costs and referral rates of 3 universal newborn hearing screening protocols. The Journal Of Pediatrics 2001, 139: 238-244. PMID: 11487750, DOI: 10.1067/mpd.2001.115971.
- Oh W, George D, Kaufman D, Moss K, Smith M, Richie J, Kantoff P. Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report. Seminars In Oncology 2001, 28: 40-44. DOI: 10.1053/sonc.2001.26899.
- Stevenson D, Fanaroff A, Maisels M, Young B, Wong R, Vreman H, MacMahon J, Yeung C, Seidman D, Gale R, Oh W, Bhutani V, Johnson L, Kaplan M, Hammerman C, Nakamura H. Prediction of Hyperbilirubinemia in Near-Term and Term Infants. Pediatrics 2001, 108: 31-39. PMID: 11433051, DOI: 10.1542/peds.108.1.31.
- Hintz, Gaylord T, Oh W, Fanaroff A, Mele L, Stevenson D, NICHD N. Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula‐fed term infants delivered by cesarean section. Acta Paediatrica 2001, 90: 776-781. PMID: 11519981, DOI: 10.1111/j.1651-2227.2001.tb02804.x.
- Burgess G, Oh W, Brann B, Brubakk A, Stonestreet B. Effects of Phenobarbital on Cerebral Blood Flow Velocity After Endotracheal Suctioning in Premature Neonates. JAMA Pediatrics 2001, 155: 723-727. PMID: 11386965, DOI: 10.1001/archpedi.155.6.723.
- Stark A, Carlo W, Tyson J, Papile L, Wright L, Shankaran S, Donovan E, Oh W, Bauer C, Saha S, Poole W, Stoll B, Fanaroff A, Ehrenkranz R, Korones S, Stevenson D. Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants. New England Journal Of Medicine 2001, 344: 95-101. PMID: 11150359, DOI: 10.1056/nejm200101113440203.
- Kelly W, Curley T, Slovin S, Heller G, McCaffrey J, Bajorin D, Ciolino A, Regan K, Schwartz M, Kantoff P, George D, Oh W, Smith M, Kaufman D, Small E, Schwartz L, Larson S, Tong W, Scher H. Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. Journal Of Clinical Oncology 2001, 19: 44-53. PMID: 11134194, DOI: 10.1200/jco.2001.19.1.44.
- Gilligan T, Oh W. Overall Survival after Prostate‐Specific‐Antigen‐Detected Recurrence Following Conformal Radiation Therapy. The Prostate Journal 2001, 3: 43-44. DOI: 10.1046/j.1525-1411.2001.31007-2.x.
- Oh W, George D, Hackmann K, Manola J, Kantoff P. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology 2001, 57: 122-126. PMID: 11164156, DOI: 10.1016/s0090-4295(00)00986-9.
- Gilligan T, Oh W. Bicalutamide Monotherapy Compared with Castration in Patients with Nonmetastatic Locally Advanced Prostate Cancer: 6.3 Years of Follow‐up. The Prostate Journal 2001, 3: 42-43. DOI: 10.1046/j.1525-1411.2001.003001042.x.
- Lemons J, Bauer C, Oh W, Korones S, Papile L, Stoll B, Verter J, Temprosa M, Wright L, Ehrenkranz R, Fanaroff A, Stark A, Carlo W, Tyson J, Donovan E, Shankaran S, Stevenson D. Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996. Pediatrics 2001, 107: e1-e1. PMID: 11134465, DOI: 10.1542/peds.107.1.e1.
- Oh W. Anemia Related to Hormonal Ablation Therapy for Prostate Cancer. The Prostate Journal 2001, 3: 14-17. DOI: 10.1046/j.1525-1411.2001.003001014.x.
- Gilligan T, Oh W. Prospective Trial of the Herbal Supplement PC‐SPEC in Patients with Progressive Prostate Cancer. The Prostate Journal 2001, 3: 44-45. DOI: 10.1046/j.1525-1411.2001.31007-3.x.
- Gilligan T, Oh W. Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer. The Prostate Journal 2001, 3: 45-46. DOI: 10.1046/j.1525-1411.2001.31007-4.x.
- McGrath M, Sullivan M, Lester B, Oh W. Longitudinal Neurologic Follow-Up in Neonatal Intensive Care Unit Survivors With Various Neonatal Morbidities. Pediatrics 2000, 106: 1397-1405. PMID: 11099595, DOI: 10.1542/peds.106.6.1397.
- Stevenson D, Verter J, Fanaroff A, Oh W, Ehrenkranz R, Shankaran S, Donovan E, Wright L, Lemons J, Tyson J, Korones S, Bauer C, Stoll B, Papile L. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Archives Of Disease In Childhood Fetal & Neonatal 2000, 83: f182. PMID: 11040165, PMCID: PMC1721180, DOI: 10.1136/fn.83.3.f182.
- Smith M, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff P. Vinorelbine and estramustine in androgen‐independent metastatic prostate cancer. Cancer 2000, 89: 1824-1828. PMID: 11042579, DOI: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r.
- Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman D, Oh W, Demetri G, Figg W, Zhou X, Eng C, Spiegelman B, Kantoff P. Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer. Proceedings Of The National Academy Of Sciences Of The United States Of America 2000, 97: 10990-10995. PMID: 10984506, PMCID: PMC27136, DOI: 10.1073/pnas.180329197.
- George D, Paz‐Ares L, Oh W. Article Reviews. The Prostate Journal 2000, 2: 163-167. DOI: 10.1046/j.1525-1411.2000.23006.x.
- Oh W. Chemotherapy for patients with advanced prostate carcinoma. Cancer 2000, 88: 3015-3021. PMID: 10898346, DOI: 10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m.
- Goldstein M, Rehan V, Oh W, Stonestreet B. Cerebral and intestinal perfusion and metabolism in normocythemic hyperviscous hypoxic newborn pigs. Journal Of Applied Physiology 2000, 88: 2107-2115. PMID: 10846024, DOI: 10.1152/jappl.2000.88.6.2107.
- Kaufman D, Raghavan D, Carducci M, Levine E, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2000, 18: 1921-7. PMID: 10784633, DOI: 10.1200/jco.2000.18.9.1921.
- Eder J, Kantoff P, Roper K, Xu G, Bubley G, Boyden J, Gritz L, Mazzara G, Oh W, Arlen P, Tsang K, Panicali D, Schlom J, Kufe D. A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clinical Cancer Research 2000, 6: 1632-8. PMID: 10815880.
- Reid P, Oh W. Article Reviews. The Prostate Journal 2000, 2: 102-105. DOI: 10.1046/j.1525-1411.2000.22008.x.
- Walsh-Sukys M, Tyson J, Wright L, Bauer C, Korones S, Stevenson D, Verter J, Stoll B, Lemons J, Papile L, Shankaran S, Donovan E, Oh W, Ehrenkranz R, Fanaroff A. Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. Pediatrics 2000, 105: 14-20. PMID: 10617698, DOI: 10.1542/peds.105.1.14.
- Oh W, Manola J, Renshaw A, Brodkin D, Loughlin K, Richie J, Shapiro C, Kantoff P. Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma. Urology 2000, 55: 31-35. PMID: 10654890, DOI: 10.1016/s0090-4295(99)00408-2.
- Kleinman M, Oh W, Stonestreet B. Comparison of intravenous and endotracheal epinephrine during cardiopulmonary resuscitation in newborn piglets. Critical Care Medicine 1999, 27: 2748-2754. PMID: 10628621, DOI: 10.1097/00003246-199912000-00024.
- Nelson J, Chen R, Bishoff J, Oh W, Kantoff P, Donehower R, Kavoussi L. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 1999, 54: 1064-1067. PMID: 10604709, DOI: 10.1016/s0090-4295(99)00289-7.
- Oh W, Kantoff P. Treatment of locally advanced prostate cancer: is chemotherapy the next step? Journal Of Clinical Oncology 1999, 17: 3664-75. PMID: 10550165, DOI: 10.1200/jco.1999.17.11.3664.
- Bubley G, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg W, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak D, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small E, Smith M, Trump D, Vollmer R, Wilding G. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. Journal Of Clinical Oncology 1999, 17: 3461-7. PMID: 10550143, DOI: 10.1200/jco.1999.17.11.3461.
- Stoll B, Temprosa M, Tyson J, Papile L, Wright L, Bauer C, Donovan E, Korones S, Lemons J, Fanaroff A, Stevenson D, Oh W, Ehrenkranz R, Shankaran S, Verter J. Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants. Pediatrics 1999, 104: e63-e63. PMID: 10545589, DOI: 10.1542/peds.104.5.e63.
- Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.Oh W, Kantoff P. Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer. Seminars In Oncology 1999, 26: 49-54. PMID: 10604270.
- Oh W, Manola J, Richie J, Loughlin K, Kantoff P. A phase II trial of methotrexate, cisplatin, 5‐fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma. Cancer 1999, 86: 1329-1334. PMID: 10506721, DOI: 10.1002/(sici)1097-0142(19991001)86:7<1329::aid-cncr31>3.0.co;2-r.
- Ehrenkranz R, Younes N, Lemons J, Fanaroff A, Donovan E, Wright L, Katsikiotis V, Tyson J, Oh W, Shankaran S, Bauer C, Korones S, Stoll B, Stevenson D, Papile L. Longitudinal Growth of Hospitalized Very Low Birth Weight Infants. Pediatrics 1999, 104: 280-289. PMID: 10429008, DOI: 10.1542/peds.104.2.280.
- Donovan E, Tyson J, Ehrenkranz R, Verter J, Wright L, Korones S, Bauer C, Shankaran S, Stoll B, Fanaroff A, Oh W, Lemons J, Stevenson D, Papile L, Network F. Inaccuracy of Ballard scores before 28 weeks’ gestation. The Journal Of Pediatrics 1999, 135: 147-152. PMID: 10431107, DOI: 10.1016/s0022-3476(99)70015-6.
- Reid P, Kantoff P, Oh W. Antiandrogens in Prostate Cancer. Investigational New Drugs 1999, 17: 271-284. PMID: 10665479, DOI: 10.1023/a:1006344807086.
- Yanowitz T, Yao A, Pettigrew K, Werner J, Oh W, Stonestreet B. Postnatal hemodynamic changes in very-low-birthweight infants. Journal Of Applied Physiology 1999, 87: 370-380. PMID: 10409597, DOI: 10.1152/jappl.1999.87.1.370.
- Oh W. Article Reviews. The Prostate Journal 1999, 1: 203-207. DOI: 10.1046/j.1525-1411.1999.14006.x.
- Smith M, Kantoff P, Oh W, Elson G, Manola J, McMullin M, Jacobsen J, Brufsky A, Kaufman D. Phase II Trial of the Antiestrogen Toremifene for Androgen‐Independent Prostate Cancer. The Prostate Journal 1999, 1: 185-189. DOI: 10.1046/j.1525-1411.1999.14003.x.
- Tyson J, Wright L, Oh W, Kennedy K, Mele L, Ehrenkranz R, Stoll B, Lemons J, Stevenson D, Bauer C, Korones S, Donovan E, Carlo W, Shankaran S, Stark A, Papile L, Jobe A, Stacewicz-Sapuntzakis M, Verter J, Fanaroff A. Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants. New England Journal Of Medicine 1999, 340: 1962-1968. PMID: 10379020, DOI: 10.1056/nejm199906243402505.
- Yanowitz T, Yao A, Hansen N, Oh W, Stonestreet B. Doppler Ultrasound Prediction of Cerebral Vascular Resistance: Relative Vascular Resistance Is More Accurate than Pourcelot's Index. Pediatric Research 1999, 45: 234-234. DOI: 10.1203/00006450-199904020-01393.
- The Effects of Low Dose Indomethacin Prophylaxis (LDIP) in Extremely Low Birth Weight (ELBW) InfantsOh W, Lemons J, Stevenson D, Poole K, Bauer C, Papile L, Korones S, Stoll B, Wright L. The Effects of Low Dose Indomethacin Prophylaxis (LDIP) in Extremely Low Birth Weight (ELBW) Infants. Pediatric Research 1999, 45: 216-216. DOI: 10.1203/00006450-199904020-01283.
- Lemons J, Stevenson D, Poole K, Bearden-Branch A, Bauer C, Papile L, Korones S, Stoll B, Oh W, Wright L. In Utero Magnesium Exposure: Effects on Extremely Low Birth Weight (ELBW) Infants. Pediatric Research 1999, 45: 207-207. DOI: 10.1203/00006450-199904020-01229.
- Kelly K, Gaudin P, Slovin S, Curley T, McCaffrey J, Ciolino A, Dalbagni G, Donat S, Scardino P, Scher H, Kantoff P, Smith M, Oh W, Smith D, Small E. PACLITAXEL(T), ESTRAMUSTINE(E) AND CARBOPLATIN(C) IN PATIENTS (Pts) WITH ADVANCED PROSTATE CANCER(PC). Journal Of Urology 1999, 161: 177.. DOI: 10.1097/00005392-199904010-00711.
- Kavoussi L, Nelson J, Chen R, Bishoff J, Donehower R, Oh W, Kantoff P. LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TESTICULAR TUMORS (NSGCT). Journal Of Urology 1999, 161: 4.. DOI: 10.1097/00005392-199904010-00018.
- Oh W. Article Reviews. The Prostate Journal 1999, 1: 103-108. DOI: 10.1046/j.1525-1411.1999.09916.x.
- Stevenson D, Wright L, Lemons J, Oh W, Korones S, Papile L, Bauer C, Stoll B, Tyson J, Shankaran S, Fanaroff A, Donovan E, Ehrenkranz R, Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. American Journal Of Obstetrics And Gynecology 1998, 179: 1632-1639. PMID: 9855609, DOI: 10.1016/s0002-9378(98)70037-7.
- OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER. Journal Of Urology 1998, 160: 1220-1229.. DOI: 10.1097/00005392-199810000-00003.
- OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS. Journal Of Urology 1998, 160: 1220-1229. PMID: 9751323, DOI: 10.1016/s0022-5347(01)62501-1.
- Stonestreet B, Ocampo S, Oh W. Reductions in cardiac output in hypoxic young pigs: systemic and regional perfusion and oxygen metabolism. Journal Of Applied Physiology 1998, 85: 874-882. PMID: 9729560, DOI: 10.1152/jappl.1998.85.3.874.
- Donovan E, Ehrenkranz R, Shankaran S, Stevenson D, Wright L, Younes N, Fanaroff A, Korones S, Stoll B, Tyson J, Bauer C, Lemons J, Oh W, Papile L, Network F. Outcomes of very low birth weight twins cared for in the National Institute of Child Health and Human Development Neonatal Research Network’s intensive care units. American Journal Of Obstetrics And Gynecology 1998, 179: 742-749. PMID: 9757982, DOI: 10.1016/s0002-9378(98)70075-4.
- Lin C, Gelardi N, M C, Oh W. Cerebral metabolic response to hypoglycemia in severe intrauterine growth-retarded rat pups. Early Human Development 1998, 52: 1-11. PMID: 9758243, DOI: 10.1016/s0378-3782(97)00124-2.
- FANAROFF A, KORONES S, WRIGHT L, VERTER J, POLAND R, BAUER C, TYSON J, PHILIPS J, EDWARDS W, LUCEY J, CATZ C, SHANKARAN S, OH W. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The Pediatric Infectious Disease Journal 1998, 17: 593-598. PMID: 9686724, DOI: 10.1097/00006454-199807000-00004.
- Lin C, Gelardi N, M C, Oh W. Cerebral metabolic response to hypoglycemia in severe intrauterine growth-retarded rat pups. Early Human Development 1998, 51: 147-157. PMID: 9605467, DOI: 10.1016/s0378-3782(97)00109-6.
- Papile L, Tyson J, Stoll B, Wright L, Donovan E, Bauer C, Krause-Steinrauf H, Verter J, Korones S, Lemons J, Fanaroff A, Stevenson D, Oh W, Ehrenkranz R, Shankaran S. A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants. New England Journal Of Medicine 1998, 338: 1112-1119. PMID: 9545359, DOI: 10.1056/nejm199804163381604.
- Tyson J, Ehrenkranz R, Stoll B, Wright L, Mele L, Kennedy K, Oh W, Lemons J, Stevenson D, Verter J. Vitamin (Vit.) A Supplementation to Increase Survival without Chronic Lung Disease (CLD) in Extremely Low Birth Weight (ELBW) Infants: A 14-Center Randomized Trial • 1161. Pediatric Research 1998, 43: 199-199. DOI: 10.1203/00006450-199804001-01182.
- Kennedy K, Tyson J, Mele L, Ehrenkranz R, Stoll B, Oh W, Wright L, Stevenson D, Lemons J, Verter J. How Should Normal Values be Defined and Used for an Abnormal Population? Complexities Highlighted in a Multicenter Trial of Vitamin A Supplementation to Prevent Chronic Lung Disease (CLD) among Extremely Low Birth Weight(ELBW;≤1000 g) Infants 528. Pediatric Research 1998, 43: 93-93. DOI: 10.1203/00006450-199804001-00549.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. The Journal Of Pediatrics 1998, 132: 28-34. PMID: 9469996, DOI: 10.1016/s0022-3476(98)70480-9.
- Bier J, Ferguson A, Morales Y, Liebling J, Oh W, Vohr B. Breastfeeding Infants Who Were Extremely Low Birth Weight. Pediatrics 1997, 100: e3-e3. PMID: 9382904, DOI: 10.1542/peds.100.6.e3.
- Meyer E, Kennally K, E Z, Cashore W, Oh W. Attitudes about sibling visitation in the neonatal intensive care unit. Dimensions Of Critical Care Nursing 1997, 16: 313. DOI: 10.1097/00003465-199711000-00008.
- The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm InfantsShankaran S, Papile L, Wright L, Ehrenkranz R, Mele L, Lemons J, Korones S, Stevenson D, Donovan E, Stoll B, Fanaroff A, Oh W, Verter J, Taylor G, Seibert J, DiPietro M. The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm Infants. New England Journal Of Medicine 1997, 337: 466-471. PMID: 9250849, DOI: 10.1056/nejm199708143370705.
- Kennedy K, Stoll B, Ehrenkranz R, Oh W, Wright L, Stevenson D, Lemons J, Sowell A, Mele L, Tyson J, Verter J. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? Early Human Development 1997, 49: 19-31. PMID: 9179535, DOI: 10.1016/s0378-3782(97)01869-0.
- Kennedy K, Verter J, Tyson J, Stevenson D, Wright L, Stoll B, Oh W, Ehrenkranz R, Korones S, Bauer C, Papile L, Lemons J. CENTER DIFFERENCES IN SURVIVAL WITHOUT CHRONIC LUNG DISEASE (CLD) IN VERY-LOW-BIRTH-WEIGHT (VLBW) INFANTS ARE NOT EXPLAINED BY POPULATION DIFFERENCES, OR THE PRESENCE AND EARLY MANAGEMENT OF RESPIRATORY DISTRESS SYNDROME (RDS) • 1524. Pediatric Research 1997, 41: 256-256. DOI: 10.1203/00006450-199704001-01543.
- Wright L, Verter J, Stevenson D, Lemons J, Stoll B, Korones S, Bauer C, Papile L, Oh W. Increased antenatal glucocorticoid use decreases mortality and morbidity in the NICHD Neonatal Research Network's very low birth weight (VLBW) infants.• 1269. Pediatric Research 1997, 41: 214-214. DOI: 10.1203/00006450-199704001-01288.
- Stoll B, Verter J, Bauer C, Korones S, Lemons J, Oh W, Stevenson D, Papile L, Wright L. Racial Differences Among Very Low Birthweight (VLBW) Neonates. 1251. Pediatric Research 1997, 41: 211-211. DOI: 10.1203/00006450-199704001-01270.
- Yanowitz T, Yao A, Pettigrew K, Werner J, Oh W, Stonestreet B. Antenatal Steroids and Hemodynamic Maturation of Very Low Birth Weight (VLBW) Infants † 1114. Pediatric Research 1997, 41: 188-188. DOI: 10.1203/00006450-199704001-01133.
- Papile L, Fanaroff A, Verter J, Stevenson D, Korones S, Stoll B, Lemons J, Bauer C, Oh W, Wright L. PREDICTING NOSOCOMIAL BACTEREMIA IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS: UTILITY OF THE CRIB SCORE. † 998. Pediatric Research 1997, 41: 169-169. DOI: 10.1203/00006450-199704001-01017.
- Alemany C, Oh W, Stonestreet B. Effects of nitric oxide synthesis inhibition on mesenteric perfusion in young pigs. American Journal Of Physiology 1997, 272: g612-g616. PMID: 9124582, DOI: 10.1152/ajpgi.1997.272.3.g612.
- Kim C, Oh W, Stonestreet B. Magnesium is a cerebrovasodilator in newborn piglets. American Journal Of Physiology 1997, 272: h511-h516. PMID: 9038973, DOI: 10.1152/ajpheart.1997.272.1.h511.
- Farrag H, Nawrath L, Healey J, Dorcus E, Rapoza R, Oh W, Cowett R. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. American Journal Of Physiology 1997, 272: e86-e93. PMID: 9038856, DOI: 10.1152/ajpendo.1997.272.1.e86.
- Bier J, Ferguson A, Morales Y, Liebling J, Archer D, Oh W, Vohr B. Comparison of Skin-to-Skin Contact With Standard Contact in Low-Birth-Weight Infants Who Are Breast-Fed. JAMA Pediatrics 1996, 150: 1265-1269. PMID: 8953998, DOI: 10.1001/archpedi.1996.02170370043006.
- Ment L, Vohr B, Oh W, Scott D, Allan W, Westerveld M, Duncan C, Ehrenkranz R, Katz K, Schneider K, Makuch R. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 1996, 98: 714-8. PMID: 8885951, DOI: 10.1542/peds.98.4.714.
- Meyer E, Kennally K, Zika-Beres E, Cashore W, Oh W. Attitudes About Sibling Visitation in the Neonatal Intensive Care Unit. JAMA Pediatrics 1996, 150: 1021-1026. PMID: 8859132, DOI: 10.1001/archpedi.1996.02170350023003.
- Coll C, Halpern L, Seifer R, Meyer E, Kilis E, Lester B, Vohr B, Oh W. Behavioral intervention and post-natal growth in full-term intrauterine growth retarded (IUGR) infants. Early Human Development 1996, 46: 105-116. PMID: 8899359, DOI: 10.1016/0378-3782(96)01748-3.
- Napiorkowski B, Lester B, Freier M, Brunner S, Dietz L, Nadra A, Oh W. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 1996, 98: 71-5. PMID: 8668415, DOI: 10.1542/peds.98.1.71.
- Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal Of Pediatrics 1996, 129: 72-80. PMID: 8757565, DOI: 10.1016/s0022-3476(96)70192-0.
- Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal Of Pediatrics 1996, 129: 63-71. PMID: 8757564, DOI: 10.1016/s0022-3476(96)70191-9.
- Vreman H, Verter J, Oh W, Fanaroff A, Wright L, Lemons J, Shankaran S, Tyson J, Korones S, Bauer C, Stoll B, Papile L, Donovan E, Ehrenkranz R, Stevenson D. Interlaboratory variability of bilirubin measurements. Clinical Chemistry 1996, 42: 869-873. PMID: 8665677, DOI: 10.1093/clinchem/42.6.869.
- Ment L, Oh W, Ehrenkranz R, Allan W. Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent intraventricular hemorrhage. Pediatrics 1996, 97: 601. PMID: 8632956.
- Lemons J, Stevenson D, Vreman H, Oh W, Fanaroff A, Mele L, Wright L. SERUM BILIRUBIN, BILIRUBIN PRODUCTION AND WEIGHT LOSS IN BREAST-FED ONLY OR FORMULA-FED ONLY WELL TERM INFANTS. † 1871. Pediatric Research 1996, 39: 314-314. DOI: 10.1203/00006450-199604001-01895.
- Meyer E, Coll C, Halpern L, Leach T, Ramos A, Ristow R, Oh W. FULL-TERM SMALL FOR GESTATIONAL AGE (SGA) INFANTS HAVE POORER MOTHER-INFANT INTERACTIONS AT 8 MONTHS AND LOWER VERBAL IQ AT 3 YEARS THAN APPROPRIATE FOR GESTATIONAL AGE (AGA) INFANTS. † 1622. Pediatric Research 1996, 39: 273-273. DOI: 10.1203/00006450-199604001-01645.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. EFFECTS OF LOW DOSE PROPHYLACTIC INDOMETHACIN (plndo) ON HEMODYNAMICS IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS. † 1512. Pediatric Research 1996, 39: 255-255. DOI: 10.1203/00006450-199604001-01535.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. HEMODYNAMIC MATURATION IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS.† 1511. Pediatric Research 1996, 39: 254-254. DOI: 10.1203/00006450-199604001-01534.
- Wright L, Verter J, Stevenson D, Korones S, Bauer C, Oh W, Papile L, Tyson J, Lemons J, Stoll B. IMPACT OF THE NIH CONSENSUS DEVELOPMENT CONFERENCE ON CORTICOSTEROIDS FOR FETAL MATURATION: INCREASED ANTENATAL STEROID USE IN NICHD NETWORK VLBW INFANTS. † 1507. Pediatric Research 1996, 39: 254-254. DOI: 10.1203/00006450-199604001-01530.
- Oh W, Fanaroff A, Verter J, Stevenson D, Papile L, Stoll B, Lemons J, Bauer C, Wright L. NEONATAL MORTALITY AND MORBIDITIES IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS: A SEVEN-YEAR TREND ANALYSIS OF THE NEONATAL RESEARCH NETWORK DATA. † 1392. Pediatric Research 1996, 39: 235-235. DOI: 10.1203/00006450-199604001-01415.
- Lemons J, Stevenson D, Verter J, Bauer C, Papile L, Korones S, Stoll B, Oh W, Wright L. IN UTERO MAGNESIUM EXPOSURE: RISK OF DEATH AND OF INTRAVENTRICULAR HEMORRHAGE (IVH) IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS. • 1336. Pediatric Research 1996, 39: 225-225. DOI: 10.1203/00006450-199604001-01359.
- Kang S, Katz K, Ment L, Oh W. EFFECTS OF INCREASED USE OF LOW-DOSE PROPHYLACTIC INDOMETHACIN AND ANTENATAL STEROIDS ON NEONATAL OUTCOMES AMONG VLBW INFANTS. † 1305. Pediatric Research 1996, 39: 220-220. DOI: 10.1203/00006450-199604001-01328.
- Bier J, Ferguson A, Morales Y, Liebling J, Oh W, Vohr B. BREAST-FEEDING IMPROVES PHYSIOLOGIC STATES OF EXTREMELY-LOW-BIRTH-WEIGHT(ELBW) INFANTS (≤800 gms). † 598. Pediatric Research 1996, 39: 102-102. DOI: 10.1203/00006450-199604001-00619.
- AbuLaimoun B, Gelardi N, Cashore W, Oh W, Peter G. IMMUNE RESPONSE OF PRETERM INFANTS TO HEPATITIS B ˙VACCINE.† 595. Pediatric Research 1996, 39: 102-102. DOI: 10.1203/00006450-199604001-00616.
- Levy A, Coll C, Meyer E, Seifer R, Leach T, Ramos A, Oh W. Mother-infant interaction in preterm infants: Influences of biological and environmental risk. Infant Behavior And Development 1996, 19: 574. DOI: 10.1016/s0163-6383(96)90628-1.
- Meyer E, Coll C, Seifer R, Kilis E, Ramos A, Kelly L, Oh W. Feeding interactions of preterm small for gestational age infants and their mothers. Infant Behavior And Development 1996, 19: 619. DOI: 10.1016/s0163-6383(96)90673-6.
- MEYER E, COLL C, SEIFER R, RAMOS A, KILIS E, OH W. Psychological Distress in Mothers of Preterm Infants. Journal Of Developmental And Behavioral Pediatrics 1995, 16: 412-417. PMID: 8746550, DOI: 10.1097/00004703-199512000-00004.
- Fanaroff A, Wright L, Stevenson D, Shankaran S, Donovan E, Ehrenkranz R, Younes N, Korones S, Stoll B, Tyson J, Bauer C, Oh W, Lemons J, Papile L, Verter J. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. American Journal Of Obstetrics And Gynecology 1995, 173: 1423-1431. PMID: 7503180, DOI: 10.1016/0002-9378(95)90628-2.
- Coyle M, Oh W, Petersson K, Stonestreet B. Effects of indomethacin on brain blood flow, cerebral metabolism, and sagittal sinus prostanoids after hypoxia. American Journal Of Physiology 1995, 269: h1450-h1459. PMID: 7485580, DOI: 10.1152/ajpheart.1995.269.4.h1450.
- Lee C, Stonestreet B, Oh W, Outerbridge E, Cashore W. Postnatal maturation of the blood-brain barrier for unbound bilirubin in newborn piglets. Brain Research 1995, 689: 233-238. PMID: 7583326, DOI: 10.1016/0006-8993(95)00572-8.
- Lester B, Boukydis C, Garcia-Coll C, Peucker M, McGrath M, Vohr B, Brem F, Oh W. Developmental outcome as a function of the goodness of fit between the infant's cry characteristics and the mother's perception of her infant's cry. Pediatrics 1995, 95: 516-21. PMID: 7700751, DOI: 10.1542/peds.95.4.516.
- Ment L, Oh W, Ehrenkranz R, Philip A, Duncan C, Makuch R. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. American Journal Of Obstetrics And Gynecology 1995, 172: 795-800. PMID: 7892866, DOI: 10.1016/0002-9378(95)90001-2.
- Porcelli P, Oh W. Effects of Single Dose Calcium Gluconate Infusion in Hypocalcemic Preterm Infants. American Journal Of Perinatology 1995, 12: 18-21. PMID: 7710569, DOI: 10.1055/s-2007-994391.
- Partyka C, Gelardi N, Fadden K, Rifai A, Gruppuso P, Oh W, Reddy G. Lack of Production and Growth-Modulating Effects of 1α,25-Dihydroxyvitamin D3 in Cultured Fetal Rat Hepatocytes. Neonatology 1995, 67: 194-202. PMID: 7640319, DOI: 10.1159/000244163.
- Blaymore‐Bier J, Pezzullo J, Kim E, Oh W, Garcia‐Coll C, Vohr B. Outcome of extremely low‐birth‐weight infants: 1980–1990. Acta Paediatrica 1994, 83: 1244-1248. PMID: 7734862, DOI: 10.1111/j.1651-2227.1994.tb13005.x.
- Stevenson D, Vreman H, Oh W, Fanaroff A, Wright L, Lemons J, Verter J, Shankaran S, Tyson J, Korones S. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clinical Chemistry 1994, 40: 1934-1939. PMID: 7923775, DOI: 10.1093/clinchem/40.10.1934.
- Vreman H, Stevenson D, Oh W, Fanaroff A, Wright L, Lemons J, Wright E, Shankaran S, Tyson J, Korones S. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clinical Chemistry 1994, 40: 1927-1933. PMID: 7923774, DOI: 10.1093/clinchem/40.10.1927.
- BRANN B, MAYFIELD S, GOLDSTEIN M, OH W, STONESTREET B. Cardiovascular effects of hypoxia/hypercarbia and tension pneumothorax in newborn piglets. Critical Care Medicine 1994, 22: 1453-1460. PMID: 8062569, DOI: 10.1097/00003246-199409000-00016.
- Ment L, Oh W, Ehrenkranz R, Philip A, Vohr B, Allan W, Dunean C, Scott D, Taylor K, Katz K, Schneider K, Makuch R. Low-Dose Indomethacin and Prevention of Intraventricular Hemorrhage. Obstetrical & Gynecological Survey 1994, 49: 613-614. DOI: 10.1097/00006254-199409000-00011.
- Ment L, Oh W, Ehrenkranz R, Phillip A, Vohr B, Allan W, Makuch R, Taylor K, Schneider K, Katz K, Scott D, Duncan C. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trial. The Journal Of Pediatrics 1994, 124: 951-955. PMID: 8201485, DOI: 10.1016/s0022-3476(05)83191-9.
- Fanaroff A, Korones S, Wright L, Wright E, Poland R, Bauer C, Tyson J, Philips J, Edwards W, Lucey J, Catz C, Shankaran S, Oh W. A Controlled Trial of Intravenous Immune Globulin to Reduce Nosocomial Infections in Very-Low-Birth-Weight Infants. New England Journal Of Medicine 1994, 330: 1107-1113. PMID: 8133853, DOI: 10.1056/nejm199404213301602.
- Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.Ment L, Ehrenkranz R, Duncan C, Scott D, Taylor K, Katz K, Schneider K, Makuch R, Oh W, Vohr B, Philip A, Allan W. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994, 93: 543-50. PMID: 8134206, DOI: 10.1542/peds.93.4.543.
- Bauer K, Cowett R, Oh W. Postnatal solid accretion in preterm infants is similar to that reported in utero, but may be overestimated by energy balance techniques. Seminars In Perinatology 1994, 18: 11-4. PMID: 8209280.
- Meyer E, Coll C, Lester B, Boukydis C, McDonough S, Oh W. Family-based intervention improves maternal psychological well-being and feeding interaction of preterm infants. Pediatrics 1994, 93: 241-6. PMID: 8121735, DOI: 10.1542/peds.93.2.241.
- Bier J, Ferguson A, Anderson L, Solomon E, Voltas C, Oh W, Vohr B. Breast-feeding of very low birth weight infants. The Journal Of Pediatrics 1993, 123: 773-778. PMID: 8229489, DOI: 10.1016/s0022-3476(05)80858-3.
- Curran T, Bahner R, Oh W, Gruppuso P. Mitogen-Independent DNA Synthesis by Fetal Rat Hepatocytes in Primary Culture. Experimental Cell Research 1993, 209: 53-57. PMID: 8224006, DOI: 10.1006/excr.1993.1284.
- LESTER B, CUCCA J, ANDREOZZI L, FLANAGAN P, OH W. Possible Association between Fluoxetine Hydrochloride and Colic in an Infant. Journal Of The American Academy Of Child & Adolescent Psychiatry 1993, 32: 1253-1255. PMID: 8282672, DOI: 10.1097/00004583-199311000-00020.
- Horbar J, Wright L, Soll R, Wright E, Fanaroff A, Korones S, Shankaran S, Oh W, Fletcher B, Bauer C, Tyson J, Lemons J, Donovan E, Stoll B, Stevenson D, Papile L, Philips J, Network I. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. The Journal Of Pediatrics 1993, 123: 757-766. PMID: 8229487, DOI: 10.1016/s0022-3476(05)80856-x.
- Ment L, Oh W, Ehrenkranz R, Philip A, Schneider K, Katz K, Taylor K, Duncan C, Makuch R. Risk period for intraventricular hemorrhage of the preterm neonate is independent of gestational age. Seminars In Perinatology 1993, 17: 338-41. PMID: 8290976.
- Sung I, Vohr B, Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. The Journal Of Pediatrics 1993, 123: 618-624. PMID: 7692029, DOI: 10.1016/s0022-3476(05)80965-5.
- Bier J, Ferguson A, Cho C, Oh W, Vohr B. The Oral Motor Development of Low-Birth-Weight Infants Who Underwent Orotracheal Intubation During the Neonatal Period. JAMA Pediatrics 1993, 147: 858-862. PMID: 7688931, DOI: 10.1001/archpedi.1993.02160320060020.
- Bauer K, Cowett R, Howard G, vanEpp J, Oh W. Effect of intrauterine growth retardation on postnatal weight change in preterm infants. The Journal Of Pediatrics 1993, 123: 301-306. PMID: 8345431, DOI: 10.1016/s0022-3476(05)81707-x.
- Chen S, Vohr B, Oh W. Effects of birth order, gender, and intrauterine growth retardation on the outcome of very low birth weight in twins. The Journal Of Pediatrics 1993, 123: 132-136. PMID: 8320607, DOI: 10.1016/s0022-3476(05)81556-2.
- Hansen T, Wallach M, Dey A, Boivin P, Vohr B, Oh W. Prognostic value of clinical and radiological status on day 28 of life for subsequent course in very low birthweight (< 1,500g) babies with bronchopulmonary dysplasia. Pediatric Pulmonology 1993, 15: 327-331. PMID: 8337009, DOI: 10.1002/ppul.1950150603.
- VOHR B, COLL C, FLANAGAN P, OH W. Effects of Intraventricular Hemorrhage and Socioeconomic Status on Perceptual, Cognitive, and Neurologic Status of Low Birth Weight Infants at 5 Years of Age. Obstetrical & Gynecological Survey 1993, 48: 176-178. DOI: 10.1097/00006254-199303000-00012.
- Coyle M, Oh W, Stonestreet B. Effects of indomethacin on brain blood flow and cerebral metabolism in hypoxic newborn piglets. American Journal Of Physiology 1993, 264: h141-h149. PMID: 8430841, DOI: 10.1152/ajpheart.1993.264.1.h141.
- Hansen T, Maynard E, Cashore W, Oh W. Endotoxemia and Brain Bilirubin in the Rat. Neonatology 1993, 63: 171-176. PMID: 8324097, DOI: 10.1159/000243928.
- Yunis K, Oh W, Kalhan S, Cowett R. Glucose kinetics following administration of an intravenous fat emulsion to low-birth-weight neonates. American Journal Of Physiology 1992, 263: e844-e849. PMID: 1443115, DOI: 10.1152/ajpendo.1992.263.5.e844.
- Hansen T, Cashore W, Oh W. Changes in Piglet Auditory Brainstem Response Amplitudes without Increases in Serum or Cerebrospinal Fluid Neuron-Specific Enolase. Pediatric Research 1992, 32: 524-529. PMID: 1480452, DOI: 10.1203/00006450-199211000-00005.
- Ment L, Oh W, Philip A, Ehrenkranz R, Duncan C, Allan W, Taylor K, Schneider K, Katz K, Makuch R. Risk factors for early intraventricular hemorrhage in low birth weight infants. The Journal Of Pediatrics 1992, 121: 776-783. PMID: 1432433, DOI: 10.1016/s0022-3476(05)81915-8.
- Vohr B, Coll C, Flanagan P, Oh W. Effects of intraventricular hemorrhage and socioeconomic status on perceptual, cognitive, and neurologic status of low birth weight infants at 5 years of age. The Journal Of Pediatrics 1992, 121: 280-285. PMID: 1640298, DOI: 10.1016/s0022-3476(05)81204-1.
- Malone T, Stonestreet B, Goddard M, Sicard R, Werner J, Oh W. Atrial Natriuretic Peptide in Newborn Piglets with a Patent Ductus arteriosus. Neonatology 1992, 19: 155-160. PMID: 1340436, DOI: 10.1159/000457477.
- Coll C, Halpern L, Vohr B, Seifer R, Oh W. Stability and correlates of change of early temperament in preterm and full-term infants. Infant Behavior And Development 1992, 15: 137-153. DOI: 10.1016/0163-6383(92)80020-u.
- Werner J, Sicard R, Hansen T, Solomon E, Cowett R, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. The Journal Of Pediatrics 1992, 120: 286-291. PMID: 1735831, DOI: 10.1016/s0022-3476(05)80446-9.
- Barefield E, Oh W, Stonestreet B. Group B Streptococcus-induced acidosis in newborn swine: regional oxygen transport and lactate flux. Journal Of Applied Physiology 1992, 72: 272-277. PMID: 1537725, DOI: 10.1152/jappl.1992.72.1.272.
- Gruppuso P, Curran T, Mead J, Fausto N, Oh W. Fetal Growth Factors as Determinants of Intrauterine Hepatic Growth. Diabetes 1991, 40: 51-55. PMID: 1660827, DOI: 10.2337/diab.40.2.s51.
- Monin P, Stonestreet B, Oh W. Hyperventilation Restores Autoregulation of Cerebral Blood Flow in Postictal Piglets. Pediatric Research 1991, 30: 294-298. PMID: 1945571, DOI: 10.1203/00006450-199109000-00020.
- Vohr B, Coll C, Lobato D, Yunis K, O'Dea C, Oh W. NEURODEVELOPMENTAL AND MEDICAL STATUS OF LOW‐BIRTHWEIGHT SURVIVORS OF BRONCHOPULMONARY DYSPLASIA AT 10 TO 12 YEARS OF AGE. Developmental Medicine & Child Neurology 1991, 33: 690-697. PMID: 1717327, DOI: 10.1111/j.1469-8749.1991.tb14946.x.
- GELARDI N, CHA C, OH W. Evaluation of Insulin Sensitivity in Obese Offspring of Diabetic Rats by Hyperinsulinemic-Euglycemic Clamp Technique. Pediatric Research 1991, 30: 40???44. DOI: 10.1203/00006450-199107010-00008.
- Gelardi N, Cha C, Oh W. Evaluation of Insulin Sensitivity in Obese Offspring of Diabetic Rats by Hyperinsulinemic-Euglycemic Clamp Technique. Pediatric Research 1991, 30: 40-44. PMID: 1891280, DOI: 10.1203/00006450-199107000-00008.
- Oh W, Gelardi N, Cha C. The Cross-Generation Effect of Neonatal Macrosomia in Rat Pups of Streptozotocin-Induced Diabetes. Pediatric Research 1991, 29: 606-610. PMID: 1866217, DOI: 10.1203/00006450-199106010-00016.
- Vohr B, Oh W, Cashore W. Reply. The Journal Of Pediatrics 1991, 118: 653. DOI: 10.1016/s0022-3476(05)83399-2.
- Ju S, Lester B, Coll C, Oh W, Vohr B. Maternal perceptions of the sleep patterns of premature infants at seven months corrected age compared to full‐term infants. Infant Mental Health Journal 1991, 12: 338-346. DOI: 10.1002/1097-0355(199124)12:4<338::aid-imhj2280120407>3.0.co;2-a.
- Gelardi N, Cha C, Oh W. Glucose Metabolism in Adipocytes of Obese Offspring of Mild Hyperglycemic Rats. Pediatric Research 1990, 28: 641-645. PMID: 2284163, DOI: 10.1203/00006450-199012000-00020.
- Lin H, Maguire C, Oh W, Cowett R. Reply. The Journal Of Pediatrics 1990, 117: 674. DOI: 10.1016/s0022-3476(05)80716-4.
- Vohr B, Karp D, O'Dea C, Darrow D, Coll C, Lester B, Brown L, Oh W, Cashore W. Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. The Journal Of Pediatrics 1990, 117: 288-291. PMID: 2380830, DOI: 10.1016/s0022-3476(05)80549-9.
- Soll R, Hoekstra R, Fangman J, Corbet A, Adams J, James L, Schulze K, Oh W, Roberts J, Dorst J, Kramer S, Gold A, Zola E, Horbar J, McAuliffe T, Lucey J. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Pediatrics 1990, 85: 1092-102. PMID: 2187176, DOI: 10.1542/peds.85.6.1092.
- Malone T, Stonestreet B, Goddard M, Oh W. Hemodynamic Changes in a Term Newborn Piglet Model of Patent Ductus Arteriosus. American Journal Of Perinatology 1990, 7: 184-188. PMID: 2331282, DOI: 10.1055/s-2007-999477.
- Lin H, Maguire C, Oh W, Cowett R. Accuracy and reliability of glucose reflectance meters in the high-risk neonate. The Journal Of Pediatrics 1989, 115: 998-1000. PMID: 2585238, DOI: 10.1016/s0022-3476(89)80757-7.
- Stonestreet B, Goldstein M, Oh W, Widness J. Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep. American Journal Of Physiology 1989, 257: r1199-r1204. PMID: 2511768, DOI: 10.1152/ajpregu.1989.257.5.r1199.
- Gastrointestinal blood flow and oxygen delivery during environmental cold stress: effect of anaemia.Mayfield S, Shaul P, Oh W, Stonestreet B. Gastrointestinal blood flow and oxygen delivery during environmental cold stress: effect of anaemia. Journal Of Developmental Physiology 1989, 12: 219-23. PMID: 2634063.
- Stonestreet B, Ogburn P, Goldstein M, Oh W, Widness J. Effects of chronic fetal hyperinsulinemia on plasma arachidonic acid and prostaglandin concentrations. American Journal Of Obstetrics And Gynecology 1989, 161: 894-899. PMID: 2679106, DOI: 10.1016/0002-9378(89)90746-1.
- Vohr B, Garcia‐Coll C, Oh W. LANGUAGE AND NEURODEVELOPMENTAL OUTCOME OF LOW‐BIRTHWEIGHT INFANTS AT THREE YEARS. Developmental Medicine & Child Neurology 1989, 31: 582-590. PMID: 2806739, DOI: 10.1111/j.1469-8749.1989.tb04043.x.
- Nowicki P, Oh W. Methylxanthines and Necrotizing Enterocolitis Revisited. Journal Of Pediatric Gastroenterology And Nutrition 1989, 9: 137-137. DOI: 10.1002/j.1536-4801.1989.tb09845.x.
- Vohr B, Barry L, Rapisardi G, O'Dea C, Brown L, Peucker M, Cashore W, Oh W. Abnormal brain-stem function (brain-stem auditory evoked response) correlates with acoustic cry features in term infants with hyperbilirubinemia. The Journal Of Pediatrics 1989, 115: 303-308. PMID: 2754560, DOI: 10.1016/s0022-3476(89)80090-3.
- Vohr B, Garcia-Coll C, Mayfield S, Brann B, Shaul P, Oh W. Neurologic and developmental status related to the evolution of visual-motor abnormalities from birth to 2 years of age in preterm infants with intraventricular hemorrhage. The Journal Of Pediatrics 1989, 115: 296-302. PMID: 2474065, DOI: 10.1016/s0022-3476(89)80089-7.
- Yunis K, Oh W. Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia. The Journal Of Pediatrics 1989, 115: 127-132. PMID: 2500510, DOI: 10.1016/s0022-3476(89)80347-6.
- Mayfield S, Stonestreet B, Shaul P, Brubakk A, Susa J, Oh W. Plasma catecholamine concentrations of newborn piglets in thermoneutral and cold environments. Journal Of Developmental Physiology 1989, 11: 331-4. PMID: 2592750.
- Maynard E, Oh W. Topical nitroglycerin ointment as an aid to insertion of peripheral venous catheters in neonates. The Journal Of Pediatrics 1989, 114: 474-476. PMID: 2493523, DOI: 10.1016/s0022-3476(89)80577-3.
- Mayfield S, Oh W, Piva D, Stonestreet B. Postprandial gastrointestinal blood flow and oxygen consumption during environmental cold stress. American Journal Of Physiology 1989, 256: g364-g368. PMID: 2919679, DOI: 10.1152/ajpgi.1989.256.2.g364.
- Anderson L, Coll C, Vohr B, Emmons L, Brann B, Shaul P, Mayfield S, Oh W. Behavioral characteristics and early temperament of premature infants with intracranial hemorrhage. Early Human Development 1989, 18: 273-283. PMID: 2702952, DOI: 10.1016/0378-3782(89)90022-4.
- Roberts J, Oh W. Pulmonary oxygen toxicity in the guinea pig. Effect of indomethacin. Neonatology 1989, 12: 106-12. PMID: 2714157, DOI: 10.1159/000480972.
- Oh W, Gelardi N, Cha C. Maternal hyperglycemia in pregnant rats: Its effect on growth and carbohydrate metabolism in the offspring. Metabolism 1988, 37: 1146-1151. PMID: 2973549, DOI: 10.1016/0026-0495(88)90192-8.
- Vohr B, Coll C, Oh W. LANGUAGE DEVELOPMENT OF LOW‐BIRTHWEIGHT INFANTS AT TWO YEARS. Developmental Medicine & Child Neurology 1988, 30: 608-615. PMID: 3229558, DOI: 10.1111/j.1469-8749.1988.tb04798.x.
- Garcia-Coll C, Emmons L, Vohr B, Ward A, Brann B, Shaul P, Mayfield S, Oh W. Behavioral responsiveness in preterm infants with intraventricular hemorrhage. Pediatrics 1988, 81: 412-8. PMID: 3344184, DOI: 10.1542/peds.81.3.412.
- Cowett R, Andersen G, Maguire C, Oh W. Ontogeny of glucose homeostasis in low birth weight infants. The Journal Of Pediatrics 1988, 112: 462-465. PMID: 3279177, DOI: 10.1016/s0022-3476(88)80337-8.
- Karplus M, Lee C, Cashore W, Oh W. The effects of brain bilirubin deposition on auditory brain stem evoked responses in rats. Early Human Development 1988, 16: 185-194. PMID: 3378524, DOI: 10.1016/0378-3782(88)90098-9.
- Vohr B, Chen A, Garcia Coll C, Oh W. Mothers of Preterm and Full-Term Infants on Home Apnea Monitors. JAMA Pediatrics 1988, 142: 229-231. PMID: 3341329, DOI: 10.1001/archpedi.1988.02150020131048.
- Mullen M, Coll C, Vohr B, Muriel A, Oh W. Mother-infant feeding interaction in full-term small-for-gestational-age infants. The Journal Of Pediatrics 1988, 112: 143-148. PMID: 3335952, DOI: 10.1016/s0022-3476(88)80141-0.
- Oh W. Renal Function and Fluid Therapy in High Risk Infants. Neonatology 1988, 53: 230-236. PMID: 3046669, DOI: 10.1159/000242795.
- M. C, Gelardi N, Oh W. Growth and Cellular Composition in Rats with Intrauterine Growth Retardation: Effects of Postnatal Nutrition. Journal Of Nutrition 1987, 117: 1463-1468. PMID: 3625318, DOI: 10.1093/jn/117.8.1463.
- Coll C, Hoffman J, Oh W. The social ecology and early parenting of Caucasian adolescent mothers. Child Development 1987, 58: 955-63. PMID: 3608665, DOI: 10.2307/1130536.
- Cowett R, Andersen G, Maguire C, Oh W. ONTOGENY OF GLUCOSE KINETICS IN THE NEWBORN. Pediatric Research 1987, 22: 235-235. DOI: 10.1203/00006450-198708000-00131.
- Garcia Coll C, Hoffman J, Van Houten L, Oh W. The social context of teenage childbearing: Effects on the infant's care-giving environment. Journal Of Youth And Adolescence 1987, 16: 345-360. PMID: 12280674, DOI: 10.1007/bf02138466.
- Brann B, Stonestreet B, Oh W, Cashore W. The in Vivo Effect of Bilirubin and Sulfisoxazole on Cerebral Oxygen, Glucose, and Lactate Metabolism in Newborn Piglets. Pediatric Research 1987, 22: 135-140. PMID: 3658536, DOI: 10.1203/00006450-198708000-00006.
- Mayfield S, Shaul P, Oh W, Stonestreet B. Anemia Blunts the Thermogenic Response to Environmental Cold Stress in Newborn Piglets. Pediatric Research 1987, 21: 482-486. PMID: 3588087, DOI: 10.1203/00006450-198705000-00012.
- Coll C, Vohr B, Emmons L, Brann B, Shaul P, Oh W. TEMPERAMENT CHARACTERISTICS OF PRETERM (PT) INFANTS AND CONCURRENT NEUROLOGICAL ABNORMALITIES. Pediatric Research 1987, 21: 180-180. DOI: 10.1203/00006450-198704010-00082.
- Malone T, Widness J, Mufson A, Oh W. ONTOGENY OF ERYTHROPOIETIN (EP) KINETICS IN FETAL, NEWBORN, AND JUVENILE SHEEP. Pediatric Research 1987, 21: 218-218. DOI: 10.1203/00006450-198704010-00309.
- Cha C, Figueira G, Gelardi N, Oh W. SECONDARY FETAL HYPERINSULINEMIA(SFH) IN RAT: NEONATAL GLUCOSE HOMEOSTASIS AND SUBSEQUENT GROWTH. Pediatric Research 1987, 21: 211-211. DOI: 10.1203/00006450-198704010-00267.
- Mullen M, Coll C, Vobr B, Muriel A, Oh W. MOTHER-INFANT FEEDING INTERACTION IN FULL-TERM SMALL-FOR-GESTATIONAL AGE (SGA) INFANTS. Pediatric Research 1987, 21: 183-183. DOI: 10.1203/00006450-198704010-00099.
- Cha C, Gelardi N, Oh W. Accelerated Growth and Abnormal Glucose Tolerance in Young Female Rats Exposed to Fetal Hyperinsulinemia. Pediatric Research 1987, 21: 83-87. PMID: 2432459, DOI: 10.1203/00006450-198701000-00018.
- Brubakk A, Oh W, Stonestreet B. Prolonged Hypercarbia in the Awake Newborn Piglet: Effect on Brain Blood Flow and Cardiac Output. Pediatric Research 1987, 21: 29-33. PMID: 3797131, DOI: 10.1203/00006450-198701000-00008.
- Szabo J, Mayfield S, Oh W, Stonestreet B. Postprandial Gastrointestinal Blood Flow and Oxygen Consumption: Effects of Hypoxemia in Neonatal Piglets. Pediatric Research 1987, 21: 93-98. PMID: 3797137, DOI: 10.1203/00006450-198701000-00020.
- Catlin E, Carpenter M, Brann B, Mayfield S, Shaul P, Goldstein M, Oh W. The Apgar score revisited: Influence of gestational age. The Journal Of Pediatrics 1986, 109: 865-868. PMID: 3772665, DOI: 10.1016/s0022-3476(86)80715-6.
- Mayfield S, Stonestreet B, Brubakk A, Shaul P, Oh W. Regional blood flow in newborn piglets during environmental cold stress. American Journal Of Physiology 1986, 251: g308-g313. PMID: 3752246, DOI: 10.1152/ajpgi.1986.251.3.g308.
- COLL C, VOHR B, HOFFMAN J, OH W. Maternal and Environmental Factors Affecting Developmental Outcome of Infants of Adolescent Mothers. Journal Of Developmental And Behavioral Pediatrics 1986, 7: 230-236. PMID: 3745449, DOI: 10.1097/00004703-198608000-00003.
- M. C, Oh W. Growth and Fatty Acid Metabolism in Experimental Intrauterine Growth Retardation: Effect of Postnatal Nutrition in Rat. Journal Of Nutrition 1986, 116: 1080-1087. PMID: 3723203, DOI: 10.1093/jn/116.6.1080.
- Oh W. Neonatal Polycythemia and Hyperviscosity. Pediatric Clinics Of North America 1986, 33: 523-532. PMID: 3714337, DOI: 10.1016/s0031-3955(16)36040-0.
- Cowett R, Coustan D, Oh W. Effects of maternal transport on admission patterns at a tertiary care center. American Journal Of Obstetrics And Gynecology 1986, 154: 1098-1100. PMID: 3706436, DOI: 10.1016/0002-9378(86)90760-x.
- Coustan D, Widness J, Carpenter M, Rotondo L, Pratt D, Oh W. Should the fifty-gram, one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? American Journal Of Obstetrics And Gynecology 1986, 154: 1031-1035. PMID: 3706427, DOI: 10.1016/0002-9378(86)90744-1.
- Vohr B, Oh W. Age of diphtheria, tetanus, and pertussis immunization of special care nursery graduates. Pediatrics 1986, 77: 569-71. PMID: 3485786, DOI: 10.1542/peds.77.4.569.
- Fatoba I, M. C, Oh W. Effect of respiratory acidosis on glucose homeostasis in experimental intrauterine growth retardation in rats. Early Human Development 1986, 13: 107-114. PMID: 3754205, DOI: 10.1016/0378-3782(86)90104-0.
- Rosenkrantz T, Oh W. Neonatal Polycythemia and Hyperviscosity. 1986, 93-123. DOI: 10.1007/978-1-4615-9468-0_3.
- Catlin E, M. C, Oh W. Postnatal growth and fatty acid synthesis in overgrown rat pups induced by fetal hyperinsulinemia. Metabolism 1985, 34: 1110-1114. PMID: 3906351, DOI: 10.1016/0026-0495(85)90155-6.
- Weinstein M, Bell E, Oh W. Energy Intake, Norepinephrine Excretion, and Oxygen Consumption in Low Birthweight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1985, 4: 774-777. PMID: 4045635, DOI: 10.1097/00005176-198510000-00016.
- Walker D, Vohr B, Oh W. Economic analysis of regionalized neonatal care for very low-birth-weight infants in the state of Rhode Island. Pediatrics 1985, 76: 69-74. PMID: 3925429, DOI: 10.1542/peds.76.1.69.
- Burgess G, Oh W, Bratlid D, Brubakk A, Cashore W, Stonestreet B. The Effects of Brain Blood Flow on Brain Bilirubin Deposition in Newborn Piglets. Pediatric Research 1985, 19: 691-696. PMID: 4040628, DOI: 10.1203/00006450-198507000-00011.
- Iwamoto H, Oh W, Rudolph A. Renal Metabolism in Fetal and Newborn Sheep. Pediatric Research 1985, 19: 641-644. PMID: 4022671, DOI: 10.1203/00006450-198507000-00001.
- Widness J, Cowett R, Coustan D, Carpenter M, Oh W. Neonatal Morbidities in Infants of Mothers with Glucose Intolerance in Pregnancy. Diabetes 1985, 34: 61-65. PMID: 3996769, DOI: 10.2337/diab.34.2.s61.
- Burgess G, Stonestreet B, Cashore W, Oh W. Brain Bilirubin Deposition and Brain Blood Flow during Acute Urea-Induced Hyperosmolality in Newborn Piglets. Pediatric Research 1985, 19: 537-542. PMID: 4011334, DOI: 10.1203/00006450-198506000-00007.
- Szabo J, Stonestreet B, Oh W. Effects of Hypoxemia on Gastrointestinal Blood Flow and Gastric Emptying in the Newborn Piglet. Pediatric Research 1985, 19: 466-471. PMID: 4000773, DOI: 10.1203/00006450-198505000-00012.
- LEVINE L, COLL C, OH W. Determinants of mother-infant interaction in adolescent mothers. Journal Of The American Academy Of Child & Adolescent Psychiatry 1985, 24: 374-375. DOI: 10.1016/s0002-7138(09)61123-7.
- Vohr B, Coll C, Oh W. 63 LANGUAGE DEVELOPMENT AT 2 YEARS OF AGE IN LOW BIRTH WEIGHT (LBW)(<1500 GRAMS) INFANTS. Pediatric Research 1985, 19: 121-121. DOI: 10.1203/00006450-198504000-00093.
- Coll C, Houten L, Vohr B, Oh W. 4 LANGUAGE DELAY IN 2 YR. OLD CHILDREN OF AADOLESCENT MOTHERS. Pediatric Research 1985, 19: 111-111. DOI: 10.1203/00006450-198504000-00034.
- Schanler R, Oh W. Nitrogen and Mineral Balance in Preterm Infants Fed Human Milks or Formula. Journal Of Pediatric Gastroenterology And Nutrition 1985, 4: 214-219. PMID: 3989621, DOI: 10.1097/00005176-198504000-00010.
- WALKER D, FELDMAN A, VOHR B, OH W. Neonatal Intensive Care: Cost-Benefit Analysis. Pediatrics 1985, 75: 799-800. DOI: 10.1542/peds.75.4.799a.
- Cha C, Oh W. 246 GROWTH AND FATTY ACID METABOLISM IN EXPERIMENTAL INTRAUTERINE GROWTH RETARDATION: EFFECTS OF POSTNATAL NUTRITION. Pediatric Research 1985, 19: 151-151. DOI: 10.1203/00006450-198504000-00276.
- Mayfield S, Stonestreet B, Brubakk A, Shaul P, Oh W. 1456 REGIONAL BLOOD FLOW (Q) DURING ENVIRONMENTAL COLD STRESS(ECS). Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01480.
- Catlln E, Cha C, Oh W. 245 POSTNATAL GROWTH AND FATTY ACID SYNTHESIS IN INSULIN-INDUCED MACROSOMIC RAT PUPS. Pediatric Research 1985, 19: 151-151. DOI: 10.1203/00006450-198504000-00275.
- Burgess G, Brann B, Stonestreet B, Oh W, Brubakk A. 1356 THE EFFECT OF PHENOBARBITAL (PB) ON CEREBRAL BLOOD FLOW VELOCITY (CBFV) FOLLOWING ENDOTRACHEAL UZ3U SUCTION (ETS). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01380.
- Brann B, Stonestreet B, Oh W, Cashore W. 1350 THE EFFECT OF BILIRUBIN (BR) ON CEREBRAL CORTEX (CE) O2 AND GLUCOSE METABOLISM IN PIGLETS (P). Pediatric Research 1985, 19: 335-335. DOI: 10.1203/00006450-198504000-01374.
- Catlin E, Carpenter M, Brann B, Mayfield S, Shaul P, Goldstein M, Oh W. 1360 THE APGAR SCORE REVISITED: DEVELOPMENTAL PATTERNS IN “OPTIMAL” NEWBORNS. Pediatric Research 1985, 19: 337-337. DOI: 10.1203/00006450-198504000-01384.
- Brann B, Cashore W, Patrick R, Oh W. 1349 IN VITRO EFFECT OF BILIRUBIN ON DOPAMINE SYNTHESIS IN ADULT RAT BRAIN SYNAPTOSOMES. Pediatric Research 1985, 19: 335-335. DOI: 10.1203/00006450-198504000-01373.
- Brubakk A, Oh W, Stonestreet B. 1353 ATROPINE (AT) REDUCES BRAIN-BLOOD FLOW (BBF) AT LOWER MEAN ARTERIAL BLOOD PRESSURES (MABP) DURING HEMORRHAGIC HYPOTENSION (HH) IN THE NEWBORN PIGLET (P). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01377.
- Mayfield S, Shaul P, Oh W, Stonestreet B. 1455 REGIONAL OXYGEN(O2) DELIVERY DURING ENVIRONMENTAL COLD STRESS (ECS) IN ANEMIC PIGLETS. Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01479.
- Szabo J, Mayfield S, Oh W, Stonestreet B. 738 EFFECTS OF HYPOXEMIA ON POSTPRANDIAL GI BLOOD FLOW AND OXYGEN CONSUMPTION IN NEWBORN PIGLETS. Pediatric Research 1985, 19: 233-233. DOI: 10.1203/00006450-198504000-00768.
- Brubakk A, Oh W, Stonestreet B. 1354 ADAPTATION OF BRAIN BLOOD FLOW (BBF) TO PROLONGED HYPERCARBIA (PHC) IN THE NEWBORN PIGLET (P). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01378.
- Mayfield S, Shaul P, Oh W, Stonestreet B. 1454 ANEMIA BLUNTS THE NEONATAL HOMEOTHERMIC RESPONSE TO ENVIRONMENTAL COLD STRESS(ECS). Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01478.
- Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levelsWTDNESS J, TERAMO K, CLEMONS G, COUSTAN D, CAVALIERI R, OH W, WELCH G, SCHWARTZ R. Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levels. BJOG An International Journal Of Obstetrics & Gynaecology 1985, 92: 326-332. PMID: 3986165, DOI: 10.1111/j.1471-0528.1985.tb01104.x.
- Nowicki P, Hansen N, Stonestreet B, Yao A, Oh W. The Effect of Blood Volume Expansion on Gastrointestinal Oxygenation in Piglets. Pediatric Research 1985, 19: 268-271. PMID: 3982888, DOI: 10.1203/00006450-198503000-00002.
- Levine L, Coll C, Oh W. Determinants of mother-infant interaction in adolescent mothers. Pediatrics 1985, 75: 23-9. PMID: 3966042, DOI: 10.1542/peds.75.1.23.
- Cowett R, Tenenbaum D, Fatoba O, Oh W. The Effects of Arterial Glucose Infusion above the Celiac Axis in the Neonatal Lamb. Neonatology 1985, 47: 179-185. PMID: 3886022, DOI: 10.1159/000242111.
- Brubakk A, Bratlid D, Oh W, Yao A, Stonestreet B. Atropine Prevents Increases in Brain Blood Flow during Hypertension in Newborn Piglets. Pediatric Research 1984, 18: 1121-1126. PMID: 6514438, DOI: 10.1203/00006450-198411000-00013.
- Hansen N, Oh W, LaRochelle F, Stonestreet B. Effects of Maternal Ritodrine Administration on Neonatal Renal Function. Journal Of Urology 1984, 132: 1069. DOI: 10.1016/s0022-5347(17)50032-4.
- Hansen N, Brubakk A, Bratlid D, Oh W, Stonestreet B. The Effects of Variations in Paco2 on Brain Blood Flow and Cardiac Output in the Newborn Piglet. Pediatric Research 1984, 18: 1132-1136. PMID: 6440112, DOI: 10.1203/00006450-198411000-00015.
- Nowicki P, Oh W, Yao A, Hansen N, Stonestreet B. Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets. American Journal Of Physiology 1984, 247: g220-g225. PMID: 6476115, DOI: 10.1152/ajpgi.1984.247.3.g220.
- HANSEN N, STONESTREET B, ROSENKRANTZ T, OH W. Brain Blood Flow. Pediatrics 1984, 74: 317-317. DOI: 10.1542/peds.74.2.317.
- Walker D, Feldman A, Vohr B, Oh W. Cost-benefit analysis of neonatal intensive care for infants weighing less than 1,000 grams at birth. Pediatrics 1984, 74: 20-5. PMID: 6234507, DOI: 10.1542/peds.74.1.20.
- Stonestreet B, Laptook R, Siegel S, Oh W. The renal response to acute asphyxia in spontaneously breathing newborn lambs. Early Human Development 1984, 9: 347-361. PMID: 6378587, DOI: 10.1016/0378-3782(84)90079-3.
- Rosenkrantz T, Oh W. Aminophylline Reduces Cerebral Blood Flow Velocity in Low-Birth-Weight Infants. JAMA Pediatrics 1984, 138: 489-491. PMID: 6424433, DOI: 10.1001/archpedi.1984.02140430065017.
- Nowick P, Hansen N, Oh W, Stonestreet B. Gastrointestinal Blood Flow and Oxygen Consumption in the Newborn Lamb: Effect of Chronic Anemia and Acute Hypoxia. Pediatric Research 1984, 18: 420-425. PMID: 6728568, DOI: 10.1203/00006450-198405000-00005.
- Bratlid D, Cashore W, Oh W. Effect of acidosis on bilirubin deposition in rat brain. Pediatrics 1984, 73: 431-4. PMID: 6709423, DOI: 10.1542/peds.73.4.431.
- Garcia C, Vohr B, Oh W. MATERNAL FACTORS AFFECTING DEVELOPMENTAL OUTCOME OF INFANTS OF ADOLESCENT MOTHERS. Pediatric Research 1984, 18: 97-97. DOI: 10.1203/00006450-198404001-00026.
- Coll C, Lester B, Valcarcel M, Hoffman J, Oh W. FEEDING INTERACTIONS OF FETALLY MALNOURISHED INFANTS BORN TO TEENAGE AND OLDER MOTHERS. Pediatric Research 1984, 18: 96-96. DOI: 10.1203/00006450-198404001-00018.
- Bratlid D, Cashore W, Brubakk A, Oh W. BILIRUBIN DISPLACEMENT BY SULFISOXAZOLE: ENTRY OF UNBOUND BILIRUBIN INTO THE BRAIN. Pediatric Research 1984, 18: 150-150. DOI: 10.1203/00006450-198404001-00342.
- Chen S, Cashore W, Oh W. GRAM-NEGATIVE BACTEREMIA DOES NOT INCREASE ALBUMIN OR BILIRUBIN CONTENT IN BRAINS OF ADULT RATS. Pediatric Research 1984, 18: 271-271. DOI: 10.1203/00006450-198404001-01069.
- Brubakk A, Bratlid D, Oh W, Stonestreet B. CHANGES IN EPINEPHRINE (E) AND MEAN ARTERIAL BLOOD PRESSURE (MABP) DURING HYPERCARBIA (HC): EFFECTS ON BRAIN BLOOD FLOW (BBF) IN THE NEWBORN PIGLET. Pediatric Research 1984, 18: 337-337. DOI: 10.1203/00006450-198404001-01466.
- Walker D, Vohr B, Oh W. ECONOMIC ANALYSIS OF REGIONALIZED NEONATAL CARE FOR LOW BIRTH WEIGHT INFANTS IN THE STATE OF RI. Pediatric Research 1984, 18: 338-338. DOI: 10.1203/00006450-198404001-01468.
- Stonestreet B, Piasecki G, Oh W, Jackson B. CARDIOVASCULAR RESPONSES TO INSULIN INFUSIONS IN THE OVINE FETUS. Pediatric Research 1984, 18: 130-130. DOI: 10.1203/00006450-198404001-00223.
- Vohr B, Coll C, Oh W. INCREASED MORBIDITY IN LONG TERM FOLLOW-UP OF LOW BIRTH WEIGHT (LBW) SURVIVORS WITH STAGE III-IV RETROLENTAL FIBROPLASIA (RLF). Pediatric Research 1984, 18: 116-116. DOI: 10.1203/00006450-198404001-00138.
- Vohr B, Oh W. AGE OF DPT IMMUNIZATION OF SPECIAL CARE NURSERY (SCN) GRADUATES. Pediatric Research 1984, 18: 188-188. DOI: 10.1203/00006450-198404001-00570.
- Burgess G, Oh W, Bratlid D, Brubakk A, Cashore W, Stonestreet B. CEREBRAL HYPERPERFUSION AUGMENTS BRAIN BILIRUBIN DEPOSITION IN PIGLETS. Pediatric Research 1984, 18: 337-337. DOI: 10.1203/00006450-198404001-01467.
- Szabo J, Stonestreet B, Oh W. GASTRIC MOTILITY AND GI BLOOD FLOW: EFFECTS OF HYPOXEMIA IN THE NEWBORN PIGLET. Pediatric Research 1984, 18: 214-214. DOI: 10.1203/00006450-198404001-00727.
- Szabo J, Hillemeier A, Oh W. THE EFFECT OF NONNUTRITIVE AND NUTRITIVE SUCK ON GASTRIC EMPTYING IN PREMATURE INFANTS. Pediatric Research 1984, 18: 214-214. DOI: 10.1203/00006450-198404001-00728.
- Burgess G, Stonestreet B, Cashore W, Oh W. HYPEROSMOLALITY(HO) AUGMENTED REGIONAL BRAIN BILIRUBIN DEPOSITION(RBBD) IN NEWBORN PIGLETS(P). Pediatric Research 1984, 18: 314-314. DOI: 10.1203/00006450-198404001-01327.
- Nowicki P, Oh W, Yao A, Hansen N, Stonestreet B. EFFECT OF POLYCYTHEMIC HYPERVISCOSITY ON GASTROINTESTINAL (GI) BLOOD FLOW AND O2 CONSUMPTION IN PIGLETS. Pediatric Research 1984, 18: 350-350. DOI: 10.1203/00006450-198404001-01544.
- Rosenkrantz T, Stonestreet B, Hansen N, Nowicki P, Oh W. Cerebral blood flow in the newborn lamb with polycythemia and hyperviscosity. The Journal Of Pediatrics 1984, 104: 276-280. PMID: 6694026, DOI: 10.1016/s0022-3476(84)81012-4.
- Cowett R, Susa J, Oh W, Schwartz R. Glucose kinetics in glucose-infused small for gestational age infants. Pediatric Research 1984, 18: 74-9. PMID: 6366720.
- Oh W. Peripheral Circulatory Response to Feeding in Newborn Low‐Birth‐Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1984, 3: 14-14. DOI: 10.1002/j.1536-4801.1984.tb08612.x.
- Oh W. Peripheral Circulatory Response to Feeding in Newborn Low-Birth-Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1984, 3: 14. PMID: 6694043, DOI: 10.1097/00005176-198401000-00006.
- Widness J, Clemons G, Garcia J, Oh W, Schwartz R. Increased immunoreactive erythropoietin in cord serum after labor. American Journal Of Obstetrics And Gynecology 1984, 148: 194-197. PMID: 6691396, DOI: 10.1016/s0002-9378(84)80175-1.
- Vohr B, Oh W. Growth and development in preterm infants small for gestational age. The Journal Of Pediatrics 1983, 103: 941-945. PMID: 6644432, DOI: 10.1016/s0022-3476(83)80726-4.
- Widness J, Goldman A, Susa J, Oh W, Schwartz R. Impermeability of the rat placenta to insulin during organogenesis. Birth Defects Research Part A Clinical And Molecular Teratology 1983, 28: 327-332. PMID: 6364437, DOI: 10.1002/tera.1420280304.
- Nowicki P, Stonestreet B, Hansen N, Yao A, Oh W. Gastrointestinal blood flow and oxygen consumption in awake newborn piglets: effect of feeding. American Journal Of Physiology 1983, 245: g697-g702. PMID: 6638194, DOI: 10.1152/ajpgi.1983.245.5.g697.
- Vileisis R, Oh W. Metabolic Consequences of Intrauterine Growth Retardation. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 59-67. DOI: 10.1002/j.1536-4801.1983.tb08407.x.
- Hansen N, Oh W, LaRochelle F, Stonestreet B. Effects of maternal ritodrine administration on neonatal renal function. The Journal Of Pediatrics 1983, 103: 774-780. PMID: 6355419, DOI: 10.1016/s0022-3476(83)80484-3.
- Hansen N, Stonestreet B, Rosenkrantz T, Oh W. Validity of Doppler measurements of anterior cerebral artery blood flow velocity: correlation with brain blood flow in piglets. Pediatrics 1983, 72: 526-31. PMID: 6889067, DOI: 10.1542/peds.72.4.526.
- Stonestreet B, Hansen N, Laptook R, Oh W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Human Development 1983, 8: 331-341. PMID: 6641577, DOI: 10.1016/0378-3782(83)90016-6.
- Laptook R, Stonestreet B, Oh W. The effect of carotid artery ligation on brain blood flow in newborn piglets. Brain Research 1983, 276: 51-54. PMID: 6627001, DOI: 10.1016/0006-8993(83)90547-4.
- Tenenbaum D, Piasecki G, Oh W, Rosenkrantz T, Jackson B. Fetal polycythemia and hyperviscosity: Effect on umbilical blood flow and fetal oxygen consumption. American Journal Of Obstetrics And Gynecology 1983, 147: 48-51. PMID: 6684399, DOI: 10.1016/0002-9378(83)90082-0.
- Bell E, Weinstein M, Oh W. Effects of Intravenously Administered Safflower Oil Emulsion on Respiratory Gas Exchange of Low-Birth-Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 517-520. PMID: 6413670, DOI: 10.1097/00005176-198302030-00020.
- Cowett R, Susa J, Giletti B, Oh W, Schwartz R. Glucose kinetics in infants of diabetic mothers. American Journal Of Obstetrics And Gynecology 1983, 146: 781-786. PMID: 6346883, DOI: 10.1016/0002-9378(83)91077-3.
- Cowett R, Susa J, Kahn C, Giletti B, Oh W, Schwartz R. Glucose kinetics in nondiabetic and diabetic women during the third trimester of pregnancy. American Journal Of Obstetrics And Gynecology 1983, 146: 773-780. PMID: 6346882, DOI: 10.1016/0002-9378(83)91076-1.
- Cashore W, Oh W, Brodersen R. Bilirubin-Displacing Effect of Furosemide and Sulfisoxazole. Neonatology 1983, 6: 230-238. PMID: 6617404, DOI: 10.1159/000457309.
- Stonestreet B, Nowicki P, Hansen N, Petit R, Oh W. Effect of Aminophylline on Brain Blood Flow in the Newborn Piglet. Neonatology 1983, 6: 248-258. PMID: 6413185, DOI: 10.1159/000457311.
- Bratlid D, Cashore W, Oh W. Effect of serum hyperosmolality on opening of blood-brain barrier for bilirubin in rat brain. Pediatrics 1983, 71: 909-12. PMID: 6856404, DOI: 10.1542/peds.71.6.909.
- CASHORE W, OH W, BRODERSEN R. RESERVE ALBUMIN AND BILIRUBIN TOXICITY INDEX IN INFANT SERUM. Acta Paediatrica 1983, 72: 415-419. PMID: 6880730, DOI: 10.1111/j.1651-2227.1983.tb09739.x.
- Cowett R, Oh W, Schwartz R. Persistent glucose production during glucose infusion in the neonate. Journal Of Clinical Investigation 1983, 71: 467-475. PMID: 6338038, PMCID: PMC436894, DOI: 10.1172/jci110791.
- Stonestreet B, Bell E, Warburton D, Oh W. Renal Response in Low-Birth-Weight Neonates: Results of Prolonged Intake of Two Different Amounts of Fluid and Sodium. JAMA Pediatrics 1983, 137: 215-219. PMID: 6823919, DOI: 10.1001/archpedi.1983.02140290007002.
- Vileisis R, Oh W. Enhanced Fatty Acid Synthesis in Hyperinsulinemic Rat Fetuses. Journal Of Nutrition 1983, 113: 246-252. PMID: 6822898, DOI: 10.1093/jn/113.2.246.
- BELL E, OH W. WATER REQUIREMENT OF PREMATURE NEWBORN INFANTS. Acta Paediatrica (Oslo, Norway : 1992). Supplement 1983, 72: 21-26. PMID: 6577774, DOI: 10.1111/j.1651-2227.1983.tb09854.x.
- Laptook A, Stonestreet B, Oh W. Brain Blood Flow and O2 Delivery during Hemorrhagic Hypotension in the Piglet. Pediatric Research 1983, 17: 77-80. PMID: 6835718, DOI: 10.1203/00006450-198301000-00015.
- Vileisis R, Oh W. Metabolic Consequences of Intrauterine Growth Retardation. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 59-67. PMID: 6644479, DOI: 10.1097/00005176-198300201-00008.
- Vieleisis R, Oh W. Effect of increased substrate availability on fatty acid synthesis in the growth retarded fetus. Metabolism 1983, 32: 90-94. PMID: 6848902, DOI: 10.1016/0026-0495(83)90162-2.
- Oh W. Fluid and Electrolyte Therapy and Parenteral Nutrition in Low Birth Weight Infants. Clinics In Perinatology 1982, 9: 637-643. PMID: 6819107, DOI: 10.1016/s0095-5108(18)31017-0.
- Oh W. Foreword. Pediatric Clinics Of North America 1982, 29: 1055-1056. DOI: 10.1016/s0031-3955(16)34246-8.
- Rosenkrantz T, Oh W. Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial exchange transfusion with Plasmanate. The Journal Of Pediatrics 1982, 101: 94-98. PMID: 7086628, DOI: 10.1016/s0022-3476(82)80194-7.
- Laptook, Stonestreet B, Oh W. The effects of different rates of plasmanate infusions upon brain blood flow after asphyxia and hypotension in newborn piglets. The Journal Of Pediatrics 1982, 100: 791-796. PMID: 6896065, DOI: 10.1016/s0022-3476(82)80595-7.
- Vohr B, Bell E, Oh W. Infants With Bronchopulmonary Dysplasia: Growth Pattern and Neurologic and Developmental Outcome. JAMA Pediatrics 1982, 136: 443-447. PMID: 6177239, DOI: 10.1001/archpedi.1982.03970410061015.
- Cashore W, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics 1982, 69: 481-5. PMID: 7200229, DOI: 10.1542/peds.69.4.481.
- Vileisis R, Fain J, Oh W. Fatty acid synthesis in rat fetuses with intrauterine growth retardation. Metabolism 1982, 31: 217-222. PMID: 7078410, DOI: 10.1016/0026-0495(82)90056-7.
- Laptook, Stonestreet B, Oh W. Autoregulation of brain blood flow in the newborn piglet: Regional differences in flow reduction during hypotension. Early Human Development 1982, 6: 99-107. PMID: 6799270, DOI: 10.1016/0378-3782(82)90063-9.
- Vileisis R, Cowett R, Oh W. Glycemic response to lipid infusion in the premature neonate. The Journal Of Pediatrics 1982, 100: 108-112. PMID: 7035630, DOI: 10.1016/s0022-3476(82)80248-5.
- Weinstein M, Oh W. Oxygen consumption in infants with bronchopulmonarydysplasia. The Journal Of Pediatrics 1981, 99: 958-961. PMID: 6895525, DOI: 10.1016/s0022-3476(81)80032-7.
- LAPTOOK, OH W. Transcutaneous carbon dioxide monitoring in the newborn period. Critical Care Medicine 1981, 9: 759. PMID: 6793316, DOI: 10.1097/00003246-198110000-00019.
- Creswell J, Warburton D, Susa J, Cowett R, Oh W. Hyperviscosity in the Newborn Lamb Produces Pertubation in Glucose Homeostasis. Pediatric Research 1981, 15: 1348-1350. PMID: 7029442, DOI: 10.1203/00006450-198110000-00009.
- Leake R, Fiser R, Oh W. Rapid Glucose Disappearance in Infants with Infection. Clinical Pediatrics 1981, 20: 397-401. PMID: 7014071, DOI: 10.1177/000992288102000604.
- Cashore W, Oh W, Blumberg W, Lamola A. Letters to the Editor. Pediatrics 1981, 67: 936-937. DOI: 10.1542/peds.67.6.936.
- Widness J, Schwartz H, Zeller W, Oh W, Schwartz R. Glycohemoglobin in postpartum women. Obstetrics And Gynecology 1981, 57: 414-21. PMID: 7243085.
- Laptook A, Stonestreet B, Oh W. 1585 AUTOREGULATION OF BRAIN BLOOD FLOW (BBF): REGIONAL DIFFERENCES IN REDUCED BBP WITH HYPOTENSION. Pediatric Research 1981, 15: 707-707. DOI: 10.1203/00006450-198104001-01602.
- Cowett R, Susa J, Oh W, Schwartz R. 1112 DECREASED ENDOGENOUS GLUCOSE PRODUCTION (EGP) IN LOW BIRTHWEIGHT (LBW) INFANTS. Pediatric Research 1981, 15: 628-628. DOI: 10.1203/00006450-198104001-01138.
- Weinstein M, Oh W. 1737 BRONCHOPULMONARY DYSPLASIA (BPD) AND ITS EFFECTS ON OXYGEN CONSUMPTION (VO2). Pediatric Research 1981, 15: 733-733. DOI: 10.1203/00006450-198104001-01756.
- Widness J, Susa J, Oh W, Goldman A. 1223 MATERNAL INSULIN: AN UNLIKELY FETAL TERATOGEN. Pediatric Research 1981, 15: 646-646. DOI: 10.1203/00006450-198104001-01249.
- Stonestreet B, Laptook A, Oh W, Tsang R. 1445 ASPHYXIA INDUCED ALTERATIONS IN SERUM AND RENAL CALCIUM, MAGNESIUM AND PHOSPHATE HOMEOSTASIS. Pediatric Research 1981, 15: 684-684. DOI: 10.1203/00006450-198104001-01474.
- Vileisis R, Fain J, Oh W. 297 EFFECT OF INTRAUTERINE GROWTH RETARDATION (IUGR) ON FATTY ACID SYTHESIS. Pediatric Research 1981, 15: 489-489. DOI: 10.1203/00006450-198104001-00308.
- Cowebt R, Barcohana Y, Oh W. 395 HUMAN FETAL AND NEONATAL INSULIN RESPONSE TO MATERNAL HYPERGLYCEMIA AT CESAREAN SECTION (C/S). Pediatric Research 1981, 15: 506-506. DOI: 10.1203/00006450-198104001-00406.
- Stonestreet B, Laptook A, Siegel S, Oh W. 1544 EFFECTS OF ASPHYXIA ON RENAL FUNCTION IN TERM AND PRETERM LAMBS. Pediatric Research 1981, 15: 700-700. DOI: 10.1203/00006450-198104001-01567.
- Vileisis R, Cowett R, Oh W. 1457 GLYCEMIC EFFECT OF TRIGLYCERIDE INFUSION IN THE LOW BIRTH WEIGHT INFANT. Pediatric Research 1981, 15: 686-686. DOI: 10.1203/00006450-198104001-01486.
- Laptook A, Stonestreet B, Oh W. 1350 EFFECTS OF RATE OF VOLUME EXPANSION ON BRAIN BLOOD FLOW AFTER ASPHYXIA AND HYPOTENSION IN THE PIGLET. Pediatric Research 1981, 15: 668-668. DOI: 10.1203/00006450-198104001-01379.
- Widness J, Susa J, Garcia J, Singer D, Sehgal P, Oh W, Schwartz R, Schwartz H. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. Journal Of Clinical Investigation 1981, 67: 637-642. PMID: 7009647, PMCID: PMC370612, DOI: 10.1172/jci110078.
- Cashore W, Peter G, Lauermann M, Stonestreet B, Oh W. Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis. The Journal Of Pediatrics 1981, 98: 308-311. PMID: 7463233, DOI: 10.1016/s0022-3476(81)80667-1.
- Cowett R, Susa J, Warburton D, Stonestreet B, Schwartz R, Oh W. Endogenous Posthepatic Insulin Secretion and Metabolic Clearance Rates in the Neonatal Lamb. Pediatric Research 1980, 14: 1391-1394. PMID: 7010288, DOI: 10.1203/00006450-198012000-00027.
- Leake R, Chan G, Zakauddin S, Dodge M, Fiser R, Bier D, Oh W. Glucose Perturbation in Experimental Hyperviscosity. Pediatric Research 1980, 14: 1320-1323. PMID: 7208147, DOI: 10.1203/00006450-198012000-00009.
- Sturner W, Lipsitt L, Oh W, Barrett J, Truex R. Abnormal heart rate response during newborn sucking behavior study: Subsequent sudden infant death syndrome with cardiac conduction abnormality. Forensic Science International 1980, 16: 201-212. PMID: 7203318, DOI: 10.1016/0379-0738(80)90204-2.
- Stonestreet B, Rubin L, Pollak A, Cowett R, Oh W. Renal functions of low birth weight infants with hyperglycemia and glucosuria produced by glucose infusions. Pediatrics 1980, 66: 561-7. PMID: 7432841, DOI: 10.1542/peds.66.4.561.
- Bell E, Weinstein M, Oh W. Reply. The Journal Of Pediatrics 1980, 97: 700-701. DOI: 10.1016/s0022-3476(80)80055-2.
- Cashore W, Oh W, Blumberg W, Eisinger J, Lamola A. Rapid fluorometric assay of bilirubin and bilirubin binding capacity in blood of jaundiced neonates: comparisons with other methods. Pediatrics 1980, 66: 411-6. PMID: 7422430, DOI: 10.1542/peds.66.3.411.
- Hsieh J, Turcotte J, Waraska J, Warburton D, Oh W. High pressure liquid chromatography of standard and amniotic fluid phospholipids. Journal Of Separation Science 1980, 3: 400-404. DOI: 10.1002/jhrc.1240030804.
- Vohr B, Lipsitt L, Oh W. Somatic growth of children of diabetic mothers with reference to birth size. The Journal Of Pediatrics 1980, 97: 196-199. PMID: 7400885, DOI: 10.1016/s0022-3476(80)80473-2.
- Cowett R, Czech M, Susa J, Schwartz R, Oh W. Blunted muscle responsiveness to insulin in the neonatal rat. Metabolism 1980, 29: 563-567. PMID: 6991858, DOI: 10.1016/0026-0495(80)90083-9.
- Oh W. Fluid and Electrolyte Therapy in Low Birth Weight Infants. Pediatrics In Review 1980, 1: 313-316. DOI: 10.1542/pir.1-10-313.
- Oh W. Fluid and Electrolyte Therapy in Low Birth Weight Infants. Pediatrics In Review 1980, 1: 313-316. DOI: 10.1542/pir.1.10.313.
- Widness J, Schwartz H, Kahn C, Oh W, Schwartz R. Glycohemoglobin in diabetic pregnancy: A sequential study. American Journal Of Obstetrics And Gynecology 1980, 136: 1024-1029. PMID: 6768294, DOI: 10.1016/0002-9378(80)90631-6.
- Bell E, Warburton D, Stonestreet B, Oh W. Effect of Fluid Administration on the Development of Symptomatic Patent Ductus Arteriosus and Congestive Heart Failure in Premature Infants. New England Journal Of Medicine 1980, 302: 598-604. PMID: 7351906, DOI: 10.1056/nejm198003133021103.
- Bell E, Gray J, Weinstein M, Oh W. The effects of thermal environment on heat balance and insensible water loss in low-birth-weight infants. The Journal Of Pediatrics 1980, 96: 452-459. PMID: 7359241, DOI: 10.1016/s0022-3476(80)80697-4.
- Bell E, Weinstein M, Oh W. Heat balance in premature infants: Comparative effects of convectively heated incubator and radiant warmer, with and without plastic heat shield. The Journal Of Pediatrics 1980, 96: 460-465. PMID: 7359242, DOI: 10.1016/s0022-3476(80)80698-6.
- Boyle R, Oh W. Erythema Following Transcutaneous Po2 Monitoring. Pediatrics 1980, 65: 333-334. PMID: 7354981, DOI: 10.1542/peds.65.2.333.
- Schwartz H, Widness J, Thompson D, Tsuboi K, Oh W, Schwartz R. Glycosylation and Acetylation of Hemoglobin in Infants of Normal and Diabetic Mothers. Neonatology 1980, 38: 71-75. PMID: 7388092, DOI: 10.1159/000241341.
- Hakanson D, Oh W. Hyperviscosity in the Small-for-Gestational Age Infant. Neonatology 1980, 37: 109-112. PMID: 7188861, DOI: 10.1159/000241263.
- Susa J, McCormick K, Widness J, Singer D, Oh W, Admsons K, Schwartz R. Chronic Hyperinsulinemia in the Fetal Rhesus Monkey: Effects on Fetal Growth and Composition. Diabetes 1979, 28: 1058-1063. PMID: 116897, DOI: 10.2337/diab.28.12.1058.
- Warburton D, Singer D, Bell E, Corwin R, Oh W. Anatomic confirmation of echocardiographic measurements in neonatal hearts. Pediatrics 1979, 64: 468-71. PMID: 492813, DOI: 10.1542/peds.64.4.468.
- Stonestreet B, Bell E, Oh W. Validity of Endogenous Creatinine Clearance in Low Birthweight Infants. Pediatric Research 1979, 13: 1012-1014. PMID: 503652, DOI: 10.1203/00006450-197909000-00013.
- Bell E, Warburton D, Street B, Oh W. HIGH-VOLUME FLUID INTAKE PREDISPOSES PREMATURE INFANTS TO NECROTISING ENTEROCOLITIS. The Lancet 1979, 314: 90. PMID: 87978, DOI: 10.1016/s0140-6736(79)90135-1.
- Lipsitt L, Sturner W, Oh W, Barrett J, Truex R. Wolff-Parkinson-White and Sudden-Infant-Death Syndromes. New England Journal Of Medicine 1979, 300: 1111. PMID: 431615, DOI: 10.1056/nejm197905103001913.
- Susa J, Cowett R, Oh W, Schwartz R. Suppression of Gluconeogenesis and Endogenous Glucose Production by Exogenous Insulin Administration in the Newborn Lamb. Pediatric Research 1979, 13: 594-598. PMID: 471590, DOI: 10.1203/00006450-197905000-00003.
- Bell E, Neidich G, Cashore W, Oh W. Combined effect of radiant warmer and phototherapy oninsensible water loss in low-birth-weight infants. The Journal Of Pediatrics 1979, 94: 810-813. PMID: 448495, DOI: 10.1016/s0022-3476(79)80164-x.
- KOZUKI K, OH W, WIDNESS J, CASHORE W. INCREASE IN BILIRUBIN BINDING TO ALBUMIN WITH CORRECTION OF NEONATAL ACIDOSIS. Acta Paediatrica 1979, 68: 213-217. DOI: 10.1111/j.1651-2227.1979.tb04991.x.
- Bell E, Oh W. Fluid and Electrolyte Balance in Very Low Birth Weight Infants. Clinics In Perinatology 1979, 6: 139-150. PMID: 383360, DOI: 10.1016/s0095-5108(18)31168-0.
- Kozuki K, Oh W, Widness J, Cashore W. Increase in bilirubin binding to albumin with correction of neonatal acidosis. Acta Paediatrica 1979, 68: 213-7. PMID: 33528, DOI: 10.1111/j.1651-2227.1979.tb04991.x.
- Cowett R, Oh W, Pollak A, Schwartz R, Stonestreet B. Glucose disposal of low birth weight infants: steady state hyperglycemia produced by constant intravenous glucose infusion. Pediatrics 1979, 63: 389-96. PMID: 440840, DOI: 10.1542/peds.63.3.389.
- Pollak A, Susa J, Stonestreet B, Schwartz R, Oh W. Phosphoenolpyruvate Carboxykinase in Experimental Intrauterine Growth Retardation in Rats. Pediatric Research 1979, 13: 175-177. PMID: 582464, DOI: 10.1203/00006450-197903000-00008.
- Vohr B, Oh W, Rosenfield A, Cowett R, Berstein J. The preterm small-for-gestational age infant: A two-year follow-up study. American Journal Of Obstetrics And Gynecology 1979, 133: 422-424. PMID: 434008, DOI: 10.1016/0002-9378(79)90065-6.
- Chandler B, Kapoor N, Barker B, Boyle R, Oh W. Reply. The Journal Of Pediatrics 1979, 94: 164-165. DOI: 10.1016/s0022-3476(79)80396-0.
- Cowett R, Lipsitt L, Vohr B, Oh W. Aberrations in Sucking Behavior of Low‐birthweight Infants. Developmental Medicine & Child Neurology 1978, 20: 701-709. PMID: 729922, DOI: 10.1111/j.1469-8749.1978.tb15300.x.
- Boyle R, Chandler B, Stonestreet B, Oh W. Early identification of sepsis in infants with respiratory distress. Pediatrics 1978, 62: 744-50. PMID: 364391, DOI: 10.1542/peds.62.5.744.
- Boyle R, Nelson J, Stonestreet B, Peter G, Oh W. Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis. The Journal Of Pediatrics 1978, 93: 857-861. PMID: 361939, DOI: 10.1016/s0022-3476(78)81101-9.
- Cashore W, Gartner L, Oh W, Stern L. Clinical application of neonatal bilirubin-binding determinations: Current status. The Journal Of Pediatrics 1978, 93: 827-833. PMID: 712496, DOI: 10.1016/s0022-3476(78)81095-6.
- Widness J, Schwartz H, Thompson D, Kahn C, Oh W, Schwatrz R. HAEMOGLOBIN AIc (GLYCOHAEMOGLOBIN) IN DIABETIC PREGNANCY: AN INDICATOR OF GLUCOSE CONTROL AND FETAL SIZE. BJOG An International Journal Of Obstetrics & Gynaecology 1978, 85: 812-817. PMID: 718807, DOI: 10.1111/j.1471-0528.1978.tb15834.x.
- Boyle R, Oh W. Transcutaneous PO2 monitoring in infants with persistent fetal circulation who are receiving tolazoline therapy. Pediatrics 1978, 62: 605-7. PMID: 714594, DOI: 10.1542/peds.62.4.605.
- Boyle R, Oh W. Respiratory Distress Syndrome. Clinics In Perinatology 1978, 5: 283-297. PMID: 371895, DOI: 10.1016/s0095-5108(18)31180-1.
- Cowett R, Susa J, Oh W, Schwartz R. Endogenous Glucose Production during Constant Glucose Infusion in the Newborn Lamb. Pediatric Research 1978, 12: 853-857. PMID: 683743, DOI: 10.1203/00006450-197808000-00010.
- Stonestreet B, Oh W. Plasma creatinine levels in low-birth-weight infants during the first three months of life. Pediatrics 1978, 61: 788-9. PMID: 662522, DOI: 10.1542/peds.61.5.788.
- Pollak A, Cowett R, Schwartz R, Oh W. Glucose disposal in low-birth-weight infants during steady-state hyperglycemia: effects of exogenous insulin administration. Pediatrics 1978, 61: 546-9. PMID: 351535, DOI: 10.1542/peds.61.4.546.
- Vohr B, Oh W, Rosenfield A, Cowett R. 1159 THE PRE-TERM SMALL FOR GESTATION (SGA) INFANT: A TWO YEAR FOLLOW UP STUDY. Pediatric Research 1978, 12: 557-557. DOI: 10.1203/00006450-197804001-01165.
- Rosenfield A, Vohr B, Cowett R, Denhoff E, Oh W. 1151 THE EFFECTS OF AN EARLY INTERVENTION PROGRAM ON THE LOW BIRTH WEIGHT INFANTS. Pediatric Research 1978, 12: 555-555. DOI: 10.1203/00006450-197804001-01157.
- Widness J, Schwartz H, Thompson D, Kahn C, Oh W, Schwartz R. 223 GLYCOHEMOGLOBIN (Hb AIc): CORRELATION WITH MATERIAL BLOOD GLUCOSE CONTROL IN PREGNANCY. Pediatric Research 1978, 12: 401-401. DOI: 10.1203/00006450-197804001-00228.
- Cowett R, Czech M, Susa J, Schwartz R, Oh W. 842 BLUNTED MUSCLE RESPONSIVENESS TO INSULIN IN THE NEONATAL RAT. Pediatric Research 1978, 12: 504-504. DOI: 10.1203/00006450-197804001-00847.
- Ross B, Pollak A, Rubin L, Cowett R, Oh W. 1100 RENAL GLUCOSE HANDLING IN THE LOW BIRTH WEIGHT (LBW) INFANTS. Pediatric Research 1978, 12: 547-547. DOI: 10.1203/00006450-197804001-01106.
- Boyle R, Chandler B, Ross B, Oh W. 939 EARLY DIAGNOSIS OF EARLY ONSET NEONATAL SEPSIS. Pediatric Research 1978, 12: 520-520. DOI: 10.1203/00006450-197804001-00944.
- Chandler B, Kapoor N, Barker B, Boyle R, Oh W. Nitroblue tetrazolium test in neonates. The Journal Of Pediatrics 1978, 92: 638-640. PMID: 633030, DOI: 10.1016/s0022-3476(78)80312-6.
- Cashore W, Monin P, Oh W. Serum Bilirubin Binding Capacity and Free Bilirubin Concentration: A Comparison between Sephadex G-25 Filtration and Peroxidase Oxidation Techniques. Pediatric Research 1978, 12: 195-198. PMID: 643389, DOI: 10.1203/00006450-197803000-00006.
- Widness J, Schwartz H, Thompson D, King K, Kahn C, Oh W, Schwartz R. Glycohemoglobin (HbAIc): A predictor of birth weight in infants of diabetic mothers. The Journal Of Pediatrics 1978, 92: 8-12. PMID: 619085, DOI: 10.1016/s0022-3476(78)80059-6.
- Ross B, Pollak A, Oh W. The pharmacologic effects of furosemide therapy in the low-birth-weight infant. The Journal Of Pediatrics 1978, 92: 149-152. PMID: 22591, DOI: 10.1016/s0022-3476(78)80098-5.
- Ross B, Cowett R, Oh W. Renal Functions of Low Birth Weight Infants during the First Two Months of Life. Pediatric Research 1977, 11: 1162-1164. PMID: 917616, DOI: 10.1203/00006450-197711000-00010.
- Monin P, Cashore W, Hakanson D, Oh W. Lack of Effects of Continuous Positive Airway Pressure on Vagal Control of Breathing in Term and Preterm Newborn Lambs. Pediatric Research 1977, 11: 967-971. PMID: 333360, DOI: 10.1203/00006450-197709000-00007.
- Cashore W, Horwich A, Karotkin E, Oh W. Influence of Gestational Age and Clinical Status on Bilirubin-Binding Capacity in Newborn Infants: Sephadex G-25 Gel Filtration Technique. JAMA Pediatrics 1977, 131: 898-901. PMID: 888807, DOI: 10.1001/archpedi.1977.02120210076016.
- Chandler B, Cashore W, Monin P, Oh W. The lack of effects of phototherapy on neonatal oxygen dissociation curves and hemoglobin concentration in vivo. Pediatrics 1977, 59 Suppl: 1027-31. PMID: 865955, DOI: 10.1542/peds.59.6.1027.
- Cowett R, Susa J, Schwartz R, Oh W. Concentration of parenteral glucose solution. Pediatrics 1977, 59: 790-1. PMID: 404624, DOI: 10.1542/peds.59.5.790a.
- Vohr B, Rosenfield A, Oh W. Umbilical hernia in the low-birth-weight infant (less than 1,500 gm). The Journal Of Pediatrics 1977, 90: 807-808. PMID: 853341, DOI: 10.1016/s0022-3476(77)81257-2.
- Kozuki K, Cashore W, Widness J, Oh W. INCREASE IN BILIRUBIN-ALBUMIN BINDING AFFINITY WITH CORRECTION OF NEONATAL ACIDOSIS. Pediatric Research 1977, 11: 536-536. DOI: 10.1203/00006450-197704000-00997.
- Pollak A, Cowett R, Schwartz R, Oh W. EFFECTS OF EXOGENOUS INSULIN ON GLUCOSE DISPOSAL OF LOW BIRTH WEIGHT (LBW) INFANTS. Pediatric Research 1977, 11: 448-448. DOI: 10.1203/00006450-197704000-00473.
- Ross B, Cowett R, Oh W. POSTNATAL RENAL MATURATION IN LOW BIRTH WEIGHT INFANTS. Pediatric Research 1977, 11: 556-556. DOI: 10.1203/00006450-197704000-01116.
- Hakanson D, Oh W. HYPERVISCOSITY IN THE SMALL-FOR-GESTATIONAL AGE INFANT. Pediatric Research 1977, 11: 472-472. DOI: 10.1203/00006450-197704000-00613.
- Susa J, Cowett R, Oh W, Schwartz R. HEPATIC INSENSITIVITY TO INSULIN IN THE NEONATAL LAMB. Pediatric Research 1977, 11: 522-522. DOI: 10.1203/00006450-197704000-00914.
- Widness J, Edmunds D, Schwartz H, King K, Kahn C, Oh W, Schwartz R. GLYCOHEMOGLOBIN (HbAIc): A PROGNOSTICATOR OF BIRTH WEIGHT IN INFANTS OF DIABETIC MOTHERS. Pediatric Research 1977, 11: 523-523. DOI: 10.1203/00006450-197704000-00920.
- Siegel S, Oh W, Fisher D. FRUCTOSE 1. 6-DIPHOSPHATASE AND GLUCOSE 6-PHOSPHATASE IN NEWBORN RATS WITH INTRAUTERINE GROWTH RETARDATION. Pediatric Research 1977, 11: 521-521. DOI: 10.1203/00006450-197704000-00910.
- Cowett R, Pollak A, Ross B, Schwartz R, Oh W. GLUCOSE DISPOSAL IN THE WELL LOW BIRTH WEIGHT (LBW) INFANT. Pediatric Research 1977, 11: 512-512. DOI: 10.1203/00006450-197704000-00855.
- Hakanson D, Oh W. Necrotizing enterocolitis and hyperviscosity in the newborn infant. The Journal Of Pediatrics 1977, 90: 458-461. PMID: 839341, DOI: 10.1016/s0022-3476(77)80716-6.
- Cowett R, Peter G, Hakanson D, Stern L, Oh W. Prophylactic antibiotics in neonates with umbilical artery catheter placement: a prospective study of 137 patients. The Yale Journal Of Biology And Medicine 1977, 50: 457-63. PMID: 602256, PMCID: PMC2595562.
- Cashore W, Horwich A, Laterra J, Oh W. Effect of Postnatal Age and Clinical Status of Newborn Infants on Bilirubin-Binding Capacity. Neonatology 1977, 32: 304-309. PMID: 610767, DOI: 10.1159/000241033.
- Leake R, Zakauddin S, Trygstad C, Fu P, Oh W. The effects of large volume intravenous fluid infusion on neonatal renal function. The Journal Of Pediatrics 1976, 89: 968-972. PMID: 993925, DOI: 10.1016/s0022-3476(76)80612-9.
- Cowett R, Oh W. Foam Stability Predictions of Respiratory Distress in Infants Delivered by Repeat Elective Cesarean Section. New England Journal Of Medicine 1976, 295: 1222-1224. PMID: 980004, DOI: 10.1056/nejm197611252952204.
- Cowett R, Peter G, Hakanson D, Oh W. Reply. The Journal Of Pediatrics 1976, 89: 861-862. PMID: 978344, DOI: 10.1016/s0022-3476(76)80839-6.
- Oh W. Disorders of Fluid and Electrolytes in Newborn Infants. Pediatric Clinics Of North America 1976, 23: 601-609. PMID: 825816, DOI: 10.1016/s0031-3955(16)33347-8.
- LEAKE R, TRYGSTAD C, OH W. Inulin Clearance in the Newborn Infant. Pediatric Research 1976, 10: 759-762. DOI: 10.1203/00006450-197610080-00013.
- Karotkin E, Kido M, Cashore W, Redding R, Douglas W, Stern L, Oh W. Acceleration of Fetal Lung Maturation by Aminophyllin in Pregnant Rabbits. Pediatric Research 1976, 10: 722-724. PMID: 940698, DOI: 10.1203/00006450-197608000-00004.
- Kwong M, Moore T, Lemmi C, Oh W, Thibeault D. Histidine Decarboxylase Activity in Fetal Intrauterine Growth-retarded Rats. Pediatric Research 1976, 10: 737-739. PMID: 940700, DOI: 10.1203/00006450-197608000-00008.
- Leake R, Trygstad C, Oh W. Inulin Clearance in the Newborn Infant: Relationship to Gestational and Postnatal Age. Pediatric Research 1976, 10: 759-762. PMID: 940703, DOI: 10.1203/00006450-197608000-00013.
- Cowett R, Hakanson D, Kocon R, Oh W. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstetrics And Gynecology 1976, 48: 74s-75s. PMID: 945881.
- SIEGEL S, OH W. RENAL FUNCTION AS A MARKER OF HUMAN FETAL MATURATION. Acta Paediatrica 1976, 65: 480-486. DOI: 10.1111/j.1651-2227.1976.tb04917.x.
- Cowett R, Peter G, Hakanson D, Oh W. Reliability of bacterial culture of blood obtained from an umbilical artery catheter. The Journal Of Pediatrics 1976, 88: 1035-1036. PMID: 775042, DOI: 10.1016/s0022-3476(76)81071-2.
- Leake R, Zakauddin S, Fu P, Oh W, Trygstad C. SALT AND WATER HOMEOSTASIS IN THE NEWBORN. Pediatric Research 1976, 10: 557-557. DOI: 10.1203/00006450-197605000-00020.
- Leake R, Loew A, Oh W. Retransfer of Convalescent Infants from Newborn Intensive Care to Community Intermediate Care Nurseries. Clinical Pediatrics 1976, 15: 293-294. PMID: 1253510, DOI: 10.1177/000992287601500311.
- Karotkin E, Kido M, Redding R, Cashore W, Douglas W, Stern L, Oh W. The inhibition of pulmonary maturation in the fetal rabbit by maternal treatment with phenobarbital. American Journal Of Obstetrics And Gynecology 1976, 124: 529-531. PMID: 946581, DOI: 10.1016/0002-9378(76)90182-4.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. Umbilical Cord Cutting Triggers Hypertriiodothyroninemia and Nonshivering Thermogenesis in the Newborn Lamb. Pediatric Research 1976, 10: 169-175. PMID: 1250646, DOI: 10.1203/00006450-197603000-00005.
- Fiser R, Fisher D, Williams P, Sperling M, Oh W. Effects of fasting and theophylline on alanine-stimulated glucagon secretion in neonatal and infant sheep. American Journal Of Obstetrics And Gynecology 1976, 124: 421-424. PMID: 175657, DOI: 10.1016/0002-9378(76)90104-6.
- Cashore W, Karotkin E, Stern L, Oh W. The lack of effect of phototherapy on serum bilirubin-binding capacity in newborn infants. The Journal Of Pediatrics 1975, 87: 977-980. PMID: 1185408, DOI: 10.1016/s0022-3476(75)80922-x.
- Cowett R, Unsworth E, Hakanson D, Williams J, Oh W. Foam-Stability Test on Gastric Aspirate and the Diagnosis of Respiratory-Distress Syndrome. New England Journal Of Medicine 1975, 293: 413-416. PMID: 239347, DOI: 10.1056/nejm197508282930901.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. THE MECHANISM OF THE T3 RESPONSE TO PARTURITION. Pediatric Research 1975, 9: 682-682. DOI: 10.1203/00006450-197508000-00094.
- Fiser R, Williams P, Fisher D, DeLameter P, Sperling M, Oh W. The effect of oral alanine on blood glucose and glucagon in the human newborn infant. Pediatrics 1975, 56: 78-81. PMID: 1161364, DOI: 10.1542/peds.56.1.78.
- ASCH M, SPERLING M, FISER R, LEAKE R, MOORE T, OH W. Metabolic and Hormonal Studies Comparing Three Parenteral Nutrition Regimens in Infants. Annals Of Surgery 1975, 182: 62-65. PMID: 807170, PMCID: PMC1343880, DOI: 10.1097/00000658-197507000-00012.
- Tsang R, Gigger M, Oh W, Brown D. Studies in calcium metabolism in infants with intrauterine growth retardation. The Journal Of Pediatrics 1975, 86: 936-941. PMID: 1127536, DOI: 10.1016/s0022-3476(75)80232-0.
- Oh W, Omori K, Emmanouilides G, Phelps D. Placenta to lamb fetus transfusion in utero during acute hypoxia. American Journal Of Obstetrics And Gynecology 1975, 122: 316-322. PMID: 236656, DOI: 10.1016/0002-9378(75)90176-3.
- Williams P, Fiser R, Sperling M, Oh W. Effects of Oral Alanine Feeding on Blood Glucose, Plasma Glucagon and Insulin Concentrations in Small-for-Gestational-Age Infants. New England Journal Of Medicine 1975, 292: 612-614. PMID: 1113740, DOI: 10.1056/nejm197503202921204.
- Karotkin E, Oh W. Recent advances in the diagnosis and management of respiratory distress syndrome. Rhode Island Medical Journal 1975, 58: 131-4. PMID: 124916.
- St. Geme J, Bailey S, Koopman J, Oh W, Hobel C, Imagawa D. Neonatal Risk Following Late Gestational Genital Herpesvirus Hominis Infection. JAMA Pediatrics 1975, 129: 342-343. PMID: 1168410, DOI: 10.1001/archpedi.1975.02120400046010.
- Oh W, Omori K, Hobel C, Erenberg A, Emmanouilides G. Umbilical Blood Flow and Glucose Uptake in Lamb Fetus Following Single Umbilical Artery Ligation. Neonatology 1975, 26: 291-299. PMID: 1169079, DOI: 10.1159/000240741.
- Yamauchi T, Geme J, Oh W, Davis C. The Biological and Biochemical Pathogenesis of Mumps Virus-induced Embryonic Growth Retardation. Pediatric Research 1975, 9: 30-34. DOI: 10.1203/00006450-197501000-00006.
- Thibeault D, Emmanouilides G, Nelson R, Lachman R, Rosengart R, Oh W. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. The Journal Of Pediatrics 1975, 86: 120-126. PMID: 122840, DOI: 10.1016/s0022-3476(75)80722-0.
- Fiser R, Phelps D, Williams P, Sperling M, Fisher D, Oh W. Insulin-glucagon substrate interrelationships in the neonatal sheep. American Journal Of Obstetrics And Gynecology 1974, 120: 944-950. PMID: 4611217, DOI: 10.1016/0002-9378(74)90343-3.
- Fiser R, Erenberg A, Sperling M, Oh W, Fisher D. Insulin-Glucagon Substrate Interrelations in the Fetal Sheep. Pediatric Research 1974, 8: 951-955. PMID: 4614213, DOI: 10.1203/00006450-197412000-00007.
- DeLamater P, Sperling M, Fiser R, Phelps D, Oh W, Fisher D. Plasma alanine: Relation to plasma glucose, glucagon, and insulin in the neonate. The Journal Of Pediatrics 1974, 85: 702-706. PMID: 4422013, DOI: 10.1016/s0022-3476(74)80523-8.
- Ferguson A, Lawlor G, Neumann C, Oh W, Stiehm E. Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. The Journal Of Pediatrics 1974, 85: 717-723. PMID: 4213798, DOI: 10.1016/s0022-3476(74)80527-5.
- Erenberg A, Omori K, Menkes J, Oh W, Fisher D. Growth and Development of the Thyroidectomized Ovine Fetus. Pediatric Research 1974, 8: 783-789. PMID: 4413605, DOI: 10.1203/00006450-197409000-00001.
- Siegel S, Fisher D, Oh W. Reply. The Journal Of Pediatrics 1974, 85: 443-444. DOI: 10.1016/s0022-3476(74)80151-4.
- SIEGEL S, PHELPS D, LEAKE R, OH W. THE EFFECTS OF RAPID INFUSION OF HYPERTONIC SODIUM BICARBONATE IN INFANTS WITH RESPIRATORY DISTRESS. Survey Of Anesthesiology 1974, 18: 286. DOI: 10.1097/00132586-197406000-00053.
- Phelps D, Loew A, Oh W. THE LARYNGO-TRACHEAL FUNCTION OF SURVIVING INFANTS FOLLOWING OROTRACHEAL INTUBATION DURING THE NEONATAL PERIOD. Pediatric Research 1974, 8: 468-468. DOI: 10.1203/00006450-197404000-00771.
- Anthony B, Hobel C, Oh W, Okada D. Group B streptococcal infections in neonates. The Journal Of Pediatrics 1974, 84: 609-610. PMID: 4858169, DOI: 10.1016/s0022-3476(74)80695-5.
- Thibeault D, Emmanouilides G, Nelson R, Rosengart R, Oh W, Lachman R. PATENT DUCTUS ARTERIOSUS (PDA) IN INFANTS LESS THAN 30 WEEKS GESTATION: INDICATIONS FOR SURGERY. Pediatric Research 1974, 8: 354-354. DOI: 10.1203/00006450-197404000-00087.
- Sperling M, Delamater P, Phelps D, Fiser R, Oh W, Fisher D. Spontaneous and Amino Acid-Stimulated Glucagon Secretion in the Immediate Postnatal Period. Journal Of Clinical Investigation 1974, 53: 1159-1166. PMID: 4815080, PMCID: PMC333102, DOI: 10.1172/jci107654.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. THE MECHANISMS OF NEONATAL THYROIDAL HYPERACTIVITY IN THE NEWBORN SHEEP. Pediatric Research 1974, 8: 374-374. DOI: 10.1203/00006450-197404000-00205.
- Fiser R, Williams P, Sperling M, Oh W, Fisher D. CONTROL OF PANCREATIC ALPHA CELL FUNCTION IN THE NEONATAL AND INFANT SHEEP. Pediatric Research 1974, 8: 432-432. DOI: 10.1203/00006450-197404000-00551.
- Phelps D, Oh W. CONSTANT GLUCOSE (G) INFUSION (CGI) AND SERUM INSULIN (I) CHANGES IN SEQUENTIALLY STUDIED PRETERM INFANTS. Pediatric Research 1974, 8: 359-359. DOI: 10.1203/00006450-197404000-00113.
- DeLamater P, Sperling M, Fiser R, Phelps D, Oh W, Fisher D. ALANINE-GLUCAGON INTERRELATIONS IN HUMAN NEWBORNS. Pediatric Research 1974, 8: 356-356. DOI: 10.1203/00006450-197404000-00097.
- Williams P, Fiser R, DeLamater P, Sperling M, Fisher D, Oh W. PANCREATIC ISLET ALPHA AND BETA CELL RESPONSES TO ORAL AND IV ALANINE IN APPROPRIATE FOR GESTATIONAL AGE (AGA) AND SMALL FOR GESTATIONAL AGE (SGA) INFANTS. Pediatric Research 1974, 8: 439-439. DOI: 10.1203/00006450-197404000-00594.
- Leake R, Oh W. EFFECT OF GESTATIONAL AND POSTNATAL AGE ON GLOMERULAR FILTRATION RATE (GFR) ANO TUBULAR MAXIMA OF GLUCOSE TmG IN HUMAN INFANTS. Pediatric Research 1974, 8: 457-457. DOI: 10.1203/00006450-197404000-00701.
- Leake R, Fiser R, Oh W. GLUCOSE DISPOSAL, HORMONAL CHANGES, AND PLASMA ALANINE LEVEL IN NEONATAL SEPSIS. Pediatric Research 1974, 8: 434-434. DOI: 10.1203/00006450-197404000-00566.
- Siegel S, Fisher D, Oh W. Serum aldosterone concentrations related to sodium balance in the newborn infant. Pediatrics 1974, 53: 410-3. PMID: 4205580, DOI: 10.1542/peds.53.3.410.
- Leake R, Schroeder K, Benton D, Oh W. Soy-Based Formula in the Treatment of Infantile: Diarrhea. JAMA Pediatrics 1974, 127: 374-376. PMID: 4405999, DOI: 10.1001/archpedi.1974.02110220072010.
- Fiser R, Phelps D, Williams P, Sperling M, Oh W, Fisher D. Alanine Stimulation of the Pancreatic α- and β-Cell in the Neonatal Lamb. Neonatology 1974, 25: 171-175. PMID: 4615749, DOI: 10.1159/000240689.
- SPERLING M, ERENBERG A, FISER R, OH W, FISHER D. Notes and Comments Placental Transfer of Glucagon in Sheep. Endocrinology 1973, 93: 1435-1438. PMID: 4752892, DOI: 10.1210/endo-93-6-1435.
- Erenberg A, Omori K, Oh W, Fisher D. The Effect of Fetal Thyroidectomy on Thyroid Hormone Metabolism in Maternal and Fetal Sheep. Pediatric Research 1973, 7: 870-877. PMID: 4749003, DOI: 10.1203/00006450-197311000-00002.
- Siegel S, Fisher D, Oh W. Renal function and serum aldosterone levels in infants with respiratory distress syndrome. The Journal Of Pediatrics 1973, 83: 854-858. PMID: 4742583, DOI: 10.1016/s0022-3476(73)80389-0.
- Hobel C, Hyvarinen M, Okada D, Oh W. Prenatal and intrapartum high-risk screening I. Prediction of the high-risk neonate. American Journal Of Obstetrics And Gynecology 1973, 117: 1-9. PMID: 4722373, DOI: 10.1016/0002-9378(73)90720-5.
- Leake R, Williams P, Oh W. Validity of neonatal blood pressure obtained by the manometric method. Pediatrics 1973, 52: 293-6. PMID: 4721451, DOI: 10.1542/peds.52.2.293.
- Kwong M, Loew A, Anthony B, Oh W. The effect of hexachlorophene on staphylococcal colonization rates in the newborn infant: A controlled study using a single-bath method. The Journal Of Pediatrics 1973, 82: 982-986. PMID: 4573991, DOI: 10.1016/s0022-3476(73)80429-9.
- The effects of rapid infusion of hypertonic sodium bicarbonate in infants with respiratory distress.Siegel S, Phelps D, Leake R, Oh W. The effects of rapid infusion of hypertonic sodium bicarbonate in infants with respiratory distress. Pediatrics 1973, 51: 651-4. PMID: 4697514, DOI: 10.1542/peds.51.4.651.
- Fiser R, Erenberg A, Fisher D, Oh W. Blood gas and pH changes during glucose infusion in the fetal sheep. American Journal Of Obstetrics And Gynecology 1973, 115: 942-945. PMID: 4695310, DOI: 10.1016/0002-9378(73)90671-6.
- Hyvarinen M, Zeltzer P, Oh W, Stiehm E. Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. The Journal Of Pediatrics 1973, 82: 430-437. PMID: 4121530, DOI: 10.1016/s0022-3476(73)80116-7.
- OH W, YAO A, HANSON J, LIND J. PERIPHERAL CIRCULATORY RESPONSE TO PHOTOTHERAPY IN NEWBORN INFANTS. Acta Paediatrica 1973, 62: 49-54. DOI: 10.1111/j.1651-2227.1973.tb08064.x.
- Hobel C, Oh W, Hyvarinen M, Emmanouilides G, Erenberg A. Early versus late treatment of neonatal acidosis in low-birth-weight infants: Relation to respiratory distress syndrome. The Journal Of Pediatrics 1972, 81: 1178-1187. PMID: 4643040, DOI: 10.1016/s0022-3476(72)80259-2.
- HOBEL C, HYVARINEN M, OH W. ABNORMAL FETAL HEART RATE PATTERNS AND FETAL ACIDBASE BALANCE IN LOW BIRTH WEIGHT INFANTS IN RELATION TO RESPIRATORY DISTRESS SYNDROME. Obstetrical & Gynecological Survey 1972, 27: 350-351. DOI: 10.1097/00006254-197210000-00005.
- Phelps D, Lachman R, Leake R, Oh W. The radiologic localizationof the major aortic tributaries in the newborn infant. The Journal Of Pediatrics 1972, 81: 336-339. PMID: 5042493, DOI: 10.1016/s0022-3476(72)80306-8.
- Anthony B, Giuliano D, Oh W. Nursery Outbreak of Staphylococcal Scalded Skin Syndrome: Rapid Identification of the Epidemic Bacterial Strain. JAMA Pediatrics 1972, 124: 41-44. PMID: 5033748, DOI: 10.1001/archpedi.1972.02110130043006.
- Clements J, Platzker A, Tierney D, Hobel C, Creasy R, Margolis A, Thibeault D, Tooley W, Oh W. Assessment of the Risk of the Respiratory-Distress Syndrome by a Rapid Test for Surfactant in Amniotic Fluid. New England Journal Of Medicine 1972, 286: 1077-1081. PMID: 5067186, DOI: 10.1056/nejm197205182862004.
- Hobel C, Hyvarinen M, Oh W. ABNORMAL FETAL HEART RATE PATTERNS AND FETAL ACID-BASE BALANCE IN LOW BIRTH WEIGHT INFANTS IN RELATION TO RESPIRATORY DISTRESS SYNDROME. Obstetrical & Gynecological Survey 1972, 27: 350-351. DOI: 10.1097/00006254-197205000-00005.
- Hobel C, Hyvarinen M, Oh W. Abnormal fetal heart rate patterns and fetal acid-base balance in low birth weight infants in relation to respiratory distress syndrome. Obstetrics And Gynecology 1972, 39: 83-8. PMID: 5008290.
Departments and Programs
Locations
1
1 of 2
- Smilow Cancer Hospital at Greenwich77 Lafayette PlaceGreenwich, CT 06830
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Biography
William K. Oh, MD, is a genitourinary oncologist with decades of experience specializing in prostate cancer. He integrates molecular and genetic testing into routine cancer care, ensuring that patients receive the most personalized treatment plans possible. Throughout his career he has focused on decreasing barriers to the delivery of care for prostate cancer nationally.
Dr. Oh is the director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital, where he leads efforts to develop cohesive programs that combine basic and translational science with clinical trials. He also oversees the Precision Medicine Tumor Board, which is pivotal in guiding treatment decisions based on genetic and molecular data. Additionally, he serves as the service line medical director of Smilow Cancer Hospital at Greenwich Hospital, where he continues to develop integrated oncology care teams and expand the impact of multidisciplinary cancer care for patients in the region.
Dr. Oh completed his undergraduate degree at Yale University, received his medical degree from New York University School of Medicine, and did his internship and residency at Brigham and Women’s Hospital before his clinical fellowship in medical oncology at Dana-Farber Cancer Institute.
Dr. Oh currently serves as chair of the American Cancer Society's National Prostate Cancer Roundtable, whose mission is to improve prostate cancer outcomes and survivorship through increasing awareness and equitable access to prevention, screening, and treatment. Also, he is the chair of the Medical Advisory Council for the Chemotherapy Foundation, which is committed to discovering novel therapies for cancer.
“I love taking care of patients because it brings me tremendous personal satisfaction to both help them and learn from them,” Dr. Oh says. “I also love the precision medicine part of my job, but in the end, my patient care responsibilities always bring me back to what it’s all about and why we’re all here and I enjoy getting to know my patients and their generosity of spirit and courage. I take a lot of lessons from that.”
Titles
- Director, Precision Medicine, Yale Cancer Center and Smilow Cancer Hospital
- Service Line Medical Director, Smilow Cancer Hospital at Greenwich Hospital
Education & Training
- MDNew York University School of Medicine
- BSYale University, Molecular Biophysics and Biochemistry
Additional Information
Publications
- Carlsson S, Oh W. How Can Guidelines Give Clearer Guidance on Prostate Cancer Screening? JAMA Oncology 2024, 10: 1497-1498. PMID: 39325462, DOI: 10.1001/jamaoncol.2024.3909.
- Oh W, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson S, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci L, Omlin A, Palapattu G, Riaz I, Ryan C, Schoen M, Washington S, Gillessen S. What’s in a Name? Why Words Matter in Advanced Prostate Cancer. European Urology 2024, 87: 101-103. PMID: 39472202, DOI: 10.1016/j.eururo.2024.10.017.
- Lee K, Mai Y, Liu Z, Raja K, Jun T, Ma M, Wang T, Ai L, Calay E, Oh W, Schadt E, Wang X. CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics. Scientific Reports 2024, 14: 25387. PMID: 39455879, PMCID: PMC11511882, DOI: 10.1038/s41598-024-77447-x.
- Gillessen S, Turco F, Davis I, Efstathiou J, Fizazi K, James N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Zilli T, Agarwal N, Antonarakis E, Aparicio A, Armstrong A, Bastos D, Attard G, Axcrona K, Ayadi M, Beltran H, Bjartell A, Blanchard P, Bourlon M, Briganti A, Bulbul M, Buttigliero C, Caffo O, Castellano D, Castro E, Cheng H, Chi K, Clarke C, Clarke N, de Bono J, De Santis M, Duran I, Efstathiou E, Ekeke O, El Nahas T, Emmett L, Fanti S, Fatiregun O, Feng F, Fong P, Fonteyne V, Fossati N, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Hofman M, Hope T, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Joshua A, Kanesvaran R, Keizman D, Khauli R, Kramer G, Loeb S, Mahal B, Maluf F, Mateo J, Matheson D, Matikainen M, McDermott R, McKay R, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Mutambirwa S, Nguyen P, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Renard-Penna R, Ryan C, Saad F, Sade J, Sandhu S, Sartor O, Schaeffer E, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Suzuki H, Taplin M, Thellenberg-Karlsson C, Tilki D, Türkeri L, Uemura H, Ürün Y, Vale C, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). European Urology 2024, 87: 157-216. PMID: 39394013, DOI: 10.1016/j.eururo.2024.09.017.
- Chakrani Z, Patel M, Mellgard G, McCroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao C, Ganta T, Patel V. The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Clinical Genitourinary Cancer 2024, 22: 102227. PMID: 39437664, DOI: 10.1016/j.clgc.2024.102227.
- Mellgard G, Saffran N, Chakrani Z, McCroskery S, Taylor N, Patel M, Liaw B, Galsky M, Oh W, Tsao C, Patel V. Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy. American Journal Of Clinical Oncology 2024, 47: 459-464. PMID: 39087466, DOI: 10.1097/coc.0000000000001115.
- Lee K, Liu Z, Mai Y, Jun T, Ma M, Wang T, Ai L, Calay E, Oh W, Stolovitzky G, Schadt E, Wang X. Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. JMIR AI 2024, 3: e50800. PMID: 39073872, PMCID: PMC11319878, DOI: 10.2196/50800.
- Wang L, Izadmehr S, Sfakianos J, Tran M, Beaumont K, Brody R, Cordon-Cardo C, Horowitz A, Sebra R, Oh W, Bhardwaj N, Galsky M, Zhu J. Single-cell transcriptomic-informed deconvolution of bulk data identifies immune checkpoint blockade resistance in urothelial cancer. IScience 2024, 27: 109928. PMID: 38812546, PMCID: PMC11133924, DOI: 10.1016/j.isci.2024.109928.
- Garraway I, Carlsson S, Nyame Y, Vassy J, Chilov M, Fleming M, Frencher S, George D, Kibel A, King S, Kittles R, Mahal B, Pettaway C, Rebbeck T, Rose B, Vince R, Winn R, Yamoah K, Oh W. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evidence 2024, 3: evidoa2300289. PMID: 38815168, DOI: 10.1056/evidoa2300289.
- Chakrani Z, Mellgard G, Saffran N, McCroskery S, Taylor N, Patel M, Liaw B, Galsky M, Oh W, Tsao C, Patel V. Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy. American Journal Of Clinical Oncology 2024, 47: 271-278. PMID: 38344754, DOI: 10.1097/coc.0000000000001087.
- Garraway I, Carlsson S, Nyame Y, Vassey J, Chilov M, Fleming M, Frencher S, George D, Kibel A, King S, Kittles R, Mahal B, Pettaway C, Rebbeck T, Rose B, Vince R, Winn R, Yamoah K, Oh W. Prostate Cancer Foundation (PCF) screening guidelines for prostate cancer in Black men in the United States. Journal Of Clinical Oncology 2024, 42: 264-264. DOI: 10.1200/jco.2024.42.4_suppl.264.
- Liaw B, Joshi H, Sheng T, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC. Journal Of Clinical Oncology 2024, 42: 147-147. DOI: 10.1200/jco.2024.42.4_suppl.147.
- Williams C, Starks D, Rojas-Espaillat L, Meissner T, Elsey R, Jun T, Solomon B, Feng S, Koenen M, van Oosbree A, Clem A, Lee J, Oh W. Comprehensive molecular profiling and deep clinical annotation of electronic health records in patients with cancer: Implementation of the Avera/Sema4 oncology and analytics protocol (ASAP) in gynecologic oncology (1255). Gynecologic Oncology 2023, 176: s161-s162. DOI: 10.1016/j.ygyno.2023.06.164.
- Lee K, Liu Z, Chandran U, Kalsekar I, Laxmanan B, Higashi M, Jun T, Ma M, Li M, Mai Y, Gilman C, Wang T, Ai L, Aggarwal P, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X. Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing. JMIR AI 2023, 2: e44537. PMID: 38875565, PMCID: PMC11041451, DOI: 10.2196/44537.
- Ganta T, Anker J, Miller E, Tsao K, Oh W. Real world utilization and outcomes of immunotherapy regimens in metastatic castration resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2023, 41: e17038-e17038. DOI: 10.1200/jco.2023.41.16_suppl.e17038.
- Liu Z, Lee K, Cohn D, Zhang M, Ai L, Li M, Zhang X, Jun T, Higashi M, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X, Li S. Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival. Journal Of Thoracic Disease 2023, 0: 0-0. PMID: 37324065, PMCID: PMC10267939, DOI: 10.21037/jtd-22-1481.
- Gillessen S, Bossi A, Davis I, de Bono J, Fizazi K, James N, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis E, Aparicio A, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow R, Bulbul M, Caffo O, Castellano D, Castro E, Cheng H, Chi K, Chowdhury S, Clarke C, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman M, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Kanesvaran R, Kellokumpu-Lehtinen P, Khauli R, Klotz L, Kramer G, Leibowitz R, Logothetis C, Mahal B, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Nguyen P, Oh W, Ost P, O'Sullivan J, Padhani A, Pezaro C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Steuber T, Suzuki H, Sydes M, Taplin M, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H, Ürün Y, Vale C, van Oort I, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Zilli T, Omlin A. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. European Journal Of Cancer 2023, 185: 178-215. PMID: 37003085, DOI: 10.1016/j.ejca.2023.02.018.
- Ganta T, Anker J, Miller E, Kannry J, Bhardwaj A, Tsao K, Oh W. Oncologist-driven development of an electronic health record (EHR) clinical data visualization tool for prostate cancer. Journal Of Clinical Oncology 2023, 41: 267-267. DOI: 10.1200/jco.2023.41.6_suppl.267.
- Chakrani Z, Mellgard G, Mccroskery S, Saffran N, Taylor N, Liaw B, Oh W, Tsao K, Patel V. Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART). Journal Of Clinical Oncology 2023, 41: 135-135. DOI: 10.1200/jco.2023.41.6_suppl.135.
- Mellgard G, Mccroskery S, Chakrani Z, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao K, Patel V. Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy. Journal Of Clinical Oncology 2023, 41: 118-118. DOI: 10.1200/jco.2023.41.6_suppl.118.
- Mellgard G, Chakrani Z, Mccroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao K, Patel V. Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies. Journal Of Clinical Oncology 2023, 41: 117-117. DOI: 10.1200/jco.2023.41.6_suppl.117.
- Liaw B, Tsao C, Seng S, Jun T, Gong Y, Galsky M, Oh W. Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer. The Oncologist 2022, 28: 366-e224. PMID: 36519763, PMCID: PMC10078918, DOI: 10.1093/oncolo/oyac224.
- Gillessen S, Bossi A, Davis I, de Bono J, Fizazi K, James N, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis E, Aparicio A, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow R, Bulbul M, Caffo O, Castellano D, Castro E, Cheng H, N. K, Chowdhury S, Clarke C, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman M, Horvath L, Hussain M, Jereczek-Fossa B, Jones R, Kanesvaran R, Kellokumpu-Lehtinen P, Khauli R, Klotz L, Kramer G, Leibowitz R, Logothetis C, Mahal B, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans A, Morris M, Mrabti H, Mukherji D, Murphy D, Murthy V, Nguyen P, Oh W, Ost P, O’Sullivan J, Padhani A, Pezaro C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Sharifi N, Skoneczna I, Soule H, Spratt D, Srinivas S, Sternberg C, Steuber T, Suzuki H, Sydes M, Taplin M, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H, Ürün Y, Vale C, van Oort I, Vapiwala N, Walz J, Yamoah K, Ye D, Yu E, Zapatero A, Zilli T, Omlin A. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. European Urology 2022, 83: 267-293. PMID: 36494221, PMCID: PMC7614721, DOI: 10.1016/j.eururo.2022.11.002.
- Higashi M, Kruszka P, Francis M, Parsons K, Oh W, Onel K. Pediatric Age at Hematopoietic Stem Cell Transplant: Associations with Non-Malignant Genetic Disease and Race. Blood 2022, 140: 7973-7974. DOI: 10.1182/blood-2022-170315.
- Lee K, Paek H, Ai L, Liu Z, Jin L, Li M, Jun T, Higashi M, Onel K, Oh W, Pan Q, Stolovitzky G, Schadt E, Wang X. Treatment Profile of CAR-T Cell Therapy Induced Cytokine Release Syndrome and Neurotoxicity: Insights from Real-World Evidence. Blood 2022, 140: 12750-12752. DOI: 10.1182/blood-2022-166716.
- Al-Kateb H, Jun T, Hayes J, Rossi M, Hantash F, Oh W, Onel K. Prevalence of Pathogenic Germline Mutations in Solid Tumor Predisposition Genes Detected By Tumor-Normal Whole Exome Sequencing Analysis Among Adults with Hematologic Malignancies. Blood 2022, 140: 7852-7853. DOI: 10.1182/blood-2022-159618.
- Calvo M, Caruthers S, Tripodi J, Houldsworth J, Fink M, Newman S, Chen R, Zhang W, Liu L, Shi Y, Jun T, Onel K, Oh W, Edelmann L, Schadt E, Rossi M, Hantash F, Al-Kateb H. 61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma. Cancer Genetics 2022, 268: 20. DOI: 10.1016/j.cancergen.2022.10.064.
- Griffin J, Tsao C, Patel V, Liaw B, Guin S, Joshi H, Rossi M, Hantash F, Zhou X, Tewari A, Galsky M, Oh W, Chen R, Jun T. Clinical actionability and utilization of next-generation sequencing for prostate cancer in a changing treatment landscape. Frontiers In Urology 2022, 2: 997396. DOI: 10.3389/fruro.2022.997396.
- Sasenick J, Kleinfeld A, Huber A, Oh W, Hegyi T, Weinberger B. Effects of lipid emulsions on unbound bilirubin and response to phototherapy in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2022, 35: 10395-10400. PMID: 36176060, PMCID: PMC9852034, DOI: 10.1080/14767058.2022.2128656.
- Jin L, Govindaraj S, Liu Z, Ai L, Higashi M, Jun T, Lee K, Raja K, Zhang X, Li M, Calay E, Savic R, Ghosh K, Kasarskis A, Pan Q, Oh W, Stolovitzky G, Schadt E, Wang X. Seasonal variations of hospitalizations for chronic rhinosinusitis by different endotypes. ISEE Conference Abstracts 2022, 2022 DOI: 10.1289/isee.2022.p-1062.
- Mellgard G, Chakrani Z, McCroskery S, Saffran N, Taylor N, Liaw B, Galsky M, Oh W, Tsao C, Patel V. 1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy. Annals Of Oncology 2022, 33: s1129. DOI: 10.1016/j.annonc.2022.07.1407.
- Guin S, Liaw B, Jun T, Ayers K, Patel B, O’Connell T, Deitz M, Klein M, Mullaney T, Prentice T, Newman S, Fink M, Zhou X, Schadt E, Chen R, Oh W. Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience. PLOS ONE 2022, 17: e0264800. PMID: 35984843, PMCID: PMC9390935, DOI: 10.1371/journal.pone.0264800.
- Qin Q, Jun T, Wang B, Patel V, Mellgard G, Zhong X, Gogerly-Moragoda M, Parikh A, Leiter A, Gallagher E, Alerasool P, Garcia P, Joshi H, MBBS, Galsky M, Oh W, Tsao C. Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discover Oncology 2022, 13: 73. PMID: 35960456, PMCID: PMC9374856, DOI: 10.1007/s12672-022-00538-6.
- Mellgard G, Patel V, Zhong X, Joshi H, Qin Q, Wang B, Parikh A, Jun T, Alerasool P, Garcia P, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. Journal Of Cancer Research And Clinical Oncology 2022, 149: 2833-2841. PMID: 35788726, PMCID: PMC10739778, DOI: 10.1007/s00432-022-04159-y.
- Jin L, Ai L, Lee K, Liu Z, Raja K, Cohn D, Zhang X, Higashi M, Jun T, Oh W, Calay E, Savic R, Ghosh K, Kasarskis A, Pan Q, Stolovitzky G, Govindaraj S, Schadt E, Wang X. HSD34 Treatment Patterns and Healthcare-Resource Utilization Among Chronic Rhinosinusitis with Nasal Polyps Patients: In the New Era of Biologics. Value In Health 2022, 25: s486. DOI: 10.1016/j.jval.2022.04.1035.
- Jun T, Oh W. Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen? JAMA Oncology 2022, 8: 972-974. PMID: 35551363, DOI: 10.1001/jamaoncol.2022.0511.
- Guin S, Jun T, Patel V, Ayers K, Deitz M, Cai Y, Zhou X, Tsao C, Oh W, Chen R, Liaw B. Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer. JCO Clinical Cancer Informatics 2022, 6: e2200010. PMID: 35696627, PMCID: PMC9225507, DOI: 10.1200/cci.22.00010.
- Ai L, Higashi M, Lee K, Liu Z, Jin L, Raja K, Mai Y, Jun T, Oh W, Beckmann A, Schadt E, Schadt Z, Wallsten R, Calay E, Kasarskis A, Pan Q, Schadt E, Wang X. AB0227 TREATMENT SEQUENCING PATTERNS AND COMPARATIVE EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM A REAL-WORLD SETTING. Annals Of The Rheumatic Diseases 2022, 81: 1241. DOI: 10.1136/annrheumdis-2022-eular.4655.
- Williams C, Starks D, Elsey R, Meissner T, Solomon B, Albano M, Hantash F, Schadt E, Rojas-Espaillat L, Lee J, Oh W. Implementation of the Avera/Sema4 oncology and analytics protocol (ASAP). Journal Of Clinical Oncology 2022, 40: tps6605-tps6605. DOI: 10.1200/jco.2022.40.16_suppl.tps6605.
- Jun T, Oh W, Schadt E, Higashi M. Health outcomes modelling of RNA-based versus DNA-based detection of driver gene rearrangements in non-small cell lung cancer. Journal Of Clinical Oncology 2022, 40: e18837-e18837. DOI: 10.1200/jco.2022.40.16_suppl.e18837.
- Patel K, Jun T, Chhadwa S, Zabala V, Gill S, Branchcomb R, Naidu S, Nathwani N, Hansen G, Hubbert A, Mukhi H, Mehta D, Nixon S, Kodali A, Zimmerman M, Hantash F, Oh W. Social determinants of health in a prospective study of whole-exome sequencing in advanced cancer patients from underserved communities. Journal Of Clinical Oncology 2022, 40: e18539-e18539. DOI: 10.1200/jco.2022.40.16_suppl.e18539.
- Patel K, Oh W, Jun T, Naidu S, Nathwani N, Hansen G, Hubert A, Mukhi H, Chhadwa S, Zabala V, Gill S, Branchcomb R, Mehta D, Nixon S, Kodali A, Zimmerman M. Clinical utility of widespread germline testing of cancer patients in a diverse community cancer clinic. Journal Of Clinical Oncology 2022, 40: e18537-e18537. DOI: 10.1200/jco.2022.40.16_suppl.e18537.
- Williams C, Guin S, Elsey R, Meißner T, Xu B, Sun Y, Amallraja A, Jun T, Schadt E, Chen R, Zhou X, Higashi M, Lee J, Oh W. Landscape of tumor genetic testing and targeted therapies over an eight-year span in a rural population. Journal Of Clinical Oncology 2022, 40: e15036-e15036. DOI: 10.1200/jco.2022.40.16_suppl.e15036.
- Lee K, Cohn D, Liu Z, Ai L, Paek H, Jin L, Raja K, Li M, Zhang X, Jun T, Higashi M, Oh W, Calay E, Savic R, Ghosh K, Kasarskis A, Mullaney T, Pan Q, Schadt E, Wang X. Phenotypic and endotypic features of COPD associated with lung cancer development. Journal Of Clinical Oncology 2022, 40: e13563-e13563. DOI: 10.1200/jco.2022.40.16_suppl.e13563.
- Williams C, Karagoz K, Elsey R, Meißner T, Higashi M, Schadt E, Jun T, Wang X, Chen R, Zhou X, Guin S, Lee J, Oh W. QOPI Clinical Informatics: A digital platform to enable real-time quality reporting, clinical decision support, and rapid learning. Journal Of Clinical Oncology 2022, 40: e13545-e13545. DOI: 10.1200/jco.2022.40.16_suppl.e13545.
- Karagoz K, Ayers K, Patel B, Wells J, Newman S, Oh W, Zhou X, Chen R, Guin S. Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology. Journal Of Clinical Oncology 2022, 40: 6584-6584. DOI: 10.1200/jco.2022.40.16_suppl.6584.
- Kier M, Li Z, Casasanta N, Patel R, Agarwal P, Zimmerman B, Yang Y, Fink M, Zhou X, Newman S, Chen R, Schadt E, Oh W, Tiersten A. Socioeconomic disparities in supportive therapy use and tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer. Journal Of Clinical Oncology 2022, 40: 523-523. DOI: 10.1200/jco.2022.40.16_suppl.523.
- Laptook A, Chalak L, Pappas A, Davis A, Sanchez P, Van Meurs K, Oh W, Sommers R, Shankaran S, Hensman A, Rouse D, McDonald S, Das A, Goldberg R, Ambalavanan N, Gyamfi-Bannerman C, Thom E, Higgins R. The effects of betamethasone on the amplitude integrated EEG of infants born at 34- or 35-weeks gestation. Journal Of Perinatology 2022, 42: 1615-1621. PMID: 35618748, PMCID: PMC9699898, DOI: 10.1038/s41372-022-01415-4.
- Shah N, Patel V, Zhong X, Pina L, Hawley J, Lin E, Gartrell B, Febles V, Wise D, Qin Q, Mellgard G, Joshi H, Nauseef J, Green D, Vlachostergios P, Kwon D, Huang F, Liaw B, Tagawa S, Kantoff P, Morris M, Oh W. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI Cancer Spectrum 2022, 6: pkac035. PMID: 35657341, PMCID: PMC9165550, DOI: 10.1093/jncics/pkac035.
- Lee K, Liu Z, Ma M, Chandran U, Kalsekar I, Laxmanan B, Li M, Mai Y, Gilman C, Wang T, Zhang M, Ai L, Aggarwal P, Pan Q, Oh W, Schadt E, Wang X. Automated Extraction and Longitudinal Analysis of Ground Glass OpacityFeatures in Lung Cancer Patients Powered by Natural Language Processing. 2022, a5077-a5077. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5077.
- Oh W, Rettig M. Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 16-17. PMID: 35579581.
- Oh W. Clinical observations regarding the use of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 13-16. PMID: 35579580.
- Rettig M, Beltran H, Oh W. Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. Clinical Advances In Hematology And Oncology 2022, 20 Suppl 9: 1-20. PMID: 35579577.
- Griffin J, Jun T, Guin S, Liaw B, Patel V, Tsao C, Rossi M, Chen R, Zhou X, Hantash F, Oh W. MP27-10 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR PROSTATE CANCER IN THE CONTEXT OF A CHANGING TREATMENT LANDSCAPE. Journal Of Urology 2022, 207: e453. DOI: 10.1097/ju.0000000000002570.10.
- Jun T, Hahn N, Sonpavde G, Albany C, MacVicar G, Hauke R, Fleming M, Gourdin T, Jana B, Oh W, Taik P, Wang H, Varadarajan A, Uzilov A, Galsky M. Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma. The Oncologist 2022, 27: 432-e452. PMID: 35438782, PMCID: PMC9177111, DOI: 10.1093/oncolo/oyab075.
- Gillessen S, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ekeke O, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology 2022, 82: 115-141. PMID: 35450732, DOI: 10.1016/j.eururo.2022.04.002.
- Turco F, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ekeke O, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Gillessen S, Omlin A. Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]. European Urology 2022, 82: e18-e19. PMID: 35440417, PMCID: PMC9012951, DOI: 10.1016/j.eururo.2022.04.004.
- Mack P, Klein M, Ayers K, Zhou X, Guin S, Fink M, Rossi M, AI-Kateb H, O’Connell T, Hantash F, Oh W, Newman S, Schadt E, Chen R, Hirsch F. Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma. The Oncologist 2022, 27: 476-486. PMID: 35298662, PMCID: PMC9177106, DOI: 10.1093/oncolo/oyac035.
- Yu H, Tuminello S, Alpert N, van Gerwen M, Yoo S, Mulholland D, Aaronson S, Donovan M, Oh W, Gong Y, Wang L, Zhu J, Taioli E. Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases. Carcinogenesis 2022, 43: 528-537. PMID: 35239955, PMCID: PMC9234756, DOI: 10.1093/carcin/bgac025.
- Li S, Jun T, Tyler J, Schadt E, Kao Y, Wang Z, Konig M, Bettegowda C, Vogelstein J, Papadopoulos N, Parsons R, Chen R, Schadt E, Li L, Oh W. Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients. Frontiers In Medicine 2022, 9: 849222. PMID: 35295598, PMCID: PMC8919772, DOI: 10.3389/fmed.2022.849222.
- Welén K, Rosendal E, Freyhult E, Oh W, Gisslén M, Ahlm C, Connolly A, Överby A, Josefsson A. Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients. European Urology 2022, 81: e143-e144. PMID: 35248411, PMCID: PMC8864103, DOI: 10.1016/j.eururo.2022.02.016.
- Griffin J, Jun T, Liaw B, Guin S, Tsao C, Patel V, Rossi M, Zhou X, Hantash F, Chen R, Oh W. Clinical utility of next-generation sequencing for prostate cancer in the context of a changing treatment landscape. Journal Of Clinical Oncology 2022, 40: 112-112. DOI: 10.1200/jco.2022.40.6_suppl.112.
- Turco F, Armstrong A, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Bulbul M, Caffo O, Chi K, Clarke C, Clarke N, Davis I, de Bono J, Duran I, Eeles R, Efstathiou E, Efstathiou J, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, George D, Gleave M, Halabi S, Heinrich D, Higano C, Hofman M, Hussain M, James N, Jones R, Kanesvaran R, Khauli R, Klotz L, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ekeke Onyeanunam N, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Rabah D, Rathkopf D, Reiter R, Rubin M, Ryan C, Saad F, Pablo Sade J, Sartor O, Scher H, Shore N, Skoneczna I, Small E, Smith M, Soule H, Spratt D, Sternberg C, Suzuki H, Sweeney C, Sydes M, Taplin M, Tilki D, Tombal B, Türkeri L, Uemura H, Uemura H, van Oort I, Yamoah K, Ye D, Zapatero A, Gillessen S, Omlin A. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology 2022, 82: 6-11. PMID: 35393158, PMCID: PMC8849852, DOI: 10.1016/j.eururo.2022.02.010.
- Patel R, Li Z, Zimmerman B, Fink M, Wells J, Zhou X, Ayers K, Redfern A, Newman S, Schadt E, Oh W, Chen R, Tiersten A. Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer. Breast Cancer Research And Treatment 2022, 192: 313-319. PMID: 35006484, DOI: 10.1007/s10549-021-06504-0.
- Mirza H, Garcia J, Bell C, Jones K, Flynn V, Pepe J, Oh W. Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants. American Journal Of Perinatology 2021, 40: 1345-1350. PMID: 34384119, DOI: 10.1055/a-1585-6093.
- Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?Lin J, Zhang Y, Hou W, Qin Q, Galsky M, Oh W, Tsao C. Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging? Journal Of Kidney Cancer And VHL 2021, 8: 13-19. PMID: 34722126, PMCID: PMC8523177, DOI: 10.15586/jkcvhl.v8i4.202.
- Cirulli G, Martini A, Gandaglia G, Fossati N, Necchi A, Raggi D, Stabile A, Cucchiara V, Leni R, Robesti D, Pellegrino F, Nocera L, Scuderi S, Karakiewicz P, Galsky M, Oh W, Sfakianos J, Parikh A, Tsao C, Montorsi F, Briganti A. SC206 The obesity paradox in metastatic castration resistant prostate cancer. European Urology Open Science 2021, 32: s101. DOI: 10.1016/s2666-1683(21)00897-1.
- Izadmehr S, Lundon D, Mohamed N, Katims A, Patel V, Eilender B, Mehrazin R, Badani K, Sfakianos J, Tsao C, Wiklund P, Oh W, Cordon-Cardo C, Tewari A, Galsky M, Kyprianou N. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic. Frontiers In Oncology 2021, 11: 734963. PMID: 34646777, PMCID: PMC8504458, DOI: 10.3389/fonc.2021.734963.
- Mirza H, Garcia J, Bell C, Jones K, Flynn V, Pepe J, Oh W. Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants. American Journal Of Perinatology 2021 DOI: 10.1055/s-0041-1735623.
- Mack P, Klein M, Ayers K, Uzilov A, Zhou X, Corrigan D, Dietz M, Fink M, Guin S, Kip N, Rossi M, Oh W, Hantash F, Newman S, Schadt E, Chen R, Hirsch F. 1271P Molecular driver mutations in never-smokers with lung adenocarcinoma. Annals Of Oncology 2021, 32: s993. DOI: 10.1016/j.annonc.2021.08.1873.
- Martini A, Cirulli G, Parikh A, Sfakianos J, Galsky M, Oh W, Tsao C, Gandaglia G, Fossati N, Stabile A, Necchi A, Cucchiara V, Pellegrino F, Scuderi S, Karakiewicz P, Montorsi F, Briganti A. MP24-09 BALANCING EFFICACY AND TOXICITY OF DOCETAXEL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. RESULTS FROM A POOLED ANALYSIS OF THREE PROSPECTIVE RANDOMIZED TRIALS. Journal Of Urology 2021, 206: e415-e415. DOI: 10.1097/ju.0000000000002015.09.
- Martini A, Cirulli G, Gandaglia G, Fossati N, Necchi A, Stabile A, Cucchiara V, Mazzone E, Karakiewicz P, Sfakianos J, Galsky M, Oh W, Gallagher E, Montorsi F, Briganti A. PD05-01 THE OBESITY PARADOX IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER. Journal Of Urology 2021, 206: e55-e55. DOI: 10.1097/ju.0000000000001969.01.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care 2021, 44: 2438-2444. PMID: 34462270, PMCID: PMC8929179, DOI: 10.2337/dci21-0034.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. The Journal Of Clinical Endocrinology & Metabolism 2021, 107: 1-9. PMID: 34459898, PMCID: PMC8825709, DOI: 10.1210/clinem/dgab585.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: Definition and interpretation of remission in type 2 diabetes. Diabetic Medicine 2021, 39: e14669. PMID: 34460965, DOI: 10.1111/dme.14669.
- Riddle M, Cefalu W, Evans P, Gerstein H, Nauck M, Oh W, Rothberg A, le Roux C, Rubino F, Schauer P, Taylor R, Twenefour D. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 2021, 64: 2359-2366. PMID: 34458934, DOI: 10.1007/s00125-021-05542-z.
- Koshkin V, Patel V, Ali A, Bilen M, Ravindranathan D, Park J, Kellezi O, Cieslik M, Shaya J, Cabal A, Brown L, Labriola M, Graham L, Pritchard C, Tripathi A, Nusrat S, Barata P, Jang A, Chen S, Garje R, Acharya L, Hwang C, Pilling A, Oh W, Jun T, Natesan D, Nguyen C, Kilari D, Pierro M, Thapa B, Cackowski F, Mack A, Heath E, Marshall C, Tagawa S, Halabi S, Schweizer M, Armstrong A, Dorff T, Alva A, McKay R. PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. Prostate Cancer And Prostatic Diseases 2021, 25: 388-396. PMID: 34363009, PMCID: PMC9385488, DOI: 10.1038/s41391-021-00433-1.
- Singh D, Patel V, Oh W, Aguirre-Ghiso J. Prostate Cancer Dormancy and Reactivation in Bone Marrow. Journal Of Clinical Medicine 2021, 10: 2648. PMID: 34208521, PMCID: PMC8234151, DOI: 10.3390/jcm10122648.
- Cirulli G, Martini A, Pellegrino F, Scuderi S, Parikh A, Oh W, Sfakianos J, Karakiewicz P, Galsky M, Tsao C, Cucchiara V, Stabile A, Gandaglia G, Fossati N, Necchi A, Montorsi F, Briganti A. P0860 Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials. European Urology 2021, 79: s1203-s1204. DOI: 10.1016/s0302-2838(21)01234-3.
- Cirulli G, Martini A, Sfakianos J, Gandaglia G, Fossati N, Stabile A, Cucchiara V, Mazzone E, Necchi A, Karakiewicz P, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. P0855 The obesity paradox in metastatic castration resistant prostate cancer. European Urology 2021, 79: s1195-s1196. DOI: 10.1016/s0302-2838(21)01229-x.
- A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 PandemicTremblay D, Dunn A, Oh W. A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic. Quality Management In Health Care 2021, 30: 276-279. PMID: 34048378, PMCID: PMC8462300, DOI: 10.1097/qmh.0000000000000324.
- Liaw B, Guin S, Jun T, Ayers K, Patel B, O'Connell T, Dietz M, Klein M, Prentice T, Newman S, Fink M, Zhou X, Schadt E, Chen R, Oh W. Comparative efficacy of docetaxel versus novel hormonal agent in de novo metastatic hormone-sensitive prostate cancer: Real-world data curated by deidentified chart abstraction. Journal Of Clinical Oncology 2021, 39: e17047-e17047. DOI: 10.1200/jco.2021.39.15_suppl.e17047.
- Liaw B, Zhong X, Tsao C, Bakst R, Stewart R, Stock R, Galsky M, Oh W. Prostate cancer intensive, non-cross reactive therapy (PRINT) for CRPC: Interim analysis of efficacy endpoints. Journal Of Clinical Oncology 2021, 39: e17027-e17027. DOI: 10.1200/jco.2021.39.15_suppl.e17027.
- Ayers K, Mullaney T, Zhou X, Liu J, Lee K, Ma M, Jones S, Li L, Redfern A, Jappe W, Liu Z, Goldsweig H, Yadav K, Hahner N, Dietz M, Zimmerman M, Prentice T, Newman S, Veluswamy R, Wisnivesky J, Hirsch F, Oh W, Li S, Schadt E, Chen R. Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers. The Oncologist 2021, 26: e1226-e1239. PMID: 33829580, PMCID: PMC8265370, DOI: 10.1002/onco.13780.
- Bikkasani K, Qin Q, Zhong X, Lin J, Galsky M, Oh W, Tsao C. Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? Clinical Genitourinary Cancer 2021, 19: e346-e351. PMID: 34011488, DOI: 10.1016/j.clgc.2021.04.003.
- Wang L, Sfakianos J, Beaumont K, Akturk G, Horowitz A, Sebra R, Farkas A, Gnjatic S, Hake A, Izadmehr S, Wiklund P, Oh W, Szabo P, Wind-Rotolo M, Unsal-Kacmaz K, Yao X, Schadt E, Sharma P, Bhardwaj N, Zhu J, Galsky M. Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing. Clinical Cancer Research 2021, 27: 4287-4300. PMID: 33837006, PMCID: PMC8338756, DOI: 10.1158/1078-0432.ccr-20-4574.
- Adams-Chapman I, Watterberg K, Nolen T, Hirsch S, Cole C, Cotten C, Oh W, Poindexter B, Zaterka-Baxter K, Das A, Lacy C, Scorsone A, Duncan A, DeMauro S, Goldstein R, Colaizy T, Wilson-Costello D, Purdy I, Hintz S, Heyne R, Myers G, Fuller J, Merhar S, Harmon H, Peralta-Carcelen M, Kilbride H, Maitre N, Vohr B, Natarajan G, Mintz-Hittner H, Quinn G, Wallace D, Olson R, Orge F, Tsui I, Gaynon M, Hutchinson A, He Y, Winter T, Yang M, Haider K, Cogen M, Hug D, Bremer D, Donahue J, Lucas W, Phelps D, Higgins R. Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. Journal Of Perinatology 2021, 41: 2072-2087. PMID: 33758387, PMCID: PMC8349854, DOI: 10.1038/s41372-021-01018-5.
- Patel V, Zhong X, Shah N, Pina Martina L, Hawley J, Lin E, Gartrell B, Adorno Febles V, Wise D, Qin Q, Mellgard G, Nauseef J, Green D, Vlachostergios P, Kwon D, Huang F, Liaw B, Tagawa S, Morris M, Oh W. The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. Journal Of Clinical Oncology 2021, 39: 41-41. DOI: 10.1200/jco.2021.39.6_suppl.41.
- Martini A, Parikh A, Sfakianos J, Montorsi F, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data. Prostate Cancer And Prostatic Diseases 2021, 24: 743-749. PMID: 33531652, DOI: 10.1038/s41391-021-00326-3.
- Rosenkrantz T, Oh W. Polycythemia and Hyperviscosity in the Newborn. 2021, 185-200. DOI: 10.1017/9781108773584.013.
- Parikh A, Zhong X, Mellgard G, Qin Q, Patel V, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher E, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh W, Tsao C. Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy. American Journal Of Clinical Oncology 2021, 44: 114-120. PMID: 33417323, PMCID: PMC7902456, DOI: 10.1097/coc.0000000000000793.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Carayannopoulos M, Oh W. Unbound bilirubin levels in phototherapy‐treated preterm infants receiving soy‐based lipid emulsion. Pediatrics International 2020, 62: 1357-1363. PMID: 32535983, DOI: 10.1111/ped.14346.
- Mateo J, McKay R, Abida W, Aggarwal R, Alumkal J, Alva A, Feng F, Gao X, Graff J, Hussain M, Karzai F, Montgomery B, Oh W, Patel V, Rathkopf D, Rettig M, Schultz N, Smith M, Solit D, Sternberg C, Van Allen E, VanderWeele D, Vinson J, Soule H, Chinnaiyan A, Small E, Simons J, Dahut W, Miyahira A, Beltran H. Accelerating precision medicine in metastatic prostate cancer. Nature Cancer 2020, 1: 1041-1053. PMID: 34258585, PMCID: PMC8274325, DOI: 10.1038/s43018-020-00141-0.
- Wang Z, Zheutlin A, Kao Y, Ayers K, Gross S, Kovatch P, Nirenberg S, Charney A, Nadkarni G, De Freitas J, O’Reilly P, Just A, Horowitz C, Martin G, Branch A, Glicksberg B, Charney D, Reich D, Oh W, Schadt E, Chen R, Li L. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records. BMJ Open 2020, 10: e040441. PMID: 33109676, PMCID: PMC7592304, DOI: 10.1136/bmjopen-2020-040441.
- Schmid S, Omlin A, Higano C, Sweeney C, Chanza N, Mehra N, Kuppen M, Beltran H, Condeduca V, de Almeida D, Maluf F, Oh W, Tsao C, Sartor O, Ledet E, Di Lorenzo G, Yip S, N. K, Bianchini D, De Giorgi U, Hansen A, Beer T, Pernelle L, Morales-Barrera R, Tucci M, Castro E, Karalis K, Bergman A, Le M, Zürrer-Härdi U, Pezaro C, Suzuki H, Zivi A, Klingbiel D, Schär S, Gillessen S. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. JAMA Network Open 2020, 3: e2021692. PMID: 33112397, PMCID: PMC7593810, DOI: 10.1001/jamanetworkopen.2020.21692.
- Marco B, Martini A, Pfail J, Gandaglia G, Fossati N, Scuderi S, Fallara G, Barletta F, Robesti D, Rizzo A, Basile G, Bravi C, Rosiello G, Nocera L, Stabile A, Gallina A, Salonia A, Montorsi F, Briganti A, Galsky M, Oh W. SC242 Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial. European Urology Open Science 2020, 20: s142. DOI: 10.1016/s2666-1683(20)35564-6.
- Cignoli D, Martini A, Sfakianos J, Gandaglia G, Fossati N, Salonia A, Barletta F, Scuderi S, Robesti D, Bravi C, Mazzone E, Rosiello G, Fallara G, Nocera L, Cirulli G, Stabile A, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. SC56 The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE trials. European Urology Open Science 2020, 20: s55-s56. DOI: 10.1016/s2666-1683(20)35378-7.
- Martini A, Parikh A, Gandaglia G, Fossati N, Fallara G, Barletta F, Scuderi S, Robesti D, Cannoletta D, Leni R, Cucchiara V, Bravi C, Mazzone E, Rosiello G, Basile G, Nocera L, Necchi A, Moschini M, Sfakianos J, Galsky M, Oh W, Tsao C, Montorsi F, Briganti A. SC241 Predicting toxicity-related Docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer using open phase 3 trial data. European Urology Open Science 2020, 20: s141-s142. DOI: 10.1016/s2666-1683(20)35563-4.
- Lowrance W, Breau R, Chou R, Chapin B, Crispino T, Dreicer R, Jarrard D, Kibel A, Morgan T, Morgans A, Oh W, Resnick M, Zietman A, Cookson M. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. Journal Of Urology 2020, 205: 14-21. PMID: 32960679, DOI: 10.1097/ju.0000000000001375.
- Lowrance W, Breau R, Chou R, Chapin B, Crispino T, Dreicer R, Jarrard D, Kibel A, Morgan T, Morgans A, Oh W, Resnick M, Zietman A, Cookson M. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. Journal Of Urology 2020, 205: 22-29. PMID: 32960678, DOI: 10.1097/ju.0000000000001376.
- Brion L, Phelps D, Ward R, Nolen T, Hallman N, Das A, Zaccaro D, Ball M, Watterberg K, Frantz I, Cotten C, Poindexter B, Oh W, Lugo R, Van Meurs K, O’Shea T, Zaterka-Baxter K, Higgins R. Blood myo-inositol concentrations in preterm and term infants. Journal Of Perinatology 2020, 41: 247-254. PMID: 32934363, PMCID: PMC7889639, DOI: 10.1038/s41372-020-00799-5.
- Patel V, Oh W, Galsky M. Treatment of muscle‐invasive and advanced bladder cancer in 2020. CA A Cancer Journal For Clinicians 2020, 70: 404-423. PMID: 32767764, DOI: 10.3322/caac.21631.
- Abramson D, Fallon J, Biran N, Francis J, Jaben K, Oh W. Lacrimal sac adenocarcinoma managed with androgen deprivation. American Journal Of Ophthalmology Case Reports 2020, 19: 100607. PMID: 32760849, PMCID: PMC7393461, DOI: 10.1016/j.ajoc.2020.100607.
- Patel V, Zhong X, Liaw B, Tremblay D, Tsao C, Galsky M, Oh W. Does androgen deprivation therapy protect against severe complications from COVID-19? Annals Of Oncology 2020, 31: 1419-1420. PMID: 32653425, PMCID: PMC7347319, DOI: 10.1016/j.annonc.2020.06.023.
- Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh W, Naymagon L. Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study. Blood 2020, 136: 144-147. PMID: 32462179, PMCID: PMC7332896, DOI: 10.1182/blood.2020006941.
- Ayers K, Liu Z, Ma M, Lee K, Newman S, Li L, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Oh W, Schadt E, Li D, Chen R. Using real-world data to investigate time-dependent blood count response to PD-1 and PD-L1 inhibitors and its impact on survival in advanced non-small cell lung cancers. Journal Of Clinical Oncology 2020, 38: e21514-e21514. DOI: 10.1200/jco.2020.38.15_suppl.e21514.
- Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRPC—Early observations of efficacy. Journal Of Clinical Oncology 2020, 38: e17575-e17575. DOI: 10.1200/jco.2020.38.15_suppl.e17575.
- Lin J, Zhong X, Galsky M, Oh W, Tsao C. Predictors of successful randomized phase III studies in the treatment metastatic renal cell carcinoma: A meta-analysis. Journal Of Clinical Oncology 2020, 38: e17105-e17105. DOI: 10.1200/jco.2020.38.15_suppl.e17105.
- Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Zhong X, Parikh A, Leiter A, Gallagher E, Galsky M, Oh W, Tsao C. Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors. Journal Of Clinical Oncology 2020, 38: e15160-e15160. DOI: 10.1200/jco.2020.38.15_suppl.e15160.
- Lin J, Patel V, Qin Q, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Zhong X, Oh W, Galsky M, Tsao C. What happens at radiographic disease progression in patients with metastatic cancer receiving immune checkpoint inhibitors? A single institution analysis. Journal Of Clinical Oncology 2020, 38: e15157-e15157. DOI: 10.1200/jco.2020.38.15_suppl.e15157.
- Parikh A, Mellgard G, Qin Q, Patel V, Wang B, Zhong X, Leiter A, Gallagher E, Galsky M, Oh W, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Tsao C. Risk factors for emergency room and hospital care for patients with advanced solid tumors on immune checkpoint inhibitor therapy. Journal Of Clinical Oncology 2020, 38: e15142-e15142. DOI: 10.1200/jco.2020.38.15_suppl.e15142.
- Ganta T, Jun T, Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Clinical efficacy of immunotherapy for the treatment of solid tumors in patients with chronic kidney disease. Journal Of Clinical Oncology 2020, 38: e15109-e15109. DOI: 10.1200/jco.2020.38.15_suppl.e15109.
- Jun T, Ganta T, Qin Q, Patel V, Wang B, Mellgard G, Gogerly-Moragoda M, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Smoking status and immunotherapy outcomes in smoking-associated cancers. Journal Of Clinical Oncology 2020, 38: e15097-e15097. DOI: 10.1200/jco.2020.38.15_suppl.e15097.
- Patel V, Qin Q, Wang B, Gogerly-Moragoda M, Mellgard G, Zhong X, Parikh A, Leiter A, Gallagher E, Oh W, Galsky M, Tsao C. Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. Journal Of Clinical Oncology 2020, 38: e15068-e15068. DOI: 10.1200/jco.2020.38.15_suppl.e15068.
- Schweizer M, Ha G, Gulati R, Brown L, McKay R, Dorff T, Hoge A, Reichel J, Vats P, Kilari D, Patel V, Oh W, Chinnaiyan A, Pritchard C, Armstrong A, Montgomery R, Alva A. CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade. JCO Precision Oncology 2020, 4: 382-392. PMID: 32671317, PMCID: PMC7363399, DOI: 10.1200/po.19.00383.
- Martini A, Pfail J, Montorsi F, Galsky M, Oh W. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial. Prostate Cancer And Prostatic Diseases 2020, 23: 638-645. PMID: 32313142, DOI: 10.1038/s41391-020-0231-5.
- Martini* A, Parikh A, Sfakianos J, Fossati N, Gandaglia G, Scuderi S, Cannoletta D, Fallara G, Mazzone E, Stabile A, Barletta F, Robesti D, Bravi C, Briganti A, Montorsi F, Oh W, Galsky M, Tsao C. PD16-07 PREDICTING TOXICITY-RELATED DOCETAXEL DISCONTINUATION AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER USING OPEN PHASE 3 TRIAL DATA. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.07.
- Martini A, Pfail* J, Fossati N, Gandaglia G, Fallara G, Barletta F, Scuderi S, Robesti D, Salonia A, Briganti A, Montorsi F, Galsky M, Oh W. PD16-06 SURROGATE ENDPOINTS FOR OVERALL SURVIVAL FOR PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER IN THE CHAARTED TRIAL. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.06.
- Martini* A, Sfakianos J, Gandaglia G, Fossati N, Barletta F, Scuderi S, Robesti D, Fallara G, Salonia A, Briganti A, Montorsi F, Oh W, Gallagher E, Galsky M. PD16-05 THE INVERSE CORRELATION BETWEEN OBESITY AND MORTALITY IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: RESULTS FROM THE CONTROL ARMS OF ASCENT2, MAINSAL AND VENICE TRIALS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000859.05.
- Oh W. COVID-19 infection in cancer patients: early observations and unanswered questions. Annals Of Oncology 2020, 31: 838-839. PMID: 32243894, PMCID: PMC7270512, DOI: 10.1016/j.annonc.2020.03.297.
- Liu M, Oxnard G, Klein E, Swanton C, Seiden M, Consortium C, investigators C, Liu M, Oxnard G, Klein E, Smith D, Richards D, Yeatman T, Cohn A, Lapham R, Clement J, Parker A, Tummala M, McIntyre K, Sekeres M, Bryce A, Siegel R, Wang X, Cosgrove D, Abu-Rustum N, Trent J, Thiel D, Becerra C, Agrawal M, Garbo L, Giguere J, Michels R, Harris R, Richey S, McCarthy T, Waterhouse D, Couch F, Wilks S, Krie A, Balaraman R, Restrepo A, Meshad M, Rieger-Christ K, Sullivan T, Lee C, Greenwald D, Oh W, Tsao C, Fleshner N, Kennecke H, Khalil M, Spigel D, Manhas A, Ulrich B, Kovoor P, Stokoe C, Courtright J, Yimer H, Larson T, Swanton C, Seiden M, investigators S, Cummings S, GRAIL I, Absalan F, Alexander G, Allen B, Amini H, Aravanis A, Bagaria S, Bazargan L, Beausang J, Berman J, Betts C, Blocker A, Bredno J, Calef R, Cann G, Carter J, Chang C, Chawla H, Chen X, Chien T, Civello D, Davydov K, Demas V, Desai M, Dong Z, Fayzullina S, Fields A, Filippova D, Freese P, Fung E, Gnerre S, Gross S, Halks-Miller M, Hall M, Hartman A, Hou C, Hubbell E, Hunkapiller N, Jagadeesh K, Jamshidi A, Jiang R, Jung B, Kim T, Klausner R, Kurtzman K, Lee M, Lin W, Lipson J, Liu H, Liu Q, Lopatin M, Maddala T, Maher M, Melton C, Mich A, Nautiyal S, Newman J, Newman J, Nicula V, Nicolaou C, Nikolic O, Pan W, Patel S, Prins S, Rava R, Ronaghi N, Sakarya O, Satya R, Schellenberger J, Scott E, Sehnert A, Shaknovich R, Shanmugam A, Shashidhar K, Shen L, Shenoy A, Shojaee S, Singh P, Steffen K, Tang S, Toung J, Valouev A, Venn O, Williams R, Wu T, Xu H, Yakym C, Yang X, Yecies J, Yip A, Youngren J, Yue J, Zhang J, Zhang L, Zhang L, Zhang N, Advisors, Curtis C, Berry D. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Annals Of Oncology 2020, 31: 745-759. PMID: 33506766, PMCID: PMC8274402, DOI: 10.1016/j.annonc.2020.02.011.
- Qin Q, Patel V, Mellgard G, Parikh A, Wang B, Alerasool P, Garcia P, Jaladanki S, Leiter A, Carroll E, Brooks D, Shimol J, Eisenberg E, Gallagher E, Galsky M, Oh W, Tsao C. Type, timing, and risk factors associated with immune-related adverse event development in patients with advanced genitourinary cancers treated with immune checkpoint inhibitor. Journal Of Clinical Oncology 2020, 38: 480-480. DOI: 10.1200/jco.2020.38.6_suppl.480.
- Patel V, Qin Q, Mellgard G, Parikh A, Wang B, Alerasool P, Garcia P, Jaladanki S, Leiter A, Carroll E, Brooks D, Shimol J, Eisenberg E, Gallagher E, Galsky M, Oh W, Tsao C. Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors. Journal Of Clinical Oncology 2020, 38: 482-482. DOI: 10.1200/jco.2020.38.6_suppl.482.
- Parikh A, Martini A, Sfakianos J, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data. Journal Of Clinical Oncology 2020, 38: 75-75. DOI: 10.1200/jco.2020.38.6_suppl.75.
- PRINT: Prostate cancer intensive, non-cross reactive therapy for CRP—Early observations of efficacy.Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRP—Early observations of efficacy. Journal Of Clinical Oncology 2020, 38: 89-89. DOI: 10.1200/jco.2020.38.6_suppl.89.
- Lin J, Caress A, Ahmed F, Taylor N, Gong Y, Oh W. Elevated circulating CCL2 in prostate cancer patients. Journal Of Clinical Oncology 2020, 38: 201-201. DOI: 10.1200/jco.2020.38.6_suppl.201.
- Schweizer M, Gulati R, Brown L, McKay R, Dorff T, Kilari D, Vats P, Patel V, Oh W, Armstrong A, Montgomery R, Alva A. CDK12 -mutated prostate cancer (PC): Clinical outcomes to standard therapies and immune checkpoint blockade. Journal Of Clinical Oncology 2020, 38: 191-191. DOI: 10.1200/jco.2020.38.6_suppl.191.
- Gillessen S, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Chi K, Clarke N, Davis I, de Bono J, Drake C, Duran I, Eeles R, Efstathiou E, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano C, Hofman M, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli R, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Reiter R, Roach M, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Small E, Smith M, Soule H, Sternberg C, Steuber T, Suzuki H, Sweeney C, Sydes M, Taplin M, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology 2020, 77: 508-547. PMID: 32001144, DOI: 10.1016/j.eururo.2020.01.012.
- Mirza H, Varich L, Sensakovic W, Guruvadoo K, Royall I, Britt C, Vicenti R, Oh W. Tracheomegaly among Extremely Preterm Infants on Prolonged Mechanical Ventilation. The Journal Of Pediatrics 2019, 218: 231-233.e1. PMID: 31711760, DOI: 10.1016/j.jpeds.2019.10.024.
- Fei K, Lin J, Supoyo S, Franco R, Abramson S, Hoke G, Oh W, Stock R, Bickell N. Impact of Age and Life-expectancy on Treatment Receipt in High-risk Prostate Cancer. Journal Of Advances In Medicine And Medical Research 2019, 1-9. DOI: 10.9734/jammr/2019/v30i1130248.
- Mirza H, Garcia J, McKinley G, Hubbard L, Sensing W, Schneider J, Oh W, Wadhawan R. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. Journal Of Perinatology 2019, 39: 1648-1655. PMID: 31554913, DOI: 10.1038/s41372-019-0496-5.
- Mehrazin R, Oh W. Prostate Cancer. 2019, 23-31. DOI: 10.1002/9781119189596.ch2.
- Gong Y, Wang L, Yu H, Alpert N, Cohen M, Prophete C, Horton L, Sisco M, Park S, Lee H, Zelikoff J, Chen L, Hashim D, Suarez-Farinas M, Donovan M, Aaronson S, Galsky M, Zhu J, Taioli E, Oh W. Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade. Molecular Cancer Research 2019, 17: 1605-1612. PMID: 31221798, PMCID: PMC6684261, DOI: 10.1158/1541-7786.mcr-19-0115.
- Wang L, Gong Y, Saci A, Szabo P, Martini A, Necchi A, Siefker-Radtke A, Pal S, Plimack E, Sfakianos J, Bhardwaj N, Horowitz A, Farkas A, Mulholland D, Fischer B, Oh W, Sharma P, Zhu J, Galsky M. Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. European Urology 2019, 76: 599-603. PMID: 31272788, PMCID: PMC6801024, DOI: 10.1016/j.eururo.2019.06.025.
- Niglio S, Jia R, Ji J, Ruder S, Patel V, Martini A, Sfakianos J, Marqueen K, Waingankar N, Mehrazin R, Wiklund P, Oh W, Mazumdar M, Ferket B, Galsky M. Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis. European Urology 2019, 76: 782-789. PMID: 31200951, DOI: 10.1016/j.eururo.2019.05.037.
- Patel V, Oh W. The evolving landscape of immunotherapy in advanced prostate cancer. Immunotherapy 2019, 11: 903-912. PMID: 31161846, DOI: 10.2217/imt-2019-0019.
- Ma M, Zhou X, Goldsweig H, Hahner N, Han D, Dietz M, Jones S, Mullaney T, Redfern A, Jappe W, Liu Z, Yadav K, Zimmerman M, Prentice T, Pan Q, Hirsch F, Oh W, Schadt E, Li D, Chen R. Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC). Journal Of Clinical Oncology 2019, 37: e20642-e20642. DOI: 10.1200/jco.2019.37.15_suppl.e20642.
- Liu Z, Ma M, Grover K, Li L, Goldsweig H, Yadav K, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Pan Q, Oh W, Schadt E, Li D, Chen R. Investigating racial differences in treatment responses through analysis of real-world data (RWD). Journal Of Clinical Oncology 2019, 37: e18141-e18141. DOI: 10.1200/jco.2019.37.15_suppl.e18141.
- McCafferty J, Grover K, Li L, Li Z, Fink M, Goldsweig H, Ma M, Zhou X, Mullaney T, Redfern A, Jappe W, Zimmerman M, Prentice T, Pan Q, Oh W, Schadt E, Li D, Chen R. A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients. Journal Of Clinical Oncology 2019, 37: e18031-e18031. DOI: 10.1200/jco.2019.37.15_suppl.e18031.
- Chong* J, Muhleman M, Say R, Kostakoglu L, Ahmed J, Tewari A, Stock R, Oh W. MP13-01 PET/CT WITH 18 F-FLUCICLOVINE TO PREDICT RECURRENCE IN POST-TREATMENT PROSTATE CANCER AND ITS ROLE IN ALTERING TREATMENT PLANS. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555214.12968.a4.
- Bikkasani K, Qin Q, Lin J, Galsky M, Liaw B, Oh W, Tsao C. Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer. Journal Of Clinical Oncology 2019, 37: 184-184. DOI: 10.1200/jco.2019.37.7_suppl.184.
- Taplin M, Hussain A, Shah S, Shore N, Agrawal M, Clark W, Edenfield W, Nordquist L, Sartor O, Butrynski J, Chatta G, Fleming M, Oh W, Bradley B, Piel J, Nash D, Colak G, Li J, Lebedinsky C, Antonarakis E. ProSTAR: A phase Ib/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2019, 37: tps335-tps335. DOI: 10.1200/jco.2019.37.7_suppl.tps335.
- Lin J, Oh W, Liaw B, Galsky M, Tsao C. Evolving patterns of metastatic renal cell carcinoma: A meta-analysis. Journal Of Clinical Oncology 2019, 37: 563-563. DOI: 10.1200/jco.2019.37.7_suppl.563.
- Patel V, Oh W, Galsky M, Liaw B, Tsao C. Effect of concurrent beta-blocker (BB) use in patients receiving immune checkpoint inhibitors for metastatic urothelial (mUC) and renal cell carcinomas (mRCC). Journal Of Clinical Oncology 2019, 37: 467-467. DOI: 10.1200/jco.2019.37.7_suppl.467.
- Liaw B, Tsao C, Galsky M, Bakst R, Stewart R, Stock R, Oh W. PRINT: Prostate cancer intensive, non-cross reactive therapy for CRPC—Early observations of feasibility and efficacy. Journal Of Clinical Oncology 2019, 37: 310-310. DOI: 10.1200/jco.2019.37.7_suppl.310.
- Qin Q, Bikkasani K, Oh W, Liaw B, Galsky M, Tsao C. Patients with an extremely high prostate-specific antigen at prostate cancer diagnosis: A single institution analysis. Journal Of Clinical Oncology 2019, 37: 309-309. DOI: 10.1200/jco.2019.37.7_suppl.309.
- Chong J, Muhleman M, Say R, Kostakoglu L, Ahmed J, Tewari A, Stock R, Oh W. Positron emission tomography with 18F-fluciclovine to predict recurrence in post-treatment recurrent prostate cancer and its role in altering treatment plans. Journal Of Clinical Oncology 2019, 37: 214-214. DOI: 10.1200/jco.2019.37.7_suppl.214.
- Ahmed J, Muhleman M, Chong J, Tewari A, Oh W, Kostakoglu L, Stock R. Application of 18-F Fluciclovine PET/CT in Guiding Salvage Radiation Therapy for Recurrent Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e95-e96. DOI: 10.1016/j.ijrobp.2018.07.371.
- Phelps D, Watterberg K, Nolen T, Cole C, Cotten C, Oh W, Poindexter B, Zaterka-Baxter K, Das A, Lacy C, Scorsone A, Walsh M, Bell E, Kennedy K, Schibler K, Sokol G, Laughon M, Lakshminrusimha S, Truog W, Garg M, Carlo W, Laptook A, Van Meurs K, Carlton D, Graf A, DeMauro S, Brion L, Shankaran S, Orge F, Olson R, Mintz-Hittner H, Yang M, Haider K, Wallace D, Chung M, Hug D, Tsui I, Cogen M, Donahue J, Gaynon M, Hutchinson A, Bremer D, Quinn G, He Y, Lucas W, Winter T, Kicklighter S, Kumar K, Chess P, Colaizy T, Hibbs A, Ambalavanan N, Harmon H, McGowan E, Higgins R. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. JAMA 2018, 320: 1649-1658. PMID: 30357297, DOI: 10.1001/jama.2018.14996.
- Omidele O, Schiff H, Oh W, Tewari A. Multimodal therapy in the treatment of metastatic prostate cancer: A case report. Urology Case Reports 2018, 21: 92-94. PMID: 30258788, PMCID: PMC6154777, DOI: 10.1016/j.eucr.2018.09.010.
- Friedlander P, Wood K, Wassmann K, Christenfeld A, Bhardwaj N, Oh W. A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. Journal For ImmunoTherapy Of Cancer 2018, 6: 90. PMID: 30227886, PMCID: PMC6145108, DOI: 10.1186/s40425-018-0408-9.
- Oh W, Cheng W, Miao R, Vekeman F, Gauthier-Loiselle M, Duh M, Drea E, Szatrowski T. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting. Urologic Oncology Seminars And Original Investigations 2018, 36: 500.e1-500.e9. PMID: 30201382, DOI: 10.1016/j.urolonc.2018.08.002.
- Wang L, Saci A, Szabo P, Chasalow S, Castillo-Martin M, Domingo-Domenech J, Siefker-Radtke A, Sharma P, Sfakianos J, Gong Y, Dominguez-Andres A, Oh W, Mulholland D, Azrilevich A, Hu L, Cordon-Cardo C, Salmon H, Bhardwaj N, Zhu J, Galsky M. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications 2018, 9: 3503. PMID: 30158554, PMCID: PMC6115401, DOI: 10.1038/s41467-018-05992-x.
- Patel V, Liaw B, Oh W. The role of ketoconazole in current prostate cancer care. Nature Reviews Urology 2018, 15: 643-651. PMID: 30154429, DOI: 10.1038/s41585-018-0077-y.
- Lowrance W, Murad M, Oh W, Jarrard D, Resnick M, Cookson M. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018. Journal Of Urology 2018, 200: 1264-1272. PMID: 30086276, DOI: 10.1016/j.juro.2018.07.090.
- Resende Salgado L, Rhome R, Oh W, Stone N, Stock R. Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy. Brachytherapy 2018, 17: 874-881. PMID: 30061057, DOI: 10.1016/j.brachy.2018.07.008.
- Lee E, Collazo-Lorduy A, Castillo-Martin M, Gong Y, Wang L, Oh W, Galsky M, Cordon-Cardo C, Zhu J. Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR. Oncogene 2018, 37: 5858-5872. PMID: 29970902, PMCID: PMC6212417, DOI: 10.1038/s41388-018-0367-0.
- Hashim D, Boffetta P, Galsky M, Oh W, Lucchini R, Crane M, Luft B, Moline J, Udasin I, Harrison D, Taioli E. Prostate cancer characteristics in the World Trade Center cohort, 2002–2013. European Journal Of Cancer Prevention 2018, 27: 347-354. PMID: 27898584, PMCID: PMC5443704, DOI: 10.1097/cej.0000000000000315.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Effects of soybean lipid infusion on triglyceride and unbound free fatty acid levels in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2018, 32: 3226-3231. PMID: 29618229, PMCID: PMC6551293, DOI: 10.1080/14767058.2018.1461827.
- Chong J, Oh W, Liaw B. Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date. OncoTargets And Therapy 2018, 11: 2141-2147. PMID: 29695920, PMCID: PMC5905496, DOI: 10.2147/ott.s147168.
- McClinch K, Avelar R, Callejas D, Izadmehr S, Wiredja D, Perl A, Sangodkar J, Kastrinsky D, Schlatzer D, Cooper M, Kiselar J, Stachnik A, Yao S, Hoon D, McQuaid D, Zaware N, Gong Y, Brautigan D, Plymate S, Sprenger C, Oh W, Levine A, Kirschenbaum A, Sfakianos J, Sears R, DiFeo A, Ioannou Y, Ohlmeyer M, Narla G, Galsky M. Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer. Cancer Research 2018, 78: canres.0123.2017. PMID: 29358171, PMCID: PMC5899650, DOI: 10.1158/0008-5472.can-17-0123.
- Mirza H, Garcia J, Crawford E, Pepe J, Zussman M, Wadhawan R, Oh W. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia. The Journal Of Pediatrics 2018, 198: 187-193.e1. PMID: 29625730, DOI: 10.1016/j.jpeds.2018.02.034.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Unbound bilirubin measurements by a novel probe in preterm infants. The Journal Of Maternal-Fetal & Neonatal Medicine 2018, 32: 2721-2726. PMID: 29504491, PMCID: PMC6135709, DOI: 10.1080/14767058.2018.1448380.
- Levin R, Given R, Nemeth P, Bosch B, Chapas-Reed J, Oh W. Multicenter extension and switch study evaluating the safety of long-term treatment with abiraterone acetate fine particle formulation (AAFP) in patients with metastatic castration-resistant prostate cancer (mCRPC): The STAAR-E study. Journal Of Clinical Oncology 2018, 36: 181-181. DOI: 10.1200/jco.2018.36.6_suppl.181.
- Liaw B, Oh W. Prostate Cancer. 2018, 344-362. DOI: 10.1002/9781118592168.ch26.
- Tsao C, Oh W. First-Line Treatment of Hormone-Sensitive Metastatic Prostate Cancer: Is There a Single Standard of Care? Journal Of Clinical Oncology 2018, 36: jco.2017.77.431. PMID: 29432079, DOI: 10.1200/jco.2017.77.4315.
- Oh W, Przystac L, McKinley L, Tucker R, McGowan E, Vohr B. Association of intralipid intake in extremely low birthweight infants with neurodevelopmental outcomes. Acta Paediatrica 2018, 107: 600-604. PMID: 29274180, DOI: 10.1111/apa.14201.
- Azad A, Chang P, Devuni D, Bichoupan K, Kesar V, Branch A, Oh W, Galsky M, Ahmad J, Odin J. Real World Experience of Drug Induced Liver Injury in Patients Undergoing Chemotherapy. Journal Of Clinical Gastroenterology And Hepatology 2018, 2 PMID: 30637414, PMCID: PMC6327955, DOI: 10.21767/2575-7733.1000047.
- Rosenkrantz T, Sarkar S, Oh W. Polycythemia and Fetal-Maternal Bleeding. 2017, 431-442. DOI: 10.1017/9781316275498.029.
- Galsky M, Wang H, Hahn N, Twardowski P, Pal S, Albany C, Fleming M, Starodub A, Hauke R, Yu M, Zhao Q, Sonpavde G, Donovan M, Patel V, Sfakianos J, Domingo-Domenech J, Oh W, Akers N, Losic B, Gnjatic S, Schadt E, Chen R, Kim-Schulze S, Bhardwaj N, Uzilov A. Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. European Urology 2017, 73: 751-759. PMID: 29248319, DOI: 10.1016/j.eururo.2017.12.001.
- Bickell N, Lin J, Abramson S, Hoke G, Oh W, Hall S, Stock R, Fei K, McAlearney A. Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers. JCO Oncology Practice 2017, 14: jop.2017.025957. PMID: 29194001, PMCID: PMC5765902, DOI: 10.1200/jop.2017.025957.
- Lieberman-Cribbin W, Galsky M, Casey M, Liu B, Oh W, Flores R, Taioli E. Hospital Centralization Impacts High-Risk Lung and Bladder Cancer Surgical Patients. Cancer Investigation 2017, 35: 652-661. PMID: 29243986, DOI: 10.1080/07357907.2017.1406495.
- Galsky M, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Hu L, Tsao C, Sfakianos J, Mehrazin R, Waingankar N, Oh W, Mazumdar M, Ferket B. Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer. JCO Clinical Cancer Informatics 2017, 1: 1-12. PMID: 30657403, PMCID: PMC6874030, DOI: 10.1200/cci.17.00116.
- Galsky M, Shahin M, Jia R, Shaffer D, Gimpel-Tetra K, Tsao C, Baker C, Leiter A, Holland J, Sablinski T, Mehrazin R, Sfakianos J, Acon P, Oh W. Telemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate Cancer. JCO Clinical Cancer Informatics 2017, 1: 1-10. PMID: 30657386, DOI: 10.1200/cci.17.00044.
- Drudge-Coates L, Oh W, Tombal B, Delacruz A, Tomlinson B, Ripley A, Mastris K, O'Sullivan J, Shore N. Recognizing Symptom Burden in Advanced Prostate Cancer: A Global Patient and Caregiver Survey. Clinical Genitourinary Cancer 2017, 16: e411-e419. PMID: 29111175, DOI: 10.1016/j.clgc.2017.09.015.
- Galsky M, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Ramireddy K, Hu L, Tsao C, Sfakianos J, Mehrazin R, Hassanzadeh N, Waingankar N, Oh W, Kohli A, Otobo E, Mazumdar M, Ferket B. A Web-Based Tool to Facilitate Shared Decision-Making Regarding Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer. Iproceedings 2017, 3: e43. DOI: 10.2196/iproc.8456.
- Friedlander P, Wassmann K, Christenfeld A, Fisher D, Kyi C, Kirkwood J, Bhardwaj N, Oh W. Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab. Journal For ImmunoTherapy Of Cancer 2017, 5: 67. PMID: 28807052, PMCID: PMC5557000, DOI: 10.1186/s40425-017-0272-z.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Dhawan R, Duh M. Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting. Medical Oncology 2017, 34: 160. PMID: 28795333, PMCID: PMC5550521, DOI: 10.1007/s12032-017-1014-2.
- Gillessen S, Attard G, Beer T, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung B, Clarke N, Daugaard G, Davis I, de Bono J, dos Reis R, Drake C, Eeles R, Efstathiou E, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano C, James N, Kantoff P, Kellokumpu-Lehtinen P, Khauli R, Kramer G, Logothetis C, Maluf F, Morgans A, Morris M, Mottet N, Murthy V, Oh W, Ost P, Padhani A, Parker C, Pritchard C, Roach M, Rubin M, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg C, Suzuki H, Sweeney C, Sydes M, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European Urology 2017, 73: 178-211. PMID: 28655541, DOI: 10.1016/j.eururo.2017.06.002.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Dhawan R, Duh M. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting. Clinical Genitourinary Cancer 2017, 16: 50-57. PMID: 28729067, DOI: 10.1016/j.clgc.2017.06.004.
- Pomerantz M, Spisák S, Jia L, Cronin A, Csabai I, Ledet E, Sartor A, Rainville I, O'Connor E, Herbert Z, Szállási Z, Oh W, Kantoff P, Garber J, Schrag D, Kibel A, Freedman M. The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer. Cancer 2017, 123: 3532-3539. PMID: 28608931, PMCID: PMC5802871, DOI: 10.1002/cncr.30808.
- Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed ExtubationChawla S, Natarajan G, Shankaran S, Carper B, Brion L, Keszler M, Carlo W, Ambalavanan N, Gantz M, Das A, Finer N, Goldberg R, Cotten C, Higgins R, Network E, Jobe A, Caplan M, Polin R, Laptook R, Oh W, Hensman A, Gingras D, Barnett S, Lillie S, Francis K, Andrews D, Angela K, Walsh M, Fanaroff A, Newman N, Siner B, Schibler K, Donovan E, Narendran V, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Goldberg R, Auten K, Fisher K, Foy K, Siaw G, Stoll B, Buchter S, Piazza A, Carlton D, Hale E, Archer S, Poindexter B, Lemons J, Hamer F, Herron D, Miller L, Wilson L, Berberich M, Blaisdell C, Gail D, Kiley J, Poole W, Cunningham M, Hastings B, Irene A, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Ball M, Proud M, Frantz I, Fiascone J, Furey A, MacKinnon B, Nylen E, Collins M, Cosby S, Phillips V, Rasmussen M, Wozniak P, Rich W, Arnell K, Bridge R, Demetrio C, Bell E, Widness J, Klein J, Johnson K, Duara S, Everett-Thomas R, Watterberg K, Ohls R, Rohr J, Lacy C, Phelps D, Laroia N, Reubens L, Burnell E, Sánchez P, Rosenfeld C, Salhab W, Allen J, Guzman A, Hensley G, Lepps M, Martin M, Miller N, Solis A, Vasil D, Wilder K, Kennedy K, Tyson J, Morris B, Harris B, Lis A, Martin S, McDavid G, Tate P, Wright S, Yoder B, Faix R, Burnett J, Jensen J, Osborne K, Spencer C, Weaver-Lewis K, O'Shea T, Peters N, Sood B, Bara R, Billian E, Johnson M, Ehrenkranz R, Jacobs H, Bhandari V, Cervone P, Gettner P, Konstantino M, Poulsen J, Taft J. Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation. The Journal Of Pediatrics 2017, 189: 113-119.e2. PMID: 28600154, PMCID: PMC5657557, DOI: 10.1016/j.jpeds.2017.04.050.
- Kyi C, Sabado R, Blazquez A, Posner M, Genden E, Miles B, Khorasani H, Dottino P, Irie H, Port E, Wolf A, Cho H, Parekh S, Mandeli J, Galsky M, Oh W, Gnjatic S, Schadt E, Friedlander P, Bhardwaj N. A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers. Journal Of Clinical Oncology 2017, 35: tps3114-tps3114. DOI: 10.1200/jco.2017.35.15_suppl.tps3114.
- Di Fiore J, Martin R, Li H, Morris N, Carlo W, Finer N, Walsh M, Health A, Jobe A, Caplan M, Polin R, Laptook R, Oh W, Hensman A, Gingras D, Barnett S, Lillie S, Francis K, Andrews D, Angela K, Fanaroff A, Newman N, Siner B, Zadell A, Schibler K, Donovan E, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Goldberg R, Cotten C, Wallace D, Freedman S, Auten K, Fisher K, Foy K, Stoll B, Piazza A, Buchter S, Carlton D, Hutchinson A, Hale E, Higgins R, Archer S, Poindexter B, Lemons J, Hamer F, Herron D, Miller L, Wilson L, Berberich M, Blaisdell C, Gail D, Kiley J, Gantz M, Das A, Crawford M, Hastings B, Irene A, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Ball M, Proud M, Frantz I, Fiascone J, Furey A, MacKinnon B, Nylen E, Ambalavanan N, Collins M, Cosby S, Phillips V, Rasmussen M, Wozniak P, Rich W, Arnell K, Bridge R, Demetrio C, Bell E, Widness J, Klein J, Johnson K, Duara S, Everett-Thomas R, Watterberg K, Ohls R, Rohr J, Lacy C, Phelps D, Laroia N, Markowitz G, Reubens L, Burnell E, Sánchez P, Rosenfeld C, Salhab W, Allen J, Grau L, Guzman A, Hensley G, Lepps M, Martin M, Miller N, Solis A, Vasil D, Wilder K, Kennedy K, Tyson J, Morris B, Harris B, Lis A, Martin S, McDavid G, Tate P, Wright S, Yoder B, Faix R, Burnett J, Jensen J, Osborne K, Spencer C, Weaver-Lewis K, O'Shea T, Peters N, Shankaran S, Sood B, Bara R, Billian E, Johnson M, Ehrenkranz R, Narendran V, Bhandari V, Jacobs H, Cervone P, Gettner P, Konstantino M, Poulsen J, Taft J. Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. The Journal Of Pediatrics 2017, 186: 49-56.e1. PMID: 28279433, PMCID: PMC5484739, DOI: 10.1016/j.jpeds.2017.01.057.
- Friedlander P, Wassman K, Kyi C, Oh W, Bhardwaj N. Correlation of consistent blood-based gene expression with change in CTLA4 in two large independent clinical studies of patients with advanced melanoma treated with tremelimumab. Journal Of Clinical Oncology 2017, 35: 6-6. DOI: 10.1200/jco.2017.35.7_suppl.6.
- Oh W, Kandadi H, Sheikh N, Galsky M. Blood-based predictive biomarkers for overall survival (OS) in patients (pts) receiving the immunotherapy sipuleucel-T (sip-T). Journal Of Clinical Oncology 2017, 35: 36-36. DOI: 10.1200/jco.2017.35.7_suppl.36.
- Galsky M, Shahin M, Olson A, Shaffer D, Gimpel-Tetra K, Tsao C, Baker C, Leiter A, Holland J, Sablinski T, Mehrazin R, Sfakianos J, Acon P, Oh W. Telemedicine-enabled clinical trial of metformin in patients (pts) with biochemically-recurrent prostate cancer (PCa). Journal Of Clinical Oncology 2017, 35: 243-243. DOI: 10.1200/jco.2017.35.6_suppl.243.
- Oh W, Cheng W, Miao R, Vekeman F, Gauthier-Loiselle M, Duh M, Drea E, Szatrowski T. Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices. Journal Of Clinical Oncology 2017, 35: 214-214. DOI: 10.1200/jco.2017.35.6_suppl.214.
- Tsao C, Liaw B, He C, Galsky M, Sfakianos J, Oh W. Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications. Therapeutic Advances In Medical Oncology 2017, 9: 287-298. PMID: 28491148, PMCID: PMC5405995, DOI: 10.1177/1758834016687261.
- Hegyi T, Kleinfeld A, Huber A, Weinberger B, Memon N, Shih W, Carayannopoulos M, Oh W. Effects of Soybean Lipid Infusion on Unbound Free Fatty Acids and Unbound Bilirubin in Preterm Infants. The Journal Of Pediatrics 2017, 184: 45-50.e1. PMID: 28108102, PMCID: PMC5403563, DOI: 10.1016/j.jpeds.2016.12.026.
- McNeel DG, Bander NH, Beer TM, Drake CG, Fong L, Harrelson S, Kantoff PW, Madan RA, Oh WK, Peace DJ, Petrylak DP, Porterfield H, Sartor O, Shore ND, Slovin SF, Stein MN, Vieweg J, Gulley JL. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. Journal For ImmunoTherapy Of Cancer 2016, 4: 92. PMID: 28031820, PMCID: PMC5170901, DOI: 10.1186/s40425-016-0198-x.
- Roubaud G, Liaw B, Oh W, Mulholland D. Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer. Nature Reviews Clinical Oncology 2016, 14: 269-283. PMID: 27874061, PMCID: PMC5567685, DOI: 10.1038/nrclinonc.2016.181.
- Tsao C, Sfakianos J, Liaw B, Gimpel‐Tetra K, Kemeny M, Bulone L, Shahin M, Oh W, Galsky M. Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer. The Oncologist 2016, 21: 1414-e9. PMID: 27742908, PMCID: PMC5153336, DOI: 10.1634/theoncologist.2016-0026.
- Stock R, Sfakianos J, Oh W, Stone N. Prostate-Specific Antigen Doubling Time Posttreatment Is the Most Significant Predictor of Survival Following the Brachytherapy Management of Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e236. DOI: 10.1016/j.ijrobp.2016.06.1216.
- Gong Y, Wang L, Chippada-Venkata U, Dai X, Oh W, Zhu J. Constructing bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression. Oncotarget 2016, 7: 68688-68707. PMID: 27626693, PMCID: PMC5356583, DOI: 10.18632/oncotarget.11925.
- Wang L, Oh W, Zhu J. Disease-specific classification using deconvoluted whole blood gene expression. Scientific Reports 2016, 6: 32976. PMID: 27596246, PMCID: PMC5011717, DOI: 10.1038/srep32976.
- Casey M, Wisnivesky J, Le V, Sarpel U, Stensland K, Oh W, Galsky M. The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer. Bladder Cancer 2016, 2: 319-327. PMID: 27500199, PMCID: PMC4969695, DOI: 10.3233/blc-160058.
- Tsao C, Galsky M, Oh W. Docetaxel for Metastatic Hormone-sensitive Prostate Cancer: Urgent Need to Minimize the Risk of Neutropenic Fever. European Urology 2016, 70: 707-708. PMID: 27417033, DOI: 10.1016/j.eururo.2016.06.041.
- Galsky M, Stensland K, Sfakianos J, Mehrazin R, Diefenbach M, Mohamed N, Tsao C, Boffetta P, Wiklund P, Oh W, Mazumdar M, Ferket B. Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement. Journal Of Clinical Oncology 2016, 34: 2627-2635. PMID: 27269939, PMCID: PMC5012691, DOI: 10.1200/jco.2016.67.5033.
- Patel V, McBride R, Lorduy A, Castillo-Martin M, Cha E, Berger M, Wang L, Oh W, Zhu J, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Prognostic significance of PIK3CA mutation in patients with muscle-invasive urothelial carcinoma (UC). Journal Of Clinical Oncology 2016, 34: e16002-e16002. DOI: 10.1200/jco.2016.34.15_suppl.e16002.
- Oh W, Kandadi H, Fan L, Sheikh N, Trager J, Galsky M. Blood-based predictive biomarkers for overall survival (OS) in patients (pts) receiving the immunotherapy sipuleucel-T (sip-T). Journal Of Clinical Oncology 2016, 34: 5026-5026. DOI: 10.1200/jco.2016.34.15_suppl.5026.
- McBride R, Patel V, Lorduy A, Castillo-Martin M, Cha E, Berger M, Wang L, Oh W, Zhu J, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Prognostic significance of DNA damage repair (DDR) mutations in patients with urothelial carcinoma (UC) and associations with tumor infiltrating lymphocytes (TILs). Journal Of Clinical Oncology 2016, 34: 4538-4538. DOI: 10.1200/jco.2016.34.15_suppl.4538.
- Galsky M, Stensland K, Sfakianos J, Mehrazin R, Diefenbach M, Tsao C, Boffetta P, Oh W, Mazumdar M, Ferket B. Comparative effectiveness of treatment strategies for urothelial cancer of the bladder (UCB) with clinical lymph node involvement (cN+). Journal Of Clinical Oncology 2016, 34: 4530-4530. DOI: 10.1200/jco.2016.34.15_suppl.4530.
- Oh W, Tombal B, Delacruz A, Tomlinson B, Vella Ripley A, Drudge-Coates L, Mastris K, O'Sullivan J, Shore N. Recognizing symptom burden in advanced prostate cancer: A global patient and caregiver survey. Journal Of Clinical Oncology 2016, 34: 10124-10124. DOI: 10.1200/jco.2016.34.15_suppl.10124.
- Heck M, Thalgott M, Schmid S, Oh W, Gong Y, Wang L, Zhu J, Seitz A, Porst D, Höppner M, Retz M, Gschwend J, Nawroth R. A 2‐Gene Panel Derived From Prostate Cancer‐Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration‐Resistant Prostate Cancer. The Prostate 2016, 76: 1160-1168. PMID: 27198487, DOI: 10.1002/pros.23202.
- Collazo-Lorduy A, Castillo-Martin M, Wang L, Patel V, Iyer G, Jordan E, Al-Ahmadie H, Leonard I, Oh W, Zhu J, McBride R, Cordon-Cardo C, Solit D, Sfakianos J, Galsky M. Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition. European Urology 2016, 70: 771-775. PMID: 27178450, PMCID: PMC5489411, DOI: 10.1016/j.eururo.2016.04.037.
- Oh W, Miao R, Duh, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Fortier J, Dhawan R. PCN33 Treatment Sequences, Patient Characteristics, And Overall Survival Of Patients With Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer In The Community Setting. Value In Health 2016, 19: a139. DOI: 10.1016/j.jval.2016.03.1655.
- Colaizy T, Bartick M, Jegier B, Green B, Reinhold A, Schaefer A, Bogen D, Schwarz E, Stuebe A, Jobe A, Oh W, Vohr B, Walden R, Alksninis B, Hensman A, Leonard M, Noel L, Leach T, Watson V, Fanaroff A, Walsh M, Wilson-Costello D, Newman N, Siner B, Friedman H, Donovan E, Schibler K, Steichen J, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Gratton T, Stoll B, Adams-Chapman I, Hale E, LaRossa M, Carter S, Higgins R, Wright L, McClure E, Poindexter B, Lemons J, Dusick A, Kardatzke D, Lytle C, Appel D, Bohnke L, Eaken G, Herron D, Miller L, Richard L, Wilson L, Das A, Poole W, Wrage L, Hastings B, McClure E, Auman J, Taylor S, Stevenson D, Hintz S, Ball M, Kohn J, Baran J, Lee-Ancajas J, St. John N, Carlo W, Ambalavanan N, Nelson K, Peralta-Carcelen M, Bailey K, Biasini F, Chopko S, Collins M, Cosby S, Phillips V, Rector R, Finer N, Vaucher Y, Anderson J, Rasmussen M, Arnell K, Demetrio C, Fuller M, Henderson C, Posin D, Bell E, Colaizy T, Bauer C, Duara S, Worth A, Everett-Thomas R, Diaz A, Mathews E, Hamlin-Smith K, Jean-Gilles L, Calejo M, Frade S, Hiriart-Fajardo S, Gideon Y, Korones S, Bada H, Hudson T, Yolton K, Williams M, Laptook R, Salhab W, Broyles R, Madison S, Hickman J, Guzman A, Adams S, Madden L, Heyne E, Dooley C, Shankaran S, Delaney-Black V, Johnson Y, Bara R, Muran G, Kennedy D, Goldston L, Ehrenkranz R, Gettner P, Konstantino M, Romano E, Close N, Gilliam W, Poulsen J. Impact of Optimized Breastfeeding on the Costs of Necrotizing Enterocolitis in Extremely Low Birthweight Infants. The Journal Of Pediatrics 2016, 175: 100-105.e2. PMID: 27131403, PMCID: PMC5274635, DOI: 10.1016/j.jpeds.2016.03.040.
- Shevach J, Marcellino B, Oh W, Tsao C. Enzalutamide in Metastatic Castration Resistant Prostate Cancer. 2016, 157-169. DOI: 10.1007/978-3-319-31341-2_10.
- D'Angio CT, Ambalavanan N, Carlo WA, McDonald SA, Skogstrand K, Hougaard DM, Shankaran S, Goldberg RN, Ehrenkranz RA, Tyson JE, Stoll BJ, Das A, Higgins RD, Das A, McDonald S, Jobe A, Laptook R, Oh W, Rubin L, Hensman A, Fanaroff A, Walsh M, Newman N, Siner B, Donovan E, Narendran V, Alexander B, Grisby C, Hessling J, Mersmann M, Mincey H, Cotten C, Auten K, Hale E, Wright L, Yaffe S, McClure E, Poindexter B, Lemons J, Appel D, Herron D, Wilson L, Poole W, Hastings B, Zaterka-Baxter K, Auman J, Schaefer S, Stevenson D, Van Meurs K, Ball M, Skogstrand K, Hougaard D, Collins M, Cosby S, Finer N, Rasmussen M, Kaegi D, Arnell K, Demetrio C, Rich W, Bauer C, Duara S, Everett-Thomas R, Papile L, Lacy C, Korones S, Bada H, Hudson T, Laptook R, Salhab W, Madison S, Kennedy K, Morris B, Akpa E, Cluff P, Franco C, Lis A, McDavid G, Tate P, O'Shea T, Peters N, Konduri G, Bara R, Muran G, Gettner P, Konstantino M, Poulsen J. Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2016, 174: 45-51.e5. PMID: 27117196, PMCID: PMC4925295, DOI: 10.1016/j.jpeds.2016.03.058.
- Leiter A, Doucette J, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh W, Galsky M. Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma. Bladder Cancer 2016, 2: 341-349. PMID: 27500201, PMCID: PMC4969712, DOI: 10.3233/blc-160047.
- Phelps DL, Ward RM, Williams RL, Nolen TL, Watterberg KL, Oh W, Goedecke M, Ehrenkranz RA, Fennell T, Poindexter BB, Cotten CM, Hallman M, Frantz ID, Faix RG, Zaterka-Baxter KM, Das A, Ball MB, Lacy CB, Walsh MC, Carlo WA, Sánchez PJ, Bell EF, Shankaran S, Carlton DP, Chess PR, Higgins RD. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatric Research 2016, 80: 209-217. PMID: 27074126, PMCID: PMC5198845, DOI: 10.1038/pr.2016.97.
- Kesar V, Devuni D, Azad A, Bichoupan K, Branch A, Oh W, Galsky M, Ahmad J, Odin J. 357 The Clinical Spectrum of Liver Injury in Cancer Patients. Gastroenterology 2016, 150: s1029. DOI: 10.1016/s0016-5085(16)33482-5.
- Heck M, Thalgott M, Schmid S, Oh W, Gong Y, Wang L, Zhu J, Seitz A, Porst D, Höppner M, Retz M, Gschwend J, Nawroth R. 1072 A 2-gene panel derived from prostate cancer-enhanced transcripts in whole blood is prognostic for survival and predicts treatment benefit in metastatic castration-resistant prostate cancer. European Urology Open Science 2016, 15: e1072. DOI: 10.1016/s1569-9056(16)61073-4.
- Kim S, Isola L, Oh W. Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion. Anti-Cancer Drugs 2016, 27: 235-238. PMID: 26628483, DOI: 10.1097/cad.0000000000000321.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Boffetta P, Oh W, Mazumdar M, Wisnivesky J. Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer. Journal Of Clinical Oncology 2016, 34: 825-832. PMID: 26786930, DOI: 10.1200/jco.2015.64.1076.
- Galsky M, Stensland K, Sfakianos J, McBride R, Mehrazin R, Tsao C, Boffetta P, Oh W. Frequency and clinical implications of pathologic complete response (pCR) at cystectomy for muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy (NAC). Journal Of Clinical Oncology 2016, 34: 383-383. DOI: 10.1200/jco.2016.34.2_suppl.383.
- Galsky M, Hahn N, Albany C, Fleming M, Starodub A, Twardowski P, Pal S, Hauke R, Sonpavde G, Oh W, Bhardwaj N, Gnjatic S, Kim-Schulze S, Liu Z. Phase II trial of gemcitabine + cisplatin + ipilimumab in patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2016, 34: 357-357. DOI: 10.1200/jco.2016.34.2_suppl.357.
- Mirza H, Laptook R, Oh W, Vohr B, Stoll B, Kandefer S, Stonestreet B, Network A. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants. Archives Of Disease In Childhood Fetal & Neonatal 2016, 101: f418. PMID: 26733540, PMCID: PMC4935651, DOI: 10.1136/archdischild-2015-309112.
- Galsky M, Noah H, Starodub A, Hauke R, Twardowski P, Fleming M, Qi J, Sonpavde G, Patel M, Zhu J, Chippada-Venkata U, Albany C, Wang L, Merad M, Oh W, Bhardwaj N, Gnjatic S, Kim-Schulze S. Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer. Journal For ImmunoTherapy Of Cancer 2015, 3: p257. PMCID: PMC4649313, DOI: 10.1186/2051-1426-3-s2-p257.
- Mercer J, Erickson-Owens D, Vohr B, Tucker R, Parker A, Oh W, Padbury J. Effects of Placental Transfusion on Neonatal and 18 Month Outcomes in Preterm Infants: A Randomized Controlled Trial. The Journal Of Pediatrics 2015, 168: 50-55.e1. PMID: 26547399, PMCID: PMC4698069, DOI: 10.1016/j.jpeds.2015.09.068.
- Beer T, Vogelzang N, Bartůňková J, Miller K, Oh W, Oudard S, Pandha H, Sartor A, Špíšek R, Toole T, Borgstein N, Gerritsen W. Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer. Journal For ImmunoTherapy Of Cancer 2015, 3: p164. PMCID: PMC4646109, DOI: 10.1186/2051-1426-3-s2-p164.
- Williams E, Rodriguez-Bravo V, Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh W, Cordon-Cardo C, Domingo-Domenech J. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Journal Of Visualized Experiments 2015, 53182. PMID: 26555435, PMCID: PMC4692658, DOI: 10.3791/53182.
- Williams E, Rodriguez-Bravo V, Chippada-Venkata U, De Ia Iglesia-Vicente J, Gong Y, Galsky M, Oh W, Cordon-Cardo C, Domingo-Domenech J. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells. Journal Of Visualized Experiments 2015 DOI: 10.3791/53182-v.
- Gartrell B, Small A, Oh W, Galsky M. Renal Cell Carcinoma and Targeted Therapy. 2015, 287-295. DOI: 10.1002/9781118468678.ch29.
- Galsky M, Hahn N, Wong B, Lee K, Argiriadi P, Albany C, Gimpel-Tetra K, Lowe N, Shahin M, Patel V, Tsao C, Oh W. Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma. Cancer Chemotherapy And Pharmacology 2015, 76: 1259-1265. PMID: 26464352, DOI: 10.1007/s00280-015-2884-7.
- Oh W, Miao R, Vekeman F, Sung J, Cheng W, Gauthier-Loiselle M, Fortier J, Dhawan R, Hennessy D, Duh M. 2512 Is there a difference in outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) who receive chemotherapy (CT) vs androgen receptor-targeted therapy (ART) after 1st-line ART in the community setting? European Journal Of Cancer 2015, 51: s478. DOI: 10.1016/s0959-8049(16)31332-6.
- Wang L, Gong Y, Chippada-Venkata U, Heck M, Retz M, Nawroth R, Galsky M, Tsao C, Schadt E, de Bono J, Olmos D, Zhu J, Oh W. A robust blood gene expression-based prognostic model for castration-resistant prostate cancer. BMC Medicine 2015, 13: 201. PMID: 26297150, PMCID: PMC4546313, DOI: 10.1186/s12916-015-0442-0.
- Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky M, Oh W. Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer. Frontiers In Oncology 2015, 5: 129. PMID: 26125012, PMCID: PMC4467174, DOI: 10.3389/fonc.2015.00129.
- Gillessen S, Omlin A, Attard G, de Bono J, Efstathiou E, Fizazi K, Halabi S, Nelson P, Sartor O, Smith M, Soule H, Akaza H, Beer T, Beltran H, Chinnaiyan A, Daugaard G, Davis I, De Santis M, Drake C, Eeles R, Fanti S, Gleave M, Heidenreich A, Hussain M, James N, Lecouvet F, Logothetis C, Mastris K, Nilsson S, Oh W, Olmos D, Padhani A, Parker C, Rubin M, Schalken J, Scher H, Sella A, Shore N, Small E, Sternberg C, Suzuki H, Sweeney C, Tannock I, Tombal B. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals Of Oncology 2015, 26: 1589-1604. PMID: 26041764, PMCID: PMC4511225, DOI: 10.1093/annonc/mdv257.
- Vogelzang N, Beer T, Bartunkova J, Kuklík R, Miller K, Oh W, Oudard S, Pandha H, Sartor A, Spisek R, Borgstein N, Gerritsen W. Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer. Journal Of Clinical Oncology 2015, 33: tps5070-tps5070. DOI: 10.1200/jco.2015.33.15_suppl.tps5070.
- Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky M, Oh W. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. Journal Of Clinical Oncology 2015, 33: e16036-e16036. DOI: 10.1200/jco.2015.33.15_suppl.e16036.
- Oh W, Miao R, Duh M, Vekeman F, Sung J, Cheng W, Hennessy D, Gauthier-Loiselle M, Fortier J, Dhawan R. Clinical features and overall survival (OS) in patients (pts) with post-docetaxel (DTX) metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) therapy in the community setting. Journal Of Clinical Oncology 2015, 33: e16029-e16029. DOI: 10.1200/jco.2015.33.15_suppl.e16029.
- Liaw B, Chippada-Venkata U, Gong Y, Wang L, Zhu J, Heck M, Tsao C, Galsky M, Oh W. Influence of prostate cancer disease state and therapeutic selection on peripheral whole-blood RNA signature. Journal Of Clinical Oncology 2015, 33: 5046-5046. DOI: 10.1200/jco.2015.33.15_suppl.5046.
- Galsky M, Hahn N, Albany C, Fleming M, Starodub A, Twardowski P, Hauke R, Sonpavde G, Merad M, Gnjatic S, Bhardwaj N, Chippada-Venkata U, Oh W, Kim-Schulze S. Impact of gemcitabine + cisplatin + ipilimumab on circulating immune cells in patients (pts) with metastatic urothelial cancer (mUC). Journal Of Clinical Oncology 2015, 33: 4586-4586. DOI: 10.1200/jco.2015.33.15_suppl.4586.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Hall S, Boffetta P, Oh W, Wisnivesky J. Effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa). Journal Of Clinical Oncology 2015, 33: 4517-4517. DOI: 10.1200/jco.2015.33.15_suppl.4517.
- Liaw B, Oh W. Is docetaxel the 'black widow' of mCRPC drugs? Nature Reviews Clinical Oncology 2015, 12: 316-318. PMID: 25917253, DOI: 10.1038/nrclinonc.2015.79.
- Leiter A, Doucette J, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh W, Galsky M. Impact of obesity in patients with metastatic urothelial carcinoma. Journal Of Clinical Oncology 2015, 33: 346-346. DOI: 10.1200/jco.2015.33.7_suppl.346.
- Galsky M, Stensland K, Moshier E, Sfakianos J, McBride R, Tsao C, Casey M, Hall S, Boffetta P, Oh W, Wisnivesky J. Comparative effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa). Journal Of Clinical Oncology 2015, 33: 292-292. DOI: 10.1200/jco.2015.33.7_suppl.292.
- Liaw B, Chippada-Venkata U, Gong Y, Wang L, Zhu J, Heck M, Tsao C, Galsky M, Oh W. Influence of prostate cancer disease state and therapeutic selection on peripheral whole-blood RNA signature. Journal Of Clinical Oncology 2015, 33: 166-166. DOI: 10.1200/jco.2015.33.7_suppl.166.
- Liaw B, Shevach J, Oh W. Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy. Current Urology Reports 2015, 16: 13. PMID: 25677235, DOI: 10.1007/s11934-015-0486-x.
- Leiter A, Diefenbach M, Doucette J, Oh W, Galsky M. Clinical trial awareness: Changes over time and sociodemographic disparities. Clinical Trials 2015, 12: 215-223. PMID: 25673636, PMCID: PMC4667750, DOI: 10.1177/1740774515571917.
- Galsky M, Stensland K, McBride R, Latif A, Moshier E, Oh W, Wisnivesky J. Geographic Accessibility to Clinical Trials for Advanced Cancer in the United States. JAMA Internal Medicine 2015, 175: 293-295. PMID: 25437434, DOI: 10.1001/jamainternmed.2014.6300.
- Tsao C, Gray K, Nakabayashi M, Evan C, Kantoff P, Huang J, Galsky M, Pomerantz M, Oh W. Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease. Journal Of Urology 2015, 194: 91-97. PMID: 25623747, DOI: 10.1016/j.juro.2015.01.078.
- Casey M, Gross T, Wisnivesky J, Stensland K, Oh W, Galsky M. The Impact of Regionalization of Cystectomy on Racial Disparities in Bladder Cancer Care. Journal Of Urology 2015, 194: 36-41. PMID: 25623748, DOI: 10.1016/j.juro.2015.01.076.
- Gong Y, Chippada‐Venkata U, Galsky M, Huang J, Oh W. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer. The Prostate 2015, 75: 616-627. PMID: 25560638, DOI: 10.1002/pros.22945.
- Petrylak DP, Gandhi JG, Clark WR, Heath E, Lin J, Oh WK, Agus DB, Carthon B, Moran S, Kong N, Suri A, Bargfrede M, Liu G. Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel–prednisone in metastatic castration-resistant prostate cancer. Investigational New Drugs 2015, 33: 397-408. PMID: 25556680, PMCID: PMC4390470, DOI: 10.1007/s10637-014-0199-x.
- Tsao C, Liaw B, Oh W, Galsky M. Muscle invasive bladder cancer: closing the gap between practice and evidence. Minerva Urologica E Nefrologica 2014, 67: 65-73. PMID: 25424386.
- Ambalavanan N, Carlo W, Wrage L, Das A, Laughon M, Cotten C, Kennedy K, Laptook R, Shankaran S, Walsh M, Higgins R, Jobe A, Caplan M, Oh W, Vohr B, Hensman A, Stephens B, Alksninis B, Barnett S, Cashore W, Caskey M, Gargus R, Gingras D, Johnson K, Lainwala S, Leach T, Leonard M, Lillie S, Moore J, Noel L, Walden R, Watson V, Fanaroff A, Wilson-Costello D, Newman N, Siner B, Zadell A, Di Fiore J, Bhola M, Friedman H, Yalcinkaya G, Schibler K, Donovan E, Yolton K, Bridges K, Alexander B, Grisby C, Mersmann M, Mincey H, Hessling J, Gratton T, Goldberg R, Goldstein R, Ashley P, Auten K, Fisher K, Foy K, Freedman S, Gustafson K, Lohmeyer M, Malcolm W, Wallace D, Stoll B, Buchter S, Piazza A, Carlton D, Adams-Chapman I, Carter S, Hale E, Hutchinson A, LaRossa M, Archer S, Poindexter B, Dusick A, Lemons J, Wilson L, Hamer F, Cook A, Herron D, Lytle C, Minnich H, Poole W, Gantz M, Newman J, Hastings B, Auman J, Huitema C, Pickett J, Wallace D, Zaterka-Baxter K, Van Meurs K, Stevenson D, Hintz S, Ball M, Bentley B, Bruno E, Davis A, DeAnda M, DeBattista A, Kohn J, Proud M, Pyle R, St John N, Weiss H, Frantz I, Fiascone J, McGowan E, Furey A, MacKinnon B, Nylen E, Brussa A, Sibley C, Peralta-Carcelen M, Collins M, Cosby S, Phillips V, Bailey K, Biasini F, Johnston K, Krzywanski S, Nelson K, Patterson C, Rector R, Rodrigues L, Soong A, Whitley S, Finer N, Rasmussen M, Wozniak P, Vaucher Y, Rich W, Arnell K, Bridge R, Demetrio C, Fuller M, Zlotnik P, Bell E, Widness J, Klein J, Acarregui M, Colaizy T, Johnson K, Eastman D, Duara S, Bauer C, Everett-Thomas R, Calejo M, Diaz A, Eguaras S, Garcia A, Hamlin-Smith K, Berkowits M, Fajardo-Hiriart S, Mathews E, Pierre H, Riguard A, Stroerger A, Watterberg K, Ohls R, Fuller J, Lacy C, Lowe J, Montman R, Phelps D, Myers G, Markowitz G, Reubens L, Hust D, Johnson J, Burnell E, Jensen R, Kushner E, Merzbach J, Yost K, Sánchez P, Rosenfeld C, Salhab W, Heyne R, Brion L, Adams S, Allen J, Grau L, Guzman A, Hensley G, Heyne E, Leps M, Madden L, Martin M, Miller N, Morgan J, Solis A, Torres L, Boatman C, Vasil D, Tyson J, Alaniz N, Evans P, Harris B, Green C, Jiminez M, Lis A, Martin S, McDavid G, Morris B, Poundstone M, Reddoch S, Siddiki S, Tate P, Whitely L, Wright S, Faix R, Yoder B, Baker S, Bird K, Burnett J, Osborne K, Spencer C, Steffen M, Weaver-Lewis K, O'Shea T, Dillard R, Washburn L, Peters N, Jackson B, Chiu K, Allred D, Goldstein D, Halfond R, Peterson C, Waldrep E, Welch C, Morris M, Hounshell G, Sood B, Pappas A, Bara R, Goldston L, Johnson M, Ehrenkranz R, Bhandari V, Williams J. PaCO2 in Surfactant, Positive Pressure, and Oxygenation Randomised Trial (SUPPORT). Archives Of Disease In Childhood Fetal & Neonatal 2014, 100: f145. PMID: 25425651, PMCID: PMC4336211, DOI: 10.1136/archdischild-2014-306802.
- Sonpavde G, Wang C, Galsky M, Oh W, Armstrong A. Cytotoxic chemotherapy in the contemporary management of metastatic castration‐resistant prostate cancer (mCRPC). BJU International 2014, 116: 17-29. PMID: 25046451, DOI: 10.1111/bju.12867.
- Courtney K, Manola J, Elfiky A, Ross R, Oh W, Yap J, Van den Abbeele A, Ryan C, Beer T, Loda M, Priolo C, Kantoff P, Taplin M. A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 2014, 13: 113-123. PMID: 25450031, PMCID: PMC4418946, DOI: 10.1016/j.clgc.2014.08.007.
- Leiter A, Sablinski T, Diefenbach M, Foster M, Greenberg A, Holland J, Oh W, Galsky M. Use of Crowdsourcing for Cancer Clinical Trial Development. Journal Of The National Cancer Institute 2014, 106: dju258. PMID: 25217580, DOI: 10.1093/jnci/dju258.
- Stensland K, McBride R, Latif A, Wisnivesky J, Hendricks R, Roper N, Boffetta P, Hall S, Oh W, Galsky M. Adult Cancer Clinical Trials That Fail to Complete: An Epidemic? Journal Of The National Cancer Institute 2014, 106: dju229. PMID: 25190726, DOI: 10.1093/jnci/dju229.
- Agarwal N, Apolo A, Tsao C, Lee K, Godbold J, Soto R, Poole A, Gimpel‐Tetra K, Lowe N, Oh W, Galsky M. Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First‐Line Therapy in Patients With Metastatic Urothelial Carcinoma. The Oncologist 2014, 19: 915-916. PMID: 25052451, PMCID: PMC4153455, DOI: 10.1634/theoncologist.2014-0153.
- Martin J, Oh W. Evidence-Based Therapeutic Approaches for mCRPC Patients: Rational Sequence of Standard Treatment Options and Design for Future Drug Development. Current Clinical Urology 2014, 321-327. DOI: 10.1007/978-1-4939-1176-9_23.
- Galsky M, Posner M, Holcombe R, Lee K, Misiukiewicz K, Tsao C, Godbold J, Soto R, Gimpel-Tetra K, Lowe N, Oh W. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors. Cancer Chemotherapy And Pharmacology 2014, 74: 465-471. PMID: 25023489, PMCID: PMC4146643, DOI: 10.1007/s00280-014-2518-5.
- Elfiky A, Pomerantz M, Katz L, Oh W. Genitourinary Cancers. 2014, 118-129. DOI: 10.1093/med/9780199358274.003.0013.
- Gong Y, Chippada-Venkata U, Oh W. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression. Cancers 2014, 6: 1298-1327. PMID: 24978435, PMCID: PMC4190542, DOI: 10.3390/cancers6031298.
- Galsky M, Oh W. Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics. Cancer 2014, 120: 2944-2945. PMID: 24965362, DOI: 10.1002/cncr.28808.
- Saenger Y, Magidson J, Liaw B, de Moll E, Harcharik S, Fu Y, Wassmann K, Fisher D, Kirkwood J, Oh WK, Friedlander P. Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab. Clinical Cancer Research 2014, 20: 3310-3318. PMID: 24721645, DOI: 10.1158/1078-0432.ccr-13-2906.
- Bickell N, Hall S, Stock R, Fei K, Veluswamy R, Franco R, Oh W. Does race affect the quality of treatment for intermediate-risk and high-risk prostate cancer? Journal Of Clinical Oncology 2014, 32: e17678-e17678. DOI: 10.1200/jco.2014.32.15_suppl.e17678.
- Leiter A, Sablinski T, Diefenbach M, Foster M, Greenberg A, Holland J, Oh W, Galsky M. Use of crowdsourcing for cancer clinical trial development. Journal Of Clinical Oncology 2014, 32: e16019-e16019. DOI: 10.1200/jco.2014.32.15_suppl.e16019.
- The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questionsYu E, Oh W. The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions. Asian Journal Of Andrology 2014, 16: 331-333. PMID: 24759585, PMCID: PMC4023355, DOI: 10.4103/1008-682x.127813.
- Tsao C, Cutting E, Martin J, Oh W. The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer. Therapeutic Advances In Urology 2014, 6: 97-104. PMID: 24883107, PMCID: PMC4003844, DOI: 10.1177/1756287214528557.
- Tsao C, Small A, Hall S, Oh W, Galsky M, Buckstein M, Stock R, Ali G, Morris G. T2 Muscle-Invasive Bladder Cancer. Seminars In Oncology 2014, 41: e11-e18. PMID: 24787300, DOI: 10.1053/j.seminoncol.2014.03.005.
- Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM. Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease. Journal Of Investigative Dermatology 2014, 134: 2202-2211. PMID: 24522433, PMCID: PMC4291112, DOI: 10.1038/jid.2014.85.
- Morgan C, Oh W, Naik G, Galsky M, Sonpavde G. Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials. Critical Reviews In Oncology/Hematology 2014, 90: 253-261. PMID: 24500033, DOI: 10.1016/j.critrevonc.2013.12.001.
- Liaw B, Seng S, Galsky M, Tsao C, Febbo P, Oh W. Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer. Journal Of Clinical Oncology 2014, 32: 170-170. DOI: 10.1200/jco.2014.32.4_suppl.170.
- Galsky M, Latif A, Stensland K, Moshier E, McBride R, Hendricks R, Sonpavde G, Godbold J, Hall S, Oh W, Wisnivesky J. Distribution and geographic accessibility of prostate cancer clinical trials in the United States. Journal Of Clinical Oncology 2014, 32: 59-59. DOI: 10.1200/jco.2014.32.4_suppl.59.
- Oh W, Chippada Venkata U, Wang L, Reese E, Yee T, Kochukoshy T, Tsao C, Galsky M, Zhu J, Gong Y. Validation of a whole-blood RNA prognostic signature in metastatic castration-resistant prostate cancer (mCRPC) patients. Journal Of Clinical Oncology 2014, 32: 36-36. DOI: 10.1200/jco.2014.32.4_suppl.36.
- Tsao C, Agarwal N, Apolo A, Lee K, Godbold J, Oh W, Galsky M. Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma. Journal Of Clinical Oncology 2014, 32: 321-321. DOI: 10.1200/jco.2014.32.4_suppl.321.
- Casey M, Gross T, Stensland K, Oh W, Galsky M. Geographic and racial disparities in the utilization of low-volume cystectomy hospitals for bladder cancer. Journal Of Clinical Oncology 2014, 32: 302-302. DOI: 10.1200/jco.2014.32.4_suppl.302.
- Stensland K, McBride R, Wisnivesky J, Latif A, Hendricks R, Roper N, Boffetta P, Hall S, Oh W, Galsky M. Premature termination of genitourinary cancer clinical trials. Journal Of Clinical Oncology 2014, 32: 288-288. DOI: 10.1200/jco.2014.32.4_suppl.288.
- Naik G, Morgan C, Galsky M, Oh W, Sonpavde G. Meta-analysis of randomized trials to study the impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer. Journal Of Clinical Oncology 2014, 32: 28-28. DOI: 10.1200/jco.2014.32.4_suppl.28.
- Tsao C, Galsky M, Oh W. Is Metastatic Prostate Cancer Changing, and How Will We Know It? It's Time for Standard Nomenclature for Nonosseous Metastases in Clinical Trials of Patients with Metastatic Castration Resistant Prostate Cancer. European Urology 2014, 66: 184-185. PMID: 24433812, DOI: 10.1016/j.eururo.2013.12.061.
- Doctor S, Tsao C, Godbold J, Galsky M, Oh W. Is prostate cancer changing?: Evolving patterns of metastatic castration‐resistant prostate cancer. Cancer 2013, 120: 833-839. PMID: 25302607, DOI: 10.1002/cncr.28494.
- Sivendran S, Latif A, McBride R, Stensland K, Wisnivesky J, Haines L, Oh W, Galsky M. Adverse Event Reporting in Cancer Clinical Trial Publications. Journal Of Clinical Oncology 2013, 32: 83-89. PMID: 24323037, DOI: 10.1200/jco.2013.52.2219.
- OH W, McDERMOTT D, PORTA C, LEVY A, ELAIDI R, SCOTTE F, HAWKINS R, CASTELLANO D, BELLMUNT J, RHA S, SUN J, NATHAN P, FEINBERG B, SCOTT J, McDERMOTT R, AHN J, WAGSTAFF J, CHANG Y, OU Y, DONNELLAN P, HUANG C, McCAFFREY J, CHIANG P, CHUANG C, KORVES C, NEARY M, DIAZ J, MEHMUD F, DUH M. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review. International Journal Of Oncology 2013, 44: 5-16. PMID: 24247547, PMCID: PMC3867384, DOI: 10.3892/ijo.2013.2181.
- Ghavam S, Batra D, Mercer J, Kugelman A, Hosono S, Oh W, Rabe H, Kirpalani H. Effects of placental transfusion in extremely low birthweight infants: meta‐analysis of long‐ and short‐term outcomes. Transfusion 2013, 54: 1192-1198. PMID: 24843886, DOI: 10.1111/trf.12469.
- Oh W, Raju T. Not All “Term” Infants Are Created Equal. JAMA Pediatrics 2013, 167: 1001-1002. PMID: 24080941, DOI: 10.1001/jamapediatrics.2013.2593.
- Oh W, Venkata U, Wang L, Reese E, Yee T, Kochukoshy T, Tsao C, Galsky M, Zhu J, Gong Y. MC13-0070 Whole blood RNA signature as prognostic and predictive biomarker in genitourinary malignancies. European Journal Of Cancer 2013, 49: s32. DOI: 10.1016/s0959-8049(13)70178-3.
- Wadhawan R, Oh W, Hintz S, Blakely M, Das A, Bell E, Saha S, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. Journal Of Perinatology 2013, 34: 64-70. PMID: 24135709, PMCID: PMC3877158, DOI: 10.1038/jp.2013.128.
- Gong Y, Scott E, Lu R, Xu Y, Oh W, Yu Q. TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression. PLOS ONE 2013, 8: e77366. PMID: 24143225, PMCID: PMC3797040, DOI: 10.1371/journal.pone.0077366.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh W, Bamias A. Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy. Urologic Oncology Seminars And Original Investigations 2013, 32: 48.e1-48.e8. PMID: 24055428, DOI: 10.1016/j.urolonc.2013.07.001.
- Christensen R, Baer V, Gerday E, Sheffield M, Richards D, Shepherd J, Snow G, Bennett S, Frank E, Oh W. Whole-blood viscosity in the neonate: effects of gestational age, hematocrit, mean corpuscular volume and umbilical cord milking. Journal Of Perinatology 2013, 34: 16-21. PMID: 24030677, DOI: 10.1038/jp.2013.112.
- Stark AR, Carlo WA, Vohr BR, Papile LA, Saha S, Bauer CR, Oh W, Shankaran S, Tyson JE, Wright LL, Poole WK, Das A, Stoll BJ, Fanaroff AA, Korones SB, Ehrenkranz RA, Stevenson DK, Peralta-Carcelen M, Wilson-Costello DE, Bada HS, Heyne RJ, Johnson YR, Lee KG, Steichen JJ, Network E. Death or Neurodevelopmental Impairment at 18 to 22 Months Corrected Age in a Randomized Trial of Early Dexamethasone to Prevent Death or Chronic Lung Disease in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2013, 164: 34-39.e2. PMID: 23992673, PMCID: PMC4120744, DOI: 10.1016/j.jpeds.2013.07.027.
- Gartrell B, Ying J, Sivendran S, Boucher K, Choueiri T, Sonpavde G, Oh W, Agarwal N, Galsky M. Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. Targeted Oncology 2013, 9: 195-204. PMID: 23852656, PMCID: PMC4744485, DOI: 10.1007/s11523-013-0289-2.
- Galsky M, Oh W. Tumour angiogenesis: an elusive target in castration-resistant prostate cancer. The Lancet Oncology 2013, 14: 681-682. PMID: 23742876, DOI: 10.1016/s1470-2045(13)70239-0.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy. Cancer 2013, 119: 3020-3026. PMID: 23720197, DOI: 10.1002/cncr.28145.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Godbold J, Oh W, Bamias A. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy. Cancer 2013, 119: 3012-3019. PMID: 23720216, DOI: 10.1002/cncr.28146.
- Galsky M, Xie W, Nakabayashi M, Ross R, Fennessy F, Tempany C, Choueiri T, Khine K, Kantoff P, Taplin M, Oh W. Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer. Prostate Cancer And Prostatic Diseases 2013, 16: 266-270. PMID: 23712318, PMCID: PMC4026061, DOI: 10.1038/pcan.2013.15.
- Saenger Y, Magidson J, Liaw B, Wassmann K, Barker W, Harcharik S, Fisher D, Oh W, Friedlander P. Blood mRNA signature to predict survival in patients with metastatic melanoma treated with tremelimumab. Journal Of Clinical Oncology 2013, 31: 9080-9080. DOI: 10.1200/jco.2013.31.15_suppl.9080.
- Tsao C, Gray K, Nakabayashi M, Evan C, Galsky M, Kantoff P, Oh W, Pomerantz M. Association of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease. Journal Of Clinical Oncology 2013, 31: e16032-e16032. DOI: 10.1200/jco.2013.31.15_suppl.e16032.
- Stensland K, Latif A, Hendricks R, Roper N, McBride R, Hall S, Oh W, Galsky M. Prevalence and characteristics of prematurely terminated cancer clinical trials. Journal Of Clinical Oncology 2013, 31: 6613-6613. DOI: 10.1200/jco.2013.31.15_suppl.6613.
- Latif A, Stensland K, Hendricks R, Moshier E, Godbold J, Oh W, Galsky M. Cancer clinical trial accessibility in the United States: An analysis of travel distance. Journal Of Clinical Oncology 2013, 31: 6540-6540. DOI: 10.1200/jco.2013.31.15_suppl.6540.
- Doctor S, Tsao C, Godbold J, Galsky M, Oh W. Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011. Journal Of Clinical Oncology 2013, 31: 5015-5015. DOI: 10.1200/jco.2013.31.15_suppl.5015.
- Sivendran S, Chang R, Harcharik S, Hall L, Bernardo S, Moskalenko M, Phelps R, Sivendran M, Cohain A, DiFeo A, Parides M, Lebwohl M, Friedlander P, Banchereau J, Bhardwaj N, Oh W, Burakoff S, Palucka K, Merad M, Saenger Y. Immune gene expression in primary melanomas to predict lower risk of recurrence and death. Journal Of Clinical Oncology 2013, 31: 3014-3014. DOI: 10.1200/jco.2013.31.15_suppl.3014.
- Sivendran S, Agarwal N, Gartrell B, Ying J, Boucher K, Choueiri T, Sonpavde, Oh W, Galsky M. Metabolic complications with the use of mTOR inhibitors for cancer therapy. Cancer Treatment Reviews 2013, 40: 190-196. PMID: 23684373, PMCID: PMC4744486, DOI: 10.1016/j.ctrv.2013.04.005.
- Haines L, Bamias A, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde, Godbold J, Oh W, Galsky M. The Impact of Gender on Outcomes in Patients With Metastatic Urothelial Carcinoma. Clinical Genitourinary Cancer 2013, 11: 346-352. PMID: 23673281, DOI: 10.1016/j.clgc.2013.04.010.
- Cookson M, Roth B, Dahm P, Engstrom C, Freedland S, Hussain M, Lin D, Lowrance W, Murad M, Oh W, Penson D, Kibel A. Castration-Resistant Prostate Cancer: AUA Guideline. Journal Of Urology 2013, 190: 429-438. PMID: 23665272, DOI: 10.1016/j.juro.2013.05.005.
- Oh W. Cord milking at delivery improves the iron status of term infants at 6 weeks. BMJ Evidence-Based Medicine 2013, 18: e58. PMID: 23645906, DOI: 10.1136/eb-2013-101294.
- Mistry S, Oh W. New Paradigms in Microtubule-Mediated Endocrine Signaling in Prostate Cancer. Molecular Cancer Therapeutics 2013, 12: 555-566. PMID: 23635655, DOI: 10.1158/1535-7163.mct-12-0871.
- Tsao C, Liaw B, Yee T, Galsky M, Oh W. Metabolic and toxicological considerations of newly approved prostate cancer drugs. Expert Opinion On Drug Metabolism & Toxicology 2013, 9: 835-846. PMID: 23581700, DOI: 10.1517/17425255.2013.789019.
- Pollard M, Moskowitz A, Oh W, Galsky M, Hall S. 128 COST-EFFECTIVE ANALYSIS (CEA) OF THE CURRENT TREATMENT PARADIGM FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC). Journal Of Urology 2013, 189: e51-e52. DOI: 10.1016/j.juro.2013.02.1507.
- Mirza H, Oh W, Laptook, Vohr B, Tucker R, Stonestreet B. Indomethacin Prophylaxis to Prevent Intraventricular Hemorrhage: Association between Incidence and Timing of Drug Administration. The Journal Of Pediatrics 2013, 163: 706-710.e1. PMID: 23522865, PMCID: PMC3939677, DOI: 10.1016/j.jpeds.2013.02.030.
- Oh W, Doctor S, Godbold J, Galsky M, Tsao C. Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011. Journal Of Clinical Oncology 2013, 31: 195-195. DOI: 10.1200/jco.2013.31.6_suppl.195.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Kong N, Suri A, Bargfrede M, Liu G. A phase I/II study of safety and efficacy of orteronel (TAK-700), an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC): Updated phase II results. Journal Of Clinical Oncology 2013, 31: 59-59. DOI: 10.1200/jco.2013.31.6_suppl.59.
- Galsky M, Xie W, Nakabayashi M, Ross R, Fennessy F, Tempany C, Choueiri T, Khine K, Kantoff P, Taplin M, Oh W. Paradoxical significance of endorectal MRI (erMRI) response to neoadjuvant chemotherapy in patients with high-risk localized prostate cancer (HRLPC). Journal Of Clinical Oncology 2013, 31: 23-23. DOI: 10.1200/jco.2013.31.6_suppl.23.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Progression-free survival as an endpoint for clinical trials in first-line metastatic urothelial cancer. Journal Of Clinical Oncology 2013, 31: 251-251. DOI: 10.1200/jco.2013.31.6_suppl.251.
- Galsky M, Moshier E, Krege S, Lin C, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh W, Bamias A. Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy. Journal Of Clinical Oncology 2013, 31: 256-256. DOI: 10.1200/jco.2013.31.6_suppl.256.
- Bamias A, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Koutras A, Pu Y, Galsky M. Cisplatin-based combination chemotherapy in elderly patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2013, 31: 269-269. DOI: 10.1200/jco.2013.31.6_suppl.269.
- Gartrell B, Ying J, Sivendran S, Agarwal N, Boucher K, Choueiri T, Sonpavde G, Oh W, Galsky M. Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: A systematic review and meta-analysis. Journal Of Clinical Oncology 2013, 31: 362-362. DOI: 10.1200/jco.2013.31.6_suppl.362.
- Tsao C, Gray K, Nakabayashi M, Evan C, Galsky M, Kantoff P, Oh W, Pomerantz M. Association of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease. Journal Of Clinical Oncology 2013, 31: 157-157. DOI: 10.1200/jco.2013.31.6_suppl.157.
- Sivendran S, Ying J, Gartrell B, Agarwal N, Boucher K, Choueiri T, Sonpavde G, Oh W, Galsky M. Metabolic complications with the use of mTOR inhibitors for cancer therapy: A systematic review and meta-analysis. Journal Of Clinical Oncology 2013, 31: 398-398. DOI: 10.1200/jco.2013.31.6_suppl.398.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer. Urologic Oncology Seminars And Original Investigations 2013, 32: 30.e15-30.e21. PMID: 23428534, DOI: 10.1016/j.urolonc.2012.11.001.
- Nolen T, Das A, Higgins R, Tyson J, Oh W, Devaskar S, Londhe V. Vitamin A Supplementation in Extremely Low-Birth-Weight Infants: Subgroup Analysis in Small-for-Gestational-Age Infants. American Journal Of Perinatology 2013, 30: 771-780. PMID: 23329565, PMCID: PMC3923571, DOI: 10.1055/s-0032-1333410.
- Oh W. Early Onset Neonatal Group B Streptococcal Sepsis. American Journal Of Perinatology 2013, 30: 143-148. PMID: 23322392, DOI: 10.1055/s-0032-1332804.
- Rosenkrantz T, Oh W. Polycythemia and hyperviscosity in the newborn. 2013, 127-140. DOI: 10.1017/cbo9780511978135.011.
- Tsao C, Small A, Kates M, Moshier E, Wisnivesky J, Gartrell B, Sonpavde G, Godbold J, Palese M, Hall S, Oh W, Galsky M. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis. World Journal Of Urology 2012, 31: 1535-1539. PMID: 23223962, PMCID: PMC4744480, DOI: 10.1007/s00345-012-1001-3.
- Tsao C, Gartrell B, Oh W, Galsky M. Emerging personalized approaches for the management of advanced urothelial carcinoma. Expert Review Of Anticancer Therapy 2012, 12: 1537-1543. PMID: 23253220, PMCID: PMC4744482, DOI: 10.1586/era.12.141.
- Seng S, Tsao C, Oh W. Chemotherapy and Associated Symptoms. 2012, 835-858. DOI: 10.1142/9789814354912_0071.
- Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis. Journal Of Clinical Oncology 2012, 30: 4416-4426. PMID: 23150697, DOI: 10.1200/jco.2012.42.4358.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Mortimer P, Liu G. P114 Safety and efficacy of orteronel (TAK-700), an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC): Phase 2 results from a phase 1/2 study. European Urology Open Science 2012, 11: 230. DOI: 10.1016/s1569-9056(13)60480-7.
- Proverbs-Singh T, Chiu S, Liu Z, Seng S, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2012, 104: 1837-1840. PMID: 23093559, DOI: 10.1093/jnci/djs435.
- Oh W. Fluid and Electrolyte Management of Very Low Birth Weight Infants. Pediatrics & Neonatology 2012, 53: 329-333. PMID: 23276435, DOI: 10.1016/j.pedneo.2012.08.010.
- Tsao C, Oh W. Enzalutamide in metastatic CRPC—old dog, new tricks. Nature Reviews Clinical Oncology 2012, 9: 613-614. PMID: 23044775, DOI: 10.1038/nrclinonc.2012.181.
- Ross R, Galsky M, Scher H, Magidson J, Wassmann K, Lee G, Katz L, Subudhi S, Anand A, Fleisher M, Kantoff P, Oh W. A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. The Lancet Oncology 2012, 13: 1105-1113. PMID: 23059047, DOI: 10.1016/s1470-2045(12)70263-2.
- Lin C, Galsky M, Krege S, Hahn N, Ecke T, Sonpavde G, Oh W, Bamias A. WS14-7 Efficacy of Cisplatin-Based Chemotherapy as First-Line Treatment in Asian Patients with Metastatic Urothelial Carcinoma Results of an Exploratory Subgroup Analysis of a Pool Analysis of Phase II/III Trials. Annals Of Oncology 2012, 23: xi96-xi97. DOI: 10.1016/s0923-7534(20)32244-4.
- Tsao C, Galsky M, Small A, Yee T, Oh W. Targeting the androgen receptor signalling axis in castration‐resistant prostate cancer (CRPC). BJU International 2012, 110: 1580-1588. PMID: 22985411, DOI: 10.1111/j.1464-410x.2012.11445.x.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Carthon B, Moran S, Liu G. 918P Phase 2 Results from a Phase 1/2 Study of Tak-700 (ORTERONEL), An Oral, Investigational, Nonsteroidal 17,20-Lyase Inhibitor, with Docetaxel and Prednisone (DP) in Metastatic Castration-Resistant Prostate Cancer (MCRPC). Annals Of Oncology 2012, 23: ix302-ix303. DOI: 10.1016/s0923-7534(20)33476-1.
- Nakabayashi M, Werner L, Courtney K, Buckle G, Oh W, Bubley G, Hayes J, Weckstein D, Elfiky A, Sims D, Kantoff P, Taplin M. Phase II trial of RAD001 and bicalutamide for castration‐resistant prostate cancer. BJU International 2012, 110: 1729-1735. PMID: 22928480, DOI: 10.1111/j.1464-410x.2012.11456.x.
- Vinjamoori A, Jagannathan J, Shinagare A, Taplin M, Oh W, Van den Abbeele A, Ramaiya N. Atypical metastases from prostate cancer: 10-year experience at a single institution. American Journal Of Roentgenology 2012, 199: 367-72. PMID: 22826398, DOI: 10.2214/ajr.11.7533.
- Small A, Oh W. Bevacizumab treatment of prostate cancer. Expert Opinion On Biological Therapy 2012, 12: 1241-1249. PMID: 22775507, DOI: 10.1517/14712598.2012.704015.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde, Oh W, Galsky M. Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy. Cancer 2012, 118: 5947-5954. PMID: 22707387, DOI: 10.1002/cncr.27658.
- Wadhawan R, Oh W, Vohr B, Saha S, Das A, Bell E, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age. Archives Of Disease In Childhood Fetal & Neonatal 2012, 98: f127. PMID: 22684157, PMCID: PMC3753803, DOI: 10.1136/archdischild-2011-300659.
- Pomerantz M, Elfiky A, Katz L, Oh W. Genitourinary Cancers. 2012, 114-124. DOI: 10.1093/med/9780195366273.003.0013.
- Tyson J, Pedroza C, Langer J, Green C, Morris B, Stevenson D, Van Meurs K, Oh W, Phelps D, O'Shea M, McDavid G, Grisby C, Higgins R. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? Journal Of Perinatology 2012, 32: 677-684. PMID: 22652561, PMCID: PMC3558278, DOI: 10.1038/jp.2012.64.
- Tsao C, Small A, Moshier E, Gartrell B, Wisnivesky J, Sonpavde, Godbold J, Palese M, Hall S, Oh W, Galsky M. Trends in the Use of Cytoreductive Nephrectomy in the United States. Clinical Genitourinary Cancer 2012, 10: 159-163. PMID: 22651971, PMCID: PMC4744481, DOI: 10.1016/j.clgc.2012.03.008.
- Sivendran S, Liu Z, Portas L, Yu M, Hahn N, Sonpavde, Oh W, Galsky M. Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: A meta-analysis. Cancer Treatment Reviews 2012, 38: 919-925. PMID: 22651902, DOI: 10.1016/j.ctrv.2012.05.001.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Sonpavde G, Palese M, Hall S, Oh W, Galsky M. Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World Journal Of Urology 2012, 31: 1211-1217. PMID: 22622394, PMCID: PMC4744479, DOI: 10.1007/s00345-012-0873-6.
- Latif A, Small A, Moshier E, Adelson K, Raptis G, Godbold J, Oh W, Galsky M. Practice patterns in the use of adjuvant therapy for post-menopausal early-stage breast cancer in the pre- and post-Onco type DX era. Journal Of Clinical Oncology 2012, 30: e21032-e21032. DOI: 10.1200/jco.2012.30.15_suppl.e21032.
- Seng S, Liu Z, Chiu S, Proverbs-Singh T, Sonpavde G, Choueiri T, Tsao C, Yu M, Hahn N, Oh W, Galsky M. Risk of venous thromboembolism in cancer patients treated with cisplatin: A systematic review and meta-analysis. Journal Of Clinical Oncology 2012, 30: e21016-e21016. DOI: 10.1200/jco.2012.30.15_suppl.e21016.
- Small A, Tsao C, Moshier E, Gartrell B, Wisnivesky J, Godbold J, Smith C, Sonpavde G, Oh W, Galsky M. Prevalence and characteristics of patients with stage IV solid tumors who receive no anticancer therapy. Journal Of Clinical Oncology 2012, 30: 6065-6065. DOI: 10.1200/jco.2012.30.15_suppl.6065.
- Petrylak D, Gandhi J, Clark W, Heath E, Lin J, Oh W, Agus D, Kucuk O, Moran S, Wang J, Bargfrede M, Liu G. Phase I results from a phase I/II study of orteronel, an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2012, 30: 4656-4656. DOI: 10.1200/jco.2012.30.15_suppl.4656.
- Tsao C, Small A, Kates M, Gartrell B, Wisnivesky J, Sonpavde G, Palese M, Hall S, Oh W, Galsky M. Trends in the use of cytoreductive nephrectomy for metastatic renal cell carcinoma in the VEGFR tyrosine kinase inhibitor era. Journal Of Clinical Oncology 2012, 30: 4623-4623. DOI: 10.1200/jco.2012.30.15_suppl.4623.
- Galsky M, Krege S, Lin C, Hahn N, Ecke T, Moshier E, Sonpavde G, Godbold J, Oh W, Bamias A. Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. Journal Of Clinical Oncology 2012, 30: 4524-4524. DOI: 10.1200/jco.2012.30.15_suppl.4524.
- Oh W, Kantoff P, Scher H, Magidson J, Wassmann K, Lee G, Katz L, Subudhi S, Anand A, Fleisher M, Galsky M, Ross R. A validated whole-blood RNA transcript-based prognostic model that predicts survival in men with castration-resistant prostate cancer. Journal Of Clinical Oncology 2012, 30: 4516-4516. DOI: 10.1200/jco.2012.30.15_suppl.4516.
- Small A, Gong Y, Oh W, Hall S, van Rijn C, Galsky M. The Emerging Role of Circulating Tumor Cell Detection in Genitourinary Cancer. Journal Of Urology 2012, 188: 21-26. PMID: 22578722, DOI: 10.1016/j.juro.2012.02.2558.
- Tsao C, Small A, Galsky M, Oh W. Overcoming castration resistance in prostate cancer. Current Opinion In Urology 2012, 22: 167-174. PMID: 22472508, DOI: 10.1097/mou.0b013e3283523b8b.
- Galsky M, Small A, Tsao C, Oh W. Clinical development of novel therapeutics for castration‐resistant prostate cancer. CA A Cancer Journal For Clinicians 2012, 62: 299-308. PMID: 22535487, DOI: 10.3322/caac.21141.
- Morris B, Tyson J, Stevenson D, Oh W, Phelps D, O'Shea T, McDavid G, Van Meurs K, Vohr B, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins R. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. Journal Of Perinatology 2012, 33: 126-133. PMID: 22499082, PMCID: PMC3570170, DOI: 10.1038/jp.2012.39.
- Small A, Tsao C, Moshier E, Godbold J, Palese M, Hall S, Oh W, Galsky M. 659 RACIAL AND SOCIOECONOMIC DISPARITIES IN THE UTILIZATION OF NEPHRON-SPARING PROCEDURES FOR STAGE I KIDNEY CANCER IN THE UNITED STATES. Journal Of Urology 2012, 187: e269. DOI: 10.1016/j.juro.2012.02.739.
- Lee B, Garcia J, Dreicer R, Tendulkar R, Stephans K, Magi-Galluzzi C, Klein E, Oh W, Stephenson A. 336 ALL HIGH-GRADE PROSTATE CANCERS CREATED EQUALLY? AN ANALYSIS OF CLINICAL FEATURES AND SURVIVAL AMONG PATIENTS WITH BIOPSY GLEASON SCORE 8, 9, AND 10 DISEASE. Journal Of Urology 2012, 187: e137. DOI: 10.1016/j.juro.2012.02.397.
- Sommers R, Stonestreet B, Oh W, Laptook A, Yanowitz T, Raker C, Mercer J. Hemodynamic Effects of Delayed Cord Clamping in Premature Infants. Pediatrics 2012, 129: e667-e672. PMID: 22331336, PMCID: PMC3356138, DOI: 10.1542/peds.2011-2550.
- Tsao C, Moshier E, Small A, Sonpavde G, Godbold J, Oh W, Galsky M. Cytoreductive nephrectomy in the United States: Patterns of care and patient characteristics. Journal Of Clinical Oncology 2012, 30: 366-366. DOI: 10.1200/jco.2012.30.5_suppl.366.
- Small A, Tsao C, Moshier E, Godbold J, Sonpavde G, Oh W, Galsky M. Prevalence and characteristics of patients with metastatic prostate cancer who receive no anticancer therapy. Journal Of Clinical Oncology 2012, 30: 101-101. DOI: 10.1200/jco.2012.30.5_suppl.101.
- Ross R, Galsky M, Febbo P, Barry M, Richie J, Xie W, Fennessy F, Bhatt R, Hayes J, Choueiri T, Tempany C, Kantoff P, Taplin M, Oh W. Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer. Cancer 2012, 118: 4777-4784. PMID: 22282219, PMCID: PMC3791849, DOI: 10.1002/cncr.27416.
- Oh W. The Field of Neonatology. 2012, 85-90. DOI: 10.1007/978-3-642-02202-9_7.
- Oh W, Guignard J, Baumgart S. Preface. 2012, xi. DOI: 10.1016/b978-1-4377-2658-9.00022-4.
- Oh W. Infant of Diabetic Mother. 2012, 353-358. DOI: 10.1007/978-3-642-02202-9_30.
- Oh W. Disorders of Glucose Homeostasis in the Newborn. 2012, 347-351. DOI: 10.1007/978-3-642-02202-9_29.
- Oh W. Chapter 2 Body Water Changes in the Fetus and Newborn Normal Transition After Birth and the Effects of Intrauterine Growth Aberration*. 2012, 19-27. DOI: 10.1016/b978-1-4377-2658-9.00002-9.
- Lasky R, Church M, Orlando M, Morris B, Parikh N, Tyson J, McDavid G, Oh W, Stevenson D, Van Meurs K, Guillet R, Phelps D. The effects of aggressive vs. conservative phototherapy on the brainstem auditory evoked responses of extremely-low-birth-weight infants. Pediatric Research 2011, 71: 77-84. PMID: 22289854, PMCID: PMC3326602, DOI: 10.1038/pr.2011.17.
- Sun T, Oh W, Jacobus S, Regan M, Pomerantz M, Freedman M, Lee G, Kantoff P. The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness. Cancer Prevention Research 2011, 4: 2044-2050. PMID: 21900597, PMCID: PMC3773969, DOI: 10.1158/1940-6207.capr-11-0283.
- Tsao C, Moshier E, Seng S, Godbold J, Grossman S, Winston J, Oh W, Galsky M. Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer. Clinical Genitourinary Cancer 2011, 10: 15-20. PMID: 22130294, DOI: 10.1016/j.clgc.2011.10.004.
- Erickson-Owens D, Mercer J, Oh W. Umbilical cord milking in term infants delivered by cesarean section: a randomized controlled trial. Journal Of Perinatology 2011, 32: 580-584. PMID: 22094494, DOI: 10.1038/jp.2011.159.
- Nakabayashi M, Werner L, Oh W, Regan M, Kantoff P, Taplin M. Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 2011, 9: 95-103. PMID: 21958520, DOI: 10.1016/j.clgc.2011.06.006.
- Galsky M, Camacho L, Chiorean E, Mulkerin D, Hong D, Oh W, Bajorin D. Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors. Annals Of Oncology 2011, 23: 1037-1044. PMID: 21828377, DOI: 10.1093/annonc/mdr358.
- Carlo WA, McDonald SA, Tyson JE, Stoll BJ, Ehrenkranz RA, Shankaran S, Goldberg RN, Das A, Schendel D, Thorsen P, Skogstrand K, Hougaard DM, Oh W, Laptook R, Duara S, Fanaroff AA, Donovan EF, Korones SB, Stevenson DK, Papile LA, Finer NN, O’Shea T, Poindexter BB, Wright LL, Ambalavanan N, Higgins RD, Network E. Cytokines and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2011, 159: 919-925.e3. PMID: 21798559, PMCID: PMC3215787, DOI: 10.1016/j.jpeds.2011.05.042.
- Oh W, Galsky M, Stadler W, Srinivas S, Chu F, Bubley G, Goddard J, Dunbar J, Ross R. Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer. Urology 2011, 78: 626-630. PMID: 21762967, PMCID: PMC3166448, DOI: 10.1016/j.urology.2011.04.041.
- Galsky M, Seng S, Camacho L, Chiorean E, Mulkerin D, Hong D, Oh W, Bajorin D. Retrospective Analysis of Satraplatin in Patients with Metastatic Urothelial Cancer Refractory to Standard Platinum-Based Chemotherapy. Clinical Genitourinary Cancer 2011, 9: 27-30. PMID: 21700509, DOI: 10.1016/j.clgc.2011.05.003.
- Keating N, Landrum M, Lamont E, Bozeman S, Krasnow S, Shulman L, Brown J, Earle C, Oh W, Rabin M, McNeil B. Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Annals Of Internal Medicine 2011, 154: 727-36. PMID: 21646556, DOI: 10.7326/0003-4819-154-11-201106070-00004.
- Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, Oh W. Early Nutrition Mediates the Influence of Severity of Illness on Extremely LBW Infants. Pediatric Research 2011, 69: 522-529. PMID: 21378596, PMCID: PMC3090495, DOI: 10.1203/pdr.0b013e318217f4f1.
- Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg W, Balk S, Brown M, Taplin M, Oh W, Lee G, Kantoff P. SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer. Journal Of Clinical Oncology 2011, 29: 2565-2573. PMID: 21606417, PMCID: PMC3138634, DOI: 10.1200/jco.2010.31.2405.
- Seng S, Galsky M, Tsao C, Li J, Febbo P, Oh W. Predicting response to platinum chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) using a genomic signature for “BRCAness”: A phase II clinical trial of satraplatin in men with mCRPC who have progressed on docetaxel. Journal Of Clinical Oncology 2011, 29: tps191-tps191. DOI: 10.1200/jco.2011.29.15_suppl.tps191.
- Tsao C, Seng S, Grossman S, Oh W, Galsky M. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with bladder cancer. Journal Of Clinical Oncology 2011, 29: e15139-e15139. DOI: 10.1200/jco.2011.29.15_suppl.e15139.
- Galsky M, Chen G, Oh W, Bellmunt J, Roth B, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Journal Of Clinical Oncology 2011, 29: e15027-e15027. DOI: 10.1200/jco.2011.29.15_suppl.e15027.
- Oh W, Galsky M, Barry M, Fennessey F, Richie J, Hayes J, Bhatt R, Taplin M, Febbo P, Ross R. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients (pts) with high-risk localized prostate cancer. Journal Of Clinical Oncology 2011, 29: 4642-4642. DOI: 10.1200/jco.2011.29.15_suppl.4642.
- Galsky M, Hahn N, Rosenberg J, Sonpavde G, Hutson T, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy. Journal Of Clinical Oncology 2011, 29: 2432-2438. PMID: 21555688, DOI: 10.1200/jco.2011.34.8433.
- Galsky M, Chen G, Oh W, Bellmunt J, Roth B, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Annals Of Oncology 2011, 23: 406-410. PMID: 21543626, DOI: 10.1093/annonc/mdr156.
- Pomerantz M, Werner L, Xie W, Regan M, Lee G, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh W, Kantoff P, Freedman M. Association of Prostate Cancer Risk Loci with Disease Aggressiveness and Prostate Cancer–Specific Mortality. Cancer Prevention Research 2011, 4: 719-728. PMID: 21367958, PMCID: PMC3811002, DOI: 10.1158/1940-6207.capr-10-0292.
- Tsao C, Seng S, Oh W, Galsky M. Endocrine therapy for prostate cancer: review of the latest clinical evidence. Clinical Investigation 2011, 1: 533-541. DOI: 10.4155/cli.11.28.
- Oh W, Fanaroff A, Carlo W, Donovan E, McDonald S, Poole W. Effects of delayed cord clamping in very-low-birth-weight infants. Journal Of Perinatology 2011, 31: s68-s71. PMID: 21448208, PMCID: PMC3327157, DOI: 10.1038/jp.2010.186.
- Tai S, Sun Y, Squires J, Zhang H, Oh W, Liang C, Huang J. PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate 2011, 71: 1668-1679. PMID: 21432867, PMCID: PMC3426349, DOI: 10.1002/pros.21383.
- Misra D, Xie W, Regan M, Ross R, Lee G, Germain D, Kantoff P, Oh W. Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy. BJU International 2011, 108: 1086-1091. PMID: 21410629, DOI: 10.1111/j.1464-410x.2010.10037.x.
- Sun T, Mary L, Oh W, Freedman M, Pomerantz M, Pienta K, Kantoff P. Inherited Variants in the Chemokine CCL2 Gene and Prostate Cancer Aggressiveness in a Caucasian Cohort. Clinical Cancer Research 2011, 17: 1546-1552. PMID: 21135144, PMCID: PMC3060307, DOI: 10.1158/1078-0432.ccr-10-2015.
- Sonpavde G, Galsky M, Chen G, Bellmunt J, Roth B, Petrioli R, Hutson T, Dogliotti L, Dreicer R, Oh W. Meta-analysis of randomized trials comparing cisplatin versus carboplatin-based regimens for the first-line therapy of metastatic transitional cell carcinoma of the urothelium (TCCU). Journal Of Clinical Oncology 2011, 29: 247-247. DOI: 10.1200/jco.2011.29.7_suppl.247.
- Galsky M, Hahn N, Rosenberg J, Sonpavde G, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. Defining “cisplatin ineligible” patients with metastatic bladder cancer. Journal Of Clinical Oncology 2011, 29: 238-238. DOI: 10.1200/jco.2011.29.7_suppl.238.
- Galsky M, Hahn N, Rosenberg J, Sonpavde, Hutson T, Oh W, Dreicer R, Vogelzang N, Sternberg C, Bajorin D, Bellmunt J. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. The Lancet Oncology 2011, 12: 211-214. PMID: 21376284, DOI: 10.1016/s1470-2045(10)70275-8.
- Wadhawan R, Oh W, Vohr B, Wrage L, Das A, Bell E, Laptook A, Shankaran S, Stoll B, Walsh M, Higgins R. Neurodevelopmental Outcomes of Triplets or Higher-Order Extremely Low Birth Weight Infants. Pediatrics 2011, 127: e654-e660. PMID: 21357334, PMCID: PMC3304548, DOI: 10.1542/peds.2010-2646.
- Hintz S, Stevenson D, Yao Q, Wong R, Das A, Van Meurs K, Morris B, Tyson J, Oh W, Poole W, Phelps D, McDavid G, Grisby C, Higgins R, Information D. Is phototherapy exposure associated with better or worse outcomes in 501‐ to 1000‐g‐birth‐weight infants? Acta Paediatrica 2011, 100: 960-965. PMID: 21272067, PMCID: PMC3505994, DOI: 10.1111/j.1651-2227.2011.02175.x.
- Woo H, Lizarda A, Tucker R, Mitchell M, Vohr B, Oh W, Phornphutkul C. Congenital Hypothyroidism with a Delayed Thyroid-Stimulating Hormone Elevation in Very Premature Infants: Incidence and Growth and Developmental Outcomes. The Journal Of Pediatrics 2011, 158: 538-542. PMID: 21232766, DOI: 10.1016/j.jpeds.2010.10.018.
- Tsao C, Seng S, Oh W, Galsky M. Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer. Clinical Medicine Insights Oncology 2011, 5: cmo.s6566. PMID: 21695098, PMCID: PMC3117627, DOI: 10.4137/cmo.s6566.
- Abe M, Xie W, Regan M, King I, Stampfer M, Kantoff P, Oh W, Chan J. Single‐nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU International 2010, 107: 126-134. PMID: 20477822, PMCID: PMC3010266, DOI: 10.1111/j.1464-410x.2010.09344.x.
- Drzymalski D, Oh W, Werner L, Regan M, Kantoff P, Tuli S. Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article. Journal Of Neurosurgery Spine 2010, 13: 789-94. PMID: 21121759, DOI: 10.3171/2010.6.spine10167.
- Oh W, Burakoff S. Cancer Therapy from Bench to Bedside. Annals Of Global Health 2010, 77: 571-572. PMID: 21105120, DOI: 10.1002/msj.20221.
- Tsao C, Oh W. Selective cell death mediated by small conditional RNAs: a novel therapeutic approach to cancer therapy. Asian Journal Of Andrology 2010, 13: 181-2. PMID: 21076441, PMCID: PMC3739191, DOI: 10.1038/aja.2010.148.
- Pomerantz M, Shrestha Y, Flavin R, Regan M, Penney K, Mucci L, Stampfer M, Hunter D, Chanock S, Schafer E, Chan J, Tabernero J, Baselga J, Richardson A, Loda M, Oh W, Kantoff P, Hahn W, Freedman M. Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis. PLOS Genetics 2010, 6: e1001204. PMID: 21085629, PMCID: PMC2978684, DOI: 10.1371/journal.pgen.1001204.
- Anees M, Horak P, El‐Gazzar A, Susani M, Heinze G, Perco P, Loda M, Lis R, Krainer M, Oh W. Recurrence‐free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer 2010, 117: 1172-1182. PMID: 21381010, DOI: 10.1002/cncr.25504.
- Gansler T, Ganz P, Grant M, Greene F, Johnstone P, Mahoney M, Newman L, Oh W, Thomas C, Thun M, Vickers A, Wender R, Brawley O. Sixty Years of CA: A Cancer Journal for Clinicians. CA A Cancer Journal For Clinicians 2010, 60: 345-350. PMID: 21075954, DOI: 10.3322/caac.20088.
- Penney K, Pyne S, Schumacher F, Sinnott J, Mucci L, Kraft P, Ma J, Oh W, Kurth T, Kantoff P, Giovannucci E, Stampfer M, Hunter D, Freedman M. Genome-wide Association Study of Prostate Cancer Mortality. Cancer Epidemiology Biomarkers & Prevention 2010, 19: 2869-2876. PMID: 20978177, PMCID: PMC3197738, DOI: 10.1158/1055-9965.epi-10-0601.
- Sun T, Lee G, Oh W, Pomerantz M, Yang M, Xie W, Freedman M, Kantoff P. Single-Nucleotide Polymorphisms in p53 Pathway and Aggressiveness of Prostate Cancer in a Caucasian Population. Clinical Cancer Research 2010, 16: 5244-5251. PMID: 20855462, PMCID: PMC2970725, DOI: 10.1158/1078-0432.ccr-10-1261.
- Choueiri T, McDermott D, Duh M, Sarda S, Neary M, Oh W. Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: Results from a medical chart review study. Urologic Oncology Seminars And Original Investigations 2010, 30: 848-855. PMID: 20926319, DOI: 10.1016/j.urolonc.2010.07.009.
- Oh W, Vargas R, Jacobus S, Leitzel K, Regan M, Hamer P, Pierce K, Brown‐Shimer S, Carney W, Ali S, Kantoff P, Lipton A. Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients. Cancer 2010, 117: 517-525. PMID: 20862742, DOI: 10.1002/cncr.25394.
- Galsky M, Dritselis A, Kirkpatrick P, Oh W. Cabazitaxel. Nature Reviews Drug Discovery 2010, 9: 677-678. PMID: 20811375, DOI: 10.1038/nrd3254.
- Choueiri T, Regan M, Rosenberg J, Oh W, Clement J, Amato A, McDermott D, Cho D, Atkins M, Signoretti S. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth factor‐targeted therapy. BJU International 2010, 106: 772-778. PMID: 20230385, DOI: 10.1111/j.1464-410x.2010.09218.x.
- Brick A, Niu J, Huang J, Oh W. Platinum Agents in Prostate Cancer. 2010, 153-161. DOI: 10.1007/978-1-60327-829-4_14.
- Sun T, Lee G, Werner L, Pomerantz M, Oh W, Kantoff P, Freedman M. Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy. Cancer Epidemiology Biomarkers & Prevention 2010, 19: 1871-1878. PMID: 20615892, PMCID: PMC3755451, DOI: 10.1158/1055-9965.epi-10-0216.
- Oh W, Vohr B. Introduction. Seminars In Perinatology 2010, 34: 181-182. PMID: 20494732, DOI: 10.1053/j.semperi.2010.02.001.
- Seng S, Tsao C, Galsky M, Oh W. Cytotoxic chemotherapy for castration resistant prostate cancer: 2010 and beyond. Drug Discovery Today Therapeutic Strategies 2010, 7: 17-22. DOI: 10.1016/j.ddstr.2011.02.001.
- Harrison M, Hahn N, Pili R, Oh W, Hammers H, Sweeney C, Kim K, Perlman S, Arnott J, Sidor C, Wilding G, Liu G. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Investigational New Drugs 2010, 29: 1465-1474. PMID: 20499131, PMCID: PMC3042040, DOI: 10.1007/s10637-010-9455-x.
- Buckle G, Werner L, Oh W, Bubley G, Hayes J, Weckstein D, Elfiky A, Sims D, Kantoff P, Taplin M. Phase II trial of RAD001 (R) and bicalutamide (B) for castration-resistant prostrate cancer (CPRC). Journal Of Clinical Oncology 2010, 28: 4660-4660. DOI: 10.1200/jco.2010.28.15_suppl.4660.
- Elfiky A, Cho D, McDermott D, Rosenberg J, Fortner B, Antràs L, Chen K, Duh M, Jayawant S, Oh W, Atkins M, Choueiri T. Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma. Urologic Oncology Seminars And Original Investigations 2010, 29: 756-763. PMID: 20451414, DOI: 10.1016/j.urolonc.2010.01.008.
- Oh W, McDermott D, Duh, Antràs L, Chen K, Sarda S, Luka A, Whittemore S, Ramamurthy P, Neary M, Choueiri T. PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY. Value In Health 2010, 13: a32. DOI: 10.1016/s1098-3015(10)72139-2.
- Dial E, Duh, Antras L, Rodermund D, Neary M, Choueiri T, Oh W. PUK1 INCIDENCE AND COST OF ADVERSE EVENTS (AES) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) TREATED WITH ANGIOGENESIS INHIBITORS (AIS). Value In Health 2010, 13: a76. DOI: 10.1016/s1098-3015(10)72356-1.
- Choueiri T, Duh M, Clement J, Brick A, Rogers M, Kwabi C, Shah K, Percy A, Antràs L, Jayawant S, Chen K, Wang S, Luka A, Neary M, McDermott D, Oh W. Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice‐based on medical chart review. BJU International 2010, 105: 1247-1254. PMID: 19863525, DOI: 10.1111/j.1464-410x.2009.08972.x.
- Weinberg A, Alemozaffar M, Soukup J, Kacker R, Choi W, Oh W, Hu J. 587 THE EFFECT OF NEO-ADJUVANT CHEMOTHERAPY ON RADICAL PROSTATECTOMY OUTCOMES IN INTERMEDIATE AND HIGH-RISK PROSTATE CANCER. Journal Of Urology 2010, 183: e230-e231. DOI: 10.1016/j.juro.2010.02.859.
- Oh W, Stevenson D, Tyson J, Morris B, Ahlfors C, Bender G, Wong R, Perritt R, Vohr B, Van Meurs K, Vreman H, Das A, Phelps D, O’Shea T, Higgins R, Bethesda O. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatrica 2010, 99: 673-678. PMID: 20105142, PMCID: PMC2875328, DOI: 10.1111/j.1651-2227.2010.01688.x.
- Bellmunt J, Oh W. Review: Castration-resistant prostate cancer: new science and therapeutic prospects. Therapeutic Advances In Medical Oncology 2010, 2: 189-207. PMID: 21789134, PMCID: PMC3126017, DOI: 10.1177/1758834009359769.
- Oh W, Hu J. Preface. Urologic Clinics Of North America 2010, 37: xiii. PMID: 20152513, DOI: 10.1016/j.ucl.2009.12.001.
- Schutz F, Oh W. Neoadjuvant and Adjuvant Therapies in Prostate Cancer. Urologic Clinics Of North America 2010, 37: 97-104. PMID: 20152523, DOI: 10.1016/j.ucl.2009.11.012.
- Oh W, Ross R, Choueiri T, Kantoff P, Corless C. 8 Cancer of the Genitourinary Tract. 2010, 233-277. DOI: 10.1016/b978-0-323-05905-3.00008-x.
- Oh W, Landrum M, Lamont E, McNeil B, Keating N. Does Oral Antiandrogen Use Before Leuteinizing Hormone-releasing Hormone Therapy in Patients With Metastatic Prostate Cancer Prevent Clinical Consequences of a Testosterone Flare? Urology 2009, 75: 642-647. PMID: 19962733, DOI: 10.1016/j.urology.2009.08.008.
- Taplin M, Regan M, Ko Y, Bubley G, Duggan S, Werner L, Beer T, Ryan C, Mathew P, Tu S, Denmeade S, Oh W, Sartor O, Mantzoros C, Rittmaster R, Kantoff P, Balk S. Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer. Clinical Cancer Research 2009, 15: 7099-7105. PMID: 19887483, PMCID: PMC3644858, DOI: 10.1158/1078-0432.ccr-09-1722.
- Nakabayashi M, Oh W, Jacobus S, Regan M, Taplin M, Kantoff P, Rosenberg J. Activity of ketoconazole after taxane‐based chemotherapy in castration‐resistant prostate cancer. BJU International 2009, 105: 1392-1396. PMID: 19863532, DOI: 10.1111/j.1464-410x.2009.08971.x.
- Mercer J, Vohr B, Erickson-Owens D, Padbury J, Oh W. Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping. Journal Of Perinatology 2009, 30: 11-16. PMID: 19847185, PMCID: PMC2799542, DOI: 10.1038/jp.2009.170.
- Heng D, Xie W, Regan M, Warren M, Golshayan A, Sahi C, Eigl B, Ruether J, Cheng T, North S, Venner P, Knox J, N. K, Kollmannsberger C, McDermott D, Oh W, Atkins M, Bukowski R, Rini B, Choueiri T. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study. Journal Of Clinical Oncology 2009, 27: 5794-5799. PMID: 19826129, DOI: 10.1200/jco.2008.21.4809.
- Sartor O, Nakabayashi M, Taplin M, Ross R, Kantoff P, Balk S, Oh W. Activity of Dutasteride Plus Ketoconazole in Castration-Refractory Prostate Cancer After Progression on Ketoconazole Alone. Clinical Genitourinary Cancer 2009, 7: e90-e92. PMID: 19815488, DOI: 10.3816/cgc.2009.n.030.
- Aggarwal R, Weinberg V, Small E, Oh W, Rushakoff R, Ryan C. The Mechanism of Action of Estrogen in Castration-Resistant Prostate Cancer: Clues From Hormone Levels. Clinical Genitourinary Cancer 2009, 7: e71-e76. PMID: 19815485, DOI: 10.3816/cgc.2009.n.027.
- Oh W, Magidson J, Bankaitis-Davis D, Siconolfi L, Schurko B, Cantu R, Braitsch S, Wassman K, Kantoff P, Ross R. PP138 A whole blood RNA transcript-based model to predict biopsy Gleason score in newly diagnosed prostate cancer patients. European Journal Of Cancer Supplements 2009, 7: 27. DOI: 10.1016/s1359-6349(09)72197-4.
- Jacobsen E, Chen J, Schurko B, Benson C, Oh W. Metastatic seminoma and grade 1 follicular lymphoma presenting concurrently in a supraclavicular lymph node: a case report. Cases Journal 2009, 2: 7273. PMID: 19918516, PMCID: PMC2769346, DOI: 10.4076/1757-1626-2-7273.
- Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak J, Berman B, Henderson B, Frenkel B, Haiman C, Freedman M, Tanay A, Coetzee G. Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus. PLOS Genetics 2009, 5: e1000597. PMID: 19680443, PMCID: PMC2717370, DOI: 10.1371/journal.pgen.1000597.
- Regan M, O'Donnell E, Kelly W, Halabi S, Berry W, Urakami S, Kikuno N, Oh W. Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials. Annals Of Oncology 2009, 21: 312-318. PMID: 19633053, PMCID: PMC2852201, DOI: 10.1093/annonc/mdp308.
- Duh M, Dial E, Choueiri T, Fournier A, Antras L, Rodermund D, Neary M, Oh W. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis*. Current Medical Research And Opinion 2009, 25: 2081-2090. PMID: 19586325, DOI: 10.1185/03007990903084800.
- Pomerantz M, Beckwith C, Regan M, Wyman S, Petrovics G, Chen Y, Hawksworth D, Schumacher F, Mucci L, Penney K, Stampfer M, Chan J, Ardlie K, Fritz B, Parkin R, Lin D, Dyke M, Herman P, Lee S, Oh W, Kantoff P, Tewari M, McLeod D, Srivastava S, Freedman M. Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression. Cancer Research 2009, 69: 5568-5574. PMID: 19549893, PMCID: PMC2884104, DOI: 10.1158/0008-5472.can-09-0387.
- Rosenkrantz T, Sarkar S, Oh W. Polycythemia and fetal–maternal bleeding. 2009, 317-324. DOI: 10.1017/cbo9780511581281.030.
- Chan J, Oh W, Xie W, Regan M, Stampfer M, King I, Abe M, Kantoff P. Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer. Journal Of Clinical Oncology 2009, 27: 3577-3583. PMID: 19528373, PMCID: PMC2720077, DOI: 10.1200/jco.2008.18.8938.
- Choueiri T, Regan M, Oh W, Clement J, Amato A, McDermott D, Cho D, Atkins M, Signoretti S. Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy. Journal Of Clinical Oncology 2009, 27: e16067-e16067. DOI: 10.1200/jco.2009.27.15_suppl.e16067.
- Vinson J, Mathew P, Beer T, Carducci M, Oh W, Small E, Wilding G, Higano C, Hussain M, Scher H. Prostate cancer clinical trials consortium: A multicenter mechanism for the rapid design, development, and implementation of early phase clinical trials. Journal Of Clinical Oncology 2009, 27: e16065-e16065. DOI: 10.1200/jco.2009.27.15_suppl.e16065.
- Dial E, Duh M, Fournier A, Antras L, Rodermund D, Neary M, Oh W. Cost implications of intravenous bevacizumab treatment in patients with renal cell carcinoma (RCC): A retrospective claims database analysis. Journal Of Clinical Oncology 2009, 27: 5112-5112. DOI: 10.1200/jco.2009.27.15_suppl.5112.
- Oh W, Febbo P, Richie J, Fennessy F, Scibelli G, Hayes J, Choueiri T, Tempany C, Taplin M, Ross R. A phase II study of neoadjuvant chemotherapy with docetaxel and bevacizumab in patients (pts) with high-risk localized prostate cancer: A Prostate Cancer Clinical Trials Consortium trial. Journal Of Clinical Oncology 2009, 27: 5060-5060. DOI: 10.1200/jco.2009.27.15_suppl.5060.
- Ross R, Bankaitis-Davis D, Siconolfi L, Katz L, Storm K, Magidson J, Wassmann K, Oh W. Sensitivity and specificity of a whole-blood RNA transcript-based diagnostic test for the diagnosis of prostate cancer (CaP) compared with prostate-specific antigen (PSA) alone. Journal Of Clinical Oncology 2009, 27: 5052-5052. DOI: 10.1200/jco.2009.27.15_suppl.5052.
- Michaelson M, Regan M, Oh W, Kaufman D, Olivier K, Michaelson S, Spicer B, Gurski C, Kantoff P, Smith M. Phase II study of sunitinib in men with advanced prostate cancer. Annals Of Oncology 2009, 20: 913-920. PMID: 19403935, PMCID: PMC2674960, DOI: 10.1093/annonc/mdp111.
- Penney K, Salinas C, Pomerantz M, Schumacher F, Beckwith C, Lee G, Oh W, Sartor O, Ostrander E, Kurth T, Ma J, Mucci L, Stanford J, Kantoff P, Hunter D, Stampfer M, Freedman M. Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality. Clinical Cancer Research 2009, 15: 3223-3230. PMID: 19366828, PMCID: PMC2878092, DOI: 10.1158/1078-0432.ccr-08-2733.
- Ahlfors C, Vreman H, Wong R, Bender G, Oh W, Morris B, Stevenson D, Subcommittee T, Network O. Corrigendum to “Effects of sample dilution, peroxidise concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns” [Clinical Biochemistry 40 (2007) 261–267]. Clinical Biochemistry 2009, 42: 547. DOI: 10.1016/j.clinbiochem.2008.12.012.
- Priolo C, Oh W, Loda M. Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trials. IDrugs 2009, 12: 165-8. PMID: 19333896.
- Wadhawan R, Oh W, Perritt R, McDonald S, Das A, Poole W, Vohr B, Higgins R. Twin Gestation and Neurodevelopmental Outcome in Extremely Low Birth Weight Infants. Pediatrics 2009, 123: e220-e227. PMID: 19139085, PMCID: PMC2842087, DOI: 10.1542/peds.2008-1126.
- Sher D, Oh W. Reply. Urology 2009, 73: 362. DOI: 10.1016/j.urology.2008.09.016.
- Choueiri T, Xie W, D'Amico A, Ross R, Hu J, Pomerantz M, Regan M, Taplin M, Kantoff P, Sartor O, Oh W. Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy. Cancer 2009, 115: 981-987. PMID: 19152438, PMCID: PMC2931827, DOI: 10.1002/cncr.24064.
- Morris M, Basch E, Wilding G, Hussain M, Carducci M, Higano C, Kantoff P, Oh W, Small E, George D, Mathew P, Beer T, Slovin S, Ryan C, Logothetis C, Scher H. Department of Defense Prostate Cancer Clinical Trials Consortium: A New Instrument for Prostate Cancer Clinical Research. Clinical Genitourinary Cancer 2009, 7: 51-57. PMID: 19213669, PMCID: PMC3394090, DOI: 10.3816/cgc.2009.n.009.
- Sher D, Mantzoros C, Jacobus S, Regan M, Lee G, Oh W. Absence of Relationship Between Steroid Hormone Levels and Prostate Cancer Tumor Grade. Urology 2008, 73: 356-361. PMID: 19036418, DOI: 10.1016/j.urology.2008.07.068.
- Romanus D, Oh W, Cook F, Weeks J. PCN86 SYMPTOM PREVALENCE IN HORMONE REFRACTORY PROSTATE CANCER (HRPC). Value In Health 2008, 11: a487. DOI: 10.1016/s1098-3015(10)66623-5.
- Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O'Shea TM, McDavid GE, Perritt RL, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Pedroza C, Das A, Poole WK, Carlo WA, Duara S, Laptook AR, Salhab WA, Shankaran S, Poindexter BB, Fanaroff AA, Walsh MC, Rasmussen MR, Stoll BJ, Cotten CM, Donovan EF, Ehrenkranz RA, Guillet R, Higgins RD. Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight. New England Journal Of Medicine 2008, 359: 1885-1896. PMID: 18971491, PMCID: PMC2821221, DOI: 10.1056/nejmoa0803024.
- Rosenberg J, Oh W. What is the current status of second-line chemotherapy for castration-resistant prostate cancer? Nature Reviews Urology 2008, 5: 650-651. PMID: 18936787, DOI: 10.1038/ncpuro1232.
- Mathew P, Thall P, Wen S, Bucana C, Jones D, Horne E, Oh W, Morris M, Lee Y, Logothetis C, Lin S, Fidler I. Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer. British Journal Of Cancer 2008, 99: 1426-1432. PMID: 18841158, PMCID: PMC2579696, DOI: 10.1038/sj.bjc.6604706.
- Simon R, di Sant'Agnese P, Huang L, Xu H, Yao J, Yang Q, Liang S, Liu J, Yu R, Cheng L, Oh W, Palapattu G, Wei J, Huang J. CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers. Human Pathology 2008, 40: 252-258. PMID: 18835619, DOI: 10.1016/j.humpath.2008.07.014.
- Oh W, Sedin G. Introduction. Seminars In Perinatology 2008, 32: 323-324. PMID: 18929154, DOI: 10.1053/j.semperi.2008.08.005.
- Schurko B, Oh W. Docetaxel chemotherapy remains the standard of care in castration-resistant prostate cancer. Nature Reviews Clinical Oncology 2008, 5: 506-507. PMID: 18648352, DOI: 10.1038/ncponc1201.
- Sher D, Oh W, Jacobus S, Regan M, Lee G, Mantzoros C. Relationship between serum adiponectin and prostate cancer grade. The Prostate 2008, 68: 1592-1598. PMID: 18646046, DOI: 10.1002/pros.20823.
- Brick A, McDermott D, Clement J, Kwabi C, Shah K, Weiner J, Duh M, Neary M, Oh W, Choueiri T. Treatment discontinuations, dose reductions, and interruptions for angiogenesis inhibitor therapies in patients with metastatic renal cell carcinoma (mRCC). Journal Of Clinical Oncology 2008, 26: 14636-14636. DOI: 10.1200/jco.2008.26.15_suppl.14636.
- Dial E, Fournier A, Moyneur E, Neary M, Duh M, Oh W. Frequency and cost of adverse events in renal cell carcinoma (RCC) patients receiving angiogenesis inhibitor therapies. Journal Of Clinical Oncology 2008, 26: 14609-14609. DOI: 10.1200/jco.2008.26.15_suppl.14609.
- Pomerantz M, Beckwith C, Regan M, Xie W, Herman P, Chan J, Ardlie K, Oh W, Kantoff P, Freedman M. Quantitative gene expression at the 8q24 prostate cancer risk locus. Journal Of Clinical Oncology 2008, 26: 5055-5055. DOI: 10.1200/jco.2008.26.15_suppl.5055.
- Ross R, Manola J, Oh W, Ryan C, Kim J, Rastarhuyeva I, Yap J, Van Den Abbeele A, Kantoff P, Taplin M. Phase I trial of RAD001 (R) and docetaxel (D) in castration resistant prostate cancer (CRPC) with FDG-PET assessment of RAD001 activity. Journal Of Clinical Oncology 2008, 26: 5069-5069. DOI: 10.1200/jco.2008.26.15_suppl.5069.
- Taplin M, Ko Y, Regan M, Beer T, Carducci M, Mathew P, Bubley G, Oh W, Kantoff P, Balk S. Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC). Journal Of Clinical Oncology 2008, 26: 5068-5068. DOI: 10.1200/jco.2008.26.15_suppl.5068.
- Harrison M, Hahn N, Pili R, Oh W, Kim K, Wilding G, Sweeney C, Sidor C, Arnott J, Liu G. Phase II study of 2-methoxyestradiol (2ME2) NanoCrystal Dispersion (NCD) in patients with taxane-refractory, metastatic hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2008, 26: 5173-5173. DOI: 10.1200/jco.2008.26.15_suppl.5173.
- Jacobus S, Sher D, Regan M, Chamberland J, Oh W, Mantzoros C. Association between serum adiponectin and prostate cancer risk. Journal Of Clinical Oncology 2008, 26: 5147-5147. DOI: 10.1200/jco.2008.26.15_suppl.5147.
- Duh M, Fournier A, Moyneur E, Dial E, Neary M, Oh W. Dosing and switching patterns for renal cell carcinoma (RCC) patients receiving selected angiogenesis inhibitor therapies. Journal Of Clinical Oncology 2008, 26: 5111-5111. DOI: 10.1200/jco.2008.26.15_suppl.5111.
- Oh W, Leitzel K, Jacobus S, Vargas R, Regan M, Hamer P, Carney W, Ali S, Kantoff P, Lipton A. Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients. Journal Of Clinical Oncology 2008, 26: 11077-11077. DOI: 10.1200/jco.2008.26.15_suppl.11077.
- Clement J, McDermott D, Choueiri T, Brick A, Kwabi C, Shah K, Weiner J, Duh M, Neary M, Oh W. Patients with metastatic renal cell carcinoma (mRCC) receiving sunitinib in “real-world” clinical practice: Baseline characteristics and treatment efficacy. Journal Of Clinical Oncology 2008, 26: 16071-16071. DOI: 10.1200/jco.2008.26.15_suppl.16071.
- Oh W, Perritt R, Shankaran S, Merritts M, Donovan EF, Ehrenkranz RA, O'Shea TM, Tyson JE, Laptook R, Das A, Higgins RD. Association between Urinary Lactate to Creatinine Ratio and Neurodevelopmental Outcome in Term Infants with Hypoxic-Ischemic Encephalopathy. The Journal Of Pediatrics 2008, 153: 375-378.e2. PMID: 18534246, PMCID: PMC2953792, DOI: 10.1016/j.jpeds.2008.03.041.
- Fournier A, Duh, Moyneur É, Dial E, Neary M, Oh W. PUK15 COST IMPLICATIONS OF INTRAVENOUS (IV) BEVACIZUMAB TREATMENT IN PATIENTS WITH RENAL CELL CARCINOMA (RCC). Value In Health 2008, 11: a304-a305. DOI: 10.1016/s1098-3015(10)70960-8.
- Taplin M, Manola J, Oh W, Kantoff P, Bubley G, Smith M, Barb D, Mantzoros C, Gelmann E, Balk S. A phase II study of mifepristone (RU‐486) in castration‐resistant prostate cancer, with a correlative assessment of androgen‐related hormones. BJU International 2008, 101: 1084-1089. PMID: 18399827, DOI: 10.1111/j.1464-410x.2008.07509.x.
- Ross R, Oh W, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin M, Regan M, Kantoff P, Freedman M. Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer. Journal Of Clinical Oncology 2008, 26: 842-847. PMID: 18281655, DOI: 10.1200/jco.2007.13.6804.
- Ross R, Xie W, Regan M, Pomerantz M, Nakabayashi M, Daskivich T, Sartor O, Taplin M, Kantoff P, Oh W. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer. Cancer 2008, 112: 1247-1253. PMID: 18293426, DOI: 10.1002/cncr.23304.
- Keating N, O’Malley A, McNaughton‐Collins M, Oh W, Smith M. Use of androgen deprivation therapy for metastatic prostate cancer in older men. BJU International 2008, 101: 1077-1083. PMID: 18190632, PMCID: PMC2900629, DOI: 10.1111/j.1464-410x.2007.07405.x.
- Nakabayashi M, Sartor O, Jacobus S, Regan M, McKearn D, Ross R, Kantoff P, Taplin M, Oh W. Response to docetaxel/carboplatin‐based chemotherapy as first‐ and second‐line therapy in patients with metastatic hormone‐refractory prostate cancer. BJU International 2008, 101: 308-312. PMID: 18184327, DOI: 10.1111/j.1464-410x.2007.07331.x.
- Oh W, Guignard J, Baumgart S. Preface. 2008, xvii. DOI: 10.1016/b978-1-4160-3163-5.50006-3.
- Ross R, Beer T, Jacobus S, Bubley G, Taplin M, Ryan C, Huang J, Oh W. A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone‐refractory prostate cancer who are refractory to docetaxel. Cancer 2007, 112: 521-526. PMID: 18085595, DOI: 10.1002/cncr.23195.
- Bender G, Cashore W, Oh W. Ontogeny of Bilirubin-Binding Capacity and the Effect of Clinical Status in Premature Infants Born at Less Than 1300 Grams. Pediatrics 2007, 120: 1067-1073. PMID: 17974745, DOI: 10.1542/peds.2006-3024.
- Xie W, Nakabayashi M, Regan M, Oh W. Higher prostate‐specific antigen levels predict improved survival in patients with hormone‐refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Cancer 2007, 110: 2709-2715. PMID: 17960608, DOI: 10.1002/cncr.23111.
- Mathew P, Thall P, Bucana C, Oh W, Morris M, Jones D, Johnson M, Wen S, Pagliaro L, Tannir N, Tu S, Meluch A, Smith L, Cohen L, Kim S, Troncoso P, Fidler I, Logothetis C. Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases. Clinical Cancer Research 2007, 13: 5816-5824. PMID: 17908974, DOI: 10.1158/1078-0432.ccr-07-1269.
- Avigan D, Vasir B, George D, Oh W, Atkins M, McDermott D, Kantoff P, Figlin R, Vasconcelles M, Xu Y, Kufe D, Bukowski R. Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma. Journal Of Immunotherapy 2007, 30: 749-761. PMID: 17893567, DOI: 10.1097/cji.0b013e3180de4ce8.
- Daskivich T, Regan M, Oh W. Distinct Prognostic Role of Prostate-Specific Antigen Doubling Time and Velocity at Emergence of Androgen Independence in Patients Treated with Chemotherapy. Urology 2007, 70: 527-531. PMID: 17905110, DOI: 10.1016/j.urology.2007.04.035.
- Heller CD, O'Shea M, Yao Q, Langer J, Ehrenkranz RA, Phelps DL, Poole WK, Stoll B, Duara S, Oh W, Lemons J, Poindexter B. Human Milk Intake and Retinopathy of Prematurity in Extremely Low Birth Weight Infants. Pediatrics 2007, 120: 1-9. PMID: 17606555, DOI: 10.1542/peds.2006-1465.
- Nakabayashi M, Sartor O, Jacobus S, Regan M, McKearn D, Ross R, Kantoff P, Taplin M, Oh W. Response to docetaxel (D)/carboplatin (C)-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2007, 25: 5156-5156. DOI: 10.1200/jco.2007.25.18_suppl.5156.
- Oh W, Leitzel K, Kantoff P, Regan M, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali S, Lipton A. Elevated plasma TIMP-1 levels predict reduced survival in metastatic hormone-refractory prostate cancer patients. Journal Of Clinical Oncology 2007, 25: 5143-5143. DOI: 10.1200/jco.2007.25.18_suppl.5143.
- Samnotra V, Vassilopoulou-Sellin R, Fojo A, Oh W, LaRocca R, Ernstoff M, Memoli V, Cole B, Quinn D, Simmons P, Tretter C. A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC). Journal Of Clinical Oncology 2007, 25: 15527-15527. DOI: 10.1200/jco.2007.25.18_suppl.15527.
- Pomerantz M, Manola J, Taplin M, Bubley G, Inman M, Lowell J, Beard C, Kantoff P, Oh W. Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer. Journal Of Urology 2007, 177: 2146-2150. PMID: 17509304, DOI: 10.1016/j.juro.2007.01.119.
- Oh W. Editorial Comment. Journal Of Urology 2007, 177: 2145. DOI: 10.1016/j.juro.2007.01.265.
- Wadhawan R, Oh W, Perritt R, Laptook A, Poole K, Wright L, Fanaroff A, Duara S, Stoll B, Goldberg R. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. Journal Of Perinatology 2007, 27: 359-364. PMID: 17443198, DOI: 10.1038/sj.jp.7211751.
- Oh W. Timing of Umbilical Cord Clamping at Birth in Full-term Infants. JAMA 2007, 297: 1257-1258. PMID: 17374821, DOI: 10.1001/jama.297.11.1257.
- Nakabayashi M, Ling J, Xie W, Regan M, Oh W. Response to Vinorelbine With or Without Estramustine as Second-Line Chemotherapy in Patients with Hormone-Refractory Prostate Cancer. The Cancer Journal 2007, 13: 125-129. PMID: 17476141, DOI: 10.1097/ppo.0b013e3180465940.
- Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Daskivich T, Antràs L, Smith M, Neary M, Duh M. The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid. Cancer 2007, 109: 1090-1096. PMID: 17311345, DOI: 10.1002/cncr.22504.
- Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook R, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK, Network N. Trends in neonatal morbidity and mortality for very low birthweight infants. American Journal Of Obstetrics And Gynecology 2007, 196: 147.e1-147.e8. PMID: 17306659, DOI: 10.1016/j.ajog.2006.09.014.
- Clyman R, Saha S, Jobe A, Oh W. Indomethacin Prophylaxis for Preterm Infants: The Impact of 2 Multicentered Randomized Controlled Trials on Clinical Practice. The Journal Of Pediatrics 2007, 150: 46-50.e2. PMID: 17188612, PMCID: PMC1849955, DOI: 10.1016/j.jpeds.2006.09.001.
- Oh W, Tay M, Huang J. Is there a role for platinum chemotherapy in the treatment of patients with hormone‐refractory prostate cancer? Cancer 2006, 109: 477-486. PMID: 17186531, DOI: 10.1002/cncr.22439.
- STERNBERG C, KRAINER M, OH W, BRACARDA S, BELLMUNT J, OZEN H, ZLOTTA A, BEER T, OUDARD S, RAUCHENWALD M, SKONECZNA I, BORNER M, FITZPATRICK J. The medical management of prostate cancer: a multidisciplinary team approach. BJU International 2006, 99: 22-27. PMID: 16956362, DOI: 10.1111/j.1464-410x.2006.06477.x.
- Daskivich T, Regan M, Oh W. Prostate Specific Antigen Doubling Time Calculation: Not as Easy as 1, 2, 4. Journal Of Urology 2006, 176: 1927-1937. PMID: 17070213, DOI: 10.1016/j.juro.2006.07.002.
- Mathew P, Thall P, Wen S, Horne E, Johnson M, Oh W, Morris M, Logothetis C, Fidler I, Bucana C. 79 POSTER Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebocontrolled trial of docetaxel +/− imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM). European Journal Of Cancer Supplements 2006, 4: 28. DOI: 10.1016/s1359-6349(06)70085-4.
- Nakabayashi M, Beard C, Kelly S, Carr-Locke D, Oh W. Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer. Urologic Oncology Seminars And Original Investigations 2006, 24: 503-508. PMID: 17138131, DOI: 10.1016/j.urolonc.2006.02.002.
- Oh W, Poindexter B, Perrit R, Lemons J, Bauer C, Ehrenkranz R, Stoll B, Poole K, Wright L. Reply. The Journal Of Pediatrics 2006, 149: 732. DOI: 10.1016/j.jpeds.2006.05.043.
- Ahlfors C, Vreman H, Wong R, Bender G, Oh W, Morris B, Stevenson D, Subcommittee T, Network O. Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns. Clinical Biochemistry 2006, 40: 261-267. PMID: 17069786, PMCID: PMC1945224, DOI: 10.1016/j.clinbiochem.2006.09.006.
- Oh W. Preface. Hematology/Oncology Clinics Of North America 2006, 20: xiii-xiv. DOI: 10.1016/j.hoc.2006.07.001.
- Nakabayashi M, Xie W, Regan M, Jackman D, Kantoff P, Oh W. Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer. Cancer 2006, 107: 975-981. PMID: 16862573, DOI: 10.1002/cncr.22085.
- Michaelson M, Kaufman D, Kantoff P, Oh W, Smith M. Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer 2006, 107: 530-535. PMID: 16804927, DOI: 10.1002/cncr.22043.
- Nakabayashi M, Xie W, Regan M, Jackman D, Kantoff P, Oh W. Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Journal Of Clinical Oncology 2006, 24: 4646-4646. DOI: 10.1200/jco.2006.24.18_suppl.4646.
- Regan M, Daskivich T, Kantoff P, Oh W. Utility of prostate specific antigen doubling time (PSA-DT) at the start of androgen independent prostate cancer (AIPC) and immediately before chemotherapy in predicting efficacy of taxane chemotherapy. Journal Of Clinical Oncology 2006, 24: 4640-4640. DOI: 10.1200/jco.2006.24.18_suppl.4640.
- Daskivich T, Regan M, Kantoff P, Oh W. Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy. Journal Of Clinical Oncology 2006, 24: 4616-4616. DOI: 10.1200/jco.2006.24.18_suppl.4616.
- Mathew P, Thall P, Johnson M, Oh W, Meluch A, Morris M, Troncoso P, Bucana C, Fidler I, Logothetis C. Preliminary results of a randomized placebo-controlled double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM). Journal Of Clinical Oncology 2006, 24: 4562-4562. DOI: 10.1200/jco.2006.24.18_suppl.4562.
- Pomerantz M, Manola J, Taplin M, Bubley G, Inman M, Lowell J, Kantoff P, Oh W. Phase II study of low dose (LD) and high dose (HD) premarin in androgen independent prostate cancer (AIPC). Journal Of Clinical Oncology 2006, 24: 4560-4560. DOI: 10.1200/jco.2006.24.18_suppl.4560.
- Oh W, Manola J, Ross R, Berkowitz A, Ryan C, Eilers K, Beer T. A phase II trial of docetaxel plus carboplatin in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel chemotherapy: Preliminary results. Journal Of Clinical Oncology 2006, 24: 14533-14533. DOI: 10.1200/jco.2006.24.18_suppl.14533.
- Hayes J, Oh W, Kantoff P, Manola J, Smith M, Gelmann E, Bubley G, Balk S, Taplin M. Mifepristone (RU-486) in androgen independent prostate cancer. Journal Of Clinical Oncology 2006, 24: 14508-14508. DOI: 10.1200/jco.2006.24.18_suppl.14508.
- Smith M, Manola J, Kaufman D, Oh W, Bubley G, Kantoff P. Celecoxib Versus Placebo for Men With Prostate Cancer and a Rising Serum Prostate-Specific Antigen After Radical Prostatectomy and/or Radiation Therapy. Journal Of Clinical Oncology 2006, 24: 2723-2728. PMID: 16782912, DOI: 10.1200/jco.2005.03.7804.
- Nakabayashi M, Bartlett R, Oh W. Treatment of Bicalutamide-Induced Gynecomastia With Breast-Reduction Surgery in Prostate Cancer. Journal Of Clinical Oncology 2006, 24: 2958-2959. PMID: 16782932, DOI: 10.1200/jco.2005.03.8505.
- Gilligan T, Oh W, Kantoff P. Carboplatin for Stage I Seminoma. Journal Of Clinical Oncology 2006, 24: 2971-2972. PMID: 16782940, DOI: 10.1200/jco.2005.05.3231.
- Oh W, Manola J, Babcic V, Harnam N, Kantoff P. Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes. Urology 2006, 67: 1235-1240. PMID: 16765185, DOI: 10.1016/j.urology.2006.01.006.
- Oh W, Hayes J, Evan C, Manola J, George D, Waldron H, Donovan M, Varner J, Orechia J, Katcher B, Lu D, Nevins A, Wright R, Tormey L, Talcott J, Rubin M, Loda M, Sellers W, Richie J, Kantoff P, Weeks J. Development of an Integrated Prostate Cancer Research Information System. Clinical Genitourinary Cancer 2006, 5: 61-66. PMID: 16859581, DOI: 10.3816/cgc.2006.n.019.
- Oh W, Bard H. Introduction. Seminars In Perinatology 2006, 30: 113. DOI: 10.1053/j.semperi.2006.04.002.
- Daskivich T, Oh W. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms? Urology 2006, 67: 1084.e15-1084.e17. PMID: 16698377, DOI: 10.1016/j.urology.2005.11.015.
- Daskivich T, Oh W. Recent progress in hormonal therapy for advanced prostate cancer. Current Opinion In Urology 2006, 16: 173-178. PMID: 16679855, DOI: 10.1097/01.mou.0000193392.77469.e2.
- Mercer J, Vohr B, McGrath M, Padbury J, Wallach M, Oh W. Delayed Cord Clamping in Very Preterm Infants Reduces the Incidence of Intraventricular Hemorrhage and Late-Onset Sepsis: A Randomized, Controlled Trial. Pediatrics 2006, 117: 1235-1242. PMID: 16585320, PMCID: PMC1564438, DOI: 10.1542/peds.2005-1706.
- Nakabayashi M, Oh W. Chemotherapy for high‐risk localized prostate cancer. BJU International 2006, 97: 679-683. PMID: 16536752, DOI: 10.1111/j.1464-410x.2006.06092.x.
- Shankaran S, Laptook R, Ehrenkranz R, Tyson J, McDonald S, Donovan E, Fanaroff A, Poole W, Wright L, Higgins R, Finer N, Carlo W, Duara S, Oh W, Cotton C, Stevenson D, Stoll B, Lemons J, Guillet R, Jobe A. Whole-Body Hypothermia for Neonates With Hypoxic–Ischemic Encephalopathy. Obstetrical & Gynecological Survey 2006, 61: 158-159. DOI: 10.1097/01.ogx.0000201910.42613.6c.
- Benjamin D, Stoll B, Fanaroff A, McDonald S, Oh W, Higgins R, Duara S, Poole K, Laptook A, Goldberg R. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months. Pediatrics 2006, 117: 84-92. PMID: 16396864, DOI: 10.1542/peds.2004-2292.
- Febbo P, Thorner A, Rubin M, Loda M, Kantoff P, Oh W, Golub T, George D. Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer. Clinical Cancer Research 2006, 12: 152-158. PMID: 16397037, DOI: 10.1158/1078-0432.ccr-05-1652.
- Rosenberg J, Galsky M, Rohs N, Weinberg V, Oh W, Kelly W, Small E. A retrospective evaluation of second‐line chemotherapy response in hormone‐refractory prostate carcinoma. Cancer 2005, 106: 58-62. PMID: 16329138, DOI: 10.1002/cncr.21559.
- Oh W, Poindexter B, Perritt R, Lemons J, Bauer C, Ehrenkranz R, Stoll B, Poole K, Wright L, Network F. Association between Fluid Intake and Weight Loss during the First Ten Days of Life and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2005, 147: 786-790. PMID: 16356432, DOI: 10.1016/j.jpeds.2005.06.039.
- Oh W, Proctor K, Nakabayashi M, Evan C, Tormey L, Breierova L, Smith M, Neary M, Duh. CO4 A COMPARISON OF LOGISTIC REGRESSION AND COX PROPORTIONAL HAZARDS MODELS FOR IDENTIFICATION OF RISK FACTORS FOR RENAL IMPAIRMENT IN HORMONE REFRACTORY PROSTATE CANCER (HRPC) PATIENTS WITH BONE METASTASES (BM) TREATED WITH ZOLEDRONIC ACID (ZA). Value In Health 2005, 8: a16-a17. DOI: 10.1016/s1098-3015(10)67190-2.
- Oh W. Docetaxel in Hormone-Refractory Metastatic Prostate Cancer. Drugs 2005, 65: 2295-2297. DOI: 10.2165/00003495-200565160-00006.
- Shankaran S, Laptook R, Ehrenkranz R, Tyson J, McDonald S, Donovan E, Fanaroff A, Poole W, Wright L, Higgins R, Finer N, Carlo W, Duara S, Oh W, Cotten C, Stevenson D, Stoll B, Lemons J, Guillet R, Jobe A. Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy. New England Journal Of Medicine 2005, 353: 1574-1584. PMID: 16221780, DOI: 10.1056/nejmcps050929.
- Oh W. High-Risk Localized Prostate Cancer: Integrating Chemotherapy. The Oncologist 2005, 10: 18-22. PMID: 16272455, DOI: 10.1634/theoncologist.10-90002-18.
- Mercer J, Vohr B, Oh W. DELAYED CORD CLAMPING IN VERY PRETERM INFANTS REDUCES THE INCIDENCE OF INTRAVENTRICULAR HEMORRHAGE (IVH) AND LATE ONSET SEPSIS (LOS). Journal Of Midwifery & Women's Health 2005, 50: 439-439. DOI: 10.1016/j.jmwh.2005.04.012.
- Nakabayashi M, Regan M, Lifsey D, Kantoff P, Taplin M, Sartor O, Oh W. Efficacy of nilutamide as secondary hormonal therapy in androgen‐independent prostate cancer. BJU International 2005, 96: 783-786. PMID: 16153200, DOI: 10.1111/j.1464-410x.2005.05714.x.
- Naiman J, Rosenkrantz T, Oh W. Polycythemia and hyperviscosity in the newborn. 2005, 171-186. DOI: 10.1017/cbo9780511545306.011.
- Michael Cotten C, Oh W, McDonald S, Carlo W, Fanaroff A, Duara S, Stoll B, Laptook A, Poole K, Wright L, Goldberg R. Prolonged Hospital Stay for Extremely Premature Infants: Risk Factors, Center Differences, and the Impact of Mortality on Selecting a Best-Performing Center. Journal Of Perinatology 2005, 25: 650-655. PMID: 16079906, DOI: 10.1038/sj.jp.7211369.
- Mercer J, Vohr V, Oh W. 240 Delayed Cord Clamping in Very Low Birthweight Infants Reduces the Incidence of Intraventricular Hemorrhage and Late Onset Sepsis. Pediatric Research 2005, 58: 395-395. DOI: 10.1203/00006450-200508000-00269.
- Febbo P, Richie J, George D, Loda M, Manola J, Shankar S, Barnes A, Tempany C, Catalona W, Kantoff P, Oh W. Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer. Clinical Cancer Research 2005, 11: 5233-5240. PMID: 16033841, DOI: 10.1158/1078-0432.ccr-05-0299.
- Van Meurs K, Wright L, Ehrenkranz R, Lemons J, Ball M, Poole W, Perritt R, Higgins R, Oh W, Hudak M, Laptook R, Shankaran S, Finer N, Carlo W, Kennedy K, Fridriksson J, Steinhorn R, Sokol G, Konduri G, Aschner J, Stoll B, D'Angio C, Stevenson D. Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure. New England Journal Of Medicine 2005, 353: 13-22. PMID: 16000352, DOI: 10.1056/nejmoa043927.
- Stoll B, Hansen N, Higgins R, Fanaroff A, Duara S, Goldberg R, Laptook, Walsh M, Oh W, Hale E. Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis. The Pediatric Infectious Disease Journal 2005, 24: 635-639. PMID: 15999007, DOI: 10.1097/01.inf.0000168749.82105.64.
- Oh W, Manola J, Babcic V, Harnam N, Kantoff P. Response to second-line chemotherapy in patients with hormone refractory prostate cancer (HRPC) receiving two sequences of mitoxantrone (M) and taxanes (T). Journal Of Clinical Oncology 2005, 23: 4616-4616. DOI: 10.1200/jco.2005.23.16_suppl.4616.
- Nakabayashi M, Regan M, Lifsey D, Evan C, Kantoff P, Taplin M, Sartor O, Oh W. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer (AIPC). Journal Of Clinical Oncology 2005, 23: 4683-4683. DOI: 10.1200/jco.2005.23.16_suppl.4683.
- Michaelson M, Gilligan T, Oh W, Kantoff P, Taplin M, Izquierdo M, Flores L, Smith M. Phase II study of three hour, weekly infusion of trabectedin (ET-743) in men with metastatic, androgen-independent prostate carcinoma (AIPC). Journal Of Clinical Oncology 2005, 23: 4517-4517. DOI: 10.1200/jco.2005.23.16_suppl.4517.
- Oh W, George D, Tay M. Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy. Clinical Genitourinary Cancer 2005, 4: 61-64. PMID: 15992464, DOI: 10.3816/cgc.2005.n.014.
- Galsky M, Small E, Oh W, Chen I, Smith D, Colevas A, Martone L, Curley T, DeLaCruz A, Scher H, Kelly W. Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer. Journal Of Clinical Oncology 2005, 23: 1439-1446. PMID: 15735119, DOI: 10.1200/jco.2005.09.042.
- Hintz S, Poole W, Wright L, Fanaroff A, Kendrick D, Laptook A, Goldberg R, Duara S, Stoll B, Oh W. Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Archives Of Disease In Childhood Fetal & Neonatal 2005, 90: f128. PMID: 15724036, PMCID: PMC1721837, DOI: 10.1136/adc.2003.046268.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Jacobson J, Smith M, Kaufman D, Kantoff P. A Phase I Study of Estramustine, Weekly Docetaxel, and Carboplatin Chemotherapy in Patients with Hormone-Refractory Prostate Cancer. Clinical Cancer Research 2005, 11: 284-289. PMID: 15671557, DOI: 10.1158/1078-0432.284.11.1.
- Tay M, Oh W. Chapter 28 Metastatic Adenocarcinoma of the Prostate. 2005, 505-513. DOI: 10.1016/b978-0-7216-0003-1.50032-0.
- Ment LR, Vohr BR, Makuch RW, Westerveld M, Katz KH, Schneider KC, Duncan CC, Ehrenkranz R, Oh W, Philip AG, Scott DT, Allan WC. Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. The Journal Of Pediatrics 2004, 145: 832-834. PMID: 15580211, DOI: 10.1016/j.jpeds.2004.07.035.
- Oh W. AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER. Journal Of Urology 2004, 172: s34-s37. PMID: 15535440, DOI: 10.1097/01.ju.0000141674.92253.fe.
- CARROLL P, CHAN J, D’AMICO A, GELMANN E, IVERSEN P, KLOTZ L, NELSON J, NELSON P, NELSON W, OH W, ROSEN N, RUBIN M, SANDLER H, SELLERS W, SMITH M, XU J, McMANN M, KANTOFF P. FOURTH INTERNATIONAL CONFERENCE ON INNOVATIONS AND CHALLENGES IN PROSTATE CANCER. Journal Of Urology 2004, 172: s3-s5. PMID: 15535434, DOI: 10.1097/01.ju.0000142276.19511.ac.
- Nakabayashi M, Oh W. Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer. Current Treatment Options In Oncology 2004, 5: 349-355. PMID: 15341673, DOI: 10.1007/s11864-004-0025-3.
- Smith M, Manola J, Kaufman D, George D, Oh W, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff P. Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate‐specific antigen level after radical prostatectomy and/or radiation therapy. Cancer 2004, 101: 1569-1574. PMID: 15468186, DOI: 10.1002/cncr.20493.
- Kaufman D, Carducci M, Kuzel T, Todd M, Oh W, Smith M, Ye Z, Nicol S, Stadler W. A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer. Urologic Oncology Seminars And Original Investigations 2004, 22: 393-397. PMID: 15464919, DOI: 10.1016/j.urolonc.2004.01.002.
- Oh W, Kantoff P, Weinberg V, Jones G, Rini B, Derynck M, Bok R, Smith M, Bubley G, Rosen R, DiPaola R, Small E. Prospective, Multicenter, Randomized Phase II Trial of the Herbal Supplement, PC-SPES, and Diethylstilbestrol in Patients With Androgen-Independent Prostate Cancer. Journal Of Clinical Oncology 2004, 22: 3705-3712. PMID: 15289492, DOI: 10.1200/jco.2004.10.195.
- George D, Oh W, Gilligan T, Masson E, Souppart C, Wang Y, Ho Y, Lebwohl D, Laurent D, Kantoff P. Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4689-4689. DOI: 10.1200/jco.2004.22.90140.4689.
- Tay M, George D, Gilligan T, Kelly S, Appleby L, Taplin M, Febbo P, Kantoff P, Oh W. Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy. Journal Of Clinical Oncology 2004, 22: 4679-4679. DOI: 10.1200/jco.2004.22.90140.4679.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Smith M, Kaufman D, Kantoff P. A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4656-4656. DOI: 10.1200/jco.2004.22.90140.4656.
- Kelly W, Galsky M, Small E, Oh W, Chen I, Smith D, Martone L, Curley T, Delacruz A, Scher H. Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castrate-metastatic prostate cancer (PCMPC): Updated results. Journal Of Clinical Oncology 2004, 22: 4509-4509. DOI: 10.1200/jco.2004.22.90140.4509.
- George D, Oh W, Gilligan T, Masson E, Souppart C, Wang Y, Ho Y, Lebwohl D, Laurent D, Kantoff P. Phase I study of the novel, oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK): Evaluating the pharmacokinetic effect of a high-fat meal in patients with hormone-refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4689-4689. DOI: 10.1200/jco.2004.22.14_suppl.4689.
- Tay M, George D, Gilligan T, Kelly S, Appleby L, Taplin M, Febbo P, Kantoff P, Oh W. Docetaxel plus carboplatin (DC) may have significant activity in hormone refractory prostate cancer (HRPC) patients who have progressed after prior docetaxel-based chemotherapy. Journal Of Clinical Oncology 2004, 22: 4679-4679. DOI: 10.1200/jco.2004.22.14_suppl.4679.
- Oh W, Hagmann E, Manola J, George D, Gilligan T, Smith M, Kaufman D, Kantoff P. A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC). Journal Of Clinical Oncology 2004, 22: 4656-4656. DOI: 10.1200/jco.2004.22.14_suppl.4656.
- Kelly W, Galsky M, Small E, Oh W, Chen I, Smith D, Martone L, Curley T, Delacruz A, Scher H. Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castrate-metastatic prostate cancer (PCMPC): Updated results. Journal Of Clinical Oncology 2004, 22: 4509-4509. DOI: 10.1200/jco.2004.22.14_suppl.4509.
- Tay M, Kaufman D, Regan M, Leibowitz S, George D, Febbo P, Manola J, Smith M, Kaplan I, Kantoff P, Oh W. Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Annals Of Oncology 2004, 15: 974-978. PMID: 15151957, DOI: 10.1093/annonc/mdh221.
- Abe M, Manola J, Oh W, Parslow D, George D, Austin C, Kantoff P. Plasma Levels of Heat Shock Protein 70 in Patients with Prostate Cancer: A Potential Biomarker for Prostate Cancer. Clinical Genitourinary Cancer 2004, 3: 49-53. PMID: 15279691, DOI: 10.3816/cgc.2004.n.013.
- Poindexter B, Ehrenkranz R, Stoll B, Wright L, Poole W, Oh W, Bauer C, Papile L, Tyson J, Carlo W, Laptook A, Narendran V, Stevenson D, Fanaroff A, Korones S, Shankaran S, Finer N, Lemons J. Parenteral Glutamine Supplementation Does Not Reduce the Risk of Mortality or Late-Onset Sepsis in Extremely Low Birth Weight Infants. Pediatrics 2004, 113: 1209-1215. PMID: 15121931, DOI: 10.1542/peds.113.5.1209.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. To Tap or Not to Tap: High Likelihood of Meningitis Without Sepsis Among Very Low Birth Weight Infants. Pediatrics 2004, 113: 1181-1186. PMID: 15121927, DOI: 10.1542/peds.113.5.1181.
- Meadow W, Oh W, Vohr B, Tyson J, Fanaroff A, Stoll B, Ehrenkranz R, Carlo W, Shankaran S, Poole K, Perritt R, Wright L. Importance of Bilirubin Effect Questioned. Pediatrics 2004, 113: 627-628. PMID: 14993565, DOI: 10.1542/peds.113.3.627.
- Liu G, Gandara D, Lara P, Raghavan D, Doroshow J, Twardowski P, Kantoff P, Oh W, Kim K, Wilding G. A Phase II Trial of Flavopiridol (NSC #649890) in Patients with Previously Untreated Metastatic Androgen-Independent Prostate Cancer. Clinical Cancer Research 2004, 10: 924-928. PMID: 14871968, DOI: 10.1158/1078-0432.ccr-03-0050.
- George D, Regan M, Oh W, Tay M, Manola J, Decalo N, Duggan S, Dewolf W, Kantoff P, Bubley G. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology 2004, 63: 327-332. PMID: 14972483, DOI: 10.1016/j.urology.2003.09.059.
- Oh W, Halabi S, Kelly W, Werner C, Godley P, Vogelzang N, Small E, B F. A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma. Cancer 2003, 98: 2592-2598. PMID: 14669278, DOI: 10.1002/cncr.11829.
- Oh W. The Evolving Role of Chemotherapy and Other Systemic Therapies for Managing Localized Prostate Cancer. Journal Of Urology 2003, 170: s28-s34. PMID: 14610407, DOI: 10.1097/01.ju.0000095356.02647.64.
- CARROLL P, BENARON D, BLACKLEDGE G, COAKLEY F, D’AMICO A, HIGANO C, IVERSEN P, KATTAN M, NANUS D, NELSON J, OH W, ROACH M, SELLERS W, SMITH M, MCMANN M, KANTOFF P. Third International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. Journal Of Urology 2003, 170: s3-s5. PMID: 14610403, DOI: 10.1097/01.ju.0000095101.18470.a0.
- Oh W, Tyson J, Fanaroff A, Vohr B, Perritt R, Stoll B, Ehrenkranz R, Carlo W, Shankaran S, Poole K, Wright L. Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. Pediatrics 2003, 112: 773-779. PMID: 14523165, DOI: 10.1542/peds.112.4.773.
- LEIBOWITZ S, OH W. Overtreatment of a Patient With Presumed Recurrent Prostate Cancer Based on False-Positive Prostate Specific Antigen Results. Journal Of Urology 2003, 170: 1305. PMID: 14501750, DOI: 10.1097/01.ju.0000084670.47887.a5.
- Mercer J, McGrath M, Hensman A, Silver H, Oh W. Immediate and Delayed Cord Clamping in Infants Born Between 24 and 32 Weeks: A Pilot Randomized Controlled Trial. Journal Of Perinatology 2003, 23: 466-472. PMID: 13679933, DOI: 10.1038/sj.jp.7210970.
- Wadhawan R, Vohr B, Fanaroff A, Perritt R, Duara S, Stoll B, Goldberg R, Laptook, Poole K, Wright L, Oh W. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? American Journal Of Obstetrics And Gynecology 2003, 189: 501-506. PMID: 14520225, DOI: 10.1067/s0002-9378(03)00360-0.
- Bhayani S, Ong A, Oh W, Kantoff P, Kavoussi L. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology 2003, 62: 324-327. PMID: 12893344, DOI: 10.1016/s0090-4295(03)00324-8.
- Oh W, Manola J, Bittmann L, Brufsky A, Kaplan I, Smith M, Kaufman D, Kantoff P. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. Urology 2003, 62: 99-104. PMID: 12837431, DOI: 10.1016/s0090-4295(03)00145-6.
- Yu E, Oh W. Neoadjuvant therapy for high-risk localized prostate cancer. Current Oncology Reports 2003, 5: 250-257. PMID: 12667424, DOI: 10.1007/s11912-003-0118-3.
- Oh W, Kaplan I, Febbo P, Prisby J, Manola J, Kaufman D, Kantoff P. Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate Cancer: Feasibility and Toxicity. American Journal Of Clinical Oncology 2003, 26: 312. DOI: 10.1097/00000421-200306000-00021.
- Oh W, Kaplan I, Febbo P, Prisby J, Manola J, Kaufman D, Kantoff P. Neoadjuvant Doxil Chemotherapy Prior to Androgen Ablation Plus Radiotherapy for High-Risk Localized Prostate Cancer. American Journal Of Clinical Oncology 2003, 26: 312-316. PMID: 12796607, DOI: 10.1097/01.coc.0000020921.08768.1f.
- Leibowitz S, Garber J, Fox E, Loda M, Kaufman D, Kantoff P, Oh W. Male Patients with Diagnoses of Both Breast Cancer and Prostate Cancer. The Breast Journal 2003, 9: 208-212. PMID: 12752629, DOI: 10.1046/j.1524-4741.2003.09312.x.
- Oh W. Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints. Urologic Oncology Seminars And Original Investigations 2003, 21: 229-234. PMID: 12810211, DOI: 10.1016/s1078-1439(03)00019-x.
- Oh W, Tully P, Kantoff P, Regan M. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma. Cancer 2003, 97: 2171-2179. PMID: 12712468, DOI: 10.1002/cncr.11344.
- Poindexter B, Ehrenkranz R, Stoll B, Koch M, Wright L, Oh W, Papile L, Bauer C, Carlo W, Donovan E, Fanaroff A, Korones S, Laptook R, Shankaran S, Stevenson D, Tyson J, Lemons J, Network I. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants 1 , 2 , 3. American Journal Of Clinical Nutrition 2003, 77: 737-743. PMID: 12600870, DOI: 10.1093/ajcn/77.3.737.
- Lee D, Sartor O, Kosty M, Oh W. Highlights from the Third Annual Meeting of the Society of Urologic Oncology; Bethesda, Maryland, December 13-14, 2002. Clinical Genitourinary Cancer 2003, 1: 203-206. PMID: 15040876, DOI: 10.1016/s1540-0352(11)70002-6.
- Rosenkrantz T, Oh W. Polycythemia. 2003, 578-585. DOI: 10.1017/cbo9780511544774.030.
- Michaelson M, Kaufman D, Oh W. Transitional cell carcinoma of the upper uroepithelial tract. Clinical Advances In Hematology And Oncology 2003, 1: 102-4; discussion 105. PMID: 16224387.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth- Weight Infants. Obstetrical & Gynecological Survey 2003, 58: 17-18. DOI: 10.1097/00006254-200301000-00010.
- Oh W. Predicting Outcome in Localized Prostate Cancer: How Far Have We Come? Cancer Investigation 2003, 21: 487-488. PMID: 12901296, DOI: 10.1081/cnv-120018656.
- Oh W, Small E. Complementary and alternative therapies in prostate cancer. Seminars In Oncology 2002, 29: 575-584. PMID: 12516040, DOI: 10.1053/sonc.2002.50007.
- Smith M, Kaufman D, George D, Oh W, Kazanis M, Manola J, Kantoff P. Selective aromatase inhibition for patients with androgen‐independent prostate carcinoma. Cancer 2002, 95: 1864-1868. PMID: 12404279, DOI: 10.1002/cncr.10844.
- Carlo W, Stark A, Wright L, Tyson J, Papile L, Shankaran S, Donovan E, Oh W, Bauer C, Saha S, Poole W, Stoll B, Network* F. Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. The Journal Of Pediatrics 2002, 141: 370-375. PMID: 12219057, DOI: 10.1067/mpd.2002.127507.
- Oh W. The Evolving Role of Estrogen Therapy in Prostate Cancer. Clinical Genitourinary Cancer 2002, 1: 81-89. PMID: 15046698, DOI: 10.3816/cgc.2002.n.009.
- OH W. Secondary hormonal therapies in the treatment of prostate cancer. Urology 2002, 60: 87-92. PMID: 12231058, DOI: 10.1016/s0090-4295(02)01581-9.
- Carroll P, Kantoff P, Balk S, Brown M, D’amico A, George D, Grossfeld G, Johnson C, Kelly W, Klotz L, Lee W, Lubeck D, Mcleod D, Oh W, Pollack A, Sartor O, Smith M, Hart C. Overview consensus statement. Urology 2002, 60: 1-6. PMID: 12231036, DOI: 10.1016/s0090-4295(02)01559-5.
- Shankaran S, Laptook A, Wright L, Ehrenkranz R, Donovan E, Fanaroff A, Stark A, Tyson J, Poole K, Carlo W, Lemons J, Oh W, Stoll B, Papile L, Bauer C, Stevenson D, Korones S, McDonald S. Whole-Body Hypothermia for Neonatal Encephalopathy: Animal Observations as a Basis for a Randomized, Controlled Pilot Study in Term Infants. Pediatrics 2002, 110: 377-385. PMID: 12165594, DOI: 10.1542/peds.110.2.377.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh. W, Bauer C, Korones S, Shankaran S, Laptook A, Stevenson D, Papile L, Poole W. Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110: 285-291. PMID: 12165580, DOI: 10.1542/peds.110.2.285.
- Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R, Lemons J, Donovan E, Stark A, Tyson J, Oh W, Bauer C, Korones S, Shankaran S, Laptook R, Stevenson D, Papile L, Poole W. Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants. New England Journal Of Medicine 2002, 347: 240-247. PMID: 12140299, DOI: 10.1056/nejmoa012657.
- D'Amico A, Saegaert T, Chen M, Renshaw A, George D, Oh W, Kantoff P. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high‐risk prostate cancer. Cancer 2002, 95: 275-280. PMID: 12124826, DOI: 10.1002/cncr.10673.
- Shankaran S, Papile L, Wright L, Ehrenkranz R, Mele L, Lemons J, Korones S, Stevenson D, Donovan E, Stoll B, Fanaroff A, Oh W, Verter J. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure. American Journal Of Obstetrics And Gynecology 2002, 187: 171-177. PMID: 12114906, DOI: 10.1067/mob.2002.122445.
- Coyle M, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. The Journal Of Pediatrics 2002, 140: 561-564. PMID: 12032522, DOI: 10.1067/mpd.2002.123099.
- Shankaran S, Fanaroff A, Wright L, Stevenson D, Donovan E, Ehrenkranz R, Langer J, Korones S, Stoll B, Tyson J, Bauer C, Lemons J, Oh W, Papile L. Risk factors for early death among extremely low-birth-weight infants. American Journal Of Obstetrics And Gynecology 2002, 186: 796-802. PMID: 11967510, DOI: 10.1067/mob.2002.121652.
- OH W, LODA M, KANTOFF P, JANICEK M. PROGRESSIVE SCLEROSIS OF ISOLATED FOOT METASTASIS OF PROSTATE CANCER. Journal Of Urology 2002, 167: 1392. DOI: 10.1097/00005392-200203000-00047.
- OH W, LODA M, KANTOFF P, JANICEK M. PROGRESSIVE SCLEROSIS OF ISOLATED FOOT METASTASIS OF PROSTATE CANCER. Journal Of Urology 2002, 167: 1392. PMID: 11832744, DOI: 10.1016/s0022-5347(05)65312-8.
- Oh W, Small E. PC-SPES and prostate cancer. Urologic Clinics Of North America 2002, 29: 59-66. PMID: 12109356, DOI: 10.1016/s0094-0143(02)00017-4.
- Oh W, George D, Kantoff P. Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC‐SPES in patients with advanced prostate carcinoma. Cancer 2002, 94: 686-689. PMID: 11857300, DOI: 10.1002/cncr.10269.
- Oh W, Manola J, George D, Fierman A, Fontaine-Rothe P, Morrissey S, Prisby J, Kaufman D, Shapiro C, Kantoff P, Smith M. A Phase II Trial of Interferon-Alpha and Toremifene in Advanced Renal Cell Cancer Patients. Cancer Investigation 2002, 20: 186-191. PMID: 11901538, DOI: 10.1081/cnv-120001145.
- Stevenson D, Fanaroff A, Maisels M, Young B, Wong R, Vreman H, MacMahon J, Yeung C, Seidman D, Gale R, Oh W, Bhutani V, Johnson L, Kaplan M, Hammerman C, Nakamura H. Prediction of Hyperbilirubinemia in Near-Term and Term Infants. Journal Of Perinatology 2001, 21: s63-s72. PMID: 11803421, DOI: 10.1038/sj.jp.7210638.
- DAmico A, Saegart T, Chen M, Renshaw A, George D, Oh W, Kantoff P. The impact of anemia on psa outcome following radiation and androgen suppression therapy in patients with high-risk prostate cancer. International Journal Of Radiation Oncology • Biology • Physics 2001, 51: 113. DOI: 10.1016/s0360-3016(01)02031-4.
- Oh W, George D, Kaufman D, Moss K, Smith M, Richie J, Kantoff P. Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report. Seminars In Oncology 2001, 28: 40-44. PMID: 11685727, DOI: 10.1016/s0093-7754(01)90153-8.
- Vohr B, Oh W, Stewart E, Bentkover J, Gabbard S, Lemons J, Papile L, Pye R. Comparison of costs and referral rates of 3 universal newborn hearing screening protocols. The Journal Of Pediatrics 2001, 139: 238-244. PMID: 11487750, DOI: 10.1067/mpd.2001.115971.
- Oh W, George D, Kaufman D, Moss K, Smith M, Richie J, Kantoff P. Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report. Seminars In Oncology 2001, 28: 40-44. DOI: 10.1053/sonc.2001.26899.
- Stevenson D, Fanaroff A, Maisels M, Young B, Wong R, Vreman H, MacMahon J, Yeung C, Seidman D, Gale R, Oh W, Bhutani V, Johnson L, Kaplan M, Hammerman C, Nakamura H. Prediction of Hyperbilirubinemia in Near-Term and Term Infants. Pediatrics 2001, 108: 31-39. PMID: 11433051, DOI: 10.1542/peds.108.1.31.
- Hintz, Gaylord T, Oh W, Fanaroff A, Mele L, Stevenson D, NICHD N. Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula‐fed term infants delivered by cesarean section. Acta Paediatrica 2001, 90: 776-781. PMID: 11519981, DOI: 10.1111/j.1651-2227.2001.tb02804.x.
- Burgess G, Oh W, Brann B, Brubakk A, Stonestreet B. Effects of Phenobarbital on Cerebral Blood Flow Velocity After Endotracheal Suctioning in Premature Neonates. JAMA Pediatrics 2001, 155: 723-727. PMID: 11386965, DOI: 10.1001/archpedi.155.6.723.
- Stark A, Carlo W, Tyson J, Papile L, Wright L, Shankaran S, Donovan E, Oh W, Bauer C, Saha S, Poole W, Stoll B, Fanaroff A, Ehrenkranz R, Korones S, Stevenson D. Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants. New England Journal Of Medicine 2001, 344: 95-101. PMID: 11150359, DOI: 10.1056/nejm200101113440203.
- Kelly W, Curley T, Slovin S, Heller G, McCaffrey J, Bajorin D, Ciolino A, Regan K, Schwartz M, Kantoff P, George D, Oh W, Smith M, Kaufman D, Small E, Schwartz L, Larson S, Tong W, Scher H. Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. Journal Of Clinical Oncology 2001, 19: 44-53. PMID: 11134194, DOI: 10.1200/jco.2001.19.1.44.
- Gilligan T, Oh W. Overall Survival after Prostate‐Specific‐Antigen‐Detected Recurrence Following Conformal Radiation Therapy. The Prostate Journal 2001, 3: 43-44. DOI: 10.1046/j.1525-1411.2001.31007-2.x.
- Oh W, George D, Hackmann K, Manola J, Kantoff P. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology 2001, 57: 122-126. PMID: 11164156, DOI: 10.1016/s0090-4295(00)00986-9.
- Gilligan T, Oh W. Bicalutamide Monotherapy Compared with Castration in Patients with Nonmetastatic Locally Advanced Prostate Cancer: 6.3 Years of Follow‐up. The Prostate Journal 2001, 3: 42-43. DOI: 10.1046/j.1525-1411.2001.003001042.x.
- Lemons J, Bauer C, Oh W, Korones S, Papile L, Stoll B, Verter J, Temprosa M, Wright L, Ehrenkranz R, Fanaroff A, Stark A, Carlo W, Tyson J, Donovan E, Shankaran S, Stevenson D. Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996. Pediatrics 2001, 107: e1-e1. PMID: 11134465, DOI: 10.1542/peds.107.1.e1.
- Oh W. Anemia Related to Hormonal Ablation Therapy for Prostate Cancer. The Prostate Journal 2001, 3: 14-17. DOI: 10.1046/j.1525-1411.2001.003001014.x.
- Gilligan T, Oh W. Prospective Trial of the Herbal Supplement PC‐SPEC in Patients with Progressive Prostate Cancer. The Prostate Journal 2001, 3: 44-45. DOI: 10.1046/j.1525-1411.2001.31007-3.x.
- Gilligan T, Oh W. Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer. The Prostate Journal 2001, 3: 45-46. DOI: 10.1046/j.1525-1411.2001.31007-4.x.
- McGrath M, Sullivan M, Lester B, Oh W. Longitudinal Neurologic Follow-Up in Neonatal Intensive Care Unit Survivors With Various Neonatal Morbidities. Pediatrics 2000, 106: 1397-1405. PMID: 11099595, DOI: 10.1542/peds.106.6.1397.
- Stevenson D, Verter J, Fanaroff A, Oh W, Ehrenkranz R, Shankaran S, Donovan E, Wright L, Lemons J, Tyson J, Korones S, Bauer C, Stoll B, Papile L. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Archives Of Disease In Childhood Fetal & Neonatal 2000, 83: f182. PMID: 11040165, PMCID: PMC1721180, DOI: 10.1136/fn.83.3.f182.
- Smith M, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff P. Vinorelbine and estramustine in androgen‐independent metastatic prostate cancer. Cancer 2000, 89: 1824-1828. PMID: 11042579, DOI: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r.
- Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman D, Oh W, Demetri G, Figg W, Zhou X, Eng C, Spiegelman B, Kantoff P. Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer. Proceedings Of The National Academy Of Sciences Of The United States Of America 2000, 97: 10990-10995. PMID: 10984506, PMCID: PMC27136, DOI: 10.1073/pnas.180329197.
- George D, Paz‐Ares L, Oh W. Article Reviews. The Prostate Journal 2000, 2: 163-167. DOI: 10.1046/j.1525-1411.2000.23006.x.
- Oh W. Chemotherapy for patients with advanced prostate carcinoma. Cancer 2000, 88: 3015-3021. PMID: 10898346, DOI: 10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m.
- Goldstein M, Rehan V, Oh W, Stonestreet B. Cerebral and intestinal perfusion and metabolism in normocythemic hyperviscous hypoxic newborn pigs. Journal Of Applied Physiology 2000, 88: 2107-2115. PMID: 10846024, DOI: 10.1152/jappl.2000.88.6.2107.
- Kaufman D, Raghavan D, Carducci M, Levine E, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. Journal Of Clinical Oncology 2000, 18: 1921-7. PMID: 10784633, DOI: 10.1200/jco.2000.18.9.1921.
- Eder J, Kantoff P, Roper K, Xu G, Bubley G, Boyden J, Gritz L, Mazzara G, Oh W, Arlen P, Tsang K, Panicali D, Schlom J, Kufe D. A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clinical Cancer Research 2000, 6: 1632-8. PMID: 10815880.
- Reid P, Oh W. Article Reviews. The Prostate Journal 2000, 2: 102-105. DOI: 10.1046/j.1525-1411.2000.22008.x.
- Walsh-Sukys M, Tyson J, Wright L, Bauer C, Korones S, Stevenson D, Verter J, Stoll B, Lemons J, Papile L, Shankaran S, Donovan E, Oh W, Ehrenkranz R, Fanaroff A. Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. Pediatrics 2000, 105: 14-20. PMID: 10617698, DOI: 10.1542/peds.105.1.14.
- Oh W, Manola J, Renshaw A, Brodkin D, Loughlin K, Richie J, Shapiro C, Kantoff P. Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma. Urology 2000, 55: 31-35. PMID: 10654890, DOI: 10.1016/s0090-4295(99)00408-2.
- Kleinman M, Oh W, Stonestreet B. Comparison of intravenous and endotracheal epinephrine during cardiopulmonary resuscitation in newborn piglets. Critical Care Medicine 1999, 27: 2748-2754. PMID: 10628621, DOI: 10.1097/00003246-199912000-00024.
- Nelson J, Chen R, Bishoff J, Oh W, Kantoff P, Donehower R, Kavoussi L. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 1999, 54: 1064-1067. PMID: 10604709, DOI: 10.1016/s0090-4295(99)00289-7.
- Oh W, Kantoff P. Treatment of locally advanced prostate cancer: is chemotherapy the next step? Journal Of Clinical Oncology 1999, 17: 3664-75. PMID: 10550165, DOI: 10.1200/jco.1999.17.11.3664.
- Bubley G, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg W, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak D, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small E, Smith M, Trump D, Vollmer R, Wilding G. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. Journal Of Clinical Oncology 1999, 17: 3461-7. PMID: 10550143, DOI: 10.1200/jco.1999.17.11.3461.
- Stoll B, Temprosa M, Tyson J, Papile L, Wright L, Bauer C, Donovan E, Korones S, Lemons J, Fanaroff A, Stevenson D, Oh W, Ehrenkranz R, Shankaran S, Verter J. Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants. Pediatrics 1999, 104: e63-e63. PMID: 10545589, DOI: 10.1542/peds.104.5.e63.
- Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.Oh W, Kantoff P. Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer. Seminars In Oncology 1999, 26: 49-54. PMID: 10604270.
- Oh W, Manola J, Richie J, Loughlin K, Kantoff P. A phase II trial of methotrexate, cisplatin, 5‐fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma. Cancer 1999, 86: 1329-1334. PMID: 10506721, DOI: 10.1002/(sici)1097-0142(19991001)86:7<1329::aid-cncr31>3.0.co;2-r.
- Ehrenkranz R, Younes N, Lemons J, Fanaroff A, Donovan E, Wright L, Katsikiotis V, Tyson J, Oh W, Shankaran S, Bauer C, Korones S, Stoll B, Stevenson D, Papile L. Longitudinal Growth of Hospitalized Very Low Birth Weight Infants. Pediatrics 1999, 104: 280-289. PMID: 10429008, DOI: 10.1542/peds.104.2.280.
- Donovan E, Tyson J, Ehrenkranz R, Verter J, Wright L, Korones S, Bauer C, Shankaran S, Stoll B, Fanaroff A, Oh W, Lemons J, Stevenson D, Papile L, Network F. Inaccuracy of Ballard scores before 28 weeks’ gestation. The Journal Of Pediatrics 1999, 135: 147-152. PMID: 10431107, DOI: 10.1016/s0022-3476(99)70015-6.
- Reid P, Kantoff P, Oh W. Antiandrogens in Prostate Cancer. Investigational New Drugs 1999, 17: 271-284. PMID: 10665479, DOI: 10.1023/a:1006344807086.
- Yanowitz T, Yao A, Pettigrew K, Werner J, Oh W, Stonestreet B. Postnatal hemodynamic changes in very-low-birthweight infants. Journal Of Applied Physiology 1999, 87: 370-380. PMID: 10409597, DOI: 10.1152/jappl.1999.87.1.370.
- Oh W. Article Reviews. The Prostate Journal 1999, 1: 203-207. DOI: 10.1046/j.1525-1411.1999.14006.x.
- Smith M, Kantoff P, Oh W, Elson G, Manola J, McMullin M, Jacobsen J, Brufsky A, Kaufman D. Phase II Trial of the Antiestrogen Toremifene for Androgen‐Independent Prostate Cancer. The Prostate Journal 1999, 1: 185-189. DOI: 10.1046/j.1525-1411.1999.14003.x.
- Tyson J, Wright L, Oh W, Kennedy K, Mele L, Ehrenkranz R, Stoll B, Lemons J, Stevenson D, Bauer C, Korones S, Donovan E, Carlo W, Shankaran S, Stark A, Papile L, Jobe A, Stacewicz-Sapuntzakis M, Verter J, Fanaroff A. Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants. New England Journal Of Medicine 1999, 340: 1962-1968. PMID: 10379020, DOI: 10.1056/nejm199906243402505.
- Yanowitz T, Yao A, Hansen N, Oh W, Stonestreet B. Doppler Ultrasound Prediction of Cerebral Vascular Resistance: Relative Vascular Resistance Is More Accurate than Pourcelot's Index. Pediatric Research 1999, 45: 234-234. DOI: 10.1203/00006450-199904020-01393.
- The Effects of Low Dose Indomethacin Prophylaxis (LDIP) in Extremely Low Birth Weight (ELBW) InfantsOh W, Lemons J, Stevenson D, Poole K, Bauer C, Papile L, Korones S, Stoll B, Wright L. The Effects of Low Dose Indomethacin Prophylaxis (LDIP) in Extremely Low Birth Weight (ELBW) Infants. Pediatric Research 1999, 45: 216-216. DOI: 10.1203/00006450-199904020-01283.
- Lemons J, Stevenson D, Poole K, Bearden-Branch A, Bauer C, Papile L, Korones S, Stoll B, Oh W, Wright L. In Utero Magnesium Exposure: Effects on Extremely Low Birth Weight (ELBW) Infants. Pediatric Research 1999, 45: 207-207. DOI: 10.1203/00006450-199904020-01229.
- Kelly K, Gaudin P, Slovin S, Curley T, McCaffrey J, Ciolino A, Dalbagni G, Donat S, Scardino P, Scher H, Kantoff P, Smith M, Oh W, Smith D, Small E. PACLITAXEL(T), ESTRAMUSTINE(E) AND CARBOPLATIN(C) IN PATIENTS (Pts) WITH ADVANCED PROSTATE CANCER(PC). Journal Of Urology 1999, 161: 177.. DOI: 10.1097/00005392-199904010-00711.
- Kavoussi L, Nelson J, Chen R, Bishoff J, Donehower R, Oh W, Kantoff P. LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TESTICULAR TUMORS (NSGCT). Journal Of Urology 1999, 161: 4.. DOI: 10.1097/00005392-199904010-00018.
- Oh W. Article Reviews. The Prostate Journal 1999, 1: 103-108. DOI: 10.1046/j.1525-1411.1999.09916.x.
- Stevenson D, Wright L, Lemons J, Oh W, Korones S, Papile L, Bauer C, Stoll B, Tyson J, Shankaran S, Fanaroff A, Donovan E, Ehrenkranz R, Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. American Journal Of Obstetrics And Gynecology 1998, 179: 1632-1639. PMID: 9855609, DOI: 10.1016/s0002-9378(98)70037-7.
- OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER. Journal Of Urology 1998, 160: 1220-1229.. DOI: 10.1097/00005392-199810000-00003.
- OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS. Journal Of Urology 1998, 160: 1220-1229. PMID: 9751323, DOI: 10.1016/s0022-5347(01)62501-1.
- Stonestreet B, Ocampo S, Oh W. Reductions in cardiac output in hypoxic young pigs: systemic and regional perfusion and oxygen metabolism. Journal Of Applied Physiology 1998, 85: 874-882. PMID: 9729560, DOI: 10.1152/jappl.1998.85.3.874.
- Donovan E, Ehrenkranz R, Shankaran S, Stevenson D, Wright L, Younes N, Fanaroff A, Korones S, Stoll B, Tyson J, Bauer C, Lemons J, Oh W, Papile L, Network F. Outcomes of very low birth weight twins cared for in the National Institute of Child Health and Human Development Neonatal Research Network’s intensive care units. American Journal Of Obstetrics And Gynecology 1998, 179: 742-749. PMID: 9757982, DOI: 10.1016/s0002-9378(98)70075-4.
- Lin C, Gelardi N, M C, Oh W. Cerebral metabolic response to hypoglycemia in severe intrauterine growth-retarded rat pups. Early Human Development 1998, 52: 1-11. PMID: 9758243, DOI: 10.1016/s0378-3782(97)00124-2.
- FANAROFF A, KORONES S, WRIGHT L, VERTER J, POLAND R, BAUER C, TYSON J, PHILIPS J, EDWARDS W, LUCEY J, CATZ C, SHANKARAN S, OH W. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The Pediatric Infectious Disease Journal 1998, 17: 593-598. PMID: 9686724, DOI: 10.1097/00006454-199807000-00004.
- Lin C, Gelardi N, M C, Oh W. Cerebral metabolic response to hypoglycemia in severe intrauterine growth-retarded rat pups. Early Human Development 1998, 51: 147-157. PMID: 9605467, DOI: 10.1016/s0378-3782(97)00109-6.
- Papile L, Tyson J, Stoll B, Wright L, Donovan E, Bauer C, Krause-Steinrauf H, Verter J, Korones S, Lemons J, Fanaroff A, Stevenson D, Oh W, Ehrenkranz R, Shankaran S. A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants. New England Journal Of Medicine 1998, 338: 1112-1119. PMID: 9545359, DOI: 10.1056/nejm199804163381604.
- Tyson J, Ehrenkranz R, Stoll B, Wright L, Mele L, Kennedy K, Oh W, Lemons J, Stevenson D, Verter J. Vitamin (Vit.) A Supplementation to Increase Survival without Chronic Lung Disease (CLD) in Extremely Low Birth Weight (ELBW) Infants: A 14-Center Randomized Trial • 1161. Pediatric Research 1998, 43: 199-199. DOI: 10.1203/00006450-199804001-01182.
- Kennedy K, Tyson J, Mele L, Ehrenkranz R, Stoll B, Oh W, Wright L, Stevenson D, Lemons J, Verter J. How Should Normal Values be Defined and Used for an Abnormal Population? Complexities Highlighted in a Multicenter Trial of Vitamin A Supplementation to Prevent Chronic Lung Disease (CLD) among Extremely Low Birth Weight(ELBW;≤1000 g) Infants 528. Pediatric Research 1998, 43: 93-93. DOI: 10.1203/00006450-199804001-00549.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. The Journal Of Pediatrics 1998, 132: 28-34. PMID: 9469996, DOI: 10.1016/s0022-3476(98)70480-9.
- Bier J, Ferguson A, Morales Y, Liebling J, Oh W, Vohr B. Breastfeeding Infants Who Were Extremely Low Birth Weight. Pediatrics 1997, 100: e3-e3. PMID: 9382904, DOI: 10.1542/peds.100.6.e3.
- Meyer E, Kennally K, E Z, Cashore W, Oh W. Attitudes about sibling visitation in the neonatal intensive care unit. Dimensions Of Critical Care Nursing 1997, 16: 313. DOI: 10.1097/00003465-199711000-00008.
- The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm InfantsShankaran S, Papile L, Wright L, Ehrenkranz R, Mele L, Lemons J, Korones S, Stevenson D, Donovan E, Stoll B, Fanaroff A, Oh W, Verter J, Taylor G, Seibert J, DiPietro M. The Effect of Antenatal Phenobarbital Therapy on Neonatal Intracranial Hemorrhage in Preterm Infants. New England Journal Of Medicine 1997, 337: 466-471. PMID: 9250849, DOI: 10.1056/nejm199708143370705.
- Kennedy K, Stoll B, Ehrenkranz R, Oh W, Wright L, Stevenson D, Lemons J, Sowell A, Mele L, Tyson J, Verter J. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? Early Human Development 1997, 49: 19-31. PMID: 9179535, DOI: 10.1016/s0378-3782(97)01869-0.
- Kennedy K, Verter J, Tyson J, Stevenson D, Wright L, Stoll B, Oh W, Ehrenkranz R, Korones S, Bauer C, Papile L, Lemons J. CENTER DIFFERENCES IN SURVIVAL WITHOUT CHRONIC LUNG DISEASE (CLD) IN VERY-LOW-BIRTH-WEIGHT (VLBW) INFANTS ARE NOT EXPLAINED BY POPULATION DIFFERENCES, OR THE PRESENCE AND EARLY MANAGEMENT OF RESPIRATORY DISTRESS SYNDROME (RDS) • 1524. Pediatric Research 1997, 41: 256-256. DOI: 10.1203/00006450-199704001-01543.
- Wright L, Verter J, Stevenson D, Lemons J, Stoll B, Korones S, Bauer C, Papile L, Oh W. Increased antenatal glucocorticoid use decreases mortality and morbidity in the NICHD Neonatal Research Network's very low birth weight (VLBW) infants.• 1269. Pediatric Research 1997, 41: 214-214. DOI: 10.1203/00006450-199704001-01288.
- Stoll B, Verter J, Bauer C, Korones S, Lemons J, Oh W, Stevenson D, Papile L, Wright L. Racial Differences Among Very Low Birthweight (VLBW) Neonates. 1251. Pediatric Research 1997, 41: 211-211. DOI: 10.1203/00006450-199704001-01270.
- Yanowitz T, Yao A, Pettigrew K, Werner J, Oh W, Stonestreet B. Antenatal Steroids and Hemodynamic Maturation of Very Low Birth Weight (VLBW) Infants † 1114. Pediatric Research 1997, 41: 188-188. DOI: 10.1203/00006450-199704001-01133.
- Papile L, Fanaroff A, Verter J, Stevenson D, Korones S, Stoll B, Lemons J, Bauer C, Oh W, Wright L. PREDICTING NOSOCOMIAL BACTEREMIA IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS: UTILITY OF THE CRIB SCORE. † 998. Pediatric Research 1997, 41: 169-169. DOI: 10.1203/00006450-199704001-01017.
- Alemany C, Oh W, Stonestreet B. Effects of nitric oxide synthesis inhibition on mesenteric perfusion in young pigs. American Journal Of Physiology 1997, 272: g612-g616. PMID: 9124582, DOI: 10.1152/ajpgi.1997.272.3.g612.
- Kim C, Oh W, Stonestreet B. Magnesium is a cerebrovasodilator in newborn piglets. American Journal Of Physiology 1997, 272: h511-h516. PMID: 9038973, DOI: 10.1152/ajpheart.1997.272.1.h511.
- Farrag H, Nawrath L, Healey J, Dorcus E, Rapoza R, Oh W, Cowett R. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. American Journal Of Physiology 1997, 272: e86-e93. PMID: 9038856, DOI: 10.1152/ajpendo.1997.272.1.e86.
- Bier J, Ferguson A, Morales Y, Liebling J, Archer D, Oh W, Vohr B. Comparison of Skin-to-Skin Contact With Standard Contact in Low-Birth-Weight Infants Who Are Breast-Fed. JAMA Pediatrics 1996, 150: 1265-1269. PMID: 8953998, DOI: 10.1001/archpedi.1996.02170370043006.
- Ment L, Vohr B, Oh W, Scott D, Allan W, Westerveld M, Duncan C, Ehrenkranz R, Katz K, Schneider K, Makuch R. Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 1996, 98: 714-8. PMID: 8885951, DOI: 10.1542/peds.98.4.714.
- Meyer E, Kennally K, Zika-Beres E, Cashore W, Oh W. Attitudes About Sibling Visitation in the Neonatal Intensive Care Unit. JAMA Pediatrics 1996, 150: 1021-1026. PMID: 8859132, DOI: 10.1001/archpedi.1996.02170350023003.
- Coll C, Halpern L, Seifer R, Meyer E, Kilis E, Lester B, Vohr B, Oh W. Behavioral intervention and post-natal growth in full-term intrauterine growth retarded (IUGR) infants. Early Human Development 1996, 46: 105-116. PMID: 8899359, DOI: 10.1016/0378-3782(96)01748-3.
- Napiorkowski B, Lester B, Freier M, Brunner S, Dietz L, Nadra A, Oh W. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 1996, 98: 71-5. PMID: 8668415, DOI: 10.1542/peds.98.1.71.
- Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal Of Pediatrics 1996, 129: 72-80. PMID: 8757565, DOI: 10.1016/s0022-3476(96)70192-0.
- Stoll B, Gordon T, Korones S, Shankaran S, Tyson J, Bauer C, Fanaroff A, Lemons J, Donovan E, Oh W, Stevenson D, Ehrenkranz R, Papile L, Verter J, Wright L. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal Of Pediatrics 1996, 129: 63-71. PMID: 8757564, DOI: 10.1016/s0022-3476(96)70191-9.
- Vreman H, Verter J, Oh W, Fanaroff A, Wright L, Lemons J, Shankaran S, Tyson J, Korones S, Bauer C, Stoll B, Papile L, Donovan E, Ehrenkranz R, Stevenson D. Interlaboratory variability of bilirubin measurements. Clinical Chemistry 1996, 42: 869-873. PMID: 8665677, DOI: 10.1093/clinchem/42.6.869.
- Ment L, Oh W, Ehrenkranz R, Allan W. Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent intraventricular hemorrhage. Pediatrics 1996, 97: 601. PMID: 8632956.
- Lemons J, Stevenson D, Vreman H, Oh W, Fanaroff A, Mele L, Wright L. SERUM BILIRUBIN, BILIRUBIN PRODUCTION AND WEIGHT LOSS IN BREAST-FED ONLY OR FORMULA-FED ONLY WELL TERM INFANTS. † 1871. Pediatric Research 1996, 39: 314-314. DOI: 10.1203/00006450-199604001-01895.
- Meyer E, Coll C, Halpern L, Leach T, Ramos A, Ristow R, Oh W. FULL-TERM SMALL FOR GESTATIONAL AGE (SGA) INFANTS HAVE POORER MOTHER-INFANT INTERACTIONS AT 8 MONTHS AND LOWER VERBAL IQ AT 3 YEARS THAN APPROPRIATE FOR GESTATIONAL AGE (AGA) INFANTS. † 1622. Pediatric Research 1996, 39: 273-273. DOI: 10.1203/00006450-199604001-01645.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. EFFECTS OF LOW DOSE PROPHYLACTIC INDOMETHACIN (plndo) ON HEMODYNAMICS IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS. † 1512. Pediatric Research 1996, 39: 255-255. DOI: 10.1203/00006450-199604001-01535.
- Yanowitz T, Yao A, Werner J, Pettigrew K, Oh W, Stonestreet B. HEMODYNAMIC MATURATION IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS.† 1511. Pediatric Research 1996, 39: 254-254. DOI: 10.1203/00006450-199604001-01534.
- Wright L, Verter J, Stevenson D, Korones S, Bauer C, Oh W, Papile L, Tyson J, Lemons J, Stoll B. IMPACT OF THE NIH CONSENSUS DEVELOPMENT CONFERENCE ON CORTICOSTEROIDS FOR FETAL MATURATION: INCREASED ANTENATAL STEROID USE IN NICHD NETWORK VLBW INFANTS. † 1507. Pediatric Research 1996, 39: 254-254. DOI: 10.1203/00006450-199604001-01530.
- Oh W, Fanaroff A, Verter J, Stevenson D, Papile L, Stoll B, Lemons J, Bauer C, Wright L. NEONATAL MORTALITY AND MORBIDITIES IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS: A SEVEN-YEAR TREND ANALYSIS OF THE NEONATAL RESEARCH NETWORK DATA. † 1392. Pediatric Research 1996, 39: 235-235. DOI: 10.1203/00006450-199604001-01415.
- Lemons J, Stevenson D, Verter J, Bauer C, Papile L, Korones S, Stoll B, Oh W, Wright L. IN UTERO MAGNESIUM EXPOSURE: RISK OF DEATH AND OF INTRAVENTRICULAR HEMORRHAGE (IVH) IN VERY LOW BIRTH WEIGHT (VLBW) INFANTS. • 1336. Pediatric Research 1996, 39: 225-225. DOI: 10.1203/00006450-199604001-01359.
- Kang S, Katz K, Ment L, Oh W. EFFECTS OF INCREASED USE OF LOW-DOSE PROPHYLACTIC INDOMETHACIN AND ANTENATAL STEROIDS ON NEONATAL OUTCOMES AMONG VLBW INFANTS. † 1305. Pediatric Research 1996, 39: 220-220. DOI: 10.1203/00006450-199604001-01328.
- Bier J, Ferguson A, Morales Y, Liebling J, Oh W, Vohr B. BREAST-FEEDING IMPROVES PHYSIOLOGIC STATES OF EXTREMELY-LOW-BIRTH-WEIGHT(ELBW) INFANTS (≤800 gms). † 598. Pediatric Research 1996, 39: 102-102. DOI: 10.1203/00006450-199604001-00619.
- AbuLaimoun B, Gelardi N, Cashore W, Oh W, Peter G. IMMUNE RESPONSE OF PRETERM INFANTS TO HEPATITIS B ˙VACCINE.† 595. Pediatric Research 1996, 39: 102-102. DOI: 10.1203/00006450-199604001-00616.
- Levy A, Coll C, Meyer E, Seifer R, Leach T, Ramos A, Oh W. Mother-infant interaction in preterm infants: Influences of biological and environmental risk. Infant Behavior And Development 1996, 19: 574. DOI: 10.1016/s0163-6383(96)90628-1.
- Meyer E, Coll C, Seifer R, Kilis E, Ramos A, Kelly L, Oh W. Feeding interactions of preterm small for gestational age infants and their mothers. Infant Behavior And Development 1996, 19: 619. DOI: 10.1016/s0163-6383(96)90673-6.
- MEYER E, COLL C, SEIFER R, RAMOS A, KILIS E, OH W. Psychological Distress in Mothers of Preterm Infants. Journal Of Developmental And Behavioral Pediatrics 1995, 16: 412-417. PMID: 8746550, DOI: 10.1097/00004703-199512000-00004.
- Fanaroff A, Wright L, Stevenson D, Shankaran S, Donovan E, Ehrenkranz R, Younes N, Korones S, Stoll B, Tyson J, Bauer C, Oh W, Lemons J, Papile L, Verter J. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. American Journal Of Obstetrics And Gynecology 1995, 173: 1423-1431. PMID: 7503180, DOI: 10.1016/0002-9378(95)90628-2.
- Coyle M, Oh W, Petersson K, Stonestreet B. Effects of indomethacin on brain blood flow, cerebral metabolism, and sagittal sinus prostanoids after hypoxia. American Journal Of Physiology 1995, 269: h1450-h1459. PMID: 7485580, DOI: 10.1152/ajpheart.1995.269.4.h1450.
- Lee C, Stonestreet B, Oh W, Outerbridge E, Cashore W. Postnatal maturation of the blood-brain barrier for unbound bilirubin in newborn piglets. Brain Research 1995, 689: 233-238. PMID: 7583326, DOI: 10.1016/0006-8993(95)00572-8.
- Lester B, Boukydis C, Garcia-Coll C, Peucker M, McGrath M, Vohr B, Brem F, Oh W. Developmental outcome as a function of the goodness of fit between the infant's cry characteristics and the mother's perception of her infant's cry. Pediatrics 1995, 95: 516-21. PMID: 7700751, DOI: 10.1542/peds.95.4.516.
- Ment L, Oh W, Ehrenkranz R, Philip A, Duncan C, Makuch R. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. American Journal Of Obstetrics And Gynecology 1995, 172: 795-800. PMID: 7892866, DOI: 10.1016/0002-9378(95)90001-2.
- Porcelli P, Oh W. Effects of Single Dose Calcium Gluconate Infusion in Hypocalcemic Preterm Infants. American Journal Of Perinatology 1995, 12: 18-21. PMID: 7710569, DOI: 10.1055/s-2007-994391.
- Partyka C, Gelardi N, Fadden K, Rifai A, Gruppuso P, Oh W, Reddy G. Lack of Production and Growth-Modulating Effects of 1α,25-Dihydroxyvitamin D3 in Cultured Fetal Rat Hepatocytes. Neonatology 1995, 67: 194-202. PMID: 7640319, DOI: 10.1159/000244163.
- Blaymore‐Bier J, Pezzullo J, Kim E, Oh W, Garcia‐Coll C, Vohr B. Outcome of extremely low‐birth‐weight infants: 1980–1990. Acta Paediatrica 1994, 83: 1244-1248. PMID: 7734862, DOI: 10.1111/j.1651-2227.1994.tb13005.x.
- Stevenson D, Vreman H, Oh W, Fanaroff A, Wright L, Lemons J, Verter J, Shankaran S, Tyson J, Korones S. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clinical Chemistry 1994, 40: 1934-1939. PMID: 7923775, DOI: 10.1093/clinchem/40.10.1934.
- Vreman H, Stevenson D, Oh W, Fanaroff A, Wright L, Lemons J, Wright E, Shankaran S, Tyson J, Korones S. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clinical Chemistry 1994, 40: 1927-1933. PMID: 7923774, DOI: 10.1093/clinchem/40.10.1927.
- BRANN B, MAYFIELD S, GOLDSTEIN M, OH W, STONESTREET B. Cardiovascular effects of hypoxia/hypercarbia and tension pneumothorax in newborn piglets. Critical Care Medicine 1994, 22: 1453-1460. PMID: 8062569, DOI: 10.1097/00003246-199409000-00016.
- Ment L, Oh W, Ehrenkranz R, Philip A, Vohr B, Allan W, Dunean C, Scott D, Taylor K, Katz K, Schneider K, Makuch R. Low-Dose Indomethacin and Prevention of Intraventricular Hemorrhage. Obstetrical & Gynecological Survey 1994, 49: 613-614. DOI: 10.1097/00006254-199409000-00011.
- Ment L, Oh W, Ehrenkranz R, Phillip A, Vohr B, Allan W, Makuch R, Taylor K, Schneider K, Katz K, Scott D, Duncan C. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trial. The Journal Of Pediatrics 1994, 124: 951-955. PMID: 8201485, DOI: 10.1016/s0022-3476(05)83191-9.
- Fanaroff A, Korones S, Wright L, Wright E, Poland R, Bauer C, Tyson J, Philips J, Edwards W, Lucey J, Catz C, Shankaran S, Oh W. A Controlled Trial of Intravenous Immune Globulin to Reduce Nosocomial Infections in Very-Low-Birth-Weight Infants. New England Journal Of Medicine 1994, 330: 1107-1113. PMID: 8133853, DOI: 10.1056/nejm199404213301602.
- Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.Ment L, Ehrenkranz R, Duncan C, Scott D, Taylor K, Katz K, Schneider K, Makuch R, Oh W, Vohr B, Philip A, Allan W. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994, 93: 543-50. PMID: 8134206, DOI: 10.1542/peds.93.4.543.
- Bauer K, Cowett R, Oh W. Postnatal solid accretion in preterm infants is similar to that reported in utero, but may be overestimated by energy balance techniques. Seminars In Perinatology 1994, 18: 11-4. PMID: 8209280.
- Meyer E, Coll C, Lester B, Boukydis C, McDonough S, Oh W. Family-based intervention improves maternal psychological well-being and feeding interaction of preterm infants. Pediatrics 1994, 93: 241-6. PMID: 8121735, DOI: 10.1542/peds.93.2.241.
- Bier J, Ferguson A, Anderson L, Solomon E, Voltas C, Oh W, Vohr B. Breast-feeding of very low birth weight infants. The Journal Of Pediatrics 1993, 123: 773-778. PMID: 8229489, DOI: 10.1016/s0022-3476(05)80858-3.
- Curran T, Bahner R, Oh W, Gruppuso P. Mitogen-Independent DNA Synthesis by Fetal Rat Hepatocytes in Primary Culture. Experimental Cell Research 1993, 209: 53-57. PMID: 8224006, DOI: 10.1006/excr.1993.1284.
- LESTER B, CUCCA J, ANDREOZZI L, FLANAGAN P, OH W. Possible Association between Fluoxetine Hydrochloride and Colic in an Infant. Journal Of The American Academy Of Child & Adolescent Psychiatry 1993, 32: 1253-1255. PMID: 8282672, DOI: 10.1097/00004583-199311000-00020.
- Horbar J, Wright L, Soll R, Wright E, Fanaroff A, Korones S, Shankaran S, Oh W, Fletcher B, Bauer C, Tyson J, Lemons J, Donovan E, Stoll B, Stevenson D, Papile L, Philips J, Network I. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. The Journal Of Pediatrics 1993, 123: 757-766. PMID: 8229487, DOI: 10.1016/s0022-3476(05)80856-x.
- Ment L, Oh W, Ehrenkranz R, Philip A, Schneider K, Katz K, Taylor K, Duncan C, Makuch R. Risk period for intraventricular hemorrhage of the preterm neonate is independent of gestational age. Seminars In Perinatology 1993, 17: 338-41. PMID: 8290976.
- Sung I, Vohr B, Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. The Journal Of Pediatrics 1993, 123: 618-624. PMID: 7692029, DOI: 10.1016/s0022-3476(05)80965-5.
- Bier J, Ferguson A, Cho C, Oh W, Vohr B. The Oral Motor Development of Low-Birth-Weight Infants Who Underwent Orotracheal Intubation During the Neonatal Period. JAMA Pediatrics 1993, 147: 858-862. PMID: 7688931, DOI: 10.1001/archpedi.1993.02160320060020.
- Bauer K, Cowett R, Howard G, vanEpp J, Oh W. Effect of intrauterine growth retardation on postnatal weight change in preterm infants. The Journal Of Pediatrics 1993, 123: 301-306. PMID: 8345431, DOI: 10.1016/s0022-3476(05)81707-x.
- Chen S, Vohr B, Oh W. Effects of birth order, gender, and intrauterine growth retardation on the outcome of very low birth weight in twins. The Journal Of Pediatrics 1993, 123: 132-136. PMID: 8320607, DOI: 10.1016/s0022-3476(05)81556-2.
- Hansen T, Wallach M, Dey A, Boivin P, Vohr B, Oh W. Prognostic value of clinical and radiological status on day 28 of life for subsequent course in very low birthweight (< 1,500g) babies with bronchopulmonary dysplasia. Pediatric Pulmonology 1993, 15: 327-331. PMID: 8337009, DOI: 10.1002/ppul.1950150603.
- VOHR B, COLL C, FLANAGAN P, OH W. Effects of Intraventricular Hemorrhage and Socioeconomic Status on Perceptual, Cognitive, and Neurologic Status of Low Birth Weight Infants at 5 Years of Age. Obstetrical & Gynecological Survey 1993, 48: 176-178. DOI: 10.1097/00006254-199303000-00012.
- Coyle M, Oh W, Stonestreet B. Effects of indomethacin on brain blood flow and cerebral metabolism in hypoxic newborn piglets. American Journal Of Physiology 1993, 264: h141-h149. PMID: 8430841, DOI: 10.1152/ajpheart.1993.264.1.h141.
- Hansen T, Maynard E, Cashore W, Oh W. Endotoxemia and Brain Bilirubin in the Rat. Neonatology 1993, 63: 171-176. PMID: 8324097, DOI: 10.1159/000243928.
- Yunis K, Oh W, Kalhan S, Cowett R. Glucose kinetics following administration of an intravenous fat emulsion to low-birth-weight neonates. American Journal Of Physiology 1992, 263: e844-e849. PMID: 1443115, DOI: 10.1152/ajpendo.1992.263.5.e844.
- Hansen T, Cashore W, Oh W. Changes in Piglet Auditory Brainstem Response Amplitudes without Increases in Serum or Cerebrospinal Fluid Neuron-Specific Enolase. Pediatric Research 1992, 32: 524-529. PMID: 1480452, DOI: 10.1203/00006450-199211000-00005.
- Ment L, Oh W, Philip A, Ehrenkranz R, Duncan C, Allan W, Taylor K, Schneider K, Katz K, Makuch R. Risk factors for early intraventricular hemorrhage in low birth weight infants. The Journal Of Pediatrics 1992, 121: 776-783. PMID: 1432433, DOI: 10.1016/s0022-3476(05)81915-8.
- Vohr B, Coll C, Flanagan P, Oh W. Effects of intraventricular hemorrhage and socioeconomic status on perceptual, cognitive, and neurologic status of low birth weight infants at 5 years of age. The Journal Of Pediatrics 1992, 121: 280-285. PMID: 1640298, DOI: 10.1016/s0022-3476(05)81204-1.
- Malone T, Stonestreet B, Goddard M, Sicard R, Werner J, Oh W. Atrial Natriuretic Peptide in Newborn Piglets with a Patent Ductus arteriosus. Neonatology 1992, 19: 155-160. PMID: 1340436, DOI: 10.1159/000457477.
- Coll C, Halpern L, Vohr B, Seifer R, Oh W. Stability and correlates of change of early temperament in preterm and full-term infants. Infant Behavior And Development 1992, 15: 137-153. DOI: 10.1016/0163-6383(92)80020-u.
- Werner J, Sicard R, Hansen T, Solomon E, Cowett R, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. The Journal Of Pediatrics 1992, 120: 286-291. PMID: 1735831, DOI: 10.1016/s0022-3476(05)80446-9.
- Barefield E, Oh W, Stonestreet B. Group B Streptococcus-induced acidosis in newborn swine: regional oxygen transport and lactate flux. Journal Of Applied Physiology 1992, 72: 272-277. PMID: 1537725, DOI: 10.1152/jappl.1992.72.1.272.
- Gruppuso P, Curran T, Mead J, Fausto N, Oh W. Fetal Growth Factors as Determinants of Intrauterine Hepatic Growth. Diabetes 1991, 40: 51-55. PMID: 1660827, DOI: 10.2337/diab.40.2.s51.
- Monin P, Stonestreet B, Oh W. Hyperventilation Restores Autoregulation of Cerebral Blood Flow in Postictal Piglets. Pediatric Research 1991, 30: 294-298. PMID: 1945571, DOI: 10.1203/00006450-199109000-00020.
- Vohr B, Coll C, Lobato D, Yunis K, O'Dea C, Oh W. NEURODEVELOPMENTAL AND MEDICAL STATUS OF LOW‐BIRTHWEIGHT SURVIVORS OF BRONCHOPULMONARY DYSPLASIA AT 10 TO 12 YEARS OF AGE. Developmental Medicine & Child Neurology 1991, 33: 690-697. PMID: 1717327, DOI: 10.1111/j.1469-8749.1991.tb14946.x.
- GELARDI N, CHA C, OH W. Evaluation of Insulin Sensitivity in Obese Offspring of Diabetic Rats by Hyperinsulinemic-Euglycemic Clamp Technique. Pediatric Research 1991, 30: 40???44. DOI: 10.1203/00006450-199107010-00008.
- Gelardi N, Cha C, Oh W. Evaluation of Insulin Sensitivity in Obese Offspring of Diabetic Rats by Hyperinsulinemic-Euglycemic Clamp Technique. Pediatric Research 1991, 30: 40-44. PMID: 1891280, DOI: 10.1203/00006450-199107000-00008.
- Oh W, Gelardi N, Cha C. The Cross-Generation Effect of Neonatal Macrosomia in Rat Pups of Streptozotocin-Induced Diabetes. Pediatric Research 1991, 29: 606-610. PMID: 1866217, DOI: 10.1203/00006450-199106010-00016.
- Vohr B, Oh W, Cashore W. Reply. The Journal Of Pediatrics 1991, 118: 653. DOI: 10.1016/s0022-3476(05)83399-2.
- Ju S, Lester B, Coll C, Oh W, Vohr B. Maternal perceptions of the sleep patterns of premature infants at seven months corrected age compared to full‐term infants. Infant Mental Health Journal 1991, 12: 338-346. DOI: 10.1002/1097-0355(199124)12:4<338::aid-imhj2280120407>3.0.co;2-a.
- Gelardi N, Cha C, Oh W. Glucose Metabolism in Adipocytes of Obese Offspring of Mild Hyperglycemic Rats. Pediatric Research 1990, 28: 641-645. PMID: 2284163, DOI: 10.1203/00006450-199012000-00020.
- Lin H, Maguire C, Oh W, Cowett R. Reply. The Journal Of Pediatrics 1990, 117: 674. DOI: 10.1016/s0022-3476(05)80716-4.
- Vohr B, Karp D, O'Dea C, Darrow D, Coll C, Lester B, Brown L, Oh W, Cashore W. Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. The Journal Of Pediatrics 1990, 117: 288-291. PMID: 2380830, DOI: 10.1016/s0022-3476(05)80549-9.
- Soll R, Hoekstra R, Fangman J, Corbet A, Adams J, James L, Schulze K, Oh W, Roberts J, Dorst J, Kramer S, Gold A, Zola E, Horbar J, McAuliffe T, Lucey J. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Pediatrics 1990, 85: 1092-102. PMID: 2187176, DOI: 10.1542/peds.85.6.1092.
- Malone T, Stonestreet B, Goddard M, Oh W. Hemodynamic Changes in a Term Newborn Piglet Model of Patent Ductus Arteriosus. American Journal Of Perinatology 1990, 7: 184-188. PMID: 2331282, DOI: 10.1055/s-2007-999477.
- Lin H, Maguire C, Oh W, Cowett R. Accuracy and reliability of glucose reflectance meters in the high-risk neonate. The Journal Of Pediatrics 1989, 115: 998-1000. PMID: 2585238, DOI: 10.1016/s0022-3476(89)80757-7.
- Stonestreet B, Goldstein M, Oh W, Widness J. Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep. American Journal Of Physiology 1989, 257: r1199-r1204. PMID: 2511768, DOI: 10.1152/ajpregu.1989.257.5.r1199.
- Gastrointestinal blood flow and oxygen delivery during environmental cold stress: effect of anaemia.Mayfield S, Shaul P, Oh W, Stonestreet B. Gastrointestinal blood flow and oxygen delivery during environmental cold stress: effect of anaemia. Journal Of Developmental Physiology 1989, 12: 219-23. PMID: 2634063.
- Stonestreet B, Ogburn P, Goldstein M, Oh W, Widness J. Effects of chronic fetal hyperinsulinemia on plasma arachidonic acid and prostaglandin concentrations. American Journal Of Obstetrics And Gynecology 1989, 161: 894-899. PMID: 2679106, DOI: 10.1016/0002-9378(89)90746-1.
- Vohr B, Garcia‐Coll C, Oh W. LANGUAGE AND NEURODEVELOPMENTAL OUTCOME OF LOW‐BIRTHWEIGHT INFANTS AT THREE YEARS. Developmental Medicine & Child Neurology 1989, 31: 582-590. PMID: 2806739, DOI: 10.1111/j.1469-8749.1989.tb04043.x.
- Nowicki P, Oh W. Methylxanthines and Necrotizing Enterocolitis Revisited. Journal Of Pediatric Gastroenterology And Nutrition 1989, 9: 137-137. DOI: 10.1002/j.1536-4801.1989.tb09845.x.
- Vohr B, Barry L, Rapisardi G, O'Dea C, Brown L, Peucker M, Cashore W, Oh W. Abnormal brain-stem function (brain-stem auditory evoked response) correlates with acoustic cry features in term infants with hyperbilirubinemia. The Journal Of Pediatrics 1989, 115: 303-308. PMID: 2754560, DOI: 10.1016/s0022-3476(89)80090-3.
- Vohr B, Garcia-Coll C, Mayfield S, Brann B, Shaul P, Oh W. Neurologic and developmental status related to the evolution of visual-motor abnormalities from birth to 2 years of age in preterm infants with intraventricular hemorrhage. The Journal Of Pediatrics 1989, 115: 296-302. PMID: 2474065, DOI: 10.1016/s0022-3476(89)80089-7.
- Yunis K, Oh W. Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia. The Journal Of Pediatrics 1989, 115: 127-132. PMID: 2500510, DOI: 10.1016/s0022-3476(89)80347-6.
- Mayfield S, Stonestreet B, Shaul P, Brubakk A, Susa J, Oh W. Plasma catecholamine concentrations of newborn piglets in thermoneutral and cold environments. Journal Of Developmental Physiology 1989, 11: 331-4. PMID: 2592750.
- Maynard E, Oh W. Topical nitroglycerin ointment as an aid to insertion of peripheral venous catheters in neonates. The Journal Of Pediatrics 1989, 114: 474-476. PMID: 2493523, DOI: 10.1016/s0022-3476(89)80577-3.
- Mayfield S, Oh W, Piva D, Stonestreet B. Postprandial gastrointestinal blood flow and oxygen consumption during environmental cold stress. American Journal Of Physiology 1989, 256: g364-g368. PMID: 2919679, DOI: 10.1152/ajpgi.1989.256.2.g364.
- Anderson L, Coll C, Vohr B, Emmons L, Brann B, Shaul P, Mayfield S, Oh W. Behavioral characteristics and early temperament of premature infants with intracranial hemorrhage. Early Human Development 1989, 18: 273-283. PMID: 2702952, DOI: 10.1016/0378-3782(89)90022-4.
- Roberts J, Oh W. Pulmonary oxygen toxicity in the guinea pig. Effect of indomethacin. Neonatology 1989, 12: 106-12. PMID: 2714157, DOI: 10.1159/000480972.
- Oh W, Gelardi N, Cha C. Maternal hyperglycemia in pregnant rats: Its effect on growth and carbohydrate metabolism in the offspring. Metabolism 1988, 37: 1146-1151. PMID: 2973549, DOI: 10.1016/0026-0495(88)90192-8.
- Vohr B, Coll C, Oh W. LANGUAGE DEVELOPMENT OF LOW‐BIRTHWEIGHT INFANTS AT TWO YEARS. Developmental Medicine & Child Neurology 1988, 30: 608-615. PMID: 3229558, DOI: 10.1111/j.1469-8749.1988.tb04798.x.
- Garcia-Coll C, Emmons L, Vohr B, Ward A, Brann B, Shaul P, Mayfield S, Oh W. Behavioral responsiveness in preterm infants with intraventricular hemorrhage. Pediatrics 1988, 81: 412-8. PMID: 3344184, DOI: 10.1542/peds.81.3.412.
- Cowett R, Andersen G, Maguire C, Oh W. Ontogeny of glucose homeostasis in low birth weight infants. The Journal Of Pediatrics 1988, 112: 462-465. PMID: 3279177, DOI: 10.1016/s0022-3476(88)80337-8.
- Karplus M, Lee C, Cashore W, Oh W. The effects of brain bilirubin deposition on auditory brain stem evoked responses in rats. Early Human Development 1988, 16: 185-194. PMID: 3378524, DOI: 10.1016/0378-3782(88)90098-9.
- Vohr B, Chen A, Garcia Coll C, Oh W. Mothers of Preterm and Full-Term Infants on Home Apnea Monitors. JAMA Pediatrics 1988, 142: 229-231. PMID: 3341329, DOI: 10.1001/archpedi.1988.02150020131048.
- Mullen M, Coll C, Vohr B, Muriel A, Oh W. Mother-infant feeding interaction in full-term small-for-gestational-age infants. The Journal Of Pediatrics 1988, 112: 143-148. PMID: 3335952, DOI: 10.1016/s0022-3476(88)80141-0.
- Oh W. Renal Function and Fluid Therapy in High Risk Infants. Neonatology 1988, 53: 230-236. PMID: 3046669, DOI: 10.1159/000242795.
- M. C, Gelardi N, Oh W. Growth and Cellular Composition in Rats with Intrauterine Growth Retardation: Effects of Postnatal Nutrition. Journal Of Nutrition 1987, 117: 1463-1468. PMID: 3625318, DOI: 10.1093/jn/117.8.1463.
- Coll C, Hoffman J, Oh W. The social ecology and early parenting of Caucasian adolescent mothers. Child Development 1987, 58: 955-63. PMID: 3608665, DOI: 10.2307/1130536.
- Cowett R, Andersen G, Maguire C, Oh W. ONTOGENY OF GLUCOSE KINETICS IN THE NEWBORN. Pediatric Research 1987, 22: 235-235. DOI: 10.1203/00006450-198708000-00131.
- Garcia Coll C, Hoffman J, Van Houten L, Oh W. The social context of teenage childbearing: Effects on the infant's care-giving environment. Journal Of Youth And Adolescence 1987, 16: 345-360. PMID: 12280674, DOI: 10.1007/bf02138466.
- Brann B, Stonestreet B, Oh W, Cashore W. The in Vivo Effect of Bilirubin and Sulfisoxazole on Cerebral Oxygen, Glucose, and Lactate Metabolism in Newborn Piglets. Pediatric Research 1987, 22: 135-140. PMID: 3658536, DOI: 10.1203/00006450-198708000-00006.
- Mayfield S, Shaul P, Oh W, Stonestreet B. Anemia Blunts the Thermogenic Response to Environmental Cold Stress in Newborn Piglets. Pediatric Research 1987, 21: 482-486. PMID: 3588087, DOI: 10.1203/00006450-198705000-00012.
- Coll C, Vohr B, Emmons L, Brann B, Shaul P, Oh W. TEMPERAMENT CHARACTERISTICS OF PRETERM (PT) INFANTS AND CONCURRENT NEUROLOGICAL ABNORMALITIES. Pediatric Research 1987, 21: 180-180. DOI: 10.1203/00006450-198704010-00082.
- Malone T, Widness J, Mufson A, Oh W. ONTOGENY OF ERYTHROPOIETIN (EP) KINETICS IN FETAL, NEWBORN, AND JUVENILE SHEEP. Pediatric Research 1987, 21: 218-218. DOI: 10.1203/00006450-198704010-00309.
- Cha C, Figueira G, Gelardi N, Oh W. SECONDARY FETAL HYPERINSULINEMIA(SFH) IN RAT: NEONATAL GLUCOSE HOMEOSTASIS AND SUBSEQUENT GROWTH. Pediatric Research 1987, 21: 211-211. DOI: 10.1203/00006450-198704010-00267.
- Mullen M, Coll C, Vobr B, Muriel A, Oh W. MOTHER-INFANT FEEDING INTERACTION IN FULL-TERM SMALL-FOR-GESTATIONAL AGE (SGA) INFANTS. Pediatric Research 1987, 21: 183-183. DOI: 10.1203/00006450-198704010-00099.
- Cha C, Gelardi N, Oh W. Accelerated Growth and Abnormal Glucose Tolerance in Young Female Rats Exposed to Fetal Hyperinsulinemia. Pediatric Research 1987, 21: 83-87. PMID: 2432459, DOI: 10.1203/00006450-198701000-00018.
- Brubakk A, Oh W, Stonestreet B. Prolonged Hypercarbia in the Awake Newborn Piglet: Effect on Brain Blood Flow and Cardiac Output. Pediatric Research 1987, 21: 29-33. PMID: 3797131, DOI: 10.1203/00006450-198701000-00008.
- Szabo J, Mayfield S, Oh W, Stonestreet B. Postprandial Gastrointestinal Blood Flow and Oxygen Consumption: Effects of Hypoxemia in Neonatal Piglets. Pediatric Research 1987, 21: 93-98. PMID: 3797137, DOI: 10.1203/00006450-198701000-00020.
- Catlin E, Carpenter M, Brann B, Mayfield S, Shaul P, Goldstein M, Oh W. The Apgar score revisited: Influence of gestational age. The Journal Of Pediatrics 1986, 109: 865-868. PMID: 3772665, DOI: 10.1016/s0022-3476(86)80715-6.
- Mayfield S, Stonestreet B, Brubakk A, Shaul P, Oh W. Regional blood flow in newborn piglets during environmental cold stress. American Journal Of Physiology 1986, 251: g308-g313. PMID: 3752246, DOI: 10.1152/ajpgi.1986.251.3.g308.
- COLL C, VOHR B, HOFFMAN J, OH W. Maternal and Environmental Factors Affecting Developmental Outcome of Infants of Adolescent Mothers. Journal Of Developmental And Behavioral Pediatrics 1986, 7: 230-236. PMID: 3745449, DOI: 10.1097/00004703-198608000-00003.
- M. C, Oh W. Growth and Fatty Acid Metabolism in Experimental Intrauterine Growth Retardation: Effect of Postnatal Nutrition in Rat. Journal Of Nutrition 1986, 116: 1080-1087. PMID: 3723203, DOI: 10.1093/jn/116.6.1080.
- Oh W. Neonatal Polycythemia and Hyperviscosity. Pediatric Clinics Of North America 1986, 33: 523-532. PMID: 3714337, DOI: 10.1016/s0031-3955(16)36040-0.
- Cowett R, Coustan D, Oh W. Effects of maternal transport on admission patterns at a tertiary care center. American Journal Of Obstetrics And Gynecology 1986, 154: 1098-1100. PMID: 3706436, DOI: 10.1016/0002-9378(86)90760-x.
- Coustan D, Widness J, Carpenter M, Rotondo L, Pratt D, Oh W. Should the fifty-gram, one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? American Journal Of Obstetrics And Gynecology 1986, 154: 1031-1035. PMID: 3706427, DOI: 10.1016/0002-9378(86)90744-1.
- Vohr B, Oh W. Age of diphtheria, tetanus, and pertussis immunization of special care nursery graduates. Pediatrics 1986, 77: 569-71. PMID: 3485786, DOI: 10.1542/peds.77.4.569.
- Fatoba I, M. C, Oh W. Effect of respiratory acidosis on glucose homeostasis in experimental intrauterine growth retardation in rats. Early Human Development 1986, 13: 107-114. PMID: 3754205, DOI: 10.1016/0378-3782(86)90104-0.
- Rosenkrantz T, Oh W. Neonatal Polycythemia and Hyperviscosity. 1986, 93-123. DOI: 10.1007/978-1-4615-9468-0_3.
- Catlin E, M. C, Oh W. Postnatal growth and fatty acid synthesis in overgrown rat pups induced by fetal hyperinsulinemia. Metabolism 1985, 34: 1110-1114. PMID: 3906351, DOI: 10.1016/0026-0495(85)90155-6.
- Weinstein M, Bell E, Oh W. Energy Intake, Norepinephrine Excretion, and Oxygen Consumption in Low Birthweight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1985, 4: 774-777. PMID: 4045635, DOI: 10.1097/00005176-198510000-00016.
- Walker D, Vohr B, Oh W. Economic analysis of regionalized neonatal care for very low-birth-weight infants in the state of Rhode Island. Pediatrics 1985, 76: 69-74. PMID: 3925429, DOI: 10.1542/peds.76.1.69.
- Burgess G, Oh W, Bratlid D, Brubakk A, Cashore W, Stonestreet B. The Effects of Brain Blood Flow on Brain Bilirubin Deposition in Newborn Piglets. Pediatric Research 1985, 19: 691-696. PMID: 4040628, DOI: 10.1203/00006450-198507000-00011.
- Iwamoto H, Oh W, Rudolph A. Renal Metabolism in Fetal and Newborn Sheep. Pediatric Research 1985, 19: 641-644. PMID: 4022671, DOI: 10.1203/00006450-198507000-00001.
- Widness J, Cowett R, Coustan D, Carpenter M, Oh W. Neonatal Morbidities in Infants of Mothers with Glucose Intolerance in Pregnancy. Diabetes 1985, 34: 61-65. PMID: 3996769, DOI: 10.2337/diab.34.2.s61.
- Burgess G, Stonestreet B, Cashore W, Oh W. Brain Bilirubin Deposition and Brain Blood Flow during Acute Urea-Induced Hyperosmolality in Newborn Piglets. Pediatric Research 1985, 19: 537-542. PMID: 4011334, DOI: 10.1203/00006450-198506000-00007.
- Szabo J, Stonestreet B, Oh W. Effects of Hypoxemia on Gastrointestinal Blood Flow and Gastric Emptying in the Newborn Piglet. Pediatric Research 1985, 19: 466-471. PMID: 4000773, DOI: 10.1203/00006450-198505000-00012.
- LEVINE L, COLL C, OH W. Determinants of mother-infant interaction in adolescent mothers. Journal Of The American Academy Of Child & Adolescent Psychiatry 1985, 24: 374-375. DOI: 10.1016/s0002-7138(09)61123-7.
- Vohr B, Coll C, Oh W. 63 LANGUAGE DEVELOPMENT AT 2 YEARS OF AGE IN LOW BIRTH WEIGHT (LBW)(<1500 GRAMS) INFANTS. Pediatric Research 1985, 19: 121-121. DOI: 10.1203/00006450-198504000-00093.
- Coll C, Houten L, Vohr B, Oh W. 4 LANGUAGE DELAY IN 2 YR. OLD CHILDREN OF AADOLESCENT MOTHERS. Pediatric Research 1985, 19: 111-111. DOI: 10.1203/00006450-198504000-00034.
- Schanler R, Oh W. Nitrogen and Mineral Balance in Preterm Infants Fed Human Milks or Formula. Journal Of Pediatric Gastroenterology And Nutrition 1985, 4: 214-219. PMID: 3989621, DOI: 10.1097/00005176-198504000-00010.
- WALKER D, FELDMAN A, VOHR B, OH W. Neonatal Intensive Care: Cost-Benefit Analysis. Pediatrics 1985, 75: 799-800. DOI: 10.1542/peds.75.4.799a.
- Cha C, Oh W. 246 GROWTH AND FATTY ACID METABOLISM IN EXPERIMENTAL INTRAUTERINE GROWTH RETARDATION: EFFECTS OF POSTNATAL NUTRITION. Pediatric Research 1985, 19: 151-151. DOI: 10.1203/00006450-198504000-00276.
- Mayfield S, Stonestreet B, Brubakk A, Shaul P, Oh W. 1456 REGIONAL BLOOD FLOW (Q) DURING ENVIRONMENTAL COLD STRESS(ECS). Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01480.
- Catlln E, Cha C, Oh W. 245 POSTNATAL GROWTH AND FATTY ACID SYNTHESIS IN INSULIN-INDUCED MACROSOMIC RAT PUPS. Pediatric Research 1985, 19: 151-151. DOI: 10.1203/00006450-198504000-00275.
- Burgess G, Brann B, Stonestreet B, Oh W, Brubakk A. 1356 THE EFFECT OF PHENOBARBITAL (PB) ON CEREBRAL BLOOD FLOW VELOCITY (CBFV) FOLLOWING ENDOTRACHEAL UZ3U SUCTION (ETS). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01380.
- Brann B, Stonestreet B, Oh W, Cashore W. 1350 THE EFFECT OF BILIRUBIN (BR) ON CEREBRAL CORTEX (CE) O2 AND GLUCOSE METABOLISM IN PIGLETS (P). Pediatric Research 1985, 19: 335-335. DOI: 10.1203/00006450-198504000-01374.
- Catlin E, Carpenter M, Brann B, Mayfield S, Shaul P, Goldstein M, Oh W. 1360 THE APGAR SCORE REVISITED: DEVELOPMENTAL PATTERNS IN “OPTIMAL” NEWBORNS. Pediatric Research 1985, 19: 337-337. DOI: 10.1203/00006450-198504000-01384.
- Brann B, Cashore W, Patrick R, Oh W. 1349 IN VITRO EFFECT OF BILIRUBIN ON DOPAMINE SYNTHESIS IN ADULT RAT BRAIN SYNAPTOSOMES. Pediatric Research 1985, 19: 335-335. DOI: 10.1203/00006450-198504000-01373.
- Brubakk A, Oh W, Stonestreet B. 1353 ATROPINE (AT) REDUCES BRAIN-BLOOD FLOW (BBF) AT LOWER MEAN ARTERIAL BLOOD PRESSURES (MABP) DURING HEMORRHAGIC HYPOTENSION (HH) IN THE NEWBORN PIGLET (P). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01377.
- Mayfield S, Shaul P, Oh W, Stonestreet B. 1455 REGIONAL OXYGEN(O2) DELIVERY DURING ENVIRONMENTAL COLD STRESS (ECS) IN ANEMIC PIGLETS. Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01479.
- Szabo J, Mayfield S, Oh W, Stonestreet B. 738 EFFECTS OF HYPOXEMIA ON POSTPRANDIAL GI BLOOD FLOW AND OXYGEN CONSUMPTION IN NEWBORN PIGLETS. Pediatric Research 1985, 19: 233-233. DOI: 10.1203/00006450-198504000-00768.
- Brubakk A, Oh W, Stonestreet B. 1354 ADAPTATION OF BRAIN BLOOD FLOW (BBF) TO PROLONGED HYPERCARBIA (PHC) IN THE NEWBORN PIGLET (P). Pediatric Research 1985, 19: 336-336. DOI: 10.1203/00006450-198504000-01378.
- Mayfield S, Shaul P, Oh W, Stonestreet B. 1454 ANEMIA BLUNTS THE NEONATAL HOMEOTHERMIC RESPONSE TO ENVIRONMENTAL COLD STRESS(ECS). Pediatric Research 1985, 19: 353-353. DOI: 10.1203/00006450-198504000-01478.
- Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levelsWTDNESS J, TERAMO K, CLEMONS G, COUSTAN D, CAVALIERI R, OH W, WELCH G, SCHWARTZ R. Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levels. BJOG An International Journal Of Obstetrics & Gynaecology 1985, 92: 326-332. PMID: 3986165, DOI: 10.1111/j.1471-0528.1985.tb01104.x.
- Nowicki P, Hansen N, Stonestreet B, Yao A, Oh W. The Effect of Blood Volume Expansion on Gastrointestinal Oxygenation in Piglets. Pediatric Research 1985, 19: 268-271. PMID: 3982888, DOI: 10.1203/00006450-198503000-00002.
- Levine L, Coll C, Oh W. Determinants of mother-infant interaction in adolescent mothers. Pediatrics 1985, 75: 23-9. PMID: 3966042, DOI: 10.1542/peds.75.1.23.
- Cowett R, Tenenbaum D, Fatoba O, Oh W. The Effects of Arterial Glucose Infusion above the Celiac Axis in the Neonatal Lamb. Neonatology 1985, 47: 179-185. PMID: 3886022, DOI: 10.1159/000242111.
- Brubakk A, Bratlid D, Oh W, Yao A, Stonestreet B. Atropine Prevents Increases in Brain Blood Flow during Hypertension in Newborn Piglets. Pediatric Research 1984, 18: 1121-1126. PMID: 6514438, DOI: 10.1203/00006450-198411000-00013.
- Hansen N, Oh W, LaRochelle F, Stonestreet B. Effects of Maternal Ritodrine Administration on Neonatal Renal Function. Journal Of Urology 1984, 132: 1069. DOI: 10.1016/s0022-5347(17)50032-4.
- Hansen N, Brubakk A, Bratlid D, Oh W, Stonestreet B. The Effects of Variations in Paco2 on Brain Blood Flow and Cardiac Output in the Newborn Piglet. Pediatric Research 1984, 18: 1132-1136. PMID: 6440112, DOI: 10.1203/00006450-198411000-00015.
- Nowicki P, Oh W, Yao A, Hansen N, Stonestreet B. Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets. American Journal Of Physiology 1984, 247: g220-g225. PMID: 6476115, DOI: 10.1152/ajpgi.1984.247.3.g220.
- HANSEN N, STONESTREET B, ROSENKRANTZ T, OH W. Brain Blood Flow. Pediatrics 1984, 74: 317-317. DOI: 10.1542/peds.74.2.317.
- Walker D, Feldman A, Vohr B, Oh W. Cost-benefit analysis of neonatal intensive care for infants weighing less than 1,000 grams at birth. Pediatrics 1984, 74: 20-5. PMID: 6234507, DOI: 10.1542/peds.74.1.20.
- Stonestreet B, Laptook R, Siegel S, Oh W. The renal response to acute asphyxia in spontaneously breathing newborn lambs. Early Human Development 1984, 9: 347-361. PMID: 6378587, DOI: 10.1016/0378-3782(84)90079-3.
- Rosenkrantz T, Oh W. Aminophylline Reduces Cerebral Blood Flow Velocity in Low-Birth-Weight Infants. JAMA Pediatrics 1984, 138: 489-491. PMID: 6424433, DOI: 10.1001/archpedi.1984.02140430065017.
- Nowick P, Hansen N, Oh W, Stonestreet B. Gastrointestinal Blood Flow and Oxygen Consumption in the Newborn Lamb: Effect of Chronic Anemia and Acute Hypoxia. Pediatric Research 1984, 18: 420-425. PMID: 6728568, DOI: 10.1203/00006450-198405000-00005.
- Bratlid D, Cashore W, Oh W. Effect of acidosis on bilirubin deposition in rat brain. Pediatrics 1984, 73: 431-4. PMID: 6709423, DOI: 10.1542/peds.73.4.431.
- Garcia C, Vohr B, Oh W. MATERNAL FACTORS AFFECTING DEVELOPMENTAL OUTCOME OF INFANTS OF ADOLESCENT MOTHERS. Pediatric Research 1984, 18: 97-97. DOI: 10.1203/00006450-198404001-00026.
- Coll C, Lester B, Valcarcel M, Hoffman J, Oh W. FEEDING INTERACTIONS OF FETALLY MALNOURISHED INFANTS BORN TO TEENAGE AND OLDER MOTHERS. Pediatric Research 1984, 18: 96-96. DOI: 10.1203/00006450-198404001-00018.
- Bratlid D, Cashore W, Brubakk A, Oh W. BILIRUBIN DISPLACEMENT BY SULFISOXAZOLE: ENTRY OF UNBOUND BILIRUBIN INTO THE BRAIN. Pediatric Research 1984, 18: 150-150. DOI: 10.1203/00006450-198404001-00342.
- Chen S, Cashore W, Oh W. GRAM-NEGATIVE BACTEREMIA DOES NOT INCREASE ALBUMIN OR BILIRUBIN CONTENT IN BRAINS OF ADULT RATS. Pediatric Research 1984, 18: 271-271. DOI: 10.1203/00006450-198404001-01069.
- Brubakk A, Bratlid D, Oh W, Stonestreet B. CHANGES IN EPINEPHRINE (E) AND MEAN ARTERIAL BLOOD PRESSURE (MABP) DURING HYPERCARBIA (HC): EFFECTS ON BRAIN BLOOD FLOW (BBF) IN THE NEWBORN PIGLET. Pediatric Research 1984, 18: 337-337. DOI: 10.1203/00006450-198404001-01466.
- Walker D, Vohr B, Oh W. ECONOMIC ANALYSIS OF REGIONALIZED NEONATAL CARE FOR LOW BIRTH WEIGHT INFANTS IN THE STATE OF RI. Pediatric Research 1984, 18: 338-338. DOI: 10.1203/00006450-198404001-01468.
- Stonestreet B, Piasecki G, Oh W, Jackson B. CARDIOVASCULAR RESPONSES TO INSULIN INFUSIONS IN THE OVINE FETUS. Pediatric Research 1984, 18: 130-130. DOI: 10.1203/00006450-198404001-00223.
- Vohr B, Coll C, Oh W. INCREASED MORBIDITY IN LONG TERM FOLLOW-UP OF LOW BIRTH WEIGHT (LBW) SURVIVORS WITH STAGE III-IV RETROLENTAL FIBROPLASIA (RLF). Pediatric Research 1984, 18: 116-116. DOI: 10.1203/00006450-198404001-00138.
- Vohr B, Oh W. AGE OF DPT IMMUNIZATION OF SPECIAL CARE NURSERY (SCN) GRADUATES. Pediatric Research 1984, 18: 188-188. DOI: 10.1203/00006450-198404001-00570.
- Burgess G, Oh W, Bratlid D, Brubakk A, Cashore W, Stonestreet B. CEREBRAL HYPERPERFUSION AUGMENTS BRAIN BILIRUBIN DEPOSITION IN PIGLETS. Pediatric Research 1984, 18: 337-337. DOI: 10.1203/00006450-198404001-01467.
- Szabo J, Stonestreet B, Oh W. GASTRIC MOTILITY AND GI BLOOD FLOW: EFFECTS OF HYPOXEMIA IN THE NEWBORN PIGLET. Pediatric Research 1984, 18: 214-214. DOI: 10.1203/00006450-198404001-00727.
- Szabo J, Hillemeier A, Oh W. THE EFFECT OF NONNUTRITIVE AND NUTRITIVE SUCK ON GASTRIC EMPTYING IN PREMATURE INFANTS. Pediatric Research 1984, 18: 214-214. DOI: 10.1203/00006450-198404001-00728.
- Burgess G, Stonestreet B, Cashore W, Oh W. HYPEROSMOLALITY(HO) AUGMENTED REGIONAL BRAIN BILIRUBIN DEPOSITION(RBBD) IN NEWBORN PIGLETS(P). Pediatric Research 1984, 18: 314-314. DOI: 10.1203/00006450-198404001-01327.
- Nowicki P, Oh W, Yao A, Hansen N, Stonestreet B. EFFECT OF POLYCYTHEMIC HYPERVISCOSITY ON GASTROINTESTINAL (GI) BLOOD FLOW AND O2 CONSUMPTION IN PIGLETS. Pediatric Research 1984, 18: 350-350. DOI: 10.1203/00006450-198404001-01544.
- Rosenkrantz T, Stonestreet B, Hansen N, Nowicki P, Oh W. Cerebral blood flow in the newborn lamb with polycythemia and hyperviscosity. The Journal Of Pediatrics 1984, 104: 276-280. PMID: 6694026, DOI: 10.1016/s0022-3476(84)81012-4.
- Cowett R, Susa J, Oh W, Schwartz R. Glucose kinetics in glucose-infused small for gestational age infants. Pediatric Research 1984, 18: 74-9. PMID: 6366720.
- Oh W. Peripheral Circulatory Response to Feeding in Newborn Low‐Birth‐Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1984, 3: 14-14. DOI: 10.1002/j.1536-4801.1984.tb08612.x.
- Oh W. Peripheral Circulatory Response to Feeding in Newborn Low-Birth-Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1984, 3: 14. PMID: 6694043, DOI: 10.1097/00005176-198401000-00006.
- Widness J, Clemons G, Garcia J, Oh W, Schwartz R. Increased immunoreactive erythropoietin in cord serum after labor. American Journal Of Obstetrics And Gynecology 1984, 148: 194-197. PMID: 6691396, DOI: 10.1016/s0002-9378(84)80175-1.
- Vohr B, Oh W. Growth and development in preterm infants small for gestational age. The Journal Of Pediatrics 1983, 103: 941-945. PMID: 6644432, DOI: 10.1016/s0022-3476(83)80726-4.
- Widness J, Goldman A, Susa J, Oh W, Schwartz R. Impermeability of the rat placenta to insulin during organogenesis. Birth Defects Research Part A Clinical And Molecular Teratology 1983, 28: 327-332. PMID: 6364437, DOI: 10.1002/tera.1420280304.
- Nowicki P, Stonestreet B, Hansen N, Yao A, Oh W. Gastrointestinal blood flow and oxygen consumption in awake newborn piglets: effect of feeding. American Journal Of Physiology 1983, 245: g697-g702. PMID: 6638194, DOI: 10.1152/ajpgi.1983.245.5.g697.
- Vileisis R, Oh W. Metabolic Consequences of Intrauterine Growth Retardation. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 59-67. DOI: 10.1002/j.1536-4801.1983.tb08407.x.
- Hansen N, Oh W, LaRochelle F, Stonestreet B. Effects of maternal ritodrine administration on neonatal renal function. The Journal Of Pediatrics 1983, 103: 774-780. PMID: 6355419, DOI: 10.1016/s0022-3476(83)80484-3.
- Hansen N, Stonestreet B, Rosenkrantz T, Oh W. Validity of Doppler measurements of anterior cerebral artery blood flow velocity: correlation with brain blood flow in piglets. Pediatrics 1983, 72: 526-31. PMID: 6889067, DOI: 10.1542/peds.72.4.526.
- Stonestreet B, Hansen N, Laptook R, Oh W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Human Development 1983, 8: 331-341. PMID: 6641577, DOI: 10.1016/0378-3782(83)90016-6.
- Laptook R, Stonestreet B, Oh W. The effect of carotid artery ligation on brain blood flow in newborn piglets. Brain Research 1983, 276: 51-54. PMID: 6627001, DOI: 10.1016/0006-8993(83)90547-4.
- Tenenbaum D, Piasecki G, Oh W, Rosenkrantz T, Jackson B. Fetal polycythemia and hyperviscosity: Effect on umbilical blood flow and fetal oxygen consumption. American Journal Of Obstetrics And Gynecology 1983, 147: 48-51. PMID: 6684399, DOI: 10.1016/0002-9378(83)90082-0.
- Bell E, Weinstein M, Oh W. Effects of Intravenously Administered Safflower Oil Emulsion on Respiratory Gas Exchange of Low-Birth-Weight Infants. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 517-520. PMID: 6413670, DOI: 10.1097/00005176-198302030-00020.
- Cowett R, Susa J, Giletti B, Oh W, Schwartz R. Glucose kinetics in infants of diabetic mothers. American Journal Of Obstetrics And Gynecology 1983, 146: 781-786. PMID: 6346883, DOI: 10.1016/0002-9378(83)91077-3.
- Cowett R, Susa J, Kahn C, Giletti B, Oh W, Schwartz R. Glucose kinetics in nondiabetic and diabetic women during the third trimester of pregnancy. American Journal Of Obstetrics And Gynecology 1983, 146: 773-780. PMID: 6346882, DOI: 10.1016/0002-9378(83)91076-1.
- Cashore W, Oh W, Brodersen R. Bilirubin-Displacing Effect of Furosemide and Sulfisoxazole. Neonatology 1983, 6: 230-238. PMID: 6617404, DOI: 10.1159/000457309.
- Stonestreet B, Nowicki P, Hansen N, Petit R, Oh W. Effect of Aminophylline on Brain Blood Flow in the Newborn Piglet. Neonatology 1983, 6: 248-258. PMID: 6413185, DOI: 10.1159/000457311.
- Bratlid D, Cashore W, Oh W. Effect of serum hyperosmolality on opening of blood-brain barrier for bilirubin in rat brain. Pediatrics 1983, 71: 909-12. PMID: 6856404, DOI: 10.1542/peds.71.6.909.
- CASHORE W, OH W, BRODERSEN R. RESERVE ALBUMIN AND BILIRUBIN TOXICITY INDEX IN INFANT SERUM. Acta Paediatrica 1983, 72: 415-419. PMID: 6880730, DOI: 10.1111/j.1651-2227.1983.tb09739.x.
- Cowett R, Oh W, Schwartz R. Persistent glucose production during glucose infusion in the neonate. Journal Of Clinical Investigation 1983, 71: 467-475. PMID: 6338038, PMCID: PMC436894, DOI: 10.1172/jci110791.
- Stonestreet B, Bell E, Warburton D, Oh W. Renal Response in Low-Birth-Weight Neonates: Results of Prolonged Intake of Two Different Amounts of Fluid and Sodium. JAMA Pediatrics 1983, 137: 215-219. PMID: 6823919, DOI: 10.1001/archpedi.1983.02140290007002.
- Vileisis R, Oh W. Enhanced Fatty Acid Synthesis in Hyperinsulinemic Rat Fetuses. Journal Of Nutrition 1983, 113: 246-252. PMID: 6822898, DOI: 10.1093/jn/113.2.246.
- BELL E, OH W. WATER REQUIREMENT OF PREMATURE NEWBORN INFANTS. Acta Paediatrica (Oslo, Norway : 1992). Supplement 1983, 72: 21-26. PMID: 6577774, DOI: 10.1111/j.1651-2227.1983.tb09854.x.
- Laptook A, Stonestreet B, Oh W. Brain Blood Flow and O2 Delivery during Hemorrhagic Hypotension in the Piglet. Pediatric Research 1983, 17: 77-80. PMID: 6835718, DOI: 10.1203/00006450-198301000-00015.
- Vileisis R, Oh W. Metabolic Consequences of Intrauterine Growth Retardation. Journal Of Pediatric Gastroenterology And Nutrition 1983, 2: 59-67. PMID: 6644479, DOI: 10.1097/00005176-198300201-00008.
- Vieleisis R, Oh W. Effect of increased substrate availability on fatty acid synthesis in the growth retarded fetus. Metabolism 1983, 32: 90-94. PMID: 6848902, DOI: 10.1016/0026-0495(83)90162-2.
- Oh W. Fluid and Electrolyte Therapy and Parenteral Nutrition in Low Birth Weight Infants. Clinics In Perinatology 1982, 9: 637-643. PMID: 6819107, DOI: 10.1016/s0095-5108(18)31017-0.
- Oh W. Foreword. Pediatric Clinics Of North America 1982, 29: 1055-1056. DOI: 10.1016/s0031-3955(16)34246-8.
- Rosenkrantz T, Oh W. Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial exchange transfusion with Plasmanate. The Journal Of Pediatrics 1982, 101: 94-98. PMID: 7086628, DOI: 10.1016/s0022-3476(82)80194-7.
- Laptook, Stonestreet B, Oh W. The effects of different rates of plasmanate infusions upon brain blood flow after asphyxia and hypotension in newborn piglets. The Journal Of Pediatrics 1982, 100: 791-796. PMID: 6896065, DOI: 10.1016/s0022-3476(82)80595-7.
- Vohr B, Bell E, Oh W. Infants With Bronchopulmonary Dysplasia: Growth Pattern and Neurologic and Developmental Outcome. JAMA Pediatrics 1982, 136: 443-447. PMID: 6177239, DOI: 10.1001/archpedi.1982.03970410061015.
- Cashore W, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics 1982, 69: 481-5. PMID: 7200229, DOI: 10.1542/peds.69.4.481.
- Vileisis R, Fain J, Oh W. Fatty acid synthesis in rat fetuses with intrauterine growth retardation. Metabolism 1982, 31: 217-222. PMID: 7078410, DOI: 10.1016/0026-0495(82)90056-7.
- Laptook, Stonestreet B, Oh W. Autoregulation of brain blood flow in the newborn piglet: Regional differences in flow reduction during hypotension. Early Human Development 1982, 6: 99-107. PMID: 6799270, DOI: 10.1016/0378-3782(82)90063-9.
- Vileisis R, Cowett R, Oh W. Glycemic response to lipid infusion in the premature neonate. The Journal Of Pediatrics 1982, 100: 108-112. PMID: 7035630, DOI: 10.1016/s0022-3476(82)80248-5.
- Weinstein M, Oh W. Oxygen consumption in infants with bronchopulmonarydysplasia. The Journal Of Pediatrics 1981, 99: 958-961. PMID: 6895525, DOI: 10.1016/s0022-3476(81)80032-7.
- LAPTOOK, OH W. Transcutaneous carbon dioxide monitoring in the newborn period. Critical Care Medicine 1981, 9: 759. PMID: 6793316, DOI: 10.1097/00003246-198110000-00019.
- Creswell J, Warburton D, Susa J, Cowett R, Oh W. Hyperviscosity in the Newborn Lamb Produces Pertubation in Glucose Homeostasis. Pediatric Research 1981, 15: 1348-1350. PMID: 7029442, DOI: 10.1203/00006450-198110000-00009.
- Leake R, Fiser R, Oh W. Rapid Glucose Disappearance in Infants with Infection. Clinical Pediatrics 1981, 20: 397-401. PMID: 7014071, DOI: 10.1177/000992288102000604.
- Cashore W, Oh W, Blumberg W, Lamola A. Letters to the Editor. Pediatrics 1981, 67: 936-937. DOI: 10.1542/peds.67.6.936.
- Widness J, Schwartz H, Zeller W, Oh W, Schwartz R. Glycohemoglobin in postpartum women. Obstetrics And Gynecology 1981, 57: 414-21. PMID: 7243085.
- Laptook A, Stonestreet B, Oh W. 1585 AUTOREGULATION OF BRAIN BLOOD FLOW (BBF): REGIONAL DIFFERENCES IN REDUCED BBP WITH HYPOTENSION. Pediatric Research 1981, 15: 707-707. DOI: 10.1203/00006450-198104001-01602.
- Cowett R, Susa J, Oh W, Schwartz R. 1112 DECREASED ENDOGENOUS GLUCOSE PRODUCTION (EGP) IN LOW BIRTHWEIGHT (LBW) INFANTS. Pediatric Research 1981, 15: 628-628. DOI: 10.1203/00006450-198104001-01138.
- Weinstein M, Oh W. 1737 BRONCHOPULMONARY DYSPLASIA (BPD) AND ITS EFFECTS ON OXYGEN CONSUMPTION (VO2). Pediatric Research 1981, 15: 733-733. DOI: 10.1203/00006450-198104001-01756.
- Widness J, Susa J, Oh W, Goldman A. 1223 MATERNAL INSULIN: AN UNLIKELY FETAL TERATOGEN. Pediatric Research 1981, 15: 646-646. DOI: 10.1203/00006450-198104001-01249.
- Stonestreet B, Laptook A, Oh W, Tsang R. 1445 ASPHYXIA INDUCED ALTERATIONS IN SERUM AND RENAL CALCIUM, MAGNESIUM AND PHOSPHATE HOMEOSTASIS. Pediatric Research 1981, 15: 684-684. DOI: 10.1203/00006450-198104001-01474.
- Vileisis R, Fain J, Oh W. 297 EFFECT OF INTRAUTERINE GROWTH RETARDATION (IUGR) ON FATTY ACID SYTHESIS. Pediatric Research 1981, 15: 489-489. DOI: 10.1203/00006450-198104001-00308.
- Cowebt R, Barcohana Y, Oh W. 395 HUMAN FETAL AND NEONATAL INSULIN RESPONSE TO MATERNAL HYPERGLYCEMIA AT CESAREAN SECTION (C/S). Pediatric Research 1981, 15: 506-506. DOI: 10.1203/00006450-198104001-00406.
- Stonestreet B, Laptook A, Siegel S, Oh W. 1544 EFFECTS OF ASPHYXIA ON RENAL FUNCTION IN TERM AND PRETERM LAMBS. Pediatric Research 1981, 15: 700-700. DOI: 10.1203/00006450-198104001-01567.
- Vileisis R, Cowett R, Oh W. 1457 GLYCEMIC EFFECT OF TRIGLYCERIDE INFUSION IN THE LOW BIRTH WEIGHT INFANT. Pediatric Research 1981, 15: 686-686. DOI: 10.1203/00006450-198104001-01486.
- Laptook A, Stonestreet B, Oh W. 1350 EFFECTS OF RATE OF VOLUME EXPANSION ON BRAIN BLOOD FLOW AFTER ASPHYXIA AND HYPOTENSION IN THE PIGLET. Pediatric Research 1981, 15: 668-668. DOI: 10.1203/00006450-198104001-01379.
- Widness J, Susa J, Garcia J, Singer D, Sehgal P, Oh W, Schwartz R, Schwartz H. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. Journal Of Clinical Investigation 1981, 67: 637-642. PMID: 7009647, PMCID: PMC370612, DOI: 10.1172/jci110078.
- Cashore W, Peter G, Lauermann M, Stonestreet B, Oh W. Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis. The Journal Of Pediatrics 1981, 98: 308-311. PMID: 7463233, DOI: 10.1016/s0022-3476(81)80667-1.
- Cowett R, Susa J, Warburton D, Stonestreet B, Schwartz R, Oh W. Endogenous Posthepatic Insulin Secretion and Metabolic Clearance Rates in the Neonatal Lamb. Pediatric Research 1980, 14: 1391-1394. PMID: 7010288, DOI: 10.1203/00006450-198012000-00027.
- Leake R, Chan G, Zakauddin S, Dodge M, Fiser R, Bier D, Oh W. Glucose Perturbation in Experimental Hyperviscosity. Pediatric Research 1980, 14: 1320-1323. PMID: 7208147, DOI: 10.1203/00006450-198012000-00009.
- Sturner W, Lipsitt L, Oh W, Barrett J, Truex R. Abnormal heart rate response during newborn sucking behavior study: Subsequent sudden infant death syndrome with cardiac conduction abnormality. Forensic Science International 1980, 16: 201-212. PMID: 7203318, DOI: 10.1016/0379-0738(80)90204-2.
- Stonestreet B, Rubin L, Pollak A, Cowett R, Oh W. Renal functions of low birth weight infants with hyperglycemia and glucosuria produced by glucose infusions. Pediatrics 1980, 66: 561-7. PMID: 7432841, DOI: 10.1542/peds.66.4.561.
- Bell E, Weinstein M, Oh W. Reply. The Journal Of Pediatrics 1980, 97: 700-701. DOI: 10.1016/s0022-3476(80)80055-2.
- Cashore W, Oh W, Blumberg W, Eisinger J, Lamola A. Rapid fluorometric assay of bilirubin and bilirubin binding capacity in blood of jaundiced neonates: comparisons with other methods. Pediatrics 1980, 66: 411-6. PMID: 7422430, DOI: 10.1542/peds.66.3.411.
- Hsieh J, Turcotte J, Waraska J, Warburton D, Oh W. High pressure liquid chromatography of standard and amniotic fluid phospholipids. Journal Of Separation Science 1980, 3: 400-404. DOI: 10.1002/jhrc.1240030804.
- Vohr B, Lipsitt L, Oh W. Somatic growth of children of diabetic mothers with reference to birth size. The Journal Of Pediatrics 1980, 97: 196-199. PMID: 7400885, DOI: 10.1016/s0022-3476(80)80473-2.
- Cowett R, Czech M, Susa J, Schwartz R, Oh W. Blunted muscle responsiveness to insulin in the neonatal rat. Metabolism 1980, 29: 563-567. PMID: 6991858, DOI: 10.1016/0026-0495(80)90083-9.
- Oh W. Fluid and Electrolyte Therapy in Low Birth Weight Infants. Pediatrics In Review 1980, 1: 313-316. DOI: 10.1542/pir.1-10-313.
- Oh W. Fluid and Electrolyte Therapy in Low Birth Weight Infants. Pediatrics In Review 1980, 1: 313-316. DOI: 10.1542/pir.1.10.313.
- Widness J, Schwartz H, Kahn C, Oh W, Schwartz R. Glycohemoglobin in diabetic pregnancy: A sequential study. American Journal Of Obstetrics And Gynecology 1980, 136: 1024-1029. PMID: 6768294, DOI: 10.1016/0002-9378(80)90631-6.
- Bell E, Warburton D, Stonestreet B, Oh W. Effect of Fluid Administration on the Development of Symptomatic Patent Ductus Arteriosus and Congestive Heart Failure in Premature Infants. New England Journal Of Medicine 1980, 302: 598-604. PMID: 7351906, DOI: 10.1056/nejm198003133021103.
- Bell E, Gray J, Weinstein M, Oh W. The effects of thermal environment on heat balance and insensible water loss in low-birth-weight infants. The Journal Of Pediatrics 1980, 96: 452-459. PMID: 7359241, DOI: 10.1016/s0022-3476(80)80697-4.
- Bell E, Weinstein M, Oh W. Heat balance in premature infants: Comparative effects of convectively heated incubator and radiant warmer, with and without plastic heat shield. The Journal Of Pediatrics 1980, 96: 460-465. PMID: 7359242, DOI: 10.1016/s0022-3476(80)80698-6.
- Boyle R, Oh W. Erythema Following Transcutaneous Po2 Monitoring. Pediatrics 1980, 65: 333-334. PMID: 7354981, DOI: 10.1542/peds.65.2.333.
- Schwartz H, Widness J, Thompson D, Tsuboi K, Oh W, Schwartz R. Glycosylation and Acetylation of Hemoglobin in Infants of Normal and Diabetic Mothers. Neonatology 1980, 38: 71-75. PMID: 7388092, DOI: 10.1159/000241341.
- Hakanson D, Oh W. Hyperviscosity in the Small-for-Gestational Age Infant. Neonatology 1980, 37: 109-112. PMID: 7188861, DOI: 10.1159/000241263.
- Susa J, McCormick K, Widness J, Singer D, Oh W, Admsons K, Schwartz R. Chronic Hyperinsulinemia in the Fetal Rhesus Monkey: Effects on Fetal Growth and Composition. Diabetes 1979, 28: 1058-1063. PMID: 116897, DOI: 10.2337/diab.28.12.1058.
- Warburton D, Singer D, Bell E, Corwin R, Oh W. Anatomic confirmation of echocardiographic measurements in neonatal hearts. Pediatrics 1979, 64: 468-71. PMID: 492813, DOI: 10.1542/peds.64.4.468.
- Stonestreet B, Bell E, Oh W. Validity of Endogenous Creatinine Clearance in Low Birthweight Infants. Pediatric Research 1979, 13: 1012-1014. PMID: 503652, DOI: 10.1203/00006450-197909000-00013.
- Bell E, Warburton D, Street B, Oh W. HIGH-VOLUME FLUID INTAKE PREDISPOSES PREMATURE INFANTS TO NECROTISING ENTEROCOLITIS. The Lancet 1979, 314: 90. PMID: 87978, DOI: 10.1016/s0140-6736(79)90135-1.
- Lipsitt L, Sturner W, Oh W, Barrett J, Truex R. Wolff-Parkinson-White and Sudden-Infant-Death Syndromes. New England Journal Of Medicine 1979, 300: 1111. PMID: 431615, DOI: 10.1056/nejm197905103001913.
- Susa J, Cowett R, Oh W, Schwartz R. Suppression of Gluconeogenesis and Endogenous Glucose Production by Exogenous Insulin Administration in the Newborn Lamb. Pediatric Research 1979, 13: 594-598. PMID: 471590, DOI: 10.1203/00006450-197905000-00003.
- Bell E, Neidich G, Cashore W, Oh W. Combined effect of radiant warmer and phototherapy oninsensible water loss in low-birth-weight infants. The Journal Of Pediatrics 1979, 94: 810-813. PMID: 448495, DOI: 10.1016/s0022-3476(79)80164-x.
- KOZUKI K, OH W, WIDNESS J, CASHORE W. INCREASE IN BILIRUBIN BINDING TO ALBUMIN WITH CORRECTION OF NEONATAL ACIDOSIS. Acta Paediatrica 1979, 68: 213-217. DOI: 10.1111/j.1651-2227.1979.tb04991.x.
- Bell E, Oh W. Fluid and Electrolyte Balance in Very Low Birth Weight Infants. Clinics In Perinatology 1979, 6: 139-150. PMID: 383360, DOI: 10.1016/s0095-5108(18)31168-0.
- Kozuki K, Oh W, Widness J, Cashore W. Increase in bilirubin binding to albumin with correction of neonatal acidosis. Acta Paediatrica 1979, 68: 213-7. PMID: 33528, DOI: 10.1111/j.1651-2227.1979.tb04991.x.
- Cowett R, Oh W, Pollak A, Schwartz R, Stonestreet B. Glucose disposal of low birth weight infants: steady state hyperglycemia produced by constant intravenous glucose infusion. Pediatrics 1979, 63: 389-96. PMID: 440840, DOI: 10.1542/peds.63.3.389.
- Pollak A, Susa J, Stonestreet B, Schwartz R, Oh W. Phosphoenolpyruvate Carboxykinase in Experimental Intrauterine Growth Retardation in Rats. Pediatric Research 1979, 13: 175-177. PMID: 582464, DOI: 10.1203/00006450-197903000-00008.
- Vohr B, Oh W, Rosenfield A, Cowett R, Berstein J. The preterm small-for-gestational age infant: A two-year follow-up study. American Journal Of Obstetrics And Gynecology 1979, 133: 422-424. PMID: 434008, DOI: 10.1016/0002-9378(79)90065-6.
- Chandler B, Kapoor N, Barker B, Boyle R, Oh W. Reply. The Journal Of Pediatrics 1979, 94: 164-165. DOI: 10.1016/s0022-3476(79)80396-0.
- Cowett R, Lipsitt L, Vohr B, Oh W. Aberrations in Sucking Behavior of Low‐birthweight Infants. Developmental Medicine & Child Neurology 1978, 20: 701-709. PMID: 729922, DOI: 10.1111/j.1469-8749.1978.tb15300.x.
- Boyle R, Chandler B, Stonestreet B, Oh W. Early identification of sepsis in infants with respiratory distress. Pediatrics 1978, 62: 744-50. PMID: 364391, DOI: 10.1542/peds.62.5.744.
- Boyle R, Nelson J, Stonestreet B, Peter G, Oh W. Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis. The Journal Of Pediatrics 1978, 93: 857-861. PMID: 361939, DOI: 10.1016/s0022-3476(78)81101-9.
- Cashore W, Gartner L, Oh W, Stern L. Clinical application of neonatal bilirubin-binding determinations: Current status. The Journal Of Pediatrics 1978, 93: 827-833. PMID: 712496, DOI: 10.1016/s0022-3476(78)81095-6.
- Widness J, Schwartz H, Thompson D, Kahn C, Oh W, Schwatrz R. HAEMOGLOBIN AIc (GLYCOHAEMOGLOBIN) IN DIABETIC PREGNANCY: AN INDICATOR OF GLUCOSE CONTROL AND FETAL SIZE. BJOG An International Journal Of Obstetrics & Gynaecology 1978, 85: 812-817. PMID: 718807, DOI: 10.1111/j.1471-0528.1978.tb15834.x.
- Boyle R, Oh W. Transcutaneous PO2 monitoring in infants with persistent fetal circulation who are receiving tolazoline therapy. Pediatrics 1978, 62: 605-7. PMID: 714594, DOI: 10.1542/peds.62.4.605.
- Boyle R, Oh W. Respiratory Distress Syndrome. Clinics In Perinatology 1978, 5: 283-297. PMID: 371895, DOI: 10.1016/s0095-5108(18)31180-1.
- Cowett R, Susa J, Oh W, Schwartz R. Endogenous Glucose Production during Constant Glucose Infusion in the Newborn Lamb. Pediatric Research 1978, 12: 853-857. PMID: 683743, DOI: 10.1203/00006450-197808000-00010.
- Stonestreet B, Oh W. Plasma creatinine levels in low-birth-weight infants during the first three months of life. Pediatrics 1978, 61: 788-9. PMID: 662522, DOI: 10.1542/peds.61.5.788.
- Pollak A, Cowett R, Schwartz R, Oh W. Glucose disposal in low-birth-weight infants during steady-state hyperglycemia: effects of exogenous insulin administration. Pediatrics 1978, 61: 546-9. PMID: 351535, DOI: 10.1542/peds.61.4.546.
- Vohr B, Oh W, Rosenfield A, Cowett R. 1159 THE PRE-TERM SMALL FOR GESTATION (SGA) INFANT: A TWO YEAR FOLLOW UP STUDY. Pediatric Research 1978, 12: 557-557. DOI: 10.1203/00006450-197804001-01165.
- Rosenfield A, Vohr B, Cowett R, Denhoff E, Oh W. 1151 THE EFFECTS OF AN EARLY INTERVENTION PROGRAM ON THE LOW BIRTH WEIGHT INFANTS. Pediatric Research 1978, 12: 555-555. DOI: 10.1203/00006450-197804001-01157.
- Widness J, Schwartz H, Thompson D, Kahn C, Oh W, Schwartz R. 223 GLYCOHEMOGLOBIN (Hb AIc): CORRELATION WITH MATERIAL BLOOD GLUCOSE CONTROL IN PREGNANCY. Pediatric Research 1978, 12: 401-401. DOI: 10.1203/00006450-197804001-00228.
- Cowett R, Czech M, Susa J, Schwartz R, Oh W. 842 BLUNTED MUSCLE RESPONSIVENESS TO INSULIN IN THE NEONATAL RAT. Pediatric Research 1978, 12: 504-504. DOI: 10.1203/00006450-197804001-00847.
- Ross B, Pollak A, Rubin L, Cowett R, Oh W. 1100 RENAL GLUCOSE HANDLING IN THE LOW BIRTH WEIGHT (LBW) INFANTS. Pediatric Research 1978, 12: 547-547. DOI: 10.1203/00006450-197804001-01106.
- Boyle R, Chandler B, Ross B, Oh W. 939 EARLY DIAGNOSIS OF EARLY ONSET NEONATAL SEPSIS. Pediatric Research 1978, 12: 520-520. DOI: 10.1203/00006450-197804001-00944.
- Chandler B, Kapoor N, Barker B, Boyle R, Oh W. Nitroblue tetrazolium test in neonates. The Journal Of Pediatrics 1978, 92: 638-640. PMID: 633030, DOI: 10.1016/s0022-3476(78)80312-6.
- Cashore W, Monin P, Oh W. Serum Bilirubin Binding Capacity and Free Bilirubin Concentration: A Comparison between Sephadex G-25 Filtration and Peroxidase Oxidation Techniques. Pediatric Research 1978, 12: 195-198. PMID: 643389, DOI: 10.1203/00006450-197803000-00006.
- Widness J, Schwartz H, Thompson D, King K, Kahn C, Oh W, Schwartz R. Glycohemoglobin (HbAIc): A predictor of birth weight in infants of diabetic mothers. The Journal Of Pediatrics 1978, 92: 8-12. PMID: 619085, DOI: 10.1016/s0022-3476(78)80059-6.
- Ross B, Pollak A, Oh W. The pharmacologic effects of furosemide therapy in the low-birth-weight infant. The Journal Of Pediatrics 1978, 92: 149-152. PMID: 22591, DOI: 10.1016/s0022-3476(78)80098-5.
- Ross B, Cowett R, Oh W. Renal Functions of Low Birth Weight Infants during the First Two Months of Life. Pediatric Research 1977, 11: 1162-1164. PMID: 917616, DOI: 10.1203/00006450-197711000-00010.
- Monin P, Cashore W, Hakanson D, Oh W. Lack of Effects of Continuous Positive Airway Pressure on Vagal Control of Breathing in Term and Preterm Newborn Lambs. Pediatric Research 1977, 11: 967-971. PMID: 333360, DOI: 10.1203/00006450-197709000-00007.
- Cashore W, Horwich A, Karotkin E, Oh W. Influence of Gestational Age and Clinical Status on Bilirubin-Binding Capacity in Newborn Infants: Sephadex G-25 Gel Filtration Technique. JAMA Pediatrics 1977, 131: 898-901. PMID: 888807, DOI: 10.1001/archpedi.1977.02120210076016.
- Chandler B, Cashore W, Monin P, Oh W. The lack of effects of phototherapy on neonatal oxygen dissociation curves and hemoglobin concentration in vivo. Pediatrics 1977, 59 Suppl: 1027-31. PMID: 865955, DOI: 10.1542/peds.59.6.1027.
- Cowett R, Susa J, Schwartz R, Oh W. Concentration of parenteral glucose solution. Pediatrics 1977, 59: 790-1. PMID: 404624, DOI: 10.1542/peds.59.5.790a.
- Vohr B, Rosenfield A, Oh W. Umbilical hernia in the low-birth-weight infant (less than 1,500 gm). The Journal Of Pediatrics 1977, 90: 807-808. PMID: 853341, DOI: 10.1016/s0022-3476(77)81257-2.
- Kozuki K, Cashore W, Widness J, Oh W. INCREASE IN BILIRUBIN-ALBUMIN BINDING AFFINITY WITH CORRECTION OF NEONATAL ACIDOSIS. Pediatric Research 1977, 11: 536-536. DOI: 10.1203/00006450-197704000-00997.
- Pollak A, Cowett R, Schwartz R, Oh W. EFFECTS OF EXOGENOUS INSULIN ON GLUCOSE DISPOSAL OF LOW BIRTH WEIGHT (LBW) INFANTS. Pediatric Research 1977, 11: 448-448. DOI: 10.1203/00006450-197704000-00473.
- Ross B, Cowett R, Oh W. POSTNATAL RENAL MATURATION IN LOW BIRTH WEIGHT INFANTS. Pediatric Research 1977, 11: 556-556. DOI: 10.1203/00006450-197704000-01116.
- Hakanson D, Oh W. HYPERVISCOSITY IN THE SMALL-FOR-GESTATIONAL AGE INFANT. Pediatric Research 1977, 11: 472-472. DOI: 10.1203/00006450-197704000-00613.
- Susa J, Cowett R, Oh W, Schwartz R. HEPATIC INSENSITIVITY TO INSULIN IN THE NEONATAL LAMB. Pediatric Research 1977, 11: 522-522. DOI: 10.1203/00006450-197704000-00914.
- Widness J, Edmunds D, Schwartz H, King K, Kahn C, Oh W, Schwartz R. GLYCOHEMOGLOBIN (HbAIc): A PROGNOSTICATOR OF BIRTH WEIGHT IN INFANTS OF DIABETIC MOTHERS. Pediatric Research 1977, 11: 523-523. DOI: 10.1203/00006450-197704000-00920.
- Siegel S, Oh W, Fisher D. FRUCTOSE 1. 6-DIPHOSPHATASE AND GLUCOSE 6-PHOSPHATASE IN NEWBORN RATS WITH INTRAUTERINE GROWTH RETARDATION. Pediatric Research 1977, 11: 521-521. DOI: 10.1203/00006450-197704000-00910.
- Cowett R, Pollak A, Ross B, Schwartz R, Oh W. GLUCOSE DISPOSAL IN THE WELL LOW BIRTH WEIGHT (LBW) INFANT. Pediatric Research 1977, 11: 512-512. DOI: 10.1203/00006450-197704000-00855.
- Hakanson D, Oh W. Necrotizing enterocolitis and hyperviscosity in the newborn infant. The Journal Of Pediatrics 1977, 90: 458-461. PMID: 839341, DOI: 10.1016/s0022-3476(77)80716-6.
- Cowett R, Peter G, Hakanson D, Stern L, Oh W. Prophylactic antibiotics in neonates with umbilical artery catheter placement: a prospective study of 137 patients. The Yale Journal Of Biology And Medicine 1977, 50: 457-63. PMID: 602256, PMCID: PMC2595562.
- Cashore W, Horwich A, Laterra J, Oh W. Effect of Postnatal Age and Clinical Status of Newborn Infants on Bilirubin-Binding Capacity. Neonatology 1977, 32: 304-309. PMID: 610767, DOI: 10.1159/000241033.
- Leake R, Zakauddin S, Trygstad C, Fu P, Oh W. The effects of large volume intravenous fluid infusion on neonatal renal function. The Journal Of Pediatrics 1976, 89: 968-972. PMID: 993925, DOI: 10.1016/s0022-3476(76)80612-9.
- Cowett R, Oh W. Foam Stability Predictions of Respiratory Distress in Infants Delivered by Repeat Elective Cesarean Section. New England Journal Of Medicine 1976, 295: 1222-1224. PMID: 980004, DOI: 10.1056/nejm197611252952204.
- Cowett R, Peter G, Hakanson D, Oh W. Reply. The Journal Of Pediatrics 1976, 89: 861-862. PMID: 978344, DOI: 10.1016/s0022-3476(76)80839-6.
- Oh W. Disorders of Fluid and Electrolytes in Newborn Infants. Pediatric Clinics Of North America 1976, 23: 601-609. PMID: 825816, DOI: 10.1016/s0031-3955(16)33347-8.
- LEAKE R, TRYGSTAD C, OH W. Inulin Clearance in the Newborn Infant. Pediatric Research 1976, 10: 759-762. DOI: 10.1203/00006450-197610080-00013.
- Karotkin E, Kido M, Cashore W, Redding R, Douglas W, Stern L, Oh W. Acceleration of Fetal Lung Maturation by Aminophyllin in Pregnant Rabbits. Pediatric Research 1976, 10: 722-724. PMID: 940698, DOI: 10.1203/00006450-197608000-00004.
- Kwong M, Moore T, Lemmi C, Oh W, Thibeault D. Histidine Decarboxylase Activity in Fetal Intrauterine Growth-retarded Rats. Pediatric Research 1976, 10: 737-739. PMID: 940700, DOI: 10.1203/00006450-197608000-00008.
- Leake R, Trygstad C, Oh W. Inulin Clearance in the Newborn Infant: Relationship to Gestational and Postnatal Age. Pediatric Research 1976, 10: 759-762. PMID: 940703, DOI: 10.1203/00006450-197608000-00013.
- Cowett R, Hakanson D, Kocon R, Oh W. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstetrics And Gynecology 1976, 48: 74s-75s. PMID: 945881.
- SIEGEL S, OH W. RENAL FUNCTION AS A MARKER OF HUMAN FETAL MATURATION. Acta Paediatrica 1976, 65: 480-486. DOI: 10.1111/j.1651-2227.1976.tb04917.x.
- Cowett R, Peter G, Hakanson D, Oh W. Reliability of bacterial culture of blood obtained from an umbilical artery catheter. The Journal Of Pediatrics 1976, 88: 1035-1036. PMID: 775042, DOI: 10.1016/s0022-3476(76)81071-2.
- Leake R, Zakauddin S, Fu P, Oh W, Trygstad C. SALT AND WATER HOMEOSTASIS IN THE NEWBORN. Pediatric Research 1976, 10: 557-557. DOI: 10.1203/00006450-197605000-00020.
- Leake R, Loew A, Oh W. Retransfer of Convalescent Infants from Newborn Intensive Care to Community Intermediate Care Nurseries. Clinical Pediatrics 1976, 15: 293-294. PMID: 1253510, DOI: 10.1177/000992287601500311.
- Karotkin E, Kido M, Redding R, Cashore W, Douglas W, Stern L, Oh W. The inhibition of pulmonary maturation in the fetal rabbit by maternal treatment with phenobarbital. American Journal Of Obstetrics And Gynecology 1976, 124: 529-531. PMID: 946581, DOI: 10.1016/0002-9378(76)90182-4.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. Umbilical Cord Cutting Triggers Hypertriiodothyroninemia and Nonshivering Thermogenesis in the Newborn Lamb. Pediatric Research 1976, 10: 169-175. PMID: 1250646, DOI: 10.1203/00006450-197603000-00005.
- Fiser R, Fisher D, Williams P, Sperling M, Oh W. Effects of fasting and theophylline on alanine-stimulated glucagon secretion in neonatal and infant sheep. American Journal Of Obstetrics And Gynecology 1976, 124: 421-424. PMID: 175657, DOI: 10.1016/0002-9378(76)90104-6.
- Cashore W, Karotkin E, Stern L, Oh W. The lack of effect of phototherapy on serum bilirubin-binding capacity in newborn infants. The Journal Of Pediatrics 1975, 87: 977-980. PMID: 1185408, DOI: 10.1016/s0022-3476(75)80922-x.
- Cowett R, Unsworth E, Hakanson D, Williams J, Oh W. Foam-Stability Test on Gastric Aspirate and the Diagnosis of Respiratory-Distress Syndrome. New England Journal Of Medicine 1975, 293: 413-416. PMID: 239347, DOI: 10.1056/nejm197508282930901.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. THE MECHANISM OF THE T3 RESPONSE TO PARTURITION. Pediatric Research 1975, 9: 682-682. DOI: 10.1203/00006450-197508000-00094.
- Fiser R, Williams P, Fisher D, DeLameter P, Sperling M, Oh W. The effect of oral alanine on blood glucose and glucagon in the human newborn infant. Pediatrics 1975, 56: 78-81. PMID: 1161364, DOI: 10.1542/peds.56.1.78.
- ASCH M, SPERLING M, FISER R, LEAKE R, MOORE T, OH W. Metabolic and Hormonal Studies Comparing Three Parenteral Nutrition Regimens in Infants. Annals Of Surgery 1975, 182: 62-65. PMID: 807170, PMCID: PMC1343880, DOI: 10.1097/00000658-197507000-00012.
- Tsang R, Gigger M, Oh W, Brown D. Studies in calcium metabolism in infants with intrauterine growth retardation. The Journal Of Pediatrics 1975, 86: 936-941. PMID: 1127536, DOI: 10.1016/s0022-3476(75)80232-0.
- Oh W, Omori K, Emmanouilides G, Phelps D. Placenta to lamb fetus transfusion in utero during acute hypoxia. American Journal Of Obstetrics And Gynecology 1975, 122: 316-322. PMID: 236656, DOI: 10.1016/0002-9378(75)90176-3.
- Williams P, Fiser R, Sperling M, Oh W. Effects of Oral Alanine Feeding on Blood Glucose, Plasma Glucagon and Insulin Concentrations in Small-for-Gestational-Age Infants. New England Journal Of Medicine 1975, 292: 612-614. PMID: 1113740, DOI: 10.1056/nejm197503202921204.
- Karotkin E, Oh W. Recent advances in the diagnosis and management of respiratory distress syndrome. Rhode Island Medical Journal 1975, 58: 131-4. PMID: 124916.
- St. Geme J, Bailey S, Koopman J, Oh W, Hobel C, Imagawa D. Neonatal Risk Following Late Gestational Genital Herpesvirus Hominis Infection. JAMA Pediatrics 1975, 129: 342-343. PMID: 1168410, DOI: 10.1001/archpedi.1975.02120400046010.
- Oh W, Omori K, Hobel C, Erenberg A, Emmanouilides G. Umbilical Blood Flow and Glucose Uptake in Lamb Fetus Following Single Umbilical Artery Ligation. Neonatology 1975, 26: 291-299. PMID: 1169079, DOI: 10.1159/000240741.
- Yamauchi T, Geme J, Oh W, Davis C. The Biological and Biochemical Pathogenesis of Mumps Virus-induced Embryonic Growth Retardation. Pediatric Research 1975, 9: 30-34. DOI: 10.1203/00006450-197501000-00006.
- Thibeault D, Emmanouilides G, Nelson R, Lachman R, Rosengart R, Oh W. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants. The Journal Of Pediatrics 1975, 86: 120-126. PMID: 122840, DOI: 10.1016/s0022-3476(75)80722-0.
- Fiser R, Phelps D, Williams P, Sperling M, Fisher D, Oh W. Insulin-glucagon substrate interrelationships in the neonatal sheep. American Journal Of Obstetrics And Gynecology 1974, 120: 944-950. PMID: 4611217, DOI: 10.1016/0002-9378(74)90343-3.
- Fiser R, Erenberg A, Sperling M, Oh W, Fisher D. Insulin-Glucagon Substrate Interrelations in the Fetal Sheep. Pediatric Research 1974, 8: 951-955. PMID: 4614213, DOI: 10.1203/00006450-197412000-00007.
- DeLamater P, Sperling M, Fiser R, Phelps D, Oh W, Fisher D. Plasma alanine: Relation to plasma glucose, glucagon, and insulin in the neonate. The Journal Of Pediatrics 1974, 85: 702-706. PMID: 4422013, DOI: 10.1016/s0022-3476(74)80523-8.
- Ferguson A, Lawlor G, Neumann C, Oh W, Stiehm E. Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. The Journal Of Pediatrics 1974, 85: 717-723. PMID: 4213798, DOI: 10.1016/s0022-3476(74)80527-5.
- Erenberg A, Omori K, Menkes J, Oh W, Fisher D. Growth and Development of the Thyroidectomized Ovine Fetus. Pediatric Research 1974, 8: 783-789. PMID: 4413605, DOI: 10.1203/00006450-197409000-00001.
- Siegel S, Fisher D, Oh W. Reply. The Journal Of Pediatrics 1974, 85: 443-444. DOI: 10.1016/s0022-3476(74)80151-4.
- SIEGEL S, PHELPS D, LEAKE R, OH W. THE EFFECTS OF RAPID INFUSION OF HYPERTONIC SODIUM BICARBONATE IN INFANTS WITH RESPIRATORY DISTRESS. Survey Of Anesthesiology 1974, 18: 286. DOI: 10.1097/00132586-197406000-00053.
- Phelps D, Loew A, Oh W. THE LARYNGO-TRACHEAL FUNCTION OF SURVIVING INFANTS FOLLOWING OROTRACHEAL INTUBATION DURING THE NEONATAL PERIOD. Pediatric Research 1974, 8: 468-468. DOI: 10.1203/00006450-197404000-00771.
- Anthony B, Hobel C, Oh W, Okada D. Group B streptococcal infections in neonates. The Journal Of Pediatrics 1974, 84: 609-610. PMID: 4858169, DOI: 10.1016/s0022-3476(74)80695-5.
- Thibeault D, Emmanouilides G, Nelson R, Rosengart R, Oh W, Lachman R. PATENT DUCTUS ARTERIOSUS (PDA) IN INFANTS LESS THAN 30 WEEKS GESTATION: INDICATIONS FOR SURGERY. Pediatric Research 1974, 8: 354-354. DOI: 10.1203/00006450-197404000-00087.
- Sperling M, Delamater P, Phelps D, Fiser R, Oh W, Fisher D. Spontaneous and Amino Acid-Stimulated Glucagon Secretion in the Immediate Postnatal Period. Journal Of Clinical Investigation 1974, 53: 1159-1166. PMID: 4815080, PMCID: PMC333102, DOI: 10.1172/jci107654.
- Sack J, Beaudry M, Delamater P, Oh W, Fisher D. THE MECHANISMS OF NEONATAL THYROIDAL HYPERACTIVITY IN THE NEWBORN SHEEP. Pediatric Research 1974, 8: 374-374. DOI: 10.1203/00006450-197404000-00205.
- Fiser R, Williams P, Sperling M, Oh W, Fisher D. CONTROL OF PANCREATIC ALPHA CELL FUNCTION IN THE NEONATAL AND INFANT SHEEP. Pediatric Research 1974, 8: 432-432. DOI: 10.1203/00006450-197404000-00551.
- Phelps D, Oh W. CONSTANT GLUCOSE (G) INFUSION (CGI) AND SERUM INSULIN (I) CHANGES IN SEQUENTIALLY STUDIED PRETERM INFANTS. Pediatric Research 1974, 8: 359-359. DOI: 10.1203/00006450-197404000-00113.
- DeLamater P, Sperling M, Fiser R, Phelps D, Oh W, Fisher D. ALANINE-GLUCAGON INTERRELATIONS IN HUMAN NEWBORNS. Pediatric Research 1974, 8: 356-356. DOI: 10.1203/00006450-197404000-00097.
- Williams P, Fiser R, DeLamater P, Sperling M, Fisher D, Oh W. PANCREATIC ISLET ALPHA AND BETA CELL RESPONSES TO ORAL AND IV ALANINE IN APPROPRIATE FOR GESTATIONAL AGE (AGA) AND SMALL FOR GESTATIONAL AGE (SGA) INFANTS. Pediatric Research 1974, 8: 439-439. DOI: 10.1203/00006450-197404000-00594.
- Leake R, Oh W. EFFECT OF GESTATIONAL AND POSTNATAL AGE ON GLOMERULAR FILTRATION RATE (GFR) ANO TUBULAR MAXIMA OF GLUCOSE TmG IN HUMAN INFANTS. Pediatric Research 1974, 8: 457-457. DOI: 10.1203/00006450-197404000-00701.
- Leake R, Fiser R, Oh W. GLUCOSE DISPOSAL, HORMONAL CHANGES, AND PLASMA ALANINE LEVEL IN NEONATAL SEPSIS. Pediatric Research 1974, 8: 434-434. DOI: 10.1203/00006450-197404000-00566.
- Siegel S, Fisher D, Oh W. Serum aldosterone concentrations related to sodium balance in the newborn infant. Pediatrics 1974, 53: 410-3. PMID: 4205580, DOI: 10.1542/peds.53.3.410.
- Leake R, Schroeder K, Benton D, Oh W. Soy-Based Formula in the Treatment of Infantile: Diarrhea. JAMA Pediatrics 1974, 127: 374-376. PMID: 4405999, DOI: 10.1001/archpedi.1974.02110220072010.
- Fiser R, Phelps D, Williams P, Sperling M, Oh W, Fisher D. Alanine Stimulation of the Pancreatic α- and β-Cell in the Neonatal Lamb. Neonatology 1974, 25: 171-175. PMID: 4615749, DOI: 10.1159/000240689.
- SPERLING M, ERENBERG A, FISER R, OH W, FISHER D. Notes and Comments Placental Transfer of Glucagon in Sheep. Endocrinology 1973, 93: 1435-1438. PMID: 4752892, DOI: 10.1210/endo-93-6-1435.
- Erenberg A, Omori K, Oh W, Fisher D. The Effect of Fetal Thyroidectomy on Thyroid Hormone Metabolism in Maternal and Fetal Sheep. Pediatric Research 1973, 7: 870-877. PMID: 4749003, DOI: 10.1203/00006450-197311000-00002.
- Siegel S, Fisher D, Oh W. Renal function and serum aldosterone levels in infants with respiratory distress syndrome. The Journal Of Pediatrics 1973, 83: 854-858. PMID: 4742583, DOI: 10.1016/s0022-3476(73)80389-0.
- Hobel C, Hyvarinen M, Okada D, Oh W. Prenatal and intrapartum high-risk screening I. Prediction of the high-risk neonate. American Journal Of Obstetrics And Gynecology 1973, 117: 1-9. PMID: 4722373, DOI: 10.1016/0002-9378(73)90720-5.
- Leake R, Williams P, Oh W. Validity of neonatal blood pressure obtained by the manometric method. Pediatrics 1973, 52: 293-6. PMID: 4721451, DOI: 10.1542/peds.52.2.293.
- Kwong M, Loew A, Anthony B, Oh W. The effect of hexachlorophene on staphylococcal colonization rates in the newborn infant: A controlled study using a single-bath method. The Journal Of Pediatrics 1973, 82: 982-986. PMID: 4573991, DOI: 10.1016/s0022-3476(73)80429-9.
- The effects of rapid infusion of hypertonic sodium bicarbonate in infants with respiratory distress.Siegel S, Phelps D, Leake R, Oh W. The effects of rapid infusion of hypertonic sodium bicarbonate in infants with respiratory distress. Pediatrics 1973, 51: 651-4. PMID: 4697514, DOI: 10.1542/peds.51.4.651.
- Fiser R, Erenberg A, Fisher D, Oh W. Blood gas and pH changes during glucose infusion in the fetal sheep. American Journal Of Obstetrics And Gynecology 1973, 115: 942-945. PMID: 4695310, DOI: 10.1016/0002-9378(73)90671-6.
- Hyvarinen M, Zeltzer P, Oh W, Stiehm E. Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. The Journal Of Pediatrics 1973, 82: 430-437. PMID: 4121530, DOI: 10.1016/s0022-3476(73)80116-7.
- OH W, YAO A, HANSON J, LIND J. PERIPHERAL CIRCULATORY RESPONSE TO PHOTOTHERAPY IN NEWBORN INFANTS. Acta Paediatrica 1973, 62: 49-54. DOI: 10.1111/j.1651-2227.1973.tb08064.x.
- Hobel C, Oh W, Hyvarinen M, Emmanouilides G, Erenberg A. Early versus late treatment of neonatal acidosis in low-birth-weight infants: Relation to respiratory distress syndrome. The Journal Of Pediatrics 1972, 81: 1178-1187. PMID: 4643040, DOI: 10.1016/s0022-3476(72)80259-2.
- HOBEL C, HYVARINEN M, OH W. ABNORMAL FETAL HEART RATE PATTERNS AND FETAL ACIDBASE BALANCE IN LOW BIRTH WEIGHT INFANTS IN RELATION TO RESPIRATORY DISTRESS SYNDROME. Obstetrical & Gynecological Survey 1972, 27: 350-351. DOI: 10.1097/00006254-197210000-00005.
- Phelps D, Lachman R, Leake R, Oh W. The radiologic localizationof the major aortic tributaries in the newborn infant. The Journal Of Pediatrics 1972, 81: 336-339. PMID: 5042493, DOI: 10.1016/s0022-3476(72)80306-8.
- Anthony B, Giuliano D, Oh W. Nursery Outbreak of Staphylococcal Scalded Skin Syndrome: Rapid Identification of the Epidemic Bacterial Strain. JAMA Pediatrics 1972, 124: 41-44. PMID: 5033748, DOI: 10.1001/archpedi.1972.02110130043006.
- Clements J, Platzker A, Tierney D, Hobel C, Creasy R, Margolis A, Thibeault D, Tooley W, Oh W. Assessment of the Risk of the Respiratory-Distress Syndrome by a Rapid Test for Surfactant in Amniotic Fluid. New England Journal Of Medicine 1972, 286: 1077-1081. PMID: 5067186, DOI: 10.1056/nejm197205182862004.
- Hobel C, Hyvarinen M, Oh W. ABNORMAL FETAL HEART RATE PATTERNS AND FETAL ACID-BASE BALANCE IN LOW BIRTH WEIGHT INFANTS IN RELATION TO RESPIRATORY DISTRESS SYNDROME. Obstetrical & Gynecological Survey 1972, 27: 350-351. DOI: 10.1097/00006254-197205000-00005.
- Hobel C, Hyvarinen M, Oh W. Abnormal fetal heart rate patterns and fetal acid-base balance in low birth weight infants in relation to respiratory distress syndrome. Obstetrics And Gynecology 1972, 39: 83-8. PMID: 5008290.
Departments and Programs
Locations
1
1 of 2
- Smilow Cancer Hospital at Greenwich77 Lafayette PlaceGreenwich, CT 06830
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
1
1 of 2
- Smilow Cancer Hospital at Greenwich77 Lafayette PlaceGreenwich, CT 06830
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511